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ABSTRACT	
	
	 Adipose	 tissues	 fulfil	 functions	 of	 energy	 storage	 and	 hormone	 secretion,	 many	 of	 which	
exhibit	 daily	 variations.	 Literature	 showed	 that	 approximately	 20%	 of	 the	 murine	 adipose	
transcriptome	 exhibits	 daily	 oscillations,	 with	 2-4%	 of	 the	 transcriptome	 rhythmic	 in	 constant	
conditions;	 in	 humans	 and	 mice.	 A	 disruption	 of	 circadian	 rhythms	 is	 associated	 with	 metabolic	
disturbances	such	as	obesity	and	metabolic	syndrome,	highlighting	the	importance	of	understanding	
mechanisms	of	circadian	metabolism.	Published	work	identified	energy	substrates	as	biomarkers	of	
insulin	 resistance	 and	 glucose	 intolerance	 in	 humans;	 hallmarks	 of	 obesity	 and	 diabetes,	 with	
unknown	utilisation	dynamics	in	vitro	within	adipocytes.	My	thesis	aimed	to	provide	a	clearer	view	on	
circadian	adipose	biology	using	molecular,	electrophysiological	and	metabolic	approaches.	I	tested	the	
hypotheses	that	an	endogenous	oscillator	within	pre-adipocytes	was	driving	rhythmic	utilisation	of	
carbon	 sources	 involved	 in	 key	 metabolic	 pathways,	 that	 electrophysiological	 parameters	 in	 pre-
adipocytes	exhibited	biological	variations,	and	that	bioluminescence	rhythms	of	clock	genes	showed	
a	reduced	amplitude	and	faster	damping	in	adipocytes	in	comparison	to	pre-adipocytes.		
	
	 Using	3T3-L1	pre-adipocytes,	circadian	rhythms	of	glucose	utilisation	were	confirmed,	with	an	
acrophase	for	the	first	time	demonstrated	as	similar	or	anti-phasic	to	an	array	of	other	carbon-based	
sources	utilised	 in	a	 circadian	 fashion.	Other	 substrates	exhibited	 steady-state	utilisation	patterns.	
Dielectrophoresis	 potential	 enabled	 the	 determination	 of	 circadian	 rhythms	 in	 cellular	membrane	
capacitance,	whilst	membrane	conductance	exhibited	rhythms	of	a	shorter	period.	Finally,	persistent	
anti-phasic	circadian	rhythms	of	bioluminescence	driven	by	the	promoters	of	Per2	and	Bmal1	were	
characterised	 in	 pre-adipocytes	 and	 adipocytes,	 with	 Per2	 pre-adipocytes	 presenting	 a	 higher	
amplitude	than	their	adipocyte	counterpart.		
	
	 These	 data	 provide	 novel	 understanding	 of	 adipose	 circadian	 biology,	 especially	 revealing	
circadian	rhythmicity	of	intermediates	in	key	metabolic	pathways	strongly	linked	to	the	development	
of	metabolic	diseases.	These	findings	could	help	explain	metabolic	pathways	disruptions	 in	obesity	
and	related	pathologies.		
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CHAPTER	1:	INTRODUCTION	
	
1.1	Overview	
	
	 In	March	2015,	the	Public	Health	of	England	(PHE)	estimated	that	two	thirds	of	adults	and	a	
quarter	of	children	(between	the	age	of	two	and	ten)	were	overweight	or	obese.	Furthermore,	studies	
examining	associations	between	overweight	and/or	obesity	 in	child	and	adolescent	and	premature	
mortality	in	adulthood	showed,	in	most	cases,	a	significantly	increased	risk	of	premature	mortality	as	
well	as	physical	morbidity	worldwide	(Reilly	et	al.,	2011).	Overweight	and	obesity	have	been	defined	
by	 the	World	Health	Organisation	 (WHO)	as	an	abnormal	or	excessive	 fat	accumulation,	 risking	an	
impairment	of	one’s	health	and	resulting	in	an	untypical	body	mass	index	(BMI):	greater	or	equal	to	
25kg/m2	and	30kg/m2	for	overweight	and	obese	individuals,	respectively	(WHO,	report	from	2014).	
	
	 Body	mass	gain	and	obesity	are	consequences	of	numerous	factors	such	as	unhealthy	eating,	
lack	of	physical	activity,	sedentary	lifestyle	habits,	genetic	and	environmental	surroundings	as	well	as	
cultural	and	social	features	among	others	(figure	1.1)	(Martinez-Gonzalez	et	al.,	1999,	Sobal	2001).	In	
2006,	about	a	billion	people	were	overweight	or	obese	worldwide,	with	approximately	10%	of	children	
affected	(Lobstein	et	al.,	2004,	Yach	et	al.,	2006).	Importantly,	the	pathology	of	obesity	is	associated	
with	 major	 disorders	 and	 diseases	 such	 as	 diabetes,	 disturbances	 of	 glucose	 metabolism,	
manifestations	 of	 the	 metabolic	 syndrome,	 hypertension,	 cardio-metabolic	 diseases,	 psychiatric	
conditions	 such	 as	 anxiety	 and	 depression	 as	well	 as	 certain	 types	 of	 cancer	 (Kyrou	 et	 al.,	 2000).	
Furthermore,	 national	 surveys	 in	 the	 United	 Kingdom	 (U.K)	 have	 shown	 that	 obesity	was	 directly	
responsible	for	almost	7%	of	the	overall	morbidity	and	mortality,	with	a	cost	exceeding	five	billion	
pounds	 per	 year	 (Allender	 et	 al.,	 2007,	 Scarborough	 et	 al.,	 2011)	
https://www.gov.uk/government/publications/health-matters-obesity-and-the-food-
environment/health-matters-obesity-and-the-food-environment--2.	 Importantly,	60%	of	all	cases	of	
diabetes	can	be	directly	attributed	to	weight	gain	(Runge	2007).	There	is	also	a	growing	evidence	that	
shift	work	is	associated	with	a	higher	risk	of	developing	obesity,	diabetes	and	cardiovascular	diseases	
(CVDs),	 potentially	 as	 a	 result	 of	 physiological	maladaptation	 to	 chronically	 sleeping	 and	eating	 at	
abnormal	 circadian	 times	 (CTs)	 (Antunes	 et	 al.,	 2010,	 Roenneberg	 et	 al.,	 2012).	 Large-scale	
epidemiological	 studies	 showed	 that	 beyond	 sleep	 duration,	 social	 jetlag	 is	 associated	 with	 an	
increased	BMI	(Roenneberg	et	al.,	2012).	Figure	1.1	illustrates	the	causes	and	effects	of	obesity.	
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Figure	 1.1:	 Causes	 and	effects	
of	obesity.	Taken	from	Ranjani	
et	al.,	2014.		
	
	 Circadian	clocks	are	 likely	the	best	characterised	biological	oscillators,	and	exist	 in	all	 light-
sensitive	organisms	(Gachon	et	al.,	2004b).	In	mammals,	they	influence	nearly	all	aspects	of	physiology	
and	behaviour	such	as	sleep-wake	cycles,	endocrinology,	body	temperature	and	hepatic	metabolism	
among	 others.	 The	master	 pacemaker	 is	 located	 in	 the	 hypothalamus,	 and	more	 precisely	 in	 the	
suprachiasmatic	nuclei	 (SCN).	However,	most	peripheral	body	cells	contain	self-sustained	circadian	
oscillators	with	a	molecular	makeup	similar	to	that	of	SCN	neurons.	This	organisation	implies	that	the	
SCN	must	synchronise	countless	subsidiary	oscillators	 in	peripheral	tissues	to	ultimately	coordinate	
cyclic	physiology.		
	
	 Virtually	all	known	adipose	secreted	proteins	are	dysregulated	when	the	white	adipose	tissue	
(WAT)	mass	 is	 markedly	 altered,	 either	 increased	 in	 the	 obese	 state	 or	 decreased	 in	 lipoatrophy	
(Guerre-Millo	 2002).	 This	 strongly	 implicates	 adipose-secreted	 products	 in	 the	 pathology	 and/or	
complications	of	both	obesity	 and	 cachexia.	 Importantly,	 the	 variety	of	hormones	 released	by	 the	
adipose	tissue	are	secreted	in	a	circadian	manner	(Shostak	et	al.,	2013a).	It	then	comes	as	no	surprise	
that	the	adipose	tissue,	and	more	specifically	the	WAT,	is	the	most	important	endocrine	tissue	directly	
linked	 with	 fat	 accumulation,	 in	 addition	 to	 adipose	 factors	 impacting	 the	 body’s	 physiological	
responses	to	environmental	stimuli	(Kalsbeek	et	al.,	2001,	Kershaw	et	al.,	2004,	Gimble	et	al.,	2011).	
Furthermore,	a	study	revealed	that	4398	and	5061	genes	were	showing	oscillatory	expression	patterns	
in	the	WAT	and	in	the	brown	adipose	tissue	(BAT),	respectively,	with	another	5386	genes	in	the	liver	
(Zvonic	et	al.,	2006).	Of	all	these	genes,	650	showed	a	conserved	diurnal	expression	pattern	in	BAT,	
WAT	and	 liver,	 representing	14.8%,	12.8%	and	12%	of	the	tissue-specific	oscillatory	transcriptome,	
respectively.	As	the	presence	of	circadian	oscillator	genes	in	fat	has	significant	metabolic	implications,	
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their	 characterisation	 may	 have	 therapeutic	 relevance,	 with	 respect	 to	 the	 pathogenesis	 and	
treatment	of	diseases	such	as	type	2	diabetes	(T2D),	obesity	and	metabolic	syndrome.	For	instance,	
adipose	clocks	are	involved	in	the	regulation	of	body	fat	glucose	clearance	and	insulin	production,	in	
the	 control	of	 the	expression	of	a	 large	array	of	enzymes	 implicated	 in	 lipid	metabolism,	and	also	
influence	 adipogenesis,	 energy	 and	 vascular	 homeostasis	 (Shimba	 et	 al.,	 2005,	 Lamia	 et	 al.,	 2008,	
Maury	et	al.,	2010).		
	
1.2 The	emergence	of	biological	rhythms	research	
	
	 The	first	writings	to	recognise	diurnal	rhythms	come	from	the	fourth	century	before	Christ	
(BC),	with	the	observation	by	Androsthenes	that	leafs	of	the	Tamarind	tree	(Tamarindus	Indicus)	were	
exhibiting	daily	movements	(McClung	2006).	There	was	no	suggestion	that	the	endogenous	origin	of	
these	 rhythms	 was	 suspected	 at	 the	 time,	 and	 it	 took	 more	 than	 two	 millennia	 for	 this	 to	 be	
experimentally	tested.	In	1729,	the	scientific	literature	on	circadian	rhythms	began,	when	de	Mairan	
observed	 24-hour	 patterns	 in	 the	 leaf	 movement	 of	 the	 plant	Mimosa	 Pudica	 that	 persisted	 in	
constant	darkness	(DD)	conditions,	demonstrating	their	endogenous	origin	(de	Mairan	1729).	It	took	
30	years	for	de	Mairan’s	observations	to	be	independently	repeated	(Hill	1757,	Duhamel	du	Monceau	
1759,	Zinn	1759).	These	results	described	for	the	first	time	a	circadian	response	to	an	environmental	
stimulus,	and	recognised	a	correspondence	between	biological	and	geophysical	phenomena.	That	the	
rhythms	were	circadian,	with	a	periodicity	of	not	exactly	24	hours,	was	an	extremely	important	point	
as	 it	 was	 the	 best	 evidence,	 until	 experiments	 on	 the	 fungus	Neurospora	 Crassa	 were	 conducted	
(Sulzman	et	al.,	1984),	that	these	rhythms	were	truly	endogenous	and	not	driven	by	some	subtle	and	
undetected	geophysical	cues	associated	with	the	rotation	of	the	Earth	on	its	axis.			
	
	 Later,	it	was	revealed	that	the	human	sleep-wake	cycle	was	generated	by	a	circadian	process	
originating	from	the	suprachiasmatic	nuclei,	and	was	normally	tied	to	occur	at	a	specific	phase	relative	
to	 the	 external	 cycle	 of	 light-dark	 (LD)	 exposure	 (Dijk	 et	 al.,	 2002).	 Additionally,	 the	 core	 body	
temperature	cycles	along	with	the	sleep-wake	rhythm,	decreasing	during	the	nocturnal	sleep	phase	
and	increasing	during	the	wake	phase,	repeatedly	in	a	24-hour	circadian	rhythm	(Okamoto-Mizuno	et	
al.,	2012).		Another	example	of	daily	rhythms	was	the	feeding	pattern	of	bees,	described	in	the	early	
20th	century,	before	the	introduction	of	the	term	“circadian”	with	circa	meaning	“around”	and	diem	
“day”	(Halberg	et	al.,	1980).	
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	 In	 1948,	 Curt	 Richter	 identified	 the	 SCN	 as	 a	 structure	 located	within	 the	 anterior	 ventral	
hypothalamus	of	 the	brain,	 after	 systematically	 lesioning	 a	number	of	 endocrine	 glands	 and	brain	
areas	 in	 rats.	 The	 discovery	 that	 the	 SCN	 contain	 tissue	 necessary	 for	 the	 generation	 of	 circadian	
rhythmicity	was	established	by	lesion	studies	published	in	1972.	The	first	reported	a	loss	of	circadian	
adrenal	 corticosterone	 rhythm	 following	 suprachiasmatic	 lesions	 in	 the	 rat	 (Moore	 et	 al.,	 1972a),	
whilst	the	second	reported	that	bilateral	electrolytic	lesions	in	the	suprachiasmatic	nuclei	permanently	
eliminated	 nocturnal	 and	 circadian	 rhythms	 in	 drinking	 behaviour	 as	well	 as	 locomotor	 activity	 of	
albino	rats	SCN	(Stephan	et	al.,	1972a).	These	properties	defined	the	SCN	as	the	brain’s	internal	clock	
and	the	dominant	pacemaker	driving	circadian	rhythms	in	mammals.	Lastly,	experiments	published	in	
1994	aimed	to	search	for	genes	regulating	circadian	rhythms	in	mammals.	The	progeny	of	mice	treated	
with	 a	 mutagen	 were	 screened	 for	 circadian	 clock	 mutations,	 and	 a	 semi-dominant	 mutation	
lengthening	 the	 circadian	 period	 and	 abolishing	 the	 persistence	 of	 rhythmicity	 was	 discovered:	
Circadian	 Locomotor	 Output	 Cycles	 Kaput	 (Clock)	 (Vitaterna	 et	 al.,	 1994).	 As	 a	 complementary	
approach	 to	 positional	 cloning,	 researchers	 used	 in	 vivo	 complementation	 with	 bacterial	 artificial	
chromosome	(BAC)	clones	expressed	in	transgenic	mice,	to	identify	the	circadian	Clock	gene	(Antoch	
et	al.,	1997).	It	was	demonstrated	that	a	BAC	transgene	completely	rescued	both	the	long	period	and	
the	loss-of-rhythm	phenotypes	in	Clock	mutant	mice.		
	
	 Experimental	 evidence	 suggested	 that	 the	 mammalian	 retina	 contains	 an	 autonomous	
circadian	clock	using	albino	rats,	 indicating	the	presence	of	an	extra-SCN	clock	(LaVail	1976).	When	
animals	were	reared	in	cyclic	light,	a	burst	of	rod	outer	segment	disk	shedding	occurred	in	the	retina,	
soon	after	 the	onset	of	 light.	A	 later	 study	determined	 that	 rod	outer	 segment	disk	 shedding	was	
following	 a	 circadian	 rhythm,	 persisting	 after	 pre-chiasmatic	 nerve	 section,	 indicating	 a	 local	
oscillatory	 control	 (Teirstein	 et	 al.,	 1980).	 Following	 this	 section	 however,	 entrainment	 and	 phase	
shifting	to	LD	cycles	were	disrupted,	suggesting	the	involvement	of	central	efferent	signals	in	phase	
control	 (Terman	 et	 al.,	 1993).	 In	 these	 experiments,	 SCN	 lesions	 in	 rats	 resulted	 in	 a	 complete	
behavioural	arrhythmicity	in	most	animals,	whilst	a	small	part	of	the	cohort	presented	dampened	or	
robust	 rhythms.	 The	 disk	 shedding	 pattern	 was	 similar	 between	 the	 three	 groups,	 indicating	 an	
independence	 of	 the	 disk	 shedding	 rhythm	 from	 possible	 SCN	 humoral	 or	 neuronal	 efferent	
influences.	 In	 order	 to	 localise	 the	 clock	 driving	 rhythmic	 retinal	 functions,	 neural	 retinas	 of	 the	
hamster	were	cultured,	and	exhibited	circadian	rhythms	of	melatonin	synthesis	for	at	 least	5	days,	
entrained	by	light	cycles	applied	in	vitro	and	free	running	under	DD	(Tosini	et	al.,	1996).	Furthermore,	
retinas	of	some	strains	of	laboratory	mice	presented	robust	circadian	rhythms	of	melatonin	synthesis,	
which	could	be	entrained	by	light	in	vitro	(Tosini	et	al.,	1998).	At	around	the	same	time,	Northern	blot	
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analyses	 were	 conducted	 to	 investigate	 the	 mechanism	 that	 controls	 circadian	 rhythms	 in	 the	
mammalian	retina,	showing	that	two	circadian	oscillatory	mechanisms	were	taking	place:	one	that	can	
generate	 rhythmicity	 independently	of	 the	SCN	and	 the	other	which	 requires	 the	SCN	 to	maintain	
circadian	oscillation	(Sakamoto	et	al.,	2000).	Northern	blot	analyses	were	also	employed	to	reveal	the	
circadian	expression	of	clock	genes	outside	of	the	SCN,	in	peripheral	mononuclear	leukocytes	with	no	
neuronal	connections	(detailed	in	section	1.4.3)	(Oishi	et	al.,	1998).		
	
1.3 Properties	of	a	circadian	rhythm	
	
	 The	observations	of	de	Mairan	mentioned	in	section	1.2	above	illustrated	one	critical	feature	
of	 circadian	 rhythms:	 their	 self-sustained	 nature	 (Vitaterna	 et	 al.,	 2001).	 Thus,	 almost	 all	 diurnal	
rhythms	occurring	under	natural	conditions	continue	to	cycle	under	laboratory	conditions	devoid	of	
any	 external	 time-giving	 cues	 from	 the	 environment	 (i.e.	 constant	 darkness	 or	 constant	 light).	
Circadian	rhythms	expressed	in	the	absence	of	any	24-hour	signals	from	the	environment	are	called	
free-running,	another	important	propriety	of	a	circadian	rhythm.	This	means	that	the	rhythm	is	not	
synchronised	by	any	cyclic	changes	in	the	physical	environment.	It	should	be	noted	here	that	a	diurnal	
rhythm	 cannot	 be	 called	 circadian	 if	 it	 does	 not	 persist	 under	 constant	 environmental	 conditions.	
Hence,	diurnal	rhythms	are	simply	a	response	to	24-hour	environmental	changes,	or	to	the	interaction	
between	endogenous	circadian	rhythms	and	the	environment.	
	
	 In	1965,	a	 technique	 for	 following	the	rhythmic	behaviour	of	an	animal	without	disruption	
through	the	measurement	of	 its	 locomotor	activity	was	described	(Aschoff	1965).	When	kept	 in	an	
artificial	LD	cycle	with	12	hours	of	light	and	12	hours	of	darkness,	birds	displayed	a	24-hour	rhythm	of	
locomotor	activity	restricted	to	the	12	light	hours.	Interestingly,	the	activity	of	the	birds	continued	to	
be	cyclic	in	continuous	dim	light	as	well	as	in	brighter	light	(approximately	70	times	brighter),	indicating	
that	 the	 rhythmic	 behaviour	 was	 not	 a	 passive	 reaction	 to	 the	 periodicity	 of	 the	 environment.	
However,	 the	birds	were	 less	active	 in	dim	 light	 than	 in	bright	 light,	with	shorter	spans	of	 time.	 In	
bright	light,	the	birds	became	active	each	day	2	hours	prior	to	the	previous	day,	for	a	study	done	over	
60	days.	The	undamped	continuation	of	the	rhythm	and	the	deviation	of	the	period	from	24	hours	
reflected	that	this	rhythm	was	not	imposed	on	the	organism	by	the	environment	but	was	endogenous.	
The	oscillation	was,	 in	this	case,	self-sustained,	 free	running	under	constant	conditions	and	had	 its	
own	frequency.	The	same	study	described	that	human	subjects	kept	underground	without	any	time-
giving	cues	maintained	a	clear	cycle	of	sleep	and	wakefulness,	reflected	also	in	the	rhythms	of	their	
body	 temperature	 and	 urine	 excretion.	 A	 cycle’s	 phase	 can	 thus	 be	 entrained	 (synchronised)	 to	
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environmental	signals	(or	Zeitgeber	Time,	ZT)	mainly	modulated	by	the	light-dark	cycle.	Other	factors	
such	as	food	intake,	social	 interactions,	activity	and	temperature	can	also	modulate	the	phase	of	a	
rhythm	 (Stephan	 1984,	 Kas	 et	 al.,	 2001,	 Grandin	 et	 al.,	 2006).	 The	 circadian	 period	 is	 therefore	
synchronised	with	(or	entrained	to)	the	period	of	the	Earth’s	rotation	by	means	of	periodic	factors	in	
the	 environment	 called	 Zeitgebers,	with	 the	 temperature	 and	 the	 day-night	 cycle	 being	 the	most	
important	(Schmal	et	al.,	2015).	
	
	 Two	final	properties	of	circadian	rhythms	also	provide	important	information	on	the	rhythms’	
makeup	(Vitaterna	et	al.,	2001).	One	of	these	properties	is	the	rhythms’	ubiquity	in	nature,	as	they	
exist	in	a	broad	array	of	biological	processes	and	organisms,	with	similar	properties	and	even	similar	
phase-response	 curves	 to	 light.	 The	 other	 attribute	 of	 circadian	 rhythms	 is	 that	 they	 seem	 to	 be	
generated	at	the	cellular	level.	This	is	explained	by	the	fact	that	rhythms	of	unicellular	organisms	(i.e.	
algae)	are	the	same	as	rhythms	of	highly	complex	mammals.		
	
1.4 The	mammalian	circadian	timing	system	
	
1.4.1	The	SCN	circadian	oscillator		
	
	 In	mammals,	the	SCN	was	described	as	bilateral	collections	of	tightly	packed	cells	located	in	
the	anterior	hypothalamus,	dorsal	to	the	optic	chiasm	(OC),	one	on	each	side	of	the	third	ventricle	
(3V)	and	surrounded	by	peri-SCN	(figure	1.3)	(Cohen	et	al.,	2010).	The	SCN	contains	approximately	
20,000	 neural	 cells	 exhibiting	 daily	 rhythms	 in	 gene/protein	 expression,	 electrical	 activity	 and	
metabolism	(Evans	et	al.,	2016).	These	neurons	continue	to	display	rhythms	even	when	isolated	as	
individual	cells.	The	multiple	populations	of	cells	within	the	SCN	differ	with	respect	to	their	distribution	
and	function,	but	at	the	simplest	level	the	SCN	have	been	described	as	containing	“shell”	and	“core”	
regions	on	the	basis	of	differences	in	inputs	as	well	as	the	phenotypes	of	cells	within	(Abrahamson	et	
al.,	 2001,	 Antle	 et	 al.,	 2003).	 These	 structures	 can	 also	 be	 distinguished	 by	 connectivity,	 gene	
expression,	neuropeptide	expression	and	responses	to	environmental	stimuli.	The	“shell”	contains	a	
dense	population	of	arginine	vasopressin	(AVP)	neurons	(Abrahamson	et	al.,	2001,	Moore	et	al.,	2002),	
and	receives	input	from	the	basal	forebrain,	the	cerebral	cortex,	the	hippocampus	as	well	as	several	
hypothalamic	nuclei	among	others	(Yan	et	al.,	2007).	The	SCN	“core”	is	typically	ventral	and	contains	
cell	bodies	with	vasoactive	intestinal	polypeptide	(VIP)	and	gastrin-releasing	peptide	(GRP)	neurons	
(Cohen	et	al.,	2010).	 It	 receives	direct	 input	 from	the	retina	through	the	retino-hypothalamic	 tract	
(RHT),	secondary	visual	input	from	the	inter-geniculate	leaflet	(IGL),	and	the	lateral	geniculate	complex	
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through	 the	geniculo-hypothalamic	 tract	 (GHT),	 as	well	 as	 input	 from	 the	pretectal	nuclei	 and	 the	
midbrain	raphe	nucleus	(Moore	1973,	Moga	et	al.,	1997,	Abrahamson	et	al.,	2001,	Morin	2007,	Yan	et	
al.,	2007).	The	projection	from	the	IGL	to	the	SCN	is	known	as	the	GHT	and	contains	neuropeptide	
tyrosine	(NPY),	enkephalin,	gamma-aminobutyric	acid	(GABA)	and	neurotensin	(Morin	et	al.,	2001).	
Results	from	neuroanatomical	studies	indicate	that	both	AVP	and	VIP	neurons	form	connections	with	
proximal	 targets	 in	 the	 brain,	 often	 projecting	 to	 the	 same	 structure	 (Abrahamson	 et	 al.,	 2001,	
Kriegsfeld	et	al.,	2004).		
	
	 In	1972,	auto-radiographic	tracing	methods	labelling	the	SCN	showed	a	direct	projection	from	
the	 retina	 to	 the	hypothalamus	 in	 the	 rat,	 the	 retinohypothalamic	 tract	 (Hendrickson	 et	al.,	 1972,	
Moore	et	al.,	1972b).	Electron	microscopic	studies	further	identified	the	RHT	in	the	rat	to	arise	from	
the	ganglion	cells	of	the	retina,	or	retinal	ganglion	cells,	to	terminate	on	the	smaller	dendritic	branches	
of	 the	 SCN	 neurons	 (Moore	 et	 al.,	 1972b).	 This	 confirmed	 that	 in	 a	 wide	 range	 of	 mammals,	 a	
projection	 exists	 from	 the	 retina	 to	 the	 suprachiasmatic	 nuclei	 lying	 medially	 in	 the	 anterior	
hypothalamus	on	either	side	of	the	floor	of	the	3V.	In	these	species,	light	perception	occurs	only	in	
the	retina.	This	was	shown	by	a	study	published	in	1999	working	on	intact	and	bilaterally	enucleated	
hamsters	(eyes	removed)	(Yamazaki	et	al.,	1999).	Animals	presenting	stable	free-running	rhythms	in	
DD	were	exposed	to	direct	sunlight	for	1	or	3	hours	during	their	subjective	night.	Expected	phase	shifts	
were	shown	in	intact	animals,	whereas	the	exposure	to	sunlight	did	not	affect	the	locomotor	activity	
in	enucleated	animals.	This	indicated	that	the	circadian	pacemaker	of	enucleated	hamsters	could	still	
be	phase	shifted.	
	
	 Three	different	types	of	photoreceptors	are	present	within	the	retina:	cones,	 rods	and	the	
intrinsically	photosensitive	 retinal	 ganglion	 cells	 (ipRGCs)	 (Paul	 et	al.,	 2009).	 It	 is	believed	 that	 the	
classical	photoreceptors	(i.e.	rods	and	cones)	are	responsible	for	the	image-forming	vision,	whereas	
the	 ipRGCs	 play	 a	 key	 role	 in	 the	 non-image	 forming	 vision.	 Moreover,	 the	 photic	 circadian	
entrainment	is	only	abolished	in	animals	without	rod,	cone,	and	melanopsin	function,	or	in	mice	in	
which	the	melanopsin-containing	retinal	ganglion	cells	(RGCs)	are	genetically	ablated	(Hattar	et	al.,	
2003,	Panda	et	al.,	2003,	Guler	et	al.,	2008,	Hatori	et	al.,	2008).	Thus,	classical	visual	photopigments	
and	melanopsin	 play	 a	 complementary	 role	 in	 photic	 circadian	 entrainment,	 and	 the	melanopsin-
containing	RGCs	function	as	a	necessary	conduit	for	light	information	to	reach	the	circadian	clock	in	
the	SCN.	Photic	entrainment	of	the	mammalian	SCN,	and	thus	the	animal’s	behaviour,	 is	mediated	
exclusively	 through	 photoreception	 in	 the	 retina	 (Moore	 et	 al.,	 1972b).	 Although	 outer	 retinal	
(rod/cone)-based	 and	 melanopsin-expressing	 retinal	 ganglion	 cell-based	 photoreceptors	 are	 each	
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sufficient	for	circadian	entrainment	of	behaviour,	animals	lacking	rods,	cones,	and	melanopsin	cannot	
entrain	 to	external	 light-dark	cycles	 (Hattar	et	al.,	2003,	Panda	et	al.,	2003,	Guler	et	al.,	2008).	An	
intact	RHT	is	therefore	required	for	photic	circadian	entrainment	in	mammals,	although	light	resetting	
does	 not	 require	 the	 presence	 of	 classical	 visual	 photo-pigments	 (rhodopsin	 and	 cone	 opsins)	
(Freedman	 et	al.,	 1999).	 In	 the	absence	of	 rod	and	cone	 function,	 the	 invertebrate-like	opsin	4	or	
melanopsin	(Opn4)	is	sufficient	to	mediate	circadian	responses	to	light.	Melanopsin	is	found	primarily	
in	the	retinal	ganglion	cell	layer	of	mammals	(Provencio	et	al.,	2000),	and	both	anterograde	as	well	as	
retrograde	tracing	strategies	have	been	used	to	demonstrate	that	many	melanopsin-containing	RGCs	
project	heavily	to	the	SCN	(Gooley	et	al.,	2001,	Hannibal	et	al.,	2002).	Moreover,	there	is	now	very	
good	evidence	that	glutamate	can	mediate	the	effects	of	light	on	the	circadian	system	through	its	role	
as	a	transmitter	at	the	RHT/SCN	synaptic	connection	(Colwell	et	al.,	1996,	Ebling	1996,	Obrietan	et	al.,	
1998,	Mintz	et	al.,	1999).	Therefore,	it	was	thought	that	light	information	could	be	transmitted	by	RHT	
axons,	via	 the	 release	of	glutamate	and	pituitary	adenylate	cyclase-activating	polypeptide	 (PACAP)	
(figure	1.3)	(Hannibal	et	al.,	1997).	The	two	transmitters	have	phase	shifting	capacity	during	the	night	
and	day,	respectively,	and	are	co-stored	in	the	RHT	(Hannibal	et	al.,	2000).	
	
		 Later	 studies	 confirmed,	 in	 rats,	 that	 melanopsin	 is	 a	 photo-pigment	 whose	 presence	
throughout	the	dendritic	arbors	of	the	retinal	ganglion	cells	may	permit	spatial	integration	of	retinal	
irradiance,	also	consistent	with	the	extended	receptive	fields	of	these	cells	(Berson	et	al.,	2002,	Hattar	
et	 al.,	 2002).	 In	 the	 above	 section	 was	
mentioned	 that	 PACAP	 and	 VIP	 were	
implicated	 in	 the	 photic	 entrainment	 of	
circadian	 rhythms	 in	 the	 SCN.	 Mice	
carrying	a	null	mutation	of	the	vasoactive	
intestinal	 peptide	 receptor	2	 (VPAC2)	 for	
VIP	 and	 PACAP	 failed	 to	 show	 robust	
circadian	 rhythms	 of	 behaviour	 (Harmar	
et	al.,	2002).	The	behavioural	phenotype	
of	these	mice	is	associated	with	a	lack	of	
coordinated	clock	gene	expression	in	the	SCN	
and	 other	 brain	 areas	 associated	 with	
spontaneous	 locomotion,	 as	 well	 as	 with	 a	
lack	 of	 rhythmic	 expression	 of	 the	 gene	
encoding	AVP,	key	molecular	output	of	the	SCN	clockwork.	This	highlighted	the	role	of	intercellular	
Figure	 1.2:	 Influence	 of	 light	 on	 circadian	
rhythms	 and	 related	 physiology.	 Taken	 from	
https://www.nigms.nih.gov/education/pages/
factsheet_circadianrhythms.aspx.	
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neuropeptidergic	signalling	in	the	maintenance	of	the	circadian	function	within	the	SCN.	Figures	1.2	
and	1.3	below	summarise	the	influence	of	light	on	circadian	rhythms	and	related	physiology,	as	well	
as	the	afferent	inputs	and	efferent	pathways	of	the	SCN,	respectively.	
	 	
																				
	
	
Figure	1.3:	Afferent	inputs	and	efferent	
pathways	 of	 the	 SCN.	 Taken	 from	
Reghunandanan	 et	 al.,	 2006.	 RHT:	
Retino-hypothalamic	 tract,	 GHT:	
Geniculo-hypothalamic	tract,	OC:	Optic	
chiasm,	 3V:	 Third	 ventricle,	 IGL:	 Inter-
geniculate	 leaflet,	 DM:	 Dorsomedial	
SCN,	 VL:	 Ventrolateral	 SCN,	 NPY:	
Neuropeptide	Y,	GABA:	Gamma	amino	
butyric	acid,	PACAP:	Pituitary	adenylate	
cyclase-activating	polypeptide.		
	 	
	
	 Several	 circadian	 neuroendocrine	 rhythms	 have	 been	 eliminated	 by	 lesions	 or	 surgical	
isolation	of	the	anterior	hypothalamus	from	the	medial	basal	hypothalamus	(Halász	1969).	In	addition,	
recent	anatomical	studies	have	once	again	raised	the	possibility	of	direct	visual	input	to	the	anterior	
hypothalamus	via	retino-hypothalamic	pathways	terminating	 in	the	suprachiasmatic	nuclei	and	the	
arcuate	(ARC)	region	(Sousa-Pinto	et	al.,	1970,	Moore	et	al.,	1971).	The	entrainment	might	then	be	
accomplished	via	a	direct	retino-hypothalamic	pathway	innervating	a	pacemaker	in	the	region	of	the	
SCN.	These	considerations,	alongside	previous	reports	that	an	interruption	beyond	the	chiasm	of	the	
primary	 and	 inferior	 accessory	 optic	 systems	 of	 the	 rat	 did	 not	 interfere	with	 the	 entrainment	 of	
drinking	rhythms	to	the	illumination	cycle	(Stephan	et	al.,	1972b),	suggested	that	the	suprachiasmatic	
region	might	be	involved	in	the	generation	and	entrainment	of	behavioural	rhythms.	The	same	year	
was	 demonstrated	 that	 nocturnal	 and	 free-running	 circadian	 rhythms	 of	 drinking	 and	 locomotor	
activity	are	severely	disrupted	by	relatively	discrete	lesions	in	the	SCN	of	the	hypothalamus	(Stephan	
et	al.,	1972a).	Further	confirming	the	evidence	that	the	SCN	is	the	central	pacemaker	in	mammals,	
and	 its	 role	 as	 a	 primary	 driver	 of	 the	 circadian	 process,	 experiments	 showed	 that	 endogenous	
rhythms	in	rest/activity	were	abolished	following	SCN	lesions	(Mistlberger	et	al.,	1983,	Trachsel	et	al.,	
1992).	However,	the	homeostatic	regulation	of	seep	remained	intact.	Additionally,	Stephan	and	co-
workers	studied	the	anticipatory	wheel	running	in	response	to	restricted	feeding	schedules	(23-	and	
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24-hr	intervals,	as	well	as	12-hr	phase	shift),	in	rats	with	lesions	of	the	SCN	or	intact	(Stephan	et	al.,	
1979b).	Despite	the	absence	of	circadian	periodicity	in	activity	or	drinking	in	ad	libitum	conditions,	rats	
with	SCN	lesions	showed	anticipatory	wheel	running	to	both	feeding	schedules,	comparable	to	sham-
operated	rats.	After	the	12-hr	phase	shift,	transients	qualitatively	similar	to	those	seen	following	phase	
shifts	 in	 the	 LD	 cycle	 were	 observed.	 During	 a	 3-day	 period	 of	 total	 food	 deprivation	 following	
prolonged	 entrainment	 to	 a	 24-hr	 feeding	 schedule,	 wheel	 running	 persisted	 with	 a	 near	 24-hr	
periodicity	while	return	to	ad	libitum	conditions	resulted	in	a	rapid	desynchronization	of	activity.	These	
results	 indicated	 that	anticipatory	wheel	 running	 in	 rats	with	SCN	 lesions	 is	based	on	endogenous	
circadian	 oscillators	 entrainable	 by	 feeding	 schedules	 in	 the	 circadian	 range	 (food-entrainable	
rhythms).	Such	oscillators	 free-run	under	certain	conditions	 (food	deprivation)	but	become	rapidly	
desynchronised	 in	 others	 (ad	 libitum	 feeding).	 Besides	 showing	 the	 presence	 of	 food-entrainable	
oscillators	 (FEOs),	 these	 results	 also	 strongly	 supported	 a	 multi-oscillator	 model	 of	 the	 circadian	
system	in	mammals.	In	free-feeding	conditions,	there	is	no	circadian	periodicity	but	SCN-lesioned	rats	
were	still	able	to	anticipate	restricted	access	to	food	at	24-hr	intervals	in	the	presence	of	a	light-dark	
cycle	and	in	constant	light	(Stephan	et	al.,	1979a).	Neither	rats	with	SCN	lesions	nor	controls	were	able	
to	anticipate	feedings	at	18-hr	intervals.	These	results	also	suggested	that	circadian	oscillators	outside	
of	the	SCN	could	be	entrained	by	restricted	feeding	schedules.	
	
	 Another	 work	 on	 SCN-lesions	 revealed	 that	 this	 procedure	 caused	 failure	 of	 spontaneous	
ovulation	in	female	rats,	which	produced	abnormalities	in	other	functions	normally	influenced	by	the	
light-dark	 cycle	 (Raisman	 et	 al.,	 1977).	 In	 this	 case,	 the	 endocrine	 system	of	 the	 animals	was	 also	
perturbed,	with	plasma	concentrations	of	cortisone	abnormally	high	in	the	morning	and	low	in	the	
evening.	In	SCN-lesioned	arrhythmic	hamsters,	transplants	of	brain	grafts	containing	the	foetal	SCN	
restored	free-running	circadian	rhythms	of	 locomotor	activity,	with	transplants	of	cerebellar	 tissue	
ineffective	in	restoring	such	rhythms	(Lehman	et	al.,	1987).	The	restoration	of	free-running	rhythms	
in	conditions	of	DD	was	correlated	with	the	presence	in	the	graft	of	neuropeptides	normally	present	
in	the	SCN	of	un-lesioned	hamsters	(i.e.	NPY	and	VIP).	This	work	also	showed	that	not	all	functions	of	
the	SCN	were	reinstated	by	the	graft.	Indeed,	animals	with	restored	locomotor	rhythms	did	not	show	
gonadal	regression	in	the	absence	of	light,	and	failed	to	synchronise	to	light	intensities	to	which	SCN-
intact	 animals	 responded.	 Later	 in	 1990,	 the	 pacemaker	 role	 of	 the	 suprachiasmatic	 nuclei	 in	 a	
mammalian	circadian	system	was	tested,	by	neural	transplantation	using	mutant	hamsters	showing	a	
short	circadian	period	(Ralph	et	al.,	1990).	Small	neural	grafts	from	the	SCN	region	restored	circadian	
rhythms	to	arrhythmic	animals	whose	own	nuclei	had	been	ablated.	Interestingly,	the	period	of	the	
restored	rhythms	was	always	similar	to	the	donors,	regardless	of	the	direction	of	the	transplant	or	the	
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host’s	genotype.	 Interestingly,	when	the	SCN	was	cut	 in	half,	 separating	the	dorsomedial	 from	the	
ventrolateral	SCN,	the	electrical	response	to	the	light	pulse	was	unimodal	for	each	region,	which	were	
out	 of	 phase	 (Tackenberg	 et	 al.,	 2018).	 The	 retino-recipient	 ventrolateral	 SCN	 half	 was	 more	
responsive	to	the	light	pulse,	with	the	dorsomedial	SCN	not	undergoing	a	significant	shift.	
	
	 The	SCN	functional	activity	was	investigated	early	on	by	Schwartz	and	Gainer	in	rats,	using	the	
SCN	glucose	consumption	as	a	marker	of	 this	activity	 (Schwartz	et	al.,	1977).	They	underscored	an	
increased	glucose	consumption	during	exposure	to	light,	and	provided	some	evidence	compatible	with	
an	endogenous	rhythm	of	SCN	glucose	consumption	even	in	the	absence	of	environmental	light	cues.	
In	this	study,	rates	of	glucose	consumption	were	measured	in	vivo	within	individual	structures	of	the	
central	 nervous	 system	 (CNS)	 using	 tracer	 amounts	 of	 [14C]-deoxyglucose	 (DG).	 This	 compound	 is	
transported	from	blood	to	brain	by	the	same	carrier	that	transports	glucose,	and	is	phosphorylated	
within	 cells	 to	 [14C]-DG-6-phosphate	 (DG-6-P)	 by	 a	 brain	 hexokinase.	 The	 14C	 activity	 is	 essentially	
trapped	and	accumulates	as	DG-6-P.	This	substance	is	not	metabolized	any	further	and	does	not	leave	
the	brain	over	the	time	of	measurement.	In	the	present	case,	the	amount	of	accumulated	DG-6-P	was	
proportional	to	the	tissue’s	net	rate	of	glucose	phosphorylation.	The	concentration	of	DG-6-P	could	
be	measured	quantitatively,	from	autoradiographs	made	from	X-ray	film	exposed	to	sections	of	a	brain	
from	an	 injected	animal.	The	autoradiographs	could	then	be	used	to	calculate	the	rates	of	glucose	
consumption	of	all	the	visualised	brain	structures	or,	alternatively,	to	compare	the	relative	rates	of	
glucose	consumption	of	such	structures	with	one	another.		
	
	 In	 the	early	1980s,	 the	discharge	of	 the	SCN,	 retrochiasmatic	 (RCA)	and	ARC	neurons	 from	
rat’s	brain	slices	was	recorded	in	vitro	(Groos	et	al.,	1982).	It	was	shown	that	only	the	firing	rate	of	
cells	in	the	SCN,	and	not	in	the	RCA	and	ARC,	was	exhibiting	a	circadian	rhythm	similar	to	that	reported	
for	 the	 SCN	 in	 freely	moving	 animals.	 Thus,	 the	 conclusion	was	 that	 the	 SCN	 explant	was	 able	 to	
generate	at	 least	one	endogenous	circadian	cycle	 in	vitro.	Another	work	documented	multiple	unit	
neural	activity	recordings	from	outside	and	inside	of	the	suprachiasmatic	nuclei	in	freely	moving	male	
golden	hamsters	(Yamazaki	et	al.,	1998).	The	animals	were	housed	in	running-wheel	cages	under	LD	
cycles	and	DD	conditions.	The	recorded	circadian	period	of	activity	was	reduced	by	4	hours	from	24	to	
20	between	wild	type	(WT)	animals	and	Tau	mutant	hamsters,	with	a	peak	in	the	middle	of	the	day	
and	a	matching	period	of	 locomotor	activity.	There	were	no	observations	of	any	differences	 in	the	
periods	 of	 ultradian	 rhythms	 of	 Tau	 mutant	 and	 WT	 hamsters,	 present	 in	 addition	 to	 circadian	
rhythms,	even	though	the	circadian	periodicity	of	the	Tau	mutant	animals	was	shortened	by	>15%.	
Therefore,	the	Tau	mutation	may	affect	circadian	but	not	ultradian	rhythms	of	multiunit	activity.	
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	 In	 2003	 was	 proposed	 a	 “multiphasic”	 view	 of	 SCN	 organisation,	 in	 which	 the	 individual	
neurons	participate	in	oscillator	ensembles,	that	adopt	varying	phase	angles	to	each	other	via	coupling	
processes	influenced	by	light	input	(Quintero	et	al.,	2003).	This	multiphasic	view	better	accounts	for	
many	 properties	 of	 circadian	 organization,	 including	 the	 capacity	 of	 the	 SCN	 to	 produce	multiple-
phase	peak	rhythms	in	SCN	electrophysiology	in	vivo	and	in	vitro	(Meijer	et	al.,	1997,	Yamazaki	et	al.,	
1998,	Jagota	et	al.,	2000,	Mrugala	et	al.,	2000),	to	time	various	physiological	output	rhythms,	and	to	
respond	to	seasonal	variations	in	the	photoperiod	by	altering	the	coupling	of	its	constituent	oscillators	
(Pittendrigh	et	al.,	1976).	In	the	late	1990s,	the	multiunit	activity	in	the	SCN	of	the	rat	was	recorded,	
both	in	vivo	and	in	vitro,	in	order	to	determine	the	circadian	discharge	pattern	(Meijer	et	al.,	1997).	
The	variability	of	the	discharge	pattern	was	found	larger,	and	the	amplitude	of	the	rhythm	smaller,	in	
vivo	than	in	vitro.	Moreover,	evidence	was	shown	for	a	direct	effect	of	the	animal’s	behavioural	activity	
on	the	electrical	activity	of	the	SCN	in	vivo.		
		
1.4.2	Melatonin	and	circadian	rhythms	
	
	 Melatonin,	or	5-Methoxy-N-Acetyltryptamine,	was	discovered	and	isolated	from	the	bovine	
pineal	gland	in	1958	by	Aaron	Lerner	(Lerner	et	al.,	1958).	Melatonin	is	the	main	hormone	secreted	
by	the	pineal	gland.	Extra-pineal	sources	of	melatonin	were	reported	in	the	retina,	bone	marrow	cells,	
platelets,	skin,	lymphocytes,	cerebellum	and	gastrointestinal	tract	of	vertebrate	species	(Champier	et	
al.,	1997,	Martin	et	al.,	1998,	Conti	et	al.,	2000,	Bubenik	2002,	Carrillo-Vico	et	al.,	2004,	Slominski	et	
al.,	2005a,	Slominski	et	al.,	2005b).	Radioimmunoassay	(RIA)	studies	have	established	human	serum	
melatonin	concentrations	at	short	time	intervals	for	24	hours	(Arendt	et	al.,	1977).	A	clear	circadian	
rhythm	with	peak	values	during	the	dark	phase	was	demonstrated	in	both	men	and	women.	Melatonin	
is	highly	lipophilic	and	hydrophilic	in	nature,	allowing	it	to	easily	penetrate	target	organs	(Tamura	et	
al.,	2012).	Approximately	70%	of	melatonin	is	bound	to	albumin	and	is	released	into	capillaries	to	bind	
to	melatonin	receptors	(Cardinali	et	al.,	1972,	Macchi	et	al.,	2004).	Furthermore,	3H-Melatonin	was	
not	metabolised	when	incubated	with	rat	venous	blood	in	vitro.	Early	studies	in	mice	also	showed	that	
after	administration	of	radioactive	melatonin	to	the	animal,	the	melatonin	was	rapidly	metabolised	
with	a	small	portion	bound	and	retained	(Kopin	et	al.,	1961).	Circulating	melatonin	was	rapidly	taken	
up	by	all	tissues,	including	the	brain.		
	
	 It	was	also	demonstrated	that	a	complete	ablation	of	the	SCN	in	rats	led	to	an	augmentation	
of	daytime	pineal	messenger	ribonucleic	acid	(mRNA)	levels	of	aralkylamine	N-acetyltransferase	(AA-
NAT),	 an	 enzyme	 profoundly	 implicated	 in	melatonin	 synthesis	 (Perreau-Lenz	 et	 al.,	 2003).	 These	
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results	indicated	that	an	ablation	of	the	SCN	removed	an	inhibitory	input,	but	also	a	stimulatory	input,	
to	the	melatonin	rhythm	generating	system.	During	the	day,	a	normal	function	of	the	SCN	allows	the	
prevention	of	downstream	noradrenergic	stimulation	of	the	pineal	gland,	meaning	that	melatonin	is	
produced	at	night	when	the	SCN	activity	is	low.	Finally,	it	was	shown	in	humans	that	the	acrophase	of	
plasma	melatonin	was	occurring	between	02:00-04:00	h	(figure	1.4)	(Morgan	et	al.,	1998,	Janssens	et	
al.,	2019).	Figure	1.4	illustrates	the	circadian	rhythms	of	plasma	melatonin,	core	body	temperature,	
subjective	alertness,	task	performance	and	circulating	triacylglycerol	in	humans.	Figure	1.5	informs	on	
the	neural	pathway	between	the	retina	and	the	pineal	gland.		
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	1.4:	Representation	of	the	circadian	rhythms	of	plasma	melatonin	concentration,	subjective	
alertness,	task	performance	and	triacylglycerol	concentration	from	human	beings	held	in	constant	
routine	conditions.	Taken	from	Skene	et	al.,	2006.	(A)	The	peak	in	melatonin	rhythm	shown	by	the	
dotted	 line	 is	at	around	5	am.	 	The	 low	point	of	 the	alertness	and	performance	 rhythms	 (B	and	C	
respectively)	is	happening	shortly	after	the	melatonin	peak,	with	the	peak	in	triacylglycerol	(D)	close	
to	the	melatonin	peak.		
	
	 Linking	melatonin	with	adipose	biology,	a	study	investigated	whether	there	were	functional	
melatonin	receptors	 in	human	adipocytes	 (Brydon	et	al.,	2001).	This	would	suggest	that	melatonin	
could	 act	 directly	 on	 the	 adipose	 tissue	 and	 regulate	 its	 physiology.	 The	 use	 of	 semi-quantitative	
reverse-transcription	polymerase	 chain	 reaction	 (RT-PCR)	 revealed	an	expression	of	 the	melatonin	
receptors	MT1	and	MT2	mRNAs	in	a	human	brown	adipose	cell	line	(PAZ6),	as	well	as	in	human	brown	
BA
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and	white	adipose	tissue.	Long-term	melatonin	treatment	of	PAZ6	adipocytes	was	found	to	decrease	
the	 expression	 of	 the	 glucose	 transporter	 Glut4	 and	 glucose	 uptake,	 important	 parameters	 of	
adipocyte	metabolism.	Moreover,	the	expression	of	several	other	adipocyte	marker	genes	was	not	
altered	by	melatonin.	Figure	1.5	below	represents	the	neural	pathway	between	the	retina	and	the	
pineal	gland.								
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	1.5:	Neural	pathway	between	the	retina	and	the	pineal	gland.	Taken	from	Tan	et	al.,	2011.	
The	 changes	 in	 the	pineal	melatonin	production	 are	mediated	by	 the	 light	 perceived	by	 the	 eyes.	
Visible	 electromagnetic	 wavelengths	 in	 the	 range	 of	 460-480mm	 are	 most	 inhibitory	 to	 pineal	
melatonin	 production.	 LP,	 long	 photoperiod;	 PVN,	 paraventricular	 nucleus;	 SCN,	 suprachiasmatic	
nuclei;	SP,	short	photoperiod.		
	
1.4.3	The	clocks	of	the	periphery	
	
	 For	 a	 time	 reigned	 the	 notion	 that	 the	 SCN	 was	 the	 primary	 site	 controlling	 circadian	
phenomenon	(Ball	2007).	This	was	either	due	to	a	single	clock	localised	within	the	SCN,	or	to	multiple	
coordinated	oscillators	within	the	same	brain	nucleus.	This	idea	was	however	contradicted	as	early	on	
as	the	late	1970s,	when	Stephan	and	collaborators	worked	with	intact	and	SCN-lesioned	rats	(Stephan	
et	al.,	1979b).	As	detailed	earlier	 (section	1.4.1),	 results	 indicated	that	 rats	with	an	SCN	 lesion	still	
presented	 an	 anticipatory	 wheel	 running	 activity	 based	 on	 endogenous	 circadian	 oscillators	
entrainable	by	feeding	schedules	in	the	circadian	range	(food-entrainable	rhythms).		
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	 In	 mammals,	 a	 master	 circadian	 clock	 exists	 in	 the	 suprachiasmatic	 nuclei	 of	 the	
hypothalamus,	and	slave	oscillators	can	be	found	in	most	tissues,	in	the	brain	outside	of	the	SCN	and	
at	the	periphery	(Kudo	et	al.,	2007).	The	peripheral	clocks	play	an	integral	and	unique	role	in	each	of	
their	 respective	 tissues,	 driving	 the	 circadian	 expression	 of	 specific	 genes	 involved	 in	 a	 variety	 of	
physiological	 functions	 (Richards	 et	 al.,	 2012).	 Processes	 ranging	 from	 glucose	 transport	 to	
gluconeogenesis,	lipolysis,	adipogenesis	and	mitochondrial	oxidative	phosphorylation	are	controlled	
through	overlapping	transcription	networks	tied	to	the	clock	and	are	thus	time	sensitive	(Kohsaka	et	
al.,	2007a).	Because	disruption	of	tissue	timing	occurs	when	food	intake,	activity	and	sleep	are	altered,	
understanding	how	these	many	tissue	clocks	are	synchronised	to	tick	at	the	same	time	each	day,	and	
determining	how	each	tissue	“senses	time”	set	by	these	molecular	clocks	might	open	new	insight	into	
human	disease,	including	sleep	disorders,	circadian	disruptions,	diabetes	and	obesity.	Another	critical	
work	in	the	identification	of	peripheral	clocks	was	published	in	1996.	Cultured	retinas	of	the	golden	
hamster	showed	circadian	rhythms	of	melatonin	synthesis,	entrained	by	light	cycles	applied	in	vitro,	
free-running	in	DD	and	persistent	for	at	least	5	days,	hallmarks	of	an	autonomous	oscillator	(Tosini	et	
al.,	1996).		
	
	 Although	the	molecular	aspects	of	the	biological	clocks	will	be	described	in	detail	later	on,	it	
is	important	here	to	mention	circadian	“clock”	genes.	In	all	of	the	major	model	organisms	in	which	
circadian	 rhythms	have	been	 studied,	has	emerged	a	 central	organising	principle	of	 the	molecular	
clockwork:	within	cells,	a	set	of	clock	genes	and	their	protein	products	together	participate	in	auto-
regulatory	feedback	loops	of	transcription	and	translation	to	produce	an	oscillation	with	a	period	of	
about	24	hours	 (Lowrey	 et	al.,	 2004,	Takahashi	 et	al.,	 2008).	Among	 those	genes	are	Period	 (Per),	
shown	 to	 be	 located	 on	 the	 X	 chromosome	 of	 Drosophila	 melanogaster,	 and	 whose	 expression	
influences	biological	 clocks	 in	 this	 fruit	 fly,	 including	 the	one	 that	 sub	 serves	 circadian	 rhythms	of	
locomotor	 activity	 (Cooper	 et	 al.,	 1994).	 Oscillations	 in	 levels	 of	 Per	 transcripts	 as	 well	 as	 in	 the	
corresponding	PER	proteins	 have	 a	period	of	 approximately	 24	hours	 (Hardin	 et	 al.,	 1990,	Dunlap	
1999).	 In	 1998,	 the	 mouse	 complementary	 deoxyribonucleic	 acid	 (cDNA)	 of	 a	 new	 mammalian	
homolog	of	the	Drosophila	Period	gene,	designated	mPer3,	was	cloned	and	characterised	(Zylka	et	al.,	
1998).	 The	 three	mammalian	PER	proteins	 share	 several	 regions	of	 sequence	homology,	 and	each	
contains	a	protein	dimerization	Per-Arnt-Sim	(PAS)	domain.	mPer3	RNA	levels	were	shown	to	oscillate	
in	the	SCN	and	eyes.	An	interesting	aspect	of	this	work	was	the	finding	of	circadian	oscillations	in	RNA	
levels	for	all	three	Per	genes	in	non-neural	tissues,	reminiscent	of	the	situation	in	Drosophila,	in	which	
Per	 is	widely	expressed	throughout	 the	animal.	The	similar	oscillations	of	 these	 three	Per	genes	 in	
clock	structures	suggest	the	potential	for	protein-protein	interactions	through	their	PAS	domains,	and	
39	
	
participation	in	oscillating	transcriptional	feedback	loops.	At	the	same	time,	Northern	blot	analyses	
were	conducted,	and	revealed	the	circadian	expression	of	the	rat	Period	homolog	(rPer2)	mRNA	in	
peripheral	mononuclear	leukocytes	deprived	of	neuronal	connections	(Oishi	et	al.,	1998).	Researchers	
involved	in	this	study	also	used	Northern	Blot	analyses	in	rats	to	show	a	robust	circadian	fluctuation	
of	rPer2	mRNA	not	only	in	the	SCN	of	the	hypothalamus,	but	also	in	other	tissues	including	heart,	liver,	
spleen,	kidney,	lung,	brain	and	eye.	Furthermore,	the	peripheral	circadian	expression	of	rPer2	mRNA	
was	abolished	in	SCN-lesioned	rats	that	showed	behavioural	arrhythmicity	 (Sakamoto	et	al.,	1998).	
This	 suggested	 that	 the	 multi-tissue	 circadian	 expression	 of	 rPer2	 mRNA	 was	 governed	 by	 the	
mammalian	 brain	 clock	 SCN,	 and	 that	 the	 rPer2	 gene	 was	 involved	 in	 the	 circadian	 rhythm	 of	
locomotor	behaviour	in	mammals.		
	
	 The	presence	of	a	molecular	clock	was	later	shown	in	the	vasculature,	with	circulating	humoral	
signals	identified	as	mechanisms	accounting	for	the	synchronisation	of	this	clock	(McNamara	et	al.,	
2001).	In	the	same	study	was	reported	that	retinoic	receptors	(retinoic	X	receptor	α	-	RXRα	and	retinoic	
acid	receptor	α	-	RARα)	could	interact	with	the	proteins	CLOCK	and	its	paralog	Neuronal	Per-Arnt-Sim	
domain	protein	2	(NPAS2),	other	essential	molecular	components	of	the	mammalian	circadian	clock,	
in	a	hormone-dependent	manner.	Npas2	was	shown	to	display	a	robust	cyclical	expression	pattern	in	
the	vasculature,	and	retinoic	acid	to	be	able	to	phase	shift	Per2	mRNA	rhythmicity	in	vivo	and	in	serum-
induced	smooth	muscle	cells	in	vitro,	providing	a	molecular	mechanism	for	hormonal	control	of	clock	
gene	 expression.	 This	 suggested	 a	 role	 for	 nuclear	 receptor-mediated	 humoral	 signalling	 in	 the	
regulation	of	a	peripheral	clock	in	the	vasculature.	The	hypothesis	was	then	that	most,	and	perhaps	
all,	multicellular	organisms	contain	multiple	circadian	oscillators	interconnected	to	form	a	hierarchical	
circadian	system	regulating	many	discrete	rhythmic	outputs	(Yamazaki	et	al.,	2000).	In	mammals,	the	
SCN	contains	self-sustained	circadian	oscillators	that	act	as	a	pacemaker	at	the	top	of	the	hierarchy	
(Ralph	et	al.,	1990,	Klein	et	al.,	1991)	and	in	addition,	a	surprising	number	of	mammalian	peripheral	
tissues	 appear	 to	 contain	 the	molecular	machinery	 necessary	 for	 circadian	 oscillation	 (King	 et	 al.,	
1997b,	Tei	et	al.,	1997,	Yamazaki	et	al.,	2000).	Furthermore,	studies	showed	a	diffusible	coupling	signal	
from	a	transplanted	suprachiasmatic	nuclei	controlling	circadian	locomotor	rhythms,	confirming	that	
the	transplanted	SCN	could	sustain	circadian	activity	rhythms	by	means	of	a	diffusible	signal	(Silver	et	
al.,	1996).	
	
	 Firefly	 luciferase	 (Fluc)	 is	 frequently	 used	 to	 report	 circadian	 gene	 expression	 rhythms	 in	
mammalian	cells	and	tissues	(Feeney	et	al.,	2016b).	Constructs	are	often	built	where	the	Fluc	is	fused	
to	 the	 promoter	 of	 genes	 of	 interest,	 like	 Period,	 in	 order	 to	 help	 identify	 peripheral	 circadian	
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oscillators	(Ramanathan	et	al.,	2012,	Ramanathan	et	al.,	2014).	One	interesting	study	investigated	the	
organisation	 of	 the	 mammalian	 circadian	 system	 by	 constructing	 a	 transgenic	 rat	 line	 in	 which	
luciferase	 is	 rhythmically	expressed	under	 the	control	of	 the	mouse	Per1	 (another	homolog	of	 the	
Period	gene)	promoter	(Yamazaki	et	al.,	2000).	Liver,	 lung	and	skeletal	muscle	all	showed	circadian	
rhythms	of	light	output	that	phase-lagged	the	SCN	rhythms	by	7	to	11	hours.	The	rhythms	recorded	
from	peripheral	tissues	were	not	as	robust	as	those	from	the	SCN,	and	always	damped	after	two	to	
seven	cycles	in	culture.	Furthermore,	the	phase	difference	between	the	SCN	and	peripheral	tissues	
was	 similar	 to	 the	phase-delay	observed	 in	vivo	 (Zylka	 et	al.,	 1998).	Another	 team	cultured	neural	
tissues	 from	 rats	 carrying	 the	 Per-luciferase	 transgene,	 to	 monitor	 the	 intrinsic	 Per1	 expression	
patterns	 in	different	brain	areas,	as	well	as	their	response	to	changes	 in	the	 light	cycle	(Abe	et	al.,	
2002).	The	pineal	and	pituitary	glands	both	expressed	rhythms	persisting	for	over	3	days	in	vitro,	with	
peak	expression	during	the	subjective	night.	Nuclei	in	the	olfactory	bulb	and	the	ventral	hypothalamus	
also	 expressed	 rhythmicity	 with	 peak	 expression	 at	 night,	 whereas	 other	 brain	 areas	were	 either	
weakly	rhythmic	and	peaked	at	night,	or	arrhythmic.	After	a	6-hr	advance	or	delay	in	the	light	cycle,	
the	pineal,	paraventricular	and	arcuate	nucleus	of	the	hypothalamus	were	able	to	adjust	the	phase	of	
their	 rhythmicity	 with	 different	 kinetics.	 This	 indicated	 that	 the	 brain	 contains	 multiple,	 damped	
circadian	oscillators	outside	of	the	SCN,	and	that	the	phasing	of	these	oscillators	to	one	another	may	
play	a	critical	role	in	coordinating	brain	activity	as	well	as	its	adjustment	to	changes	in	the	light	cycle.			
	
	 In	2004,	researchers	used	a	PERIOD2::LUCIFERASE	fusion	protein	as	a	real-time	reporter	of	
circadian	rhythms	in	mice	(Yoo	et	al.,	2004).	Peripheral	tissues	such	as	the	cornea,	kidney,	lung,	liver	
and	pituitary	all	expressed	robust	and	persistent	circadian	oscillations	in	luminescence.	These	results	
demonstrated	 that	 individual	 peripheral	 tissues	 contain	 circadian	 oscillators	 capable	 of	 persistent	
rhythmicity	for	up	to	20	days,	 independent	of	SCN	input.	Additionally,	peripheral	tissues	expressed	
self-sustained,	rather	than	damped,	circadian	oscillations,	suggesting	the	existence	of	organ-specific	
synchronizers	of	circadian	rhythms	at	the	cell	and	tissue	level.	Figure	1.6	below	is	an	illustration	of	the	
study	mentioned	here,	 representing	 rhythms	of	Per2	 in	 control	 and	 SCN-lesioned	mice	within	 the	
cornea,	liver,	lung,	pituitary	gland	and	kidney.	
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Figure	 1.6:	 Phase	 and	 period	 maps	 of	
SCN-lesioned	mice.	Taken	from	Yoo	et	al.,	
2004.	 A:	 Circadian	 period	 values	 of	
mPER2::LUC	 rhythms	 in	 LD	 control	mice	
(○),	 DD	 control	 mice	 (●),	 and	 SCN-	
lesioned	 mice	 ().	 Mean	 periods	 (±	
standard	 error	 of	 the	 mean,	 SEM)	 for	
cornea,	 liver,	 pituitary,	 kidney,	 and	 lung	
are	 shown.	 B:	 Superimposed	 plots	 of	
bioluminescent	 data	 from	 pituitary	 and	
lung	for	all	animals	including	LD	controls,	
DD	controls,	and	SCN-lesioned	mice.	The	
first	 three	 cycles	 in	 culture	 are	
represented;	each	animal’s	record	is	of	a	
different	colour.	Phase	desynchronization	
is	evident	in	individual	records	of	the	SCN-
lesioned	animals	for	both	tissues.		
	
	 	
	 Subsequent	 work	 continued	 to	 demonstrate	 that	 renal	 function	 appears	 to	 vary	 with	 a	
circadian	rhythm.	For	example,	many	aspects	of	kidney	function	exhibit	circadian	fluctuations,	such	as	
glomerular	filtration	rate	(Koopman	et	al.,	1989),	sodium	excretion	and	renal	blood	flow	(Pons	et	al.,	
1996).	Furthermore,	both	the	physiological	and	pathological	 functions	of	cardiovascular	organs	are	
closely	 related	 to	 circadian	 rhythm	 (Takeda	 et	 al.,	 2011).	 The	 heart	 rate,	 blood	 pressure,	 and	
endothelial	 function	also	 show	diurnal	variations	within	a	day,	with	 the	onset	of	acute	myocardial	
infarction	demonstrating	a	clear	circadian	variation	peaking	in	the	early	morning	(Muller	et	al.,	1985).	
Compared	with	the	day	workers,	the	rotating	shift	workers	had	a	significantly	higher	risk	of	death	due	
to	ischemic	heart	disease,	whereas	fixed-night	work	was	not	associated	with	ischemic	heart	disease	
(Fujino	 et	 al.,	 2006).	 Additionally,	 circadian	 clock	 genes	were	 identified	 and	 shown	 to	 oscillate	 in	
smooth	muscle	cells,	with	many	gut-related	phenomena	(i.e.	motility	of	 the	gastro-intestinal	 tract)	
oscillating	in	a	circadian	manner	(Konturek	et	al.,	2011).	Additionally,	a	new	scenario	for	the	circadian	
control	of	ovulation	was	provided	a	decade	ago	(Nakao	et	al.,	2007).	Instead	of	the	brain	alone	being	
the	site	of	information	integration	relevant	to	ovulation	and	the	source	of	circadian	clock	gating	the	
timing	of	 ovulation,	 the	 circadian	 gate	on	 the	 timing	of	 the	 luteinizing	hormone	 (LH)	 surge	would	
reside	in	the	ovary	itself.		
B
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	 Another	strong	evidence	of	the	presence	of	clocks	at	the	periphery	can	be	provided	by	the	
secretion	of	 various	hormones	 in	daily	 cycles.	 It	 is	 the	 case,	 for	 instance,	 of	 the	hormone	ghrelin,	
produced	 in	 the	 stomach	 and	 known	 to	 stimulate	 both	 the	 appetitive	 (anticipatory	 locomotor	
behaviour)	and	the	consummatory	component	(food	intake)	(LeSauter	et	al.,	2009).	Peripheral	ghrelin	
levels	 were	 shown	 to	 rise	 sharply	 before	 main	 meals	 and	 decrease	 after	 feeding	 episodes,	 most	
strikingly	under	restricted	feeding	conditions	in	animals	such	as	rodents	and	sheep	(Kalra	et	al.,	1999,	
Sugino	et	al.,	2002,	Bodosi	et	al.,	2004).	Interestingly,	other	hormones	have	also	been	shown	to	be	
secreted	rhythmically,	with	the	example	of	glucocorticoid	hormones,	produced	by	the	adrenal	gland	
cortex	(Dickmeis	2009).	One	striking	feature	of	their	regulation	is	a	diurnal	release	pattern	under	the	
control	of	the	circadian	clock,	with	peak	levels	linked	to	the	start	of	the	activity	phase.	Glucocorticoids	
are	 therefore	 important	 timing	 signals	 for	 peripheral	 oscillators;	 with	 rhythmic	 secretion	 of	
corticosterone	tightly	controlled	by	the	SCN.	SCN	lesions	were	shown	to	abolish	the	rhythm	and	lead	
to	high	basal	corticosterone	 levels	 (Moore	et	al.,	1972a).	Glucocorticoid	receptors	are	abundant	 in	
many	 peripheral	 tissues,	 but	 not	 in	 adult	 SCN	 neurons,	 which	 makes	 these	 hormones	 suitable	
candidates	as	entraining	signals	for	circadian	oscillators	in	peripheral	organs	(Rosenfeld	et	al.,	1988,	
Balsalobre	et	al.,	2000a).				
	
	 A	1-hr	treatment	of	rat-1	fibroblasts	with	the	glucocorticoid	dexamethasone	(DEX)	has	been	
shown	to	elicit	robust	circadian	gene	expression	of	the	clock	genes	Per1,	Per2	and	Per3	but	also	Cry1,	
a	homolog	of	the	Cryptochromes	(Cry)	clock	genes	family,	and	clock-controlled	genes	(section	1.5.3)	
such	as	D	site	of	albumin	promoter	binding	protein	 (Dbp)	 and	Rev-Erbα	 (a	 clock	gene	and	a	 clock-
controlled	gene)	(Balsalobre	et	al.,	2000a).	The	effect	of	DEX	on	circadian	liver	gene	expression	in	vivo	
was	also	investigated,	and	indicated	to	transiently	induce	Per1	expression	across	the	circadian	time.	
Furthermore,	 in	 cultured	 rat-1	 fibroblasts,	 dexamethasone	 was	 shown	 to	 change	 the	 phase	 of	
circadian	gene	expression	in	liver,	kidney	and	heart,	without	affecting	the	cyclic	gene	expression	in	
neurons	of	the	SCN.	The	same	study	tested	whether	DEX	could	act	directly	on	peripheral	oscillators	
by	cell-autonomous	mechanisms.	Mice	with	a	hepatocyte-specific	inactivation	of	the	glucocorticoid	
receptor	(GR)	gene	did	not	accumulate	GRs	in	hepatocytes	as	well	as	in	biliary	duct	cells.	However,	a	
strong	elevation	of	Per1	mRNA	was	observed,	5	hours	after	DEX	injection,	in	the	kidney	and	the	heart	
of	both	mutant	and	WT	animals.	In	the	liver,	Per1	expression	remained	low	in	mutant	mice,	indicating	
that	a	functional	GR	is	necessary	for	the	activation	of	Per1	transcription	after	DEX	injection.	In	vitro,	
circadian	gene	expression	can	thus	be	triggered	by	various	well	characterised	signalling	pathways	such	
as	 the	 glucocorticoid	 receptor,	 but	 also	 involving	 the	 protein	 kinase	 C	 (PKC),	 cyclic	 adenosine	
monophosphate	 (cAMP)-dependent	 kinases,	 and	 calcium	 (Ca2+)	 (Balsalobre	 et	 al.,	 2000b).	
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Importantly,	these	pathways	induced	a	surge	of	Per1	mRNA	accumulation,	but	none	of	them	efficiently	
activated	Per2	expression.		Additionally,	the	RHT	signals	can	regulate	the	adrenal	function	during	the	
subjective	 day,	when	 the	 central	 clock	 in	 the	 SCN	 is	 relatively	 impervious	 to	 the	 effects	 of	 photic	
stimulation	 (Kiessling	 et	al.,	 2014).	This	provided	 insights	 that	peripheral	 clocks	are	predominantly	
entrained	by	SCN-controlled	release	of	a	combination	of	neural	(peripheral	autonomic	nervous	system	
(ANS))	and	humoral	factors	under	normal	conditions	(Challet	et	al.,	2003,	Kiessling	et	al.,	2014).		
	
	 It	was	also	discovered	that	the	sympathetic	pathway	to	the	liver	was	required	by	the	SCN	to	
be	able	to	generate	the	24-h	rhythm	in	plasma	glucose	concentrations,	and	that	the	rhythmic	clock-
gene	expression	in	the	liver	was	not	dependent	on	the	sympathetic	liver	innervation	(Cailotto	et	al.,	
2005).	 Finally,	 the	 clock-gene	 rhythmicity	 in	 liver	 cells	was	not	 sufficient	 for	 sustaining	a	 circadian	
rhythm	in	plasma	glucose	concentrations.	Furthermore,	the	specialisation	of	the	SCN	may	go	as	far	as	
a	single	body	structure,	that	is,	the	SCN	seems	to	contain	neurons	specifically	targeting	the	liver,	pineal	
gland	and	 the	adrenal	 gland,	 in	 line	with	 the	 results	 illustrated	 figure	1.6	 above	 (Yoo	 et	 al.,	 2004,	
Kalsbeek	et	al.,	2006).	Another	important	study	aimed	at	understanding	the	communication	pathways	
between	central	and	peripheral	oscillators,	by	studying	the	rhythmic	behaviour	of	mouse	embryonic	
fibroblasts	(MEFs)	cells	surgically	implanted	in	mice	of	different	genotypes	(Pando	et	al.,	2002).	For	
instance,	MEFs	from	mice	null	for	the	clock	gene	Per1	(Per1-/-)	had	a	much	shorter	period	in	culture	
than	do	tissues	in	the	intact	animals.	When	implanted	back	into	mice,	however,	the	Per1-/-	MEF	took	
on	 the	 rhythmic	 characteristics	 of	 the	 host.	 This	 demonstrated	 that	 under	 normal	 physiological	
conditions,	the	SCN	can	compensate	for	genetic	defects	affecting	the	period	of	peripheral	clocks,	and	
that	peripheral	 clocks	 are	 subordinated	 to	 the	dominance	exerted	by	 the	 central	 clock.	 Figure	1.7	
below	presents	a	model	of	the	synchronisation	of	peripheral	oscillators	by	the	central	SCN.	
	
												This	model	shows	that	although	the	feeding	time	does	not	affect	the	phase	of	the	SCN,	it	is	
a	dominant	ZT	for	peripheral	circadian	oscillators	(Le	Minh	et	al.,	2001).	Additionally,	another	group	
demonstrated	that	feeding	cycles	can	entrain	the	liver	independently	of	the	SCN	and	the	light	cycle	
(Stokkan	et	al.,	2001).	This	raised	the	possibility	that	peripheral	circadian	oscillators,	like	those	in	the	
liver,	may	be	coupled	to	the	SCN	primarily	through	rhythmic	behaviour	such	as	feeding.	It	was	also	
postulated	 that	 both	 endogenous	 and	 environmental	 temperature	 cycles	 could	 participate	 in	 the	
synchronization	of	peripheral	clocks	in	mammals	(Brown	et	al.,	2002).	Figure	1.8	below	summarises	
the	variety	of	function	the	circadian	timing	system	is	involved	with.				
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Figure	1.7:	The	phase	entrainment	of	circadian	oscillators	in	peripheral	organs.	Taken	from	Le	Minh	
et	al.,	2001.	The	scheme	displays	a	hypothetical	model	of	the	synchronization	of	peripheral	oscillators	
by	the	central	SCN	pacemaker	and	feeding	time.	The	SCN	is	entrained	by	the	photoperiod	via	synaptic	
connections	with	the	retina	(RHT).	In	turn,	the	SCN	master	clock	entrains	circadian	gene	expression	in	
peripheral	 tissues	 (i.e.	 adipose	 tissue,	 liver	 and	 kidney)	 through	 direct	 neuronal	 and	 humoral	
pathways,	 or	 indirectly	 by	 determining	 the	 activity	 phase	 and	 thus	 feeding	 time.	When	 food,	 the	
dominant	Zeitgeber	for	at	least	some	peripheral	oscillators,	is	only	available	during	the	resting	phase,	
the	phases	of	these	clocks	are	inverted.	This	process	is	slowed	down	by	glucocorticoid	signalling,	likely	
through	 the	 abundant	 secretion	 of	 corticosterone	 during	 the	 dark	 phase,	 in	 animals	 switched	 to	
daytime	feeding.	
	
	 	
	
	
	
	
	
	
	
	
	
	
Figure	 1.8:	 The	 central	 and	 the	
peripheral	clocks	are	responsible	for	a	
variety	 of	 functions.	 Taken	 from	
Stenvers	et	al.,	2019.		
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1.5	Circadian	clocks	at	the	molecular	level	
	
1.5.1	Clock	genes	and	feedback	loops	
	
	 The	clock	mechanism	in	the	SCN	and	the	peripheral	oscillators	are	known	to	be	the	same	at	
the	molecular	level	(Balsalobre	et	al.,	2000b,	Nagoshi	et	al.,	2004,	Welsh	et	al.,	2004,	Brown	et	al.,	
2005).	 It	 is	 established	 that	 a	 network	 of	 transcriptional-translational	 feedback	 loops	 drives	 the	
rhythmic	expression	patterns	of	core	clock	components,	and	this	with	a	periodicity	of	approximately	
24	hours	 (Reppert	 et	 al.,	 2002,	 Lowrey	 et	 al.,	 2004).	Core	 clock	 components	 are	defined	as	 genes	
whose	protein	products	are	necessary	for	the	generation	and	regulation	of	circadian	rhythms	within	
individual	cells	throughout	the	organism	(Takahashi	2004).	The	discovery	of	circadian	rhythm	genes	
rests	largely	upon	the	use	of	forward	genetic	screens	to	isolate	circadian	mutants,	which	in	turn	were	
used	to	identify	the	causative	gene.	Including	Per	(Bargiello	et	al.,	1984,	Zehring	et	al.,	1984),	almost	
every	important	circadian	locus	has	been	defined	by	so	called	“Clock	mutants”.	This	list	includes	the	
Timeless	(Tim)	and	Double-time	(Dbt)	genes	in	Drosophila,	the	Frequency	(Freq)	gene	in	Neurospora	
and	Clock,	first	identified	by	positional	cloning	(McClung	et	al.,	1989,	Myers	et	al.,	1995,	Antoch	et	al.,	
1997,	King	et	al.,	1997a,	Ishiura	et	al.,	1998,	Kloss	et	al.,	1998).	Considerable	progress	has	been	made	
in	characterising	these	genes	at	the	transcriptional	and	translational	levels	(Hardin	et	al.,	1990,	Hardin	
et	al.,	1992,	Aronson	et	al.,	1994,	Sehgal	et	al.,	1995,	Dunlap	1996,	Rosbash	et	al.,	1996),	and	the	Nobel	
Prize	 in	Physiology	or	Medicine	was	attributed	 to	 Jeffrey	C.	Hall,	Michael	Rosbash	and	Michael	W.	
Young	 for	 their	 pioneering	 work	 in	 Drosophila	 and	 their	 discoveries	 of	 molecular	 mechanisms	
controlling	circadian	rhythms.		
	 	
	 In	1994,	mice	were	screened	for	circadian	clock	mutations	after	treatment	with	a	mutagen	
(Vitaterna	et	al.,	1994).	A	semi-dominant	mutation	was	identified,	Clock,	able	to	lengthen	the	circadian	
period	and	abolish	the	persistence	of	the	rhythmicity.	This	work	reported	the	isolation	of	a	mutation	
in	the	mouse	that	changes	two	central	properties	of	circadian	rhythms:	the	intrinsic	period	length	and	
the	persistence	of	rhythmicity,	identifying	the	Clock	gene	as	essential	for	normal	circadian	behaviour.	
Later	was	generated	a	high-resolution	genetic	map	of	the	Clock	 locus	 in	order	to	 identify	the	gene	
affected	by	the	Clock	mutation	 (King	et	al.,	1997a).	Furthermore,	a	 technique	of	positional	cloning	
allowed	the	identification	of	the	circadian	Clock	gene	in	mice,	a	 large	transcription	unit	encoding	a	
novel	member	of	the	basic	helix-loop-helix	PER-ARNT-SIM	(bHLH-PAS)	family	of	transcription	factors	
(King	 et	al.,	1997b).	The	cloning	and	molecular	characterisation	of	a	novel	clock	gene	 in	mammals	
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provides	 an	 opportunity	 for	 elucidating	 the	 genetic	 and	 molecular	 mechanisms	 underlying	 the	
entrainment,	generation,	and	expression	of	circadian	rhythms	in	higher	organisms,	including	humans.	
	
	 Another	 protein	 encoding	 a	 transcription	 factor	 with	 a	 bHLH-PAS	 domain	 is	 the	 aryl	
hydrocarbon	receptor	nuclear	translocator-like	(ARNTL)	or	MOP3,	otherwise	called	brain	and	muscle	
ARNT-Like	 1	 (BMAL1),	 and	 able	 to	 interact	 with	 CLOCK	 (Bunger	 et	 al.,	 2000).	 This	 transcriptional	
activator	of	the	molecular	clock	feedback	network	is	highly	expressed	in	skeletal	muscle	(Ikeda	et	al.,	
1997,	Hogenesch	et	al.,	1998).	Importantly,	a	loss	of	the	BMAL1	protein	in	mice	results	in	an	immediate	
and	complete	loss	of	circadian	rhythmicity	in	DD,	with	a	loss	of	circadian	function	generated	at	the	
molecular	level	(Bunger	et	al.,	2000).	Moreover,	in	Bmal1-/-	mice,	the	locomotor	activity	in	LD	cycles	
was	impaired	with	reduced	activity	levels.	The	effects	of	the	Bmal1	null	allele	on	Per	gene	expression	
are	consistent	with	an	activator	role	of	the	CLOCK-BMAL1	transcription	factor	complex	(King	et	al.,	
1997b,	Gekakis	et	al.,	1998).	Expression	patterns	of	mammalian	clock	genes,	Clock	and	Bmal1,	were	
examined	by	in	situ	hybridisation	in	the	pineal	body,	olfactory	bulb,	hippocampus	and	cerebellum	in	
rats	under	DD	(Namihira	et	al.,	1999).	In	the	pineal,	for	instance,	their	expression	showed	a	significant	
daily	rhythm,	different	in	terms	of	phase	as	Clock	expression	was	high	at	ZT	18	as	compared	with	that	
at	 ZT	6,	which	was	 the	opposite	of	Bmal1	 expression,	 higher	 at	 ZT	6	 in	 comparison	 to	 ZT	18.	 The	
expressions	of	Clock	and	Bmal1	are	thus	anti-phasic.	
	
	 The	Cryptochromes	are	a	group	of	highly	conserved	proteins	belonging	to	the	flavoproteins	
superfamily,	 identified	as	circadian	blue-light	photoreceptors	 in	Drosophila	and	components	of	the	
mammalian	 circadian	 clock	 (Brautigam	 et	 al.,	 2004).	 All	 members	 of	 this	 superfamily	 have	 an	 N-
terminal	 photolyase-homologous	 region	 (PHR)	 domain.	 The	 PHR	 domain	 binds	 a	 flavin	 adenine	
dinucleotide	(FAD)	cofactor	and	a	second	light-harvesting	chromophore	(Ahmad	et	al.,	1993,	Malhotra	
et	al.,	1995,	Hsu	et	al.,	1996,	Brudler	et	al.,	2003,	Kleine	et	al.,	2003).	Basic	local	alignment	search	tool	
(BLAST)	 revealed,	 in	 Drosophila,	 an	 expressed	 sequence	 tag	 (EST)	 showing	 high	 homology	 with	
Drosophila	 6-4	 photolyase	 (Todo	 et	 al.,	 1996).	 The	 gene	was	 named	Cry.	 Two	 years	 later,	mouse	
photolyase-like	genes,	mCry1	and	mCry2,	were	 isolated	and	characterised	 (Kobayashi	et	al.,	1998).	
The	same	study	identified	different	cellular	localisation	and	deoxyribonucleic	(DNA)	binding	properties	
of	the	mammalian	photolyase	homologs,	suggesting	that	despite	the	similarity	in	the	sequence	the	
two	proteins	have	distinct	function(s).	The	transcription	of	Cry	has	been	shown	to	be	under	circadian	
regulation,	influenced	by	the	Drosophila	clock	genes	Per,	Tim,	Clock	and	Cycle,	with	Cry	protein	levels	
dramatically	affected	by	light	exposure	(Emery	et	al.,	1998).	In	Drosophila,	it	has	been	demonstrated	
that	behavioural	rhythms	were	affected	by	light,	via	at	least	two	distinct	mechanisms	(Klarsfeld	et	al.,	
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2004).	 One	 of	 them	 relies	 on	 the	 visual	 photo-transduction	 cascade,	 and	 the	 other	 involves	 a	
presumptive	photo-pigment,	Cry,	expressed	in	lateral	brain	neurons	that	control	behavioural	rhythm.	
Furthermore,	dorsal	PER-expressing	brain	neurons	are	the	only	brain	neurons	to	co-express	the	CRY	
protein.	Double	mutants	of	Per	and	Cry	have	been	constructed,	and	following	behavioural	analyses	
was	 suggested	 an	 interaction	 on	 a	 genetic	 level	 between	 the	 two	 loci	 (Rosato	 et	 al.,	 2001).	 This	
interaction	 was	 confirmed	 through	 the	 use	 of	 a	 yeast-two-hybrid	 system,	 which	 revealed	 a	
dimerization	between	PER	and	CRY,	as	well	as	by	a	co-immunoprecipitation	assay	 in	 tissue	culture	
cells.	Finally,	this	work	showed	that	the	light-dependent	nuclear	interactions	of	PER	and	TIM	with	CRY	
require	the	C	terminus	of	CRY,	and	may	involve	a	trans-acting	repressor.		
	
	 The	primary	 feedback	 loop	 includes	positive	 elements,	 such	 as	members	of	 the	bHLH-PAS	
transcription	 factor	 family,	 CLOCK	 and	 BMAL1	 (Ko	 et	 al.,	 2006).	 These	 positive	 elements	 produce	
rhythmic	transcriptional	activation	serving	as	a	basic	driving	force	behind	the	circadian	clockwork	(King	
et	al.,	1997b,	Gekakis	et	al.,	1998,	Hogenesch	et	al.,	1998,	Bunger	et	al.,	2000).	CLOCK	and	BMAL1	
interact	 through	 their	 N-terminal	 bHLH	 and	 tandem	 PAS	 domains	 (Huang	 et	 al.,	 2012).	 They	
heterodimerise	 and	 translocate	 in	 the	 nucleus	 before	 initiating	 the	 transcription	 from	 genes	
containing	 E-box	 cis-regulatory	 elements,	 including	 the	 Per	 and	 Cry	 genes	 which	 constitute	 the	
negative	limb	of	the	circadian	clock	feedback	loop	(King	et	al.,	1997b,	Gekakis	et	al.,	1998,	Kume	et	
al.,	1999,	Bunger	et	al.,	2000,	Zheng	et	al.,	2001,	Yoo	et	al.,	2005).	Positive	and	negative	core	clock	
components	 form	a	 feedback	 loop	with	a	 time	constant	of	about	24-hour	per	cycle	 (Lowrey	et	al.,	
2011).	 PER	 and	 CRY	 interact	 in	 both	 the	 cytoplasm	 and	 the	 nucleus,	 with	 the	 nuclear-cytoplasm	
shuttling	of	PER	and	CRY	regulated	by	nuclear	import	(localisation)	and	export	signals	(NLS	and	NES	
respectively)	 present	 in	 the	 PER	 protein	 (Loop	 et	 al.,	 2005).	 Once	 translated,	 PERs	 and	 CRYs	
accumulate	 in	a	cytoplasmic	complex	and	 then	 translocate	 into	 the	nucleus	 to	 repress	 the	CLOCK-
BMAL1	heterodimer,	 thereby	 repressing	 their	own	 transcription	and	ensuring	a	negative	 feedback	
(Kume	et	al.,	1999,	Okamura	et	al.,	1999,	Shearman	et	al.,	2000b,	Lee	et	al.,	2001,	Panda	et	al.,	2002b,	
Sato	et	al.,	2006).		
	
	 The	CLOCK:	BMAL1	heterodimers	are	also	able	 to	activate	 the	 transcription	of	 the	 retinoic	
acid-related	 orphan	 nuclear	 receptors,	 Rev-erba	 and	 retinoic	 acid-related	 orphan	 receptor	 alpha	
(Rora),	constituting	another	regulatory	loop	(Preitner	et	al.,	2002,	Sato	et	al.,	2004,	Triqueneaux	et	
al.,	2004,	Akashi	et	al.,	2005).	REV-ERBa	and	RORa	subsequently	compete	to	bind	retinoic	acid-related	
orphan	receptor	response	elements	(ROREs),	which	can	be	found	in	the	Bmal1	promoter	(Ko	et	al.,	
2006).	Additionally,	it	has	been	shown	that	members	of	ROR	(a,	b	and	g)	and	REV-ERB	(a	and	b)	are	
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able	to	regulate	the	transcription	of	Bmal1	through	ROREs	(Guillaumond	et	al.,	2005),	with	REV-ERBa	
identified	as	the	major	regulator	of	cyclic	Bmal1	transcription	(Preitner	et	al.,	2002,	Guillaumond	et	
al.,	2005).	RORs	activate	the	transcription	of	Bmal1	(Sato	et	al.,	2004,	Akashi	et	al.,	2005,	Guillaumond	
et	al.,	2005),	whereas	REV-ERBs	repress	the	transcription	process	(Preitner	et	al.,	2002,	Guillaumond	
et	al.,	2005).	Hence,	the	circadian	oscillation	of	Bmal1	is	both	positively	and	negatively	regulated	by	
RORs	and	REV-ERBs,	with	Bmal1	mRNA	oscillating	in	approximate	anti-phase	to	Per	and	Cry	mRNAs	
(Lee	et	al.,	2001,	Reppert	et	al.,	2002).		
	
	 These	auto-regulatory	feedback	loops	illustrated	in	figure	1.9	take	approximately	24	hours	to	
complete	a	cycle	and	constitute	a	circadian	molecular	clock	(Ko	et	al.,	2006).	This	generation	of	the	
molecular	 clock	 is	 governed	 by	 post-translational	 modifications	 (such	 as	 ubiquitination	 and	
phosphorylation).	These	processes	significantly	contribute	to	the	precision	of	the	mammalian	clock,	
by	affecting	the	stability	and	nuclear	translocation	of	aforementioned	core	clock	proteins	(Lowrey	et	
al.,	2000,	Toh	et	al.,	2001,	Akashi	et	al.,	2002,	Eide	et	al.,	2002,	Eide	et	al.,	2005,	Xu	et	al.,	2005).	Casein	
kinase	(CK)	1	epsilon	and	casein	kinase	1	delta	(CK1e	and	CK1d)	are	involved	in	the	phosphorylation	of	
the	 heterodimer	 PER/CRY	 allowing	 its	 activation,	 and	 are	 critical	 factors	 that	 regulate	 the	 core	
circadian	protein	turnover	in	mammals	(Lowrey	et	al.,	2000,	Akashi	et	al.,	2002,	Eide	et	al.,	2002,	Xu	
et	 al.,	 2005).	 The	 identification	 of	 the	 circadian	 transcripts	 has	 revealed	 that	 the	 transcriptional	
circadian	regulation	extends	beyond	core	clock	components	to	include	various	clock-controlled	genes	
(CCGs),	 including	key	 regulators	 for	 cell	 cycle	and	metabolism	 (section	1.5.3)	 (Panda	 et	al.,	 2002a,	
Storch	 et	 al.,	 2002).	 The	 above	 findings	 emphasize	 the	 significance	 of	 the	molecular	 clock	 and	 its	
regulation	 of	 the	 rhythmic	
production	 of	 CCGs,	 which	
subsequently	 influence	 different	
biochemical	pathways	involved	in	
pathophysiology	(Ko	et	al.,	2006).	
Most	of	 the	core	components	of	
the	 molecular	 clock	 maintain	
their	rhythmicity	in	the	SCN	and	in	
peripheral	 tissues,	 although	
varying	in	their	intrinsic	rhythmic	
properties	 across	 the	 tissues	
(Emery	 et	 al.,	 2004,	
Sato	 et	 al.,	 2004,	
Figure	 1.9:	 Transcriptional-translational	 feedback	 loops	 constituting	 the	
molecular	model	of	the	circadian	clocks.	Taken	from	Ko	et	al.,	2006.	
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Akashi	et	al.,	2005,	Guillaumond	et	al.,	2005).	The	way	these	transcripts	act	in	response	to	the	clock	
disruption	therefore	vary	depending	on	the	tissue	(Debruyne	et	al.,	2006).				
	
1.5.2	Importance	of	functional	regulatory	feedback	loops	for	circadian	rhythms	
	
	 Mutations	of	a	specific	gene	can	provide	a	better	understanding	of	the	overall	functionality	of	
the	molecular	clock.	The	effects	of	a	Clock	mutation	have	already	been	detailed	earlier	(section	1.5.1)	
(Vitaterna	et	al.,	1994).	Mice	homozygous	for	the	Clock	mutation	(ClockD19)	have	significantly	longer	
circadian	periods	 (approximately	27.3h)	and	become	behaviourally	arrhythmic	when	housed	 in	DD	
conditions	 (Vitaterna	 et	 al.,	 1994,	 Lee	 et	 al.,	 2001).	 CLOCK-BMAL1	 heterodimers	 were	 found	 to	
activate	the	transcription	of	the	mPer	gene	in	a	process	that	requires	binding	to	the	E-box	element	
(Gekakis	et	al.,	1998).	However,	CLOCK∆19	mutant	protein	was	not	able	to	activate	the	transcription,	
consistent	with	the	finding	that	exon	19,	which	is	skipped	in	Clock	mutant	animals,	is	necessary	for	
transactivation	(King	et	al.,	1997a,	King	et	al.,	1997b).	Moreover,	the	finding	that	the	Clock	mutation	
dramatically	decreases	the	expression	of	Per	genes	also	confirms	the	positive	regulation	of	CLOCK–
BMAL1	on	the	Per	transcription	in	situ	(Shearman	et	al.,	1999,	Vitaterna	et	al.,	2006).		
	
	 The	creation	of	a	mice	harbouring	a	null	allele	of	Bmal1	demonstrated	the	critical	role	of	this	
gene	 in	circadian	rhythm	generation	(Bunger	et	al.,	2000).	These	mutant	mice,	while	being	able	to	
entrain	to	the	light-dark	cycle,	become	arrhythmic	 immediately	upon	release	 in	constant	darkness.	
Among	all	canonical	clock	genes,	Bmal1	 is	 the	only	one	whose	deletion	results	 in	complete	 loss	of	
circadian	rhythms;	therefore,	Bmal1	knockout	(KO)	mice	have	become	a	valuable	resource	for	study	
of	the	effects	of	circadian	disruption.	Other	than	loss	of	circadian	rhythms,	these	mice	also	exhibit	a	
greatly	reduced	life	span	and	develop	various	features	consistent	with	premature	ageing	(Bunger	et	
al.,	2005,	Kondratov	et	al.,	2006,	McDearmon	et	al.,	2006,	Musiek	et	al.,	2013).	A	conventional	KO	of	
Bmal1	 also	 caused	 infertility,	 a	 reduced	 body	 weight,	 organ	 shrinkage	 (Kondratov	 et	 al.,	 2006),	
impaired	glucose	homeostasis	(Rudic	et	al.,	2004,	Lamia	et	al.,	2008)	and	abnormal	bone	calcification	
(McDearmon	et	al.,	2006).	In	mice,	deletion	of	Bmal1	prenatally	disrupts	clock-dependent	oscillatory	
gene	 expression	 and	 behavioural	 rhythmicity	 coincident	with	 reduced	 body	weight,	 impaired	 hair	
growth,	abnormal	bone	calcification,	eyes	pathologies,	neurodegeneration	and	a	shortened	lifespan	
(Bunger	et	al.,	2005,	Kondratov	et	al.,	2006,	McDearmon	et	al.,	2006,	Musiek	et	al.,	2013).	Reports	of	
a	 postnatal	 KO	of	Bmal1	 in	 the	 cartilage	 demonstrated	 a	 key	 role	 of	 normal	 circadian	 rhythm	 for	
growth	 plate	 chondrogenesis,	 and	 that	 an	 inhibition	 of	 the	 rhythm	 influences	 the	 chondrocyte	
proliferation,	 differentiation	 and	 apoptosis	 (Ma	 et	 al.,	 2019).	 Furthermore,	 pancreatic	 islet	 cell	
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maturation	was	 also	 characterised	 by	 induction	 in	 the	 expression	 of	 circadian	 transcription	 factor	
Bmal1,	deletion	of	which	altered	postnatal	development	of	glucose-stimulated	insulin	secretion	and	
the	 associated	 transcriptional	 network	 (Rakshit	 et	 al.,	 2018).	 	 Both	 prenatal	 and	 postnatal	Bmal1	
knockout	mice	displayed	similar	ocular	abnormalities	and	brain	astrogliosis	(Yang	et	al.,	2016).		
	 	
	 Moving	 towards	 the	 negative	 elements	 of	 the	molecular	 clock,	 a	 disruption	 of	 the	 genes	
implicated	allowed	for	the	assessment	of	their	role	in	regulating	circadian	rhythms.	Mice	homozygous	
for	the	targeted	allele	of	either	mPer1	or	mPer2	had	severely	disrupted	locomotor	activity	rhythms	
during	an	extended	exposure	to	DD	(Bae	et	al.,	2001).	Homozygous	mPer1	mutants	display	a	shorter	
circadian	period	with	reduced	precision	and	stability	(Zheng	et	al.,	2001).	In	vivo,	the	function	of	mPer2	
was	assessed:	a	deletion	mutation	in	the	PAS	domain	of	the	mouse	mPer2	gene	was	generated	and	
characterised	(Zheng	et	al.,	1999).	It	was	shown	that	mice	homozygous	for	this	mutation	displayed	a	
shorter	 circadian	 period	 followed	 by	 a	 loss	 of	 circadian	 rhythmicity	 in	 DD	 (in	 line	with	 the	 above	
statement).	 Additionally,	 behavioural	 rhythms	 of	mPer1/mPer3	 and	mPer2/mPer3	 double-mutant	
mice	resembled	rhythms	of	mice	with	disruption	of	mPer1	or	mPer2	alone,	respectively,	confirming	
the	 placement	 of	 mPer3	 outside	 the	 core	 circadian	 clockwork	 (Bae	 et	 al.,	 2001).	 In	 contrast,	
mPer1/mPer2	double-mutant	mice	were	immediately	arrhythmic.	Thus,	mPER1	influences	rhythmicity	
mainly	through	interaction	with	other	clock	proteins,	while	mPER2	positively	regulates	rhythmic	gene	
expression.	Mutations	in	the	Per1	and	Per2	genes	altered	phase	resetting	in	response	to	a	nocturnal	
light	pulse,	with	Per2	mutant	mice	known	to	become	arrhythmic	 in	DD	 (Steinlechner	et	al.,	2002).		
Under	 constant	 light	 conditions,	Per2	mutant	mice	exhibit	 robust	activity	 rhythms	as	well	 as	body	
temperature	rhythms	with	a	period	length	of	less	than	24	hours.	In	Per1	mutants,	the	period	length	
of	both	activity	and	body	temperature	rhythms	is	longer	than	24	hours	in	constant	light.	Per1	mutants	
prolong	 their	 period	 length	 when	 illuminance	 is	 increased,	 whereas	 Per2	 mutant	 shorten	 their	
endogenous	period.	Locomotor	activity	rhythms	in	mPER3-deficient	mice	were	grossly	normal,	but	the	
circadian	cycle	length	was	significantly	(0.5h)	shorter	than	that	in	controls	(Shearman	et	al.,	2000a).	
This	demonstrated	that	mPer3	is	not	necessary	for	circadian	rhythms	in	mice.	Mice	lacking	the	CRY1	
or	 CRY2	 protein	 display	 accelerated	 and	 delayed	 free-running	 periodicity	 of	 locomotor	 activity,	
respectively	(van	der	Horst	et	al.,	1999).	Strikingly,	in	the	absence	of	both	proteins,	an	instantaneous	
and	 complete	 loss	 of	 free-running	 rhythmicity	 is	 observed.	 This	 suggests	 that	 both	 proteins	 are	
essential	 for	 the	maintenance	of	 circadian	 rhythmicity.	Another	 study	generated	Cry1-/-	 and	Cry1-/-
Cry2-/-	 mice,	 with	 the	 aim	 of	 analysing	 their	 circadian	 clocks	 at	 behavioural	 and	molecular	 levels.	
Behaviourally,	the	Cry1-/-	mice	had	a	1	hour	shorter	circadian	period	compared	to	wild	types,	and	the	
Cry1-/-Cry2-/-	mice	were	arrhythmic	in	DD	(Vitaterna	et	al.,	1999).	Interestingly,	the	clock	continues	to	
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oscillate	when	 a	 single	 gene	 is	mutated	within	 the	 PER	 or	 CRY	 family	 (van	 der	Horst	 et	 al.,	 1999,	
Vitaterna	et	al.,	1999,	Zheng	et	al.,	1999,	Bae	et	al.,	2001,	Cermakian	et	al.,	2001,	Zheng	et	al.,	2001).		
	
	 The	 importance	 of	 the	 post-translational	 regulation	 within	 the	 core	 mechanism	 of	 the	
circadian	clock	is	supported	by	the	fact	that	mutations	in	CK1e	and	CK1d	have	dramatic	effects	on	the	
circadian	period	 (Ko	et	al.,	2006).	 Indeed,	 these	mutations	 resulted	 in	altered	kinase	activities	and	
shorter	circadian	periods	in	mammals	(Ralph	et	al.,	1988,	Lowrey	et	al.,	2000,	Xu	et	al.,	2005,	Gallego	
et	al.,	2006),	becoming	of	particular	interest	in	humans	as	implicated	in	familial	advanced	sleep	phase	
syndrome	(FASPS)	(Toh	et	al.,	2001,	Xu	et	al.,	2005).	Most	of	the	core	components	of	the	molecular	
clock	mentioned	above	maintain	their	rhythmicity	in	the	SCN	and	in	peripheral	tissues	(Ko	et	al.,	2006).	
However,	some	components	vary	in	their	intrinsic	rhythmic	properties	across	the	tissues.	Clock	mRNA,	
for	instance,	is	expressed	constitutively	in	the	SCN	but	cycles	in	peripheral	tissues	(Lowrey	et	al.,	2004).	
In	addition,	members	of	 the	Ror	 family	 (a,	β and	g)	display	strikingly	different	expression	patterns	
across	tissues	with	varying	circadian	peak	times	(Akashi	et	al.,	2005,	Guillaumond	et	al.,	2005).	Rora	
presents	a	robust	circadian	rhythm	in	the	SCN,	but	only	a	slight	oscillation	at	the	periphery	(Sato	et	
al.,	 2004,	 Akashi	 et	 al.,	 2005,	 Guillaumond	 et	 al.,	 2005).	 On	 the	 contrary,	 Rorg	 shows	 rhythmic	
expression	in	peripheral	tissues	and	is	not	expressed	in	the	SCN	(Sato	et	al.,	2004,	Guillaumond	et	al.,	
2005).	 Lastly,	 mice	 lacking	 functional	 Rora	 have	 normal	 clock	 gene	 rhythms	 in	 peripheral	 tissues	
including	Bmal1	mRNA	rhythm;	suggesting	that	ROR	proteins	(a,	β and	g)	may	contribute	differently	
to	rhythmic	Bmal1	activation	in	a	tissue-dependent	manner	(Emery	et	al.,	2004,	Sato	et	al.,	2004).	
	
1.5.3	Clock	controlled	genes	
	
	 Genes	 under	 the	 control	 of	 clock	 proteins	 and	 whose	 time-of-day	 specific	 expression	 is	
dependent	upon	the	circadian	oscillator	are	 termed	clock	controlled	genes	(Ripperger	et	al.,	2000,	
Ueda	et	al.,	2005).	A	decade	ago,	thousands	of	CCGs	had	already	been	identified,	and	the	complexity	
of	 their	 tissue-	 and	 day	 time-specific	 regulation	 suggested	 that	 many	 regulatory	 mechanisms	
contributed	to	the	transcriptional	output	of	the	circadian	clock	(Bozek	et	al.,	2009).	Indeed,	a	meta-
analysis	of	DNA-array	data	from	rodent	tissues	was	carried	out,	and	the	promoter	regions	of	over	2000	
CCGs	were	 searched	 for	 highly	 overrepresented	 transcription	 factor	 binding	 sites,	many	 of	 which	
exhibited	circadian	rhythms.	These	CCGs	modulate	essential	physiological	processes	in	an	optimised	
tissue-specific	manner	(Korencic	et	al.,	2014).	Examples	are	the	gating	of	cell	division	via	Myc	and	Weel	
(Fu	et	al.,	2003),	the	control	of	metabolism	due	to	rhythmic	nuclear	receptors	(Yang	et	al.,	2006)	as	
well	 as	 the	modulation	of	 the	 immune	 response	 (Keller	 et	al.,	 2009)	among	others.	Genome-wide	
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transcription	profiles	revealed	that	CCGs	differ	drastically	from	tissue	to	tissue	(Yan	et	al.,	2008),	with	
the	corresponding	gene	sets	exhibiting	little	overlap	(about	10%)	and	featuring	different	peak	phase	
distributions	(Storch	et	al.,	2002).	
	
	 An	important	CCG	is	Dbp,	founding	member	of	the	proline	and	acidic	amino	acid-rich	basic	
leucine	zipper	(PAR	bZip)	transcription	factors.	DBP	protein	and	mRNA	accumulation	were	shown	to	
undergo	circadian	cycles	with	amplitudes	 in	excess	of	one	hundred-fold	 (Wuarin	 et	al.,	1990).	The	
expression	of	the	Dbp	gene	oscillates	with	a	large	daily	amplitude	in	the	liver,	pancreas,	heart,	muscle	
and	 lung	 (Wuarin	 et	al.,	 1992,	 Fonjallaz	 et	al.,	 1996),	 and	with	a	moderate	amplitude	 in	 the	brain	
(Lopez-Molina	et	al.,	1997).	Furthermore,	peak	and	minimum	levels	of	Dbp	mRNA	are	reached	about	
4	hours	earlier	in	the	SCN	than	in	the	liver,	suggesting	that	circadian	Dbp	expression	is	controlled	by	
different	 mechanisms	 in	 the	 SCN	 and	 peripheral	 tissues.	 Mice	 homozygous	 for	 a	 Dbp-null	 allele	
displayed	less	locomotor	activity	and	free-ran	with	a	shorter	period	than	otherwise	wild	type	animals.	
The	altered	locomotor	activity	in	Dbp	mutant	mice	and	the	highly	rhythmic	expression	of	the	Dbp	gene	
in	SCN	neurons	suggested	that	Dbp	was	involved	in	controlling	circadian	behaviour.	However,	Dbp-/-	
mice	are	still	rhythmic	and	since	the	DBP	protein	is	not	required	for	the	circadian	expression	of	its	own	
gene,	Dbp	is	more	likely	to	be	a	component	of	the	circadian	pathway	than	a	master	gene	of	the	clock.	
	
	 In	2000,	the	way	the	central	negative	feedback	loop	was	driving	the	circadian	expression	of	
CCGs	was	 studied,	 and	Dbp	 was	 used	 to	 answer	 this	 question	 (Ripperger	 et	 al.,	 2000).	 This	work	
showed	that	circadian	Dbp	transcription	requires	the	basic	helix-loop-helix-PAS	protein	CLOCK,	which	
regulates	Dbp	expression	by	binding	to	E-box	motifs,	previously	found	in	the	promoter	sequence	of	
the	 murine	 clock	 gene	 mPeriod1.	 Hence,	 the	 same	 molecular	 mechanisms	 generating	 circadian	
oscillations	in	the	expression	of	clock	genes	may	directly	control	the	rhythmic	transcription	of	clock	
output	regulators	such	as	Dbp.	Others	bZip	transcription	factors	are	the	hepatic	leukaemia	factor	(HLF)	
and	 the	 thyrotroph	 embryonic	 factor	 (TEF),	 also	 accumulating	 in	 the	 SCN,	 liver,	 kidney	 and	 other	
peripheral	 tissues	 according	 to	 high-amplitude	 circadian	 rhythms	 (Schibler	 2005).	 Genetic	 loss-of-
function	studies	revealed	that	mice	deficient	for	only	one	of	these	circadian	transcription	factors	have	
a	normal	 life	expectancy	and	display	only	mild	phenotypes.	However,	PAR	bZip	 triple	KO	mice	are	
behaviourally	 rhythmic	 and	 exhibit	 nearly	 WT	 cycles	 in	 core	 clock	 gene	 expression,	 although	
presenting	a	dramatically	shortened	lifespan	(Gachon	et	al.,	2004a,	Schibler	2005).	Hence,	DBP,	HLF,	
and	TEF	are	output	regulators	rather	than	central	components	of	the	molecular	oscillator	(Gachon	et	
al.,	2004a).	In	2006,	it	was	confirmed	that	the	PAR	bZIP	transcription	factors	DBP,	TEF	and	HLF	were	
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the	transcripts	of	tissue-specific	clock-controlled	genes,	accumulating	in	a	highly	circadian	manner	in	
several	tissues,	including	the	liver	and	kidney	(Gachon	et	al.,	2006).		
	
	 Differentiated	Embryo	Chondrocytes	genes	1	and	2	(Dec1	and	Dec2)	are	also	basic	helix-loop-
helix	transcription	factors,	able	to	repress	CLOCK/BMAL1-induced	transactivation	of	the	mouse	Per1	
promoter	 through	 direct	 protein-protein	 interactions	 with	 BMAL1	 and/or	 competition	 for	 E-box	
elements	 (Honma	 et	 al.,	 2002).	 Dec1	 and	Dec2	 are	 expressed	 in	 the	 suprachiasmatic	 nucleus	 in	 a	
circadian	fashion,	with	a	peak	in	the	subjective	day.	In	addition,	the	rhythmic	expression	of	Dec1	and	
Dec2	outside	the	SCN	may	reflect	their	roles	in	the	interacting	molecular	feedback	loops	of	peripheral	
clocks	(Yamazaki	et	al.,	2000).	As	DEC	expression	is	up-regulated	by	CLOCK/BMAL1	heterodimers,	DECs	
seem	to	be	important	components	of	an	additional	auto-regulatory	feedback	loop	interlocking	with	
the	core	feedback	loop	of	circadian	oscillation	(Honma	et	al.,	2002).	A	year	later,	microarray	analyses	
using	 liver	 RNA	 isolated	 from	 Clock	 mutant	 mice	 were	 performed,	 in	 order	 to	 examine	 CLOCK-
regulated	circadian	transcription	in	peripheral	tissues	and	compare	expression	profiles	with	those	of	
Cry1	and	Cry2	double	knockout	mice	(Oishi	et	al.,	2003).	In	Clock	mutant	mice,	the	expression	levels	
of	Dbp	were	decreased	across	all	time	points	examined,	whereas	the	expression	levels	of	most	of	the	
CLOCK-regulated	circadian	genes	were	depressed,	but	still	rhythmic,	in	the	mouse	liver.	Thus,	CLOCK	
is	either	absolutely	concerned	with	the	circadian	transcriptional	regulation	of	some	genes	(such	as	
Dbp	and	Tef),	and	partially	with	that	of	others	(mPer1,	mPer2,	mDec1).	In	addition,	the	expression	of	
mDec1	mRNA	was	demonstrated	circadian	in	the	liver	(Oishi	et	al.,	2003)	as	well	as	in	the	SCN	(Honma	
et	al.,	2002),	and	considered	to	be	positively	regulated	by	CLOCK/BMAL1	heterodimers	(Honma	et	al.,	
2002).	 These	 results	 highlighted	 that	 CLOCK	 and	 CRY	 proteins	 are	 involved	 in	 the	 transcriptional	
regulation	of	many	circadian	output	genes	in	the	mouse	liver.	
	
	 Further	work	 identified	clock-controlled	elements	on	clock	and	clock-controlled	genes,	 in	a	
comprehensive	 surveillance	 of	 evolutionarily	 conserved	 cis	 elements	 and	 measurement	 of	 their	
transcriptional	dynamics	(Ueda	et	al.,	2005).	The	roles	of	E/E’	boxes,	DBP/E4	Promoter-Binding	Protein	
4	(E4BP4,	an	additional	leucine	zipper	transcription	factor)	and	REV-ERBα/ROR	binding	elements	were	
reported.	Results	showed	that	circadian	transcriptional	circuits	are	governed	by	two	design	principles:	
the	 regulation	 of	 E/E’	 boxes	 and	 REV-ERBα/ROR	 binding	 elements	 follows	 a	 repressor-precedes-
activator	pattern,	resulting	in	delayed	transcriptional	activity,	whereas	the	regulation	of	DBP/E4BP4	
binding	elements	follows	a	repressor-antiphasic-to-activator	mechanism,	generating	high-amplitude	
transcriptional	activity.		
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1.6	Adipose	tissue	
	
1.6.1	Overview	
	
	 Adipose	tissue	is	a	major	metabolic	organ,	traditionally	classified	as	either	WAT	or	BAT.	Both	
are	involved	in	energy	balance	(Klaus	2004,	Rosen	et	al.,	2006),	as	they	are	not	only	lipid	storing	and	
mobilising	tissues	but	also	functionally	specialised	tissues	able	to	dissipate	energy	in	the	form	of	heat	
(BAT)	 (Cannon	 et	 al.,	 2004),	 and	 to	 release	 a	 vast	 number	 of	 hormones	 called	 adipokines	 (WAT)	
(Trayhurn	 et	 al.,	 2006).	 Adipokines	 are	 important	 components	 of	 the	 neuroendocrine-immune	
network	and	molecular	links	between	obesity	and	several	pathologies	(Chadt	et	al.,	2000,	Lorincz	et	
al.,	2006,	Wang	et	al.,	2010,	Emanuela	et	al.,	2012,	Zamanian-Azodi	et	al.,	2013,	Andreone	et	al.,	2018).	
BAT	and	WAT	differ	by	their	anatomical	locations,	morphological	structures,	functions	and	regulations	
(Park	et	al.,	2014).	WAT	 is	distributed	 throughout	 the	body	 (Park	et	al.,	2014),	whereas	BAT	has	a	
distinct	 localisation	 to	 the	 posterior	 regions	 of	 the	 neck,	 thorax,	 and	 abdomen,	 which	 may	 have	
physiological	implications	regarding	the	role	and	growth	pattern	of	BAT	in	adult	humans	(Leitner	et	
al.,	2017).	
	
	 The	function	of	BAT	is	to	transfer	energy	from	food	into	heat;	physiologically,	both	the	heat	
produced	 and	 the	 resulting	decrease	 in	metabolic	 efficiency	 can	be	of	 significance	 (Cannon	 et	 al.,	
2004).	Both	the	acute	activity	of	the	tissue,	such	as	heat	production,	as	well	as	the	recruitment	process	
in	the	tissue	leading	to	a	higher	thermogenic	capacity,	are	under	the	control	of	noradrenaline	released	
from	the	sympathetic	nerves.	In	terms	of	morphology,	brown	adipocytes	are	normally	smaller	than	
white	 fat	 cells.	 Indeed,	 brown	 adipocytes	 are	 characterised	 by	 smaller,	 multiple	 droplets	 of	
triglycerides	(TGs),	accessible	for	rapid	hydrolysis	and	oxidation	of	the	fatty	acids	(FAs).	A	high	content	
of	mitochondria	 (which	 produce	 the	 brown	 colour)	 and	 the	 presence	 of	 the	 uncoupling	 protein	 1	
(UCP1)	 allow	 the	 use	 of	 the	 energy	 derived	 from	 fatty	 acid	 oxidation	 for	 the	 generation	 of	 heat.	
Furthermore,	significant	depots	of	brown	fat	are	found	in	rodents	and	other	animals	throughout	life,	
which	are	present	in	human	infants	and	might	persist	in	adults	(Nedergaard	et	al.,	2007).	Brown	fat	is	
primarily	distributed	around	interscapular	BAT	(iBAT),	axillary,	paravertebral	and	perirenal	sites	(Park	
et	 al.,	 2014).	 In	 humans	 and	 other	 large	mammalian	 species,	 BAT	was	 traditionally	 thought	 to	 be	
restricted	to	the	neonatal	and	early	childhood	periods	(Lean	1989,	Enerback	2010).	However,	positron	
emission	 tomography	 (PET)	 scanning	used	 to	analyse	BAT	clearly	 showed	an	active	BAT	present	 in	
adult	 humans	 at	 discrete	 anatomical	 sites,	 especially	 in	 the	 upper	 trunk,	 such	 as	 cervical,	
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supraclavicular,	paravertebral	and	pericardial	areas	among	others	(Nedergaard	et	al.,	2007,	Cypess	et	
al.,	2009,	van	Marken	Lichtenbelt	et	al.,	2009,	Virtanen	et	al.,	2009).	
		
	 White	adipose	tissue	has	long	been	recognized	as	the	main	site	of	storage	of	excess	energy	
(Ribeiro	et	al.,	2012).	In	addition,	adipocytes	have	been	studied	with	increasing	intensity	as	a	result	of	
the	emergence	of	obesity	as	a	serious	public	health	problem	and	the	realisation	that	adipose	tissue	
serves	as	an	integrator	of	various	physiological	pathways	(Rosen	et	al.,	2006).	In	particular,	their	role	
in	calorie	storage	makes	adipocytes	well	suited	to	the	regulation	of	energy	balance,	and	adipose	tissue	
also	serves	as	an	important	integrator	of	glucose	homeostasis.	The	importance	of	the	adipose	tissue	
in	the	development	of	obesity	and	diabetes	linked	with	circadian	desynchrony	made	this	tissue	the	
subject	of	this	thesis	and	will	be	detailed	in	sections	1.6.2,	1.6.3	and	1.6.4	of	this	introduction.		
	
	 Recently,	a	new	type	of	brown-like	adipocytes	was	discovered,	with	a	distinct	gene	expression	
pattern	from	either	white	or	brown	fat	(Wu	et	al.,	2012).	These	brown-like	cells	within	white	adipose	
depots	were	termed	beige	(or	brite)	adipocytes	(Seale	et	al.,	2008,	Ishibashi	et	al.,	2010,	Petrovic	et	
al.,	 2010).	 Moreover,	 beige	 cells	 resemble	 white	 fat	 cells	 in	 the	 basal	 state,	 but	 respond	 to	
thermogenic	stimuli	with	increased	levels	of	thermogenic	genes	as	well	as	respiration	rates	(Park	et	
al.,	2014).	Beige	fat	develops	postnatally	and	is	highly	inducible	(Rui	2017).	Its	recruitment	is	mediated	
by	multiple	mechanisms,	including	de	novo	beige	adipogenesis	and	white-to-brown	adipocyte	trans-
differentiation.	Interestingly,	metabolic	hormones,	paracrine/autocrine	factors,	and	various	immune	
cells	also	play	a	critical	role	in	regulating	brown	and	beige	fat	functions.	Furthermore,	BAT	and	beige	
fat	defend	temperature	homeostasis,	and	contribute	to	the	control	of	body	weight,	glucose	as	well	as	
lipid	metabolism.				
	
	 It	 is	worth	noting	 that	some	areas	of	 the	adipose	depots	are	brown	 (corresponding	 to	 the	
BAT),	but	many	are	white	and	match	the	white	adipose	tissue	(Cinti	2005).	Adipose	(or	fat)	tissue	is	
often	referred	to	as	a	mesodermally-derived	organ	(Strem	et	al.,	2005),	is	highly	vascularised	(Haugen	
et	al.,	2007)	and	has	a	major	role	in	the	survival	of	the	body	through	allowing	storage	and	dispensing	
of	 energy	 for	 the	 regulation	 of	 thermogenesis,	 metabolism,	 lactation	 and	 immune	 responses.	
Originally,	 BAT	 derived	 from	 a	 myogenic	 factor	 5	 (Myf5)-expressing	 cell	 lineage	 and	 WAT	
predominantly	arise	from	non-Myf5	lineages,	although	a	subpopulation	of	adipocytes	in	some	WAT	
depots	can	be	derived	from	the	Myf5	lineage	(Shan	et	al.,	2013).	Furthermore,	it	was	found	that	the	
Myf5-lineage	constitution	in	subcutaneous	WAT	depots	was	negatively	correlated	to	the	expression	
of	classical	BAT	and	beige/brite	adipocyte-specific	genes.	The	brown-like	cells	are	thus	not	derived	
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from	the	Myf-5	 lineage	(Seale	et	al.,	2008,	 Ishibashi	et	al.,	2010,	Petrovic	et	al.,	2010).	Figure	1.10	
below	illustrates	the	differentiation	of	mesenchymal	cells	into	white,	brown	or	beige	adipocytes.	
																
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	1.10:	Differentiation	of	mesenchymal	stem	cells	into	white,	brown	or	beige	adipocytes.	Taken	
from	Park	et	al.,	2014.	Previously,	white	and	brown	adipocytes	were	thought	to	be	derived	from	the	
same	precursor	cell.		However,	recent	studies	demonstrated	that	brown	fat	shares	a	progenitor	cell	
(Myf5+)	with	the	skeletal	muscle	and	not	with	white	adipocytes.	The	Myf5+	precursors	are	induced	to	
transform	into	mature	brown	adipocytes	by	the	bone	morphogenetic	protein	7	(BMP7),	peroxisome	
proliferator-activated	 receptor-g	 (PPAR-g)	 and	 CCAAT/enhancer-binding	 proteins	 (C/EBPs)	 in	
cooperation	with	the	transcriptional	co-regulator	PR	domain-containing	16	(PRDM16)	and	peroxisome	
proliferator-activated	 receptor	gamma	coactivator	1-alpha	 (PGC-1α).	White	adipocytes	can	also	be	
transformed	to	brown-like	adipocytes,	called	beige/brite	adipocytes,	by	cold	exposure,	a	α-adrenergic	
agonist	or	a	PPAR-g	agonist.	AR:	Adrenergic	 receptor;	FGF21:	Fibroblast	growth	 factor	21;	PGC-1α:	
Peroxisome	proliferator-activated	receptor	gamma	coactivator	1-alpha.	 
	
1.6.2	Adipogenesis	and	general	anatomy	of	white	adipose	tissue	
	
	 Adipose	 tissue	 contains	 a	 stromal	 population	 of	 microvascular	 endothelial	 cells,	 smooth	
muscle	cells	and	stem	cells	 (Zuk	et	al.,	2001).	The	stem	cells	 forming	this	adipose	stromal	vascular	
fraction	 (SVF)	 have	been	 referred	 to	 as	 resident	 “adipose	 stem	 cells”,	 corresponding	 to	 adipocyte	
progenitors,	 which	 can	 be	 differentiated	 down	 adipogenic,	 cartilage-forming	 chondrocyte	 and	
osteoblastic	 bone	 lineages	 when	 induced	 in	 vitro	 with	 appropriate	 stimulation	 (figure	 1.11)	
(Rodeheffer	et	al.,	2008).	Another	site	of	adipocyte	formation	is	the	bone	marrow,	developing	post-
natally	and	accounting	for	50-70%	of	the	bone	marrow	volume	in	healthy	adult	individuals	(Gimble	et	
al.,	 1996,	 Cawthorn	 et	 al.,	 2017).	 After	 enzymatic	 digestion,	 the	 cells	 constituting	 the	 SVF	 can	 be	
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separated	 from	 the	 buoyant	 adipocytes	 by	 centrifugation,	 and	 a	 more	 homogeneous	 population	
emerges	 in	culture	(Strem	et	al.,	2005).	This	population,	termed	adipose	tissue-derived	stems	cells	
(ADSCs,	figure	1.11),	 is	capable	of	an	extensive	proliferative	potential	and	to	undergo	multi-lineage	
differentiation	(Zuk	et	al.,	2002,	De	Ugarte	et	al.,	2003).	It	is	believed	that	the	adipose	tissue	derives	
from	ADSCs,	which	can	develop	into	fat,	bone,	muscle,	heart,	blood	vessels,	nerves	and	cartilage	as	
illustrated	in	figure	1.11	below.	
	
	
	
	
	
	
	
	
	
	
Figure	 1.11:	 Adipose	 Tissue-Derived	
Stem	Cells	are	multipotent,	extending	
beyond	 the	 traditional	 mesenchymal	
lineages.	Taken	from	Strem	et	al.,	2005.	
	
	 Adipogenesis	 is	 then	defined	as	 the	process	by	which	multipotent	precursor	mesenchymal	
stem	cells	differentiate	into	lipid	laden	adipocytes	(Moseti	et	al.,	2016).	This	process	is	regulated	by	a	
complex	and	highly	orchestrated	gene	expression	program	involving	a	cascade	of	transcription	factors	
that	together	lead	to	the	establishment	of	the	differentiated	state	(Rosen	2005,	Moseti	et	al.,	2016).	
In	 the	presence	of	 the	 correct	 hormonal	 cues,	 committed	pre-adipocytes	 express	 the	bZIP	 factors	
C/EBPb	and	C/EBPd	(Rosen	2005).	These	factors	in	turn	induce	the	expression	of	C/EBPa	and	PPARg.	
C/EBPa	and	PPARg	together	promote	differentiation	by	activating	adipose-specific	gene	expression	
and	by	maintaining	each	other’s	expression	at	high	level	(figure	1.10).	This	could	be	followed	using	cell	
lines	known	to	be	able	to	undergo	adipogenesis	after	addition	of	an	appropriate	adipogenic	cocktail,	
such	as	3-day	transfer,	inoculum	3x105	(3T3)-L1	pre-adipocytes	(section	1.6.5).	Using	these	cells,	it	was	
shown	that	C/EBPa		and	PPARg	remained	elevated	after	initiation	of	their	expression,	for	the	rest	of	
the	differentiation	process	and	for	the	life	of	the	mature	adipocyte	(Yeh	et	al.,	1995,	Darlington	et	al.,	
1998).	C/EBPa	 	and	PPARg	 remain	the	most	critical	 factors	yet	discovered	 for	adipogenesis	 (Rosen	
2005).	Another	work	used	two	pluripotent	cell	lines	to	confirm	that	C/EBPs	were	playing	an	integral	
role	in	the	determination	and	differentiation	of	pre-adipocytes	(Darlington	et	al.,	1998).	It	was	found	
that	C/EBPb	committed	cells	to	the	pre-adipocyte	lineage,	and	that	C/EBPb	as	well	as	d	were	initiating	
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the	 differentiation	 cascade.	 Embryonic	 fibroblasts	 from	 mice	 lacking	 both	 C/EBPb	 and	 C/EBPd	
expression	are	unable	to	differentiate	in	response	to	hormonal	stimulation	(Tanaka	et	al.,	1997).	These	
cells	fail	to	express	C/EBPa	 	and	PPARg	as	well	as	adipocyte	markers	such	as	phosphoenolpyruvate	
carboxykinase	(PEPCK),	suggesting	that	the	absence	of	both	C/EBPb	and	C/EBPd	blocks	adipogenesis.	
In	 addition	 to	 its	 involvement	 in	 the	 sequence	 of	 genetic	 events	 leading	 to	 pre-adipocyte	
differentiation,	C/EBPb	may	play	a	more	global	role	in	adipocyte	development	by	causing	pluripotent	
cells	to	become	committed	to	the	adipocyte	lineage,	such	as	NIH	3T3	and	C3H10T1/2	(Darlington	et	
al.,	 1998).	 Although	 the	 introduction	 of	 C/EBPb	 into	 pluripotent	 NIH	 3T3	 cells	 does	 not	 cause	
spontaneous	differentiation,	C/EBPb	(but	not	C/EBPa	or	C/EBPd)	confers	the	ability	of	these	cells	to	
be	 differentiated	 into	 adipocytes	 by	 hormonal	 inducers	 (Wu	 et	 al.,	 1995,	 Yeh	 et	 al.,	 1995).	
Interestingly,	 the	expression	of	C/EBPb	 in	 these	cells	causes	pre-adipocytes	differentiation	without	
induction	of	C/EBPa,	perhaps	indicating	that	C/EBPb	can	functionally	replace	C/EBPa,	or	that	C/EBPa	
is	not	required	for	adipogenesis	(Darlington	et	al.,	1998).	
	
	 To	 induce	 adipogenesis	 of	 3T3-L1	 cells	 in	 culture,	 an	 adipogenic	 cocktail	 constituted	 of	
dexamethasone,	3-isobutyl-1-methylxanthine	(IBMX)	and	insulin.		The	role	of	these	three	components	
in	adipocyte	differentiation	has	been	quite	broadly	discussed	in	the	literature.	For	instance,	insulin	has	
been	shown	to	be	a	potent	adipogenic	hormone	triggering	the	induction	of	a	series	of	transcription	
factors	governing	the	differentiation	of	pre-adipocytes	into	mature	adipocytes	(Klemm	et	al.,	2001).	
This	especially	through	the	activation	of	the	Mitogen-Activated	Protein	(MAP)	kinase	pathway	and	the	
cyclic	 adenosine	monophosphate	 response	 element-binding	 (CREB)	 protein,	 central	 transcriptional	
activator	of	the	adipocyte	differentiation	program	(Reusch	et	al.,	2000,	Klemm	et	al.,	2001,	Petersen	
et	al.,	2008).	 IBMX	 is	a	phosphodiesterase	 inhibitor,	which	has	also	been	 indicated	to	 increase	the	
cellular	 levels	 of	 cAMP,	 promoting	 the	 expression	of	 C/EBPβ	 (Zhang	 et	 al.,	 2004).	Once	 the	 cAMP	
content	 increases,	 the	 protein	 kinase	 A	 (PKA)	 as	well	 as	 the	 exchange	 protein	 activated	 by	 cyclic	
adenosine	monophosphate	(EPAC)	are	activated	(Gabrielli	et	al.,	2014).	This	leads	to	the	increase	of	
C/EBPβ	but	also	of	PPAR-γ.	PPAR-γ	has	been	shown	 to	be	 induced	during	adipogenesis,	and	 to	be	
necessary	 as	 well	 as	 sufficient	 for	 adipocyte	 differentiation	 (Chawla	 et	 al.,	 1994,	 Tontonoz	 et	 al.,	
1994b),	thereby	establishing	this	component	as	a	master	regulator	of	adipogenesis	(Tontonoz	et	al.,	
1994a).	 DEX	 is	 a	 synthetic	 glucocorticoid	 agonist,	 traditionally	 used	 to	 stimulate	 glucocorticoid	
receptor	 pathway	 (Higgins	 et	 al.,	 1973).	 It	 is	 able	 to	 promote	 the	 differentiation	 of	 cultured	 pre-
adipose	cell	lines,	through	an	effect	mediated	by	the	GR.	Interestingly,	the	effects	of	DEX	on	human	
adipocyte	differentiation	was	revealed	to	be	mediated	by	the	regulation	of	the	expression	of	nuclear	
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factors,	such	as	PPAR-γ	and	C/EBPα,	already	mentioned	earlier	for	IBMX	and	insulin	(Zilberfarb	et	al.,	
2001).	
	
	 White	adipose	tissue	in	vertebrates,	especially	in	mammals,	birds,	reptiles	and	amphibians,	
contain	classical	fat-storing	cells	(Church	et	al.,	2012).	White	adipocytes	are	unilocular	and	allow	FA	
accumulation	after	a	meal	 (Cinti	2005).	This	unusual	property	of	accumulation	and	release	of	 fatty	
acids	 are	 at	 the	 base	 of	 the	 activity	 of	WAT,	 expressing	 the	 AR	 b3.	 The	 adipose	 tissue	 is	 mostly	
constituted	of	adipocytes	but	 also	of	other	 cell	 types	 such	as	pre-adipocytes,	pericytes,	white	and	
brown	adipocytes,	fibroblasts,	endothelial	cells	and	immune	cells	(macrophages,	dendritic	cells,	mast	
cells,	granulocytes	and	lymphocytes)	as	well	as	nerve	cells	 linked	to	the	ANS	(Haugen	et	al.,	2007).	
Figure	1.12	below	represents	an	anatomical	model	of	WAT.	
	
	
	
	
Figure	 1.12:	 Anatomy	 of	 white	 adipose	
tissue.	 Taken	 from	 Radin	 et	 al.,	 2009.	
Adipose	 tissue	 makes	 up	 a	 diffuse	 organ	
comprised	 of	 adipocytes	 representing	
approximately	 50%	 of	 the	 total	 cellular	
content.	 The	 other	 part	 of	 the	 cellular	
content	of	 the	adipose	 tissue	 includes	pre-
adipocytes,	multipotent	mesenchymal	stem	
cells	 as	well	 as	 endothelial	 cells,	 pericytes,	
nerve	cells,	monocytes	and	macrophages.	
	 	
	
	 There	are	mainly	two	representative	types	of	WAT:	visceral	(vWAT)	and	subcutaneous	(sWAT).	
The	sWAT	is	located	under	the	skin	and	provide	insulation	from	heat	or	cold,	whereas	the	vWAT	can	
be	found	inside	the	peritoneum	and	around	internal	organs	(i.e.	stomach,	liver,	intestines,	kidneys)	
(Park	et	al.,	2014).	The	distribution	of	these	two	fat	depots	vary	between	individuals	and	depend	on	
several	factors	such	as	age,	nutrition,	sex,	and	the	energy	homeostasis	of	the	individual	adipose	tissues	
(Wajchenberg	2000).	The	vWAT	can	again	be	divided	into	omental	and	mesenteric,	the	latter	being	
the	more	deeply	buried	depot	surrounding	the	intestine	(Bjorndal	et	al.,	2011).	In	humans,	the	sWAT	
is	divided	into	superficial	and	deep	subcutaneous	adipose	tissue,	with	distinct	histological	features.	
The	subcutaneous	gluteofemoral	fat	tissue	is	measured	by	hip	or	thigh	circumference,	or	leg	adipose	
tissue	mass.	Accumulation	of	fat	in	this	depot	is	believed	to	have	a	protective	role	against	diabetes	
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and	CVDs	(Manolopoulos	et	al.,	2010).	Indeed,	a	low	amount	of	this	tissue	has	been	associated	with	
an	unfavourable	lipid	and	glucose	profile	(Snijder	et	al.,	2005).	Visceral	WAT	depots	include	gonadal	
fat,	one	of	the	largest	adipose	depots	in	rodents	found	around	the	testis	of	males	(epididymal)	and	
around	the	ovaries	of	females	(periovarian)	(Bjorndal	et	al.,	2011).	Additionally,	epicardial	fat	is	the	
visceral	layer	located	around	the	heart	and	believed	to	be	important	for	the	buffering	of	the	coronary	
arteries,	as	well	as	in	providing	FAs	as	a	source	of	energy	for	the	cardiac	muscle	(Iacobellis	et	al.,	2008).	
Other	depots	include	the	intermuscular	fat,	for	which	few	studies	have	focused	on.	However,	due	to	
its	 increased	 level	 in	 type	 2	 diabetes	 mellitus	 (T2DM)	 patients,	 the	 intermuscular	 fat	 has	 been	
suggested	to	be	a	risk	factor	for	the	development	of	obesity-related	diseases	(Gallagher	et	al.,	2009).	
Figure	1.13	illustrates	the	localisation	of	the	main	white	adipose	tissue	depots.	
	
	
Figure	1.13:	The	main	WAT	depots.	Taken	
from	 Bjorndal	 et	 al.,	 2011.	 The	 principal	
WATs	 are	 abdominal	 subcutaneous	 white	
adipose	tissue	(sWAT,	a),	and	visceral	white	
adipose	 tissue	 (vWAT).	 	 Visceral	 WAT	
surrounds	 the	 inner	 organs	 and	 can	 be	
divided	 in	 omental	 (b),	 mesenteric	 (c),	
retroperitoneal	 ((d):	 surrounding	 the	
kidney),	gonadal	((e):	attached	to	the	uterus	
and	ovaries	of	females	and	epididymis	and	
testis	 of	 men),	 and	 pericardial	 (f).	 The	
gluteo-femoral	 adipose	 tissue	 (g)	 is	 the	
sWAT	located	to	the	lower-body	parts.	WAT	
can	 also	 be	 found	 intramuscularly	 (h).	
Brown	 adipose	 tissue	 is	 found	 above	 the	
clavicle	 ((i):	 supraclavicular)	 and	 in	 the	
subscapular	region	(j).		
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1.6.3	General	physiology	of	white	adipose	tissue	
	
1.6.3.1	Adipose	depots:	physiology	
	
1.6.3.1.1	Visceral	fat	
	
	 Visceral	fat	depots,	 including	omental	and	mesenteric,	represent	a	particular	risk	factor	for	
the	development	of	T2DM	and	CVDs	(Bjorndal	et	al.,	2011).	Visceral	adipose	tissue	mass	correlates	
with	 the	 development	 of	 insulin	 resistance,	 while	 total	 or	 subcutaneous	 tissue	 mass	 does	 not	
(Chowdhury	et	al.,	1994,	Hoffstedt	et	al.,	1997,	Wajchenberg	2000).	Additionally,	it	has	been	largely	
confirmed	that	the	adipocytes	of	visceral	fat	tissue	were	more	lipolytically	active	than	subcutaneous	
adipocytes,	and	thus	contributed	more	to	the	plasma	free	fatty	acids	(FFAs)	levels	(Wajchenberg	2000,	
Hajer	et	al.,	2008).	This	was	found	in	particular	in	diabetic	obese	individuals,	where	it	was	linked	to	a	
significant	upregulation	of	leptin	and	downregulation	of	adiponectin	gene	expression	in	mesenteric	
vWAT	as	compared	to	sWAT	and	omental	vWAT	(Yang	et	al.,	2008).	Moreover,	it	should	be	noted	that	
the	metabolic	activity	of	a	cell	is	dependent	on	its	mitochondrial	content.	In	rats,	it	was	indicated	that	
epididymal	vWAT	adipocytes	contained	more	mitochondria	than	inguinal	sWAT	adipocytes	(Deveaud	
et	al.,	2004).	Individuals	with	a	polymorphism	in	the	Ucp1	promoter	reducing	Ucp1	gene	expression	
are	prone	to	have	a	high	BMI,	in	particular	due	to	abdominal	obesity	(Sramkova	et	al.,	2007).	Thus,	
the	level	of	mitochondrial	uncoupling	and	energy	efficiency	may	have	an	effect	on	obesity	in	WAT	as	
well	as	in	BAT	(Bjorndal	et	al.,	2011).		
	 	
	 In	the	adipose	tissue	of	obese	subjects,	 the	expression	of	Pparg	mRNA	 is	 increased,	with	a	
significantly	higher	expression	in	mesenteric	vWAT,	especially	in	obese	diabetic	subjects	(Yang	et	al.,	
2008).	This	supports	the	notion	that	PPARg	is	involved	in	mesenteric	adipose	tissue	lipolysis.	In	rats,	
lipid	synthesis	was	shown	to	be	higher	in	internal	adipose	tissues	compared	to	sWAT	(Jamdar	1978).	
Interestingly,	 larger	 cells	 were	 found	 in	 the	 retroperitoneal	 vWAT	 expressing	 high	 amounts	 of	
lipogenic	 transcription	 factors	 such	 as	 Pparg	 and	 sterol	 regulatory	 element-binding	 protein-1c	
(Srebp1c),	when	mesenteric	vWAT	and	inguinal	sWAT	showed	a	high	expression	of	lipogenesis-related	
genes	as	well	as	a	low	expression	of	fatty	acid	oxidation-related	genes	(Palou	et	al.,	2009).		
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1.6.3.1.2	Subcutaneous	fat	 	
	
	 The	subcutaneous	white	adipose	tissue	is	less	metabolically	active	than	the	visceral	WAT,	but	
may	have	a	better	short-term	and	long-term	storage	capacity	(Bjorndal	et	al.,	2011).	This	depot	is	thus	
important	to	accumulate	TGs	in	periods	of	excess	energy	intake,	and	to	supply	the	organism	with	FFAs	
in	periods	of	fasting,	starvation	or	exercise.	Another	suggested	role	of	sWAT	is	to	be	a	buffer	during	
intake	 of	 dietary	 lipids,	 protecting	 other	 tissues	 from	 lipotoxic	 effects	 (Frayn	 2002).	 While	 the	
superficial	sWAT	has	not	been	linked	to	risk	for	T2DM,	the	size	of	the	deep	sWAT	depots	is	significantly	
associated	to	the	fasting	insulin	level	and	insulin-stimulated	glucose	utilization,	as	is	total	fat	and	vWAT	
(Kelley	et	al.,	2000,	Smith	et	al.,	2001).	The	association	between	deep	sWAT	and	insulin	resistance	is	
particularly	seen	in	male	obese	patients	(Smith	et	al.,	2001,	Miyazaki	et	al.,	2002).	
	
1.6.3.2	White	adipose	tissue	as	an	energy	storage	site	
	
	 Adipose	cells	are	unique	in	the	dynamism	of	their	sizes,	a	requisite	for	their	main	function	of	
storing	and	releasing	 lipid	(Jo	et	al.,	2012).	Adipose	tissue	 is	the	body’s	 largest	storage	site	for	TGs	
(Bjorndal	et	al.,	2011),	which	are	released	 in	the	circulation	when	fuel	 is	 required	(Trayhurn	et	al.,	
2001).	The	traditional	role	attributed	to	WAT	was	therefore	energy	storage,	with	the	tissue	able	to	
provide	a	long-term	fuel	reserve	which	can	be	mobilised	during	food	deprivation,	and	the	release	of	
fatty	acids	for	oxidation	in	other	organs.	Interestingly,	various	anatomical	depots	i.e.	subcutaneous,	
and	visceral	fat	depots	can	store	energy;	with	a	small	portion	of	around	5%	stored	in	the	liver	or	muscle	
(Gray	et	al.,	2007,	Lefterova	et	al.,	2009).	The	size	of	the	adipose	tissue	stores	increases	in	periods	of	
positive	energy	balance	(hypertrophy)	and	declines	when	energy	expenditure	 is	 in	excess	of	 intake	
(Trayhurn	et	al.,	2001).	Indeed,	the	mature	adipocytes	can	expand	in	size	to	accommodate	increased	
storage	needs	and	in	situations	of	over-nutrition	become	hypertrophic	(Gray	et	al.,	2007).	As	a	result,	
adipocyte	number	and	morphology	vary	in	response	to	energy	balance,	via	the	biochemical	processes	
involved	in	lipid	uptake,	esterification,	lipolysis,	and	differentiation	of	pre-adipocytes.	In	addition,	the	
adipose	 tissue	 expands	 to	 accommodate	 increased	 lipid,	 this	 through	 hypertrophy	 of	 existing	
adipocytes,	 and	by	 initiating	 the	differentiation	of	 pre-adipocytes.	 Researchers	 suggested	 that	 the	
capacity	of	the	adipose	tissue	to	expand	was	critical	for	accommodating	changes	in	energy	availability,	
but	 that	 this	 capacity	 was	 not	 an	 unlimited	 process	 and	 likely	 changed	 between	 individuals.	 In	
addition,	the	capacity	of	adipose	tissue	to	expand	was	thought	to	affect	metabolic	homeostasis,	rather	
than	the	absolute	amount	of	adipose	tissue.	
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	 Fat	accumulation	 is	determined	by	 the	balance	between	 fat	synthesis	 (lipogenesis)	and	 fat	
breakdown	(lipolysis/fatty	acid	oxidation)	(Kersten	2001).	Lipogenesis	encompasses	the	processes	of	
fatty	acid	synthesis	and	subsequent	triglyceride	synthesis,	and	takes	place	in	both	liver	and	adipose	
tissue.	It	differs	from	adipogenesis,	which	refers	to	the	differentiation	of	pre-adipocytes	into	mature	
fat	cells	 (Rosen	et	al.,	2000).	The	regulation	of	 fatty	acid	flow	appeared	to	depend	on	coordinated	
changes	 in	hormone-sensitive	 lipase	 (HSL)	 and	 lipoprotein	 lipase	 (LPL)	 action,	 as	well	 as	 fatty	 acid	
esterification	(Frayn	et	al.,	1994).	The	enzymes	LPL	and	HSL	apparently	catalyse	opposing	functions	in	
WAT:	the	former	is	concerned	with	fat	storage,	whereas	the	latter	is	involved	in	fat	mobilization	(Frayn	
et	al.,	1995).	They	are	both	regulated	in	a	broadly	reciprocal	manner:	in	the	overnight-fasted	state,	
HSL	is	more	active,	but	is	supressed	after	a	meal	whilst	LPL	is	activated.	The	movement	of	fatty	acids	
in	and	out	of	adipose	tissue	appears	to	be	driven	by	concentration	gradients	generated	by	regulation	
of	these	two	enzymes,	and	also	by	activation,	in	the	postprandial	period,	of	the	process	of	fatty	acid	
esterification.		
	
	 Several	 decades	 of	 science	 and	 animal	 research	 have	 provided	 considerable	 support	 for	 a	
causal	role	of	free	fatty	acids	in	the	aetiology	of	T2D,	possibly	through	detrimental	effects	on	insulin	
and	glucose	metabolism	(Bergman	et	al.,	2000).	Higher	FFAs	may	cause	peripheral	insulin	resistance	
by	interfering	with	the	access	of	insulin	to	skeletal	muscle	or	interfering	with	insulin	signalling	resulting	
in	reduced	glucose	transport	into	muscle	(Groop	et	al.,	1991,	Randle	1998).	Levels	of	circulating	free	
fatty	acids	are	elevated	in	the	case	of	obesity,	and	this	is	associated	with	atherosclerosis	and	insulin	
resistance	among	others	(Opie	et	al.,	1963,	Lewis	et	al.,	2002).	Indeed,	chronically	elevated	FFAs	may	
impair	 insulin	 secretory	 function	 through	 toxic	 effects	 on	 pancreatic	 b-cells	 as	 predicted	 by	 the	
“lipotoxicity	 hypothesis”	 (Unger	 1995).	 Insulin-resistant	 hypertrophic	 adipocytes	 have	 increased	
lipolytic	activity,	together	with	an	impaired	ability	to	take	up	FFAs,	and	consequently,	a	redirection	of	
lipids	towards	non-adipose	tissues	(ectopic	fat	deposition)	ensues	(Bluher	2009).	These	non-adipose	
tissues	 normally	 contain	 only	 small	 amount	 of	 fats,	 such	 as	 the	 liver,	 skeletal	 muscle,	 heart	 and	
pancreas	(Snel	et	al.,	2012).	If	fat	accumulates	in	these	tissues,	an	adipose	tissue	dysfunction	emerges,	
with	 effects	 on	 organs	 involved	 in	 the	 insulin-resistant	 pathogenesis	 of	 T2DM	 (liver	 and	 skeletal	
muscle	cell)	and	on	the	heart	 (because	of	 the	strongly	 increased	risk	 for	coronary	heart	disease	 in	
T2DM).	Whilst	it	is	well-known	that	the	WAT	was	able	to	store	large	amounts	of	lipids	in	the	form	of	
triglycerides,	it	is	also	important	to	emphasize	that	the	timing	of	FFAs	release	from	adipose	stores	has	
to	 be	 tightly	 controlled	 (Shostak	 et	 al.,	 2013b).	 This	 as	 an	 excess	 of	 circulating	 lipids	may	 lead	 to	
lipotoxicity	and	promote	cardiovascular	disorders	 (Unger	 et	al.,	 2010).	During	extended	periods	of	
energy	storage	(i.e.	fasting),	the	release	of	lipids	from	WAT	mediated	by	the	hydrolysis	of	TGs	to	FFAs	
64	
	
and	glycerol	(lipolysis)	becomes	an	important	energy	source	for	other	organs	(Shostak	et	al.,	2013b).	
It	was	reported	that	blood	FFAs	and	glycerol	concentrations	show	strong	variations	across	the	day.	
This	 rhythm	 appeared	 critically	 dependent	 on	 the	 presence	 of	 a	 functional	 CLOCK/BMAL1	
heterodimer.	Rhythms	in	FFAs	serum	levels	were	abolished	in	Clock∆19	mutant	mice,	with	decreased	
overall	 levels,	 suggesting	 an	 involvement	 of	 the	 circadian	 clock	machinery	 in	 the	 regulation	 of	 FA	
release	from	TG	stores.	Ultimately,	this	showed	that	adipose-tissue	clocks	may	directly	affect	diurnal	
lipid	homeostasis	by	regulating	FFAs/glycerol	mobilization	directly	from	WAT	stores	via	transcriptional	
regulation	of	the	lipolytic	machinery.	
	
1.6.3.3	White	adipose	tissue	as	an	endocrine	organ	
	
	 The	traditional	view	of	adipose	tissue	as	a	passive	reservoir	for	energy	storage	became	un-
validated	in	the	late	1980s,	when	the	adipose	tissue	was	identified	as	a	major	site	for	the	metabolism	
of	 sex	 steroids	 (Siiteri	 1987).	 In	 the	 same	 year	was	 revealed	 that	 a	 serine	 protease	 homolog	 and	
endocrine	 factor	 called	 adipsin,	 synthesized	 and	 secreted	 by	 adipose	 cells,	 had	 reduced	 mRNA	
abundance	during	continuous	infusion	of	glucose,	which	induces	a	hyperglycaemic,	hyperinsulinemic	
state	(Flier	et	al.,	1987).	Adipsin	mRNA	abundance	was	suppressed	in	two	strains	of	genetically	obese	
mice,	 and	 reduced	when	obesity	was	 induced	 chemically.	 Further	 revising	 the	 concept	 of	 adipose	
tissue	considered	merely	as	an	energy	storage	depot	was	the	discovery	of	leptin,	the	first	adipocyte-
derived	cytokine,	by	Friedman’s	group	 in	1991.	Leptin	release	by	the	adipose	tissue	 in	response	to	
changes	in	nutritional	status	indicates	that	the	adipose	tissue	acts	as	an	endocrine	organ	involved	in	
modulating	 energy	 homeostasis	 (Friedman	 et	 al.,	 1991,	 Zhang	 et	 al.,	 1994).	 The	 discovery	 that	 a	
circulating	protein	secreted	almost	exclusively	by	adipocytes	could	regulate	body	weight	through	its	
effects	on	food	intake	and	energy	expenditure	was	a	remarkable	breakthrough	in	our	understanding	
of	the	molecular	components	of	the	systems	involved	in	energy	homeostasis	(Farooqi	et	al.,	2009).	
Leptin-deficient	patients	were	shown	to	have	a	partial	leptin	deficiency,	a	higher	prevalence	of	obesity	
than	that	seen	in	a	control	population	of	similar	age	and	ethnicity,	as	well	as	an	increased	percentage	
of	body	fat	compared	with	control	subjects	of	the	same	ethnicity	and	BMI	(Farooqi	et	al.,	2001).	Leptin	
is	 one	 of	 the	most	welI-studied	 adipokines,	 and	 is	 secreted	 in	 response	 to	 food	 intake,	 inhibiting	
appetite	by	regulating	neural	circuits	located	in	the	brain	(Choe	et	al.,	2016).	Leptin	acts	on	surface	
receptors	 expressed	 in	 Agouti-Related	 Peptide	 (AgRP)	 neurons	 in	 the	 lateral	 hypothalamus	 and	
proopiomelanocortin	(POMC)	neurons	in	the	medial	hypothalamus	to	inhibit	appetite	and	stimulate	
satiety,	respectively	(Vaisse	et	al.,	1996,	Munzberg	et	al.,	2004,	Myers	et	al.,	2010).	Mice	homozygous	
for	 the	 leptin	mutation	 ob/ob	 or	 leptin	 receptor	mutation	db/db	 are	massively	 obese	 because	 of	
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uncontrolled	appetite	and	excess	food	intake	(Pelleymounter	et	al.,	1995,	Chen	et	al.,	1996).	Leptin	
also	 promotes	 lipid	 oxidation	 and	 mitochondrial	 biogenesis,	 accelerating	 energy	 expenditure	 in	
peripheral	tissues	through	both	local	signalling	and	regulation	of	brain-derived	factors	(Minokoshi	et	
al.,	2002,	Guo	et	al.,	2008).	Circulating	leptin	is	actually	elevated	in	obesity,	but	hypothalamic	leptin	
resistance	aggravates	obesity	though	inhibition	of	appetite	control	and	lipid	oxidation	(Vaisse	et	al.,	
1996,	Munzberg	et	al.,	2004,	Myers	et	al.,	2010).		
	
	 It	is	established	that	human	obesity	can	result	from	a	multiplicity	of	defects	in	the	pathways	
downstream	 of	 leptin	 signalling	 within	 the	 brain.	 These	 include	 mutations	 in	 the	 leptin	 receptor	
(Clement	et	al.,	1998,	Farooqi	et	al.,	2007);	POMC	(Krude	et	al.,	1998,	Krude	et	al.,	2003,	Farooqi	et	
al.,	 2006);	 as	 well	 as	 the	 melanocortin-4	 receptor	 (MC4R)	 (Vaisse	 et	 al.,	 1998,	 Yeo	 et	 al.,	 1998),	
activated	by	products	of	cleavage	of	the	POMC	gene;	and,	more	rarely,	defects	in	signalling	systems	
thought	to	be	downstream	of	the	MC4R,	including	the	brain-derived	neurotrophic	factor	(Gray	et	al.,	
2006)	and	its	receptor	(Yeo	et	al.,	2004).	All	of	these	disorders	are	characterised	by	hyperphagia	and	
have	allowed	the	demonstration	that	human	appetite	and	eating	behaviour	are	 in	part	biologically	
determined	(Farooqi	et	al.,	2009).	Activation	of	MC4R,	following	a	stimulation	of	POMC	and	cocaine-	
and	 amphetamine-regulated	 transcript	 (CART)-expressing	 neurons	 by	 leptin	 and	 production	 of	 α-
melanocyte-stimulating	hormone	(α-MSH),	resulted	in	decreased	food	intake	and	increased	energy	
expenditure	(Adan	et	al.,	1994,	Cone	2005).	In	humans,	mutations	in	the	POMC	and	MC4R	genes	are	
associated	with	morbid	obesity	(Krude	et	al.,	1998,	Vaisse	et	al.,	1998,	Yeo	et	al.,	1998,	Hinney	et	al.,	
1999,	Farooqi	et	al.,	2000,	Vaisse	et	al.,	2000).	In	parallel,	leptin	suppresses	a	distinct	set	of	NPY-	and	
AgRP-expressing	 neurons	 within	 the	 ARC.	 In	 the	 absence	 of	 leptin,	 such	 as	 during	 fasted	 state,	
NPY/AgRP-expressing	neurons	release	AgRP,	an	antagonist	of	the	MC4R	(Ollmann	et	al.,	1997,	Quillan	
et	 al.,	 1998,	 Rossi	 et	 al.,	 1998),	 causing	 decreased	 energy	 expenditure	 and	 increased	 appetite	
(Stephens	et	al.,	1995,	Baskin	et	al.,	1999,	Elias	et	al.,	1999,	Marsh	et	al.,	1999,	Elias	et	al.,	2000).	Thus,	
agonists	 (α-MSH)	 and	 antagonists	 (AgRP)	 of	 the	MC4R	 determine	 the	weight-regulating	 effects	 of	
leptin	in	the	CNS.	
	
	 Following	the	discovery	of	leptin,	additional	cytokines,	hormones,	and	peptides	secreted	by	
adipocytes,	 collectively	 termed	 “adipokines”,	 have	been	 identified	 and	 intensively	 investigated	 for	
roles	in	the	control	of	energy	homeostasis	(Rondinone	2006).	For	example,	a	year	after	the	discovery	
of	leptin,	a	novel	30-kilodaltons	(kDa)	secretory	protein	produced	exclusively	in	the	adipocytes	and	
whose	mRNA	 is	 induced	over	100-fold	during	adipocyte	differentiation	was	 identified,	 at	 the	 time	
called	adipocyte	complement-related	protein	of	30	kDa	(Acrp30).	The	same	study	revealed	that	like	
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adipsin	mentioned	above,	 the	 secretion	of	Acrp30	was	enhanced	by	 insulin,	and	 therefore	Acrp30	
could	potentially	participate	in	the	delicately	balanced	system	of	energy	homeostasis	involving	food	
intake	and	carbohydrate	as	well	as	lipid	catabolism	(Scherer	et	al.,	1995).	Adiponectin	is	abundant	in	
the	blood	(Scherer	et	al.,	1995,	Hu	et	al.,	1996,	Maeda	et	al.,	1996)	and	exerts	anti-obesity	and	anti-
diabetic	effects,	enabling	an	alleviation	of	 insulin	resistance	by	stimulating	 lipid	oxidation	and	anti-
inflammatory	responses	(Berg	et	al.,	2001,	Maeda	et	al.,	2002,	Yamauchi	et	al.,	2002,	Yamauchi	et	al.,	
2003,	Yoon	et	al.,	2006,	Folco	et	al.,	2009).	Two	major	receptors	for	adiponectin	AdipoR1	and	AdipoR2	
exist,	both	stimulating	5’-adenosine-monophosphate-activated	protein	kinase	(AMPK),	necessary	for	
the	anti-obesity	and	anti-diabetic	actions	of	adiponectin	(Yamauchi	et	al.,	2002,	Yamauchi	et	al.,	2003,	
Yoon	et	al.,	2006).	AdipoR1	and	AdipoR2	expression	is	significantly	decreased	in	T2DM	and	obesity	
state	(Drolet	et	al.,	2009).	Additionally,	adiponectin	is	inversely	correlated	to	BMI,	glucose,	insulin	and	
triglycerides	 levels,	degree	of	 insulin	 resistance,	 and,	 importantly,	 to	 visceral	 fat	 accumulation	 (De	
Rosa	et	al.,	2013).	The	manner	by	which	adipose	tissue	expands	(increases	in	size,	hypertrophy,	and/or	
in	number	of	cells,	hyperplasia)	could	regulate	synthesis	and	secretion	of	adiponectin	 (Nigro	et	al.,	
2014).	 Drolet	 et	 al.	 demonstrated	 an	 inverse	 relationship	 between	men	 adipocytes	 diameter	 and	
adiponectin	secretion	(Drolet	et	al.,	2009).	Adiponectin	enhances	insulin	sensitivity	 in	both	skeletal	
muscle	and	 liver	 tissue,	 stimulating	glucose	uptake	and	 fatty	acid	oxidation	 in	 skeletal	muscle	and	
reducing	gluconeogenesis	in	liver	tissue	(Sowers	2008).	In	addition	to	observational	relations	between	
reduced	 levels	 of	 circulating	 adiponectin	 and	 impaired	 insulin	 sensitivity,	 more	 evidence	 defined	
adiponectin	as	an	insulin-sensitizing	molecule.	Indeed,	in	lean	rodents	with	normal	glucose	tolerance,	
the	overexpression	of	adiponectin	produces	greater	insulin	sensitivity	(Satoh	et	al.,	2004).	
	 	
	 Adipokines	have	pro-inflammatory	or	anti-inflammatory	activities,	and	a	dysregulation	of	the	
production	or	secretion	of	these	adipokines	owing	to	adipose	tissue	dysfunction	can	contribute	to	the	
pathogenesis	of	obesity-linked	complications	(Ouchi	et	al.,	2011).	In	1993,	the	tumour	necrosis	factor	
(TNF)	was	identified	as	a	pro-inflammatory	product	of	adipose	tissue	induced	in	models	of	diabetes	
and	obesity,	providing	evidence	for	a	functional	link	between	obesity	and	inflammation	(Hotamisligil	
et	 al.,	 1993).	 Additionally,	 excess	 adipose	mass	 (as	 occurs	 in	 obese	 individuals)	 is	 associated	with	
increased	levels	of	the	pro-inflammatory	marker	C-reactive	protein	(CRP)	in	the	blood	(Visser	et	al.,	
1999).	Increased	levels	of	CRP,	and	its	inducer	interleukin-6	(IL-6),	are	predictive	of	the	development	
of	 type	2	diabetes	 in	various	populations	 (Visser	et	al.,	1999,	Pradhan	et	al.,	2001).	The	endocrine	
function	of	 the	 adipose	 tissue	 allows	 it	 to	 coordinate	 energy	 storage	 and	utilisation,	 as	well	 as	 to	
modulate	 the	 behaviour	 and	 the	 physiology	 of	 other	 organs	 (Henriksson	 et	 al.,	 2015).	 White	
adipocytes	 balance	 the	 synthesis,	 storage,	 and	 breakdown	 of	 triglycerides	 during	 times	 of	 energy	
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surplus	or	demand.	They	are	also	the	primary	sites	of	synthesis	and	secretion	of	several	adipokines,	
adipocyte-derived	 hormones	 that	 signal	 long-term	 energy	 storage	 to	 the	 CNS,	 and	 regulate	 food	
intake	 as	 well	 as	 other	 aspects	 of	 physiology.	 Figure	 1.14	 below	 summarises	 the	 endocrine	 and	
metabolic	signals	emanating	from	adipose	tissue.	
	
												
Figure	 1.14:	 Endocrine	 and	
metabolic	signals	emanating	from	
adipose	 tissue.	 Taken	 from	
Mohamed-Ali	 et	 al.,	 1998.	 The	
figure	 shows	 the	major	 effects	 of	
signals	from	adipose	tissue,	as	well	
as	 the	 hierarchy	 of	 the	 stronger	
and	weaker	signals.	Brain,	skeletal	
muscle,	 liver	 and	 pancreas	 are	
believed	to	be	the	main	targets	of	
adipose	tissue-derived	signals.	The	
width	 of	 each	 arrow	 represents	
the	 relative	 strength	 of	 each	
signal.		
	
	
1.6.4	Characterisation	of	peripheral	circadian	clocks	within	white	adipose	tissue	
	
	 Adipose	tissue	function	in	several	disease	states	is	associated	with	altered	circadian	rhythms.	
For	instance,	patients	suffering	from	bipolar	disorders	exhibit	abnormal	sleep	patterns	and	disorders	
circadian	function;	gain	weight	and	become	obese	(Fagiolini	et	al.,	2003).		Adipose	tissue	is	a	source	
of	TNF-α,	IL-6,	adiponectin,	and	leptin	among	others,	whose	circulating	levels	display	a	strong	circadian	
pattern	(Kalsbeek	et	al.,	2001,	Gavrila	et	al.,	2003,	van	der	Bom	et	al.,	2003).	Interestingly,	patients	
diagnosed	with	 obesity	 and	 T2D	 fail	 to	 display	 circadian	 variability	 in	 the	 incidence	 of	myocardial	
infarction	 (Rana	 et	 al.,	 2003).	 Furthermore,	 several	 epidemiological	 studies	 show	 that	 night	 shift	
workers,	whose	activity	period	is	chronically	reversed,	display	an	increased	incidence	of	the	metabolic	
syndrome	 (Holmback	 et	 al.,	 2003).	 Murine	 studies	 have	 demonstrated	 relationships	 between	
circadian	mechanism	dysfunction	and	metabolic	abnormalities.	One	group	demonstrated	 impaired	
glucose	metabolism	in	mice	with	Bmal1	or	Clock	mutations	(Rudic	et	al.,	2004).	A	second	group	found	
that	Clock	mutant	mice	 increased	 their	 caloric	 intake	 and	 total	 body	weight	 relative	 to	wild	 type	
controls,	with	significant	changes	in	the	diurnal	rhythms	of	locomotor	activity,	feeding,	and	metabolic	
rate	(Turek	et	al.,	2005).	Although	circadian	dysfunction	and	disease	pathogenesis	are	linked,	the	role	
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of	circadian	genes	in	adipose	tissue	physiology	remained	unexplored.	In	2006,	it	was	revealed	that	a	
significant	 percentage	 of	 genes	 in	 adipose	 tissue	 depots	 display	 robust	 and	 coordinated	 circadian	
expression	profiles,	with	a	subset	of	these	genes	conserved	among	adipose	depots	and	liver	of	AKR/J	
mice	(Zvonic	et	al.,	2006).	The	genes	concerned	were	circadian	oscillator	genes	such	as	Npas2,	Bmal1,	
Per1-3,	and	Cry1-2;	as	well	as	clock-controlled	downstream	genes	(Rev-erbα,	Rev-erbb,	Dbp,	E4bp4,	
stimulation	of	retinoic	acid	13	(Stra13)	and	inhibitor	of	DNA	binding	2	(Id2))	in	murine	BAT,	inguinal	
WAT	(iWAT)	and	epididymal	WAT	(eWAT).	Npas2	and	Bmal1	cycled	in	synchrony,	reaching	their	zenith	
at	the	end	of	the	12-h	dark	period.	Their	expression	patterns	were	consistent	among	BAT,	iWAT,	eWAT	
and	 liver,	 with	 minor	 differences	 in	 the	 amplitudes.	 Clock	 expression	 did	 not	 follow	 a	 consistent	
circadian	pattern	in	any	tissue;	whilst	Per1,	Per2	and	Per3	expression	demonstrated	synchronised	24-
h	oscillations,	reaching	zenith	at	the	end	of	the	12-h	light	period	(ZT	12),	in	phase	with	the	circadian	
expression	of	Rev-erbα,	Rev-erbb	and	Dbp.	Furthermore,	the	overall	gene	expression	of	Cry1	and	Cry2	
followed	a	 circadian	profile,	with	 a	 zenith	 around	ZT20	and	a	nadir	 around	 ZT	8.	Using	 affymetrix	
microarray	analysis,	the	same	study	identified	650	genes	that	shared	circadian	expression	profiles	in	
BAT,	iWAT,	and	liver;	representing	14.8,	12.8	and	12%	of	the	tissue-specific	oscillatory	transcriptome,	
respectively.	 Furthermore,	 the	 group	 demonstrated	 that	 temporally	 restricted	 feeding	 causes	 a	
coordinated	phase	shift	in	circadian	expression	of	the	major	oscillator	genes	and	their	downstream	
targets	 in	 adipose	 tissues;	 all-in-all	 revealing	 the	 presence	of	 circadian	oscillator	 genes	 in	 fat	with	
significant	 metabolic	 implications.	 The	 importance	 of	 their	 characterisation	 would	 have	 potential	
therapeutic	relevance	with	respect	to	the	pathogenesis	and	treatment	of	diseases	such	as	obesity,	
T2D,	and	the	metabolic	syndrome.				
	
	 At	 around	 the	 same	 time	and	 further	elucidating	whether	 the	 clock	gene	 system	works	 in	
adipose	tissue,	another	team	investigated	the	daily	mRNA	expression	profiles	of	the	clock	genes	and	
adipocytokines	 in	mouse	perigonadal	adipose	 tissues	 (figure	1.15)	 (Ando	 et	al.,	2005).	 In	C57BL/6J	
mice,	 all	 transcript	 levels	 of	 the	 clock	 genes	 (Bmal1,	 Per1,	 Per2,	 Cry1,	 Cry2	 and	 Dbp)	 and	
adipocytokines	(adiponectin,	resistin,	vistafin)	clearly	showed	24-h	rhythms.	To	bring	a	clearer	insight	
into	the	cellular	basis	of	adipose	rhythms,	the	firefly	luciferase	was	used,	which	allowed	the	hypothesis	
that	 adipocyte	 cells	 contain	 a	 circadian	 clock	 driving	 rhythmic	 mRNA	 expression	 and	 adipokines	
secretion	to	be	tested.	A	study	presented	data	from	the	murine	pre-adipocyte	3T3-L1	cell	line	(section	
1.6.5).	Researchers	observed	robust	rhythms	in	the	mRNA	expression	of	the	clock	genes	Per2,	Rev-
erbα,	and	Dbp,	but	not	of	Per1,	Cry1,	Bmal1	or	any	of	the	“metabolic”	genes	(Pparα,	Pparγ	and	Srebp1)	
(Otway	et	al.,	2009).	Adipocytes	produced	similar	temporal	profiles	of	mRNa	expression,	albeit	with	a	
markedly	 reduced	 amplitude	 of	Per2	 and	Dbp	 rhythms.	 Despite	 no	 circadian	 rhythm	of	 adipokine	
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mRNA	expression,	leptin	accumulation	in	the	culture	medium	suggested	a	circadian	control	of	leptin	
secretion	 from	 adipocytes.	 Moreover,	 adiponectin	 secretion	 presented	 temporal	 variation,	 but	
without	 any	 apparent	 circadian	 rhythmicity.	 These	 data	 suggested	 that	 an	 endogenous	 adipocyte	
clock	controls	 the	 rhythmic	expression	of	only	a	 subset	of	genes	 that	are	 reported	 to	exhibit	24-h	
rhythmicity	in	murine	adipose	tissue.	A	few	years	later,	a	stable	transduction	protocol	using	lentivirus-
mediated	gene	delivery	was	described,	allowing	the	examination	of	the	persistence	and	dynamics	of	
molecular	rhythms	(Ramanathan	et	al.,	2012).	The	lentiviral	vector	system	is	superior	to	traditional	
methods	such	as	transient	transfection	and	germline	transmission	as	efficient	and	versatile:	it	permits	
efficient	delivery	and	stable	integration	into	the	host	genome	of	both	dividing	and	non-dividing	cells	
(Tiscornia	 et	 al.,	 2006).	 Lentiviral	 reporters	were	 constructed,	where	 different	 promoters	 of	 clock	
genes	were	 inserted:	Per2,	Bmal1	 and	Cry1.	 Each	 reporter	 exhibits	 a	 distinct	 phase	 of	 oscillation.	
Indeed,	while	the	Per2	and	Cry1	promoters	drive	peak	bioluminescence	at	morning-day	phases,	the	
Bmal1	 promoter	 presented	 a	 peak	 of	 bioluminescence	 during	 the	 night	 phase.	 The	 same	 group	
reported	establishment	and	genetic	characterisation	of	three	cell-autonomous	mouse	clock	models:	
3T3	fibroblasts,	3T3-L1	adipocytes	and	met	murine	hepatocytes	(MMH)-D3,	each	genetically	tractable	
and	 with	 an	 integrated	 luciferase	 reporter	 allowing	 for	 longitudinal	 luminescence	 recording	 of	
rhythmic	clock	gene	expression,	using	an	inexpensive	off-the-shelf	microplate	reader	(Ramanathan	et	
al.,	2014).	These	cells	all	displayed	persistent	bioluminescence	rhythms	and	in	each	cell	line,	where	
the	gene	encoding	a	destabilised	luciferase	(dLuc)	enzyme	was	under	the	control	of	the	mouse	Per2	
Per2-dLuc	 or	 Bmal1	 (Bmal1-dLuc)	 promoter.	 Reporters	 displayed	 anti-phasic	 rhythms	 of	
bioluminescence,	consistent	with	the	function	of	E-box-	and	RORE-containing	promoters	in	regulating	
distinct	and	opposite	phases	of	gene	expression.		
	
	 Studies	from	Bunger	and	co-workers	generated	and	characterised	a	null	allele	at	the	mBmal1	
locus,	 in	 an	 effort	 to	 understand	 its	 role	 in	murine	 circadian	 rhythmicity	 (Bunger	 et	 al.,	 2000).	 A	
targeted	disruption	of	mBmal1	was	generated	in	embryonic	stem	cells.	Data	revealed	that	a	loss	of	
BMAL1	 in	 mice	 resulted	 in	 an	 immediate	 and	 complete	 loss	 of	 circadian	 rhythmicity	 in	 constant	
darkness,	alongside	an	impaired	locomotor	activity	in	light-dark	cycles	and	reduced	activity	levels	in	
Bmal1-/-	 mice.	 Analysis	 of	 Period	 gene	 expression	 in	 the	 SCN	 indicates	 that	 these	 behavioural	
phenotypes	arise	from	loss	of	circadian	function	at	the	molecular	level.	These	results	provided	genetic	
evidence	that	BMAL1	is	the	bona	fide	heterodimeric	partner	of	mCLOCK,	and	that	BMAL1	is	a	non-
redundant	and	essential	component	of	 the	circadian	pacemaker	 in	mammals.	Although	Bmal1	null	
mice	do	not	display	 anomalies	 in	 early	development,	 they	do	display	 reduced	activity	 as	 they	age	
(Bunger	et	al.,	2005).	To	better	understand	this,	the	physiological	and	anatomical	changes	occurring	
70	
	
with	age	were	characterised,	and	it	was	observed	that	Bmal1	null	mice	display	an	increased	mortality	
after	26	weeks	of	age	and	a	phenotype	best	described	as	a	progressive	non-inflammatory	arthropathy.		
In	a	standard	LD	cycle,	Bmal1-/-	mice	gained	weight	somewhat	more	rapidly	than	their	WT	littermates	
between	4	and	8	weeks	of	age,	but	by	young	adulthood	had	normal	bodyweight	(Lamia	et	al.,	2008).	
However,	Bmal1-/-	mice	had	increased	total	fat	content,	perhaps	reflecting	systemic	influences	on	fat,	
given	a	possible	positive	 role	of	Bmal1	 in	adipocyte	differentiation	 (Shimba	et	al.,	2005).	Although	
Bmal1-/-	 mice	 had	 normal	 resting	 blood	 glucose,	 they	 showed	 intolerance	 to	 a	 bolus	 of	 glucose,	
responding	with	abnormally	high	blood	glucose	concentrations	restored	to	normal	values	far	more	
slowly	 compared	 to	 their	 WT	 littermates	 (Lamia	 et	 al.,	 2008).	 Similar	 to	 a	 previous	 report,	 they	
exhibited	a	trend	toward	insulin	hypersensitivity	(Rudic	et	al.,	2004,	Lamia	et	al.,	2008).			
	
	 In	 2012,	 evidence	was	 provided	 that	 a	 peripheral	 circadian	 clock	 could	 generate	 circadian	
signals	 to	entrain	 rhythmicity	 in	 the	CNS	 (Paschos	 et	 al.,	 2012).	 In	 an	attempt	 to	explore	whether	
disruption	of	the	circadian	clock	in	adipocytes	has	an	impact	on	glucose	metabolism,	authors	revealed	
that	a	regular	diet-fed	Ad-Bmal1-/-	mice	kept	under	DD	showed	a	peak	in	plasma	glucose	concentration	
during	the	subjective	light	period	of	the	day-night	cycle.	WT	mice	consumed	most	of	their	daily	food	
during	the	beginning	of	the	night,	with	plasma	glucose	concentrations	of	WT	mice	rising	during	the	
early	night	and	dropping	after	the	postprandial	period	to	 lower	steady-state	concentrations	during	
the	day.	This	pattern	was	disrupted	in	Ad-Bmal1-/-	mice,	with	no	difference	in	plasma	concentrations	
of	insulin	across	the	24-h	light-dark	cycle	compared	to	control	mice.	Furthermore,	energy	expenditure	
measured	 by	 respiratory	 O2	 consumption	 was	 lower	 in	 high	 fat	 diet	 (HFD)-fed	 Ad-Bmal1-/-	 mice	
compared	to	controls,	but	stayed	the	same	under	regular	diet.	Interestingly,	the	energy	expenditure	
in	Ad-Bmal1-/-	mice	remained	rhythmic.	In	these	mice,	a	greater	food	intake	was	reproduced	during	
the	 light	 period,	 as	 well	 as	 in	 regular	 diet-fed	mice	 under	 both	 light-dark	 and	 constant	 darkness	
conditions.	 A	 disruption	 of	 adipocyte	 clock	 function	 resulted	 in	 temporal	 changes	 in	 plasma	
concentration	of	polyunsaturated	fatty	acids,	leading	to	corresponding	changes	in	the	expression	of	
neurotransmitters	responsible	for	appetite	regulation	in	hypothalamic	feeding	centres.	These	changes	
occur	without	alteration	 in	 the	 rhythmic	expression	of	 circadian	 clock	genes	 in	 the	hypothalamus,	
suggesting	a	direct	effect	of	the	adipocyte	circadian	clock	on	hypothalamic	feeding	centres	without	
the	participation	of	the	local	circadian	clocks.	This	finding	suggested	a	bidirectional	communication	
between	the	SCN	and	peripheral	clocks.	The	development	of	obesity	in	Ad-Bmal1-/-	mice	highlights	the	
importance	of	the	adipocyte	circadian	clock	in	organismal	energy	homeostasis.	A	deletion	of	Bmal1	in	
adipocytes	results	in	weight	gain,	an	effect	not	observed	with	deletion	of	Bmal1	in	the	liver	(Lamia	et	
al.,	2008)	or	pancreatic	islets	(Marcheva	et	al.,	2010).	The	adipocyte	clock	regulates	the	biosynthesis	
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of	 long-chain	 polyunsaturated	 fatty	 acids	 and	 the	 timing	 of	 fatty	 acid	 release	 into	 the	 circulation	
(Paschos	 et	 al.,	 2012).	 Remodelling	 of	 the	 triglyceride	 pool	 of	 the	 adipocyte	 in	 the	 absence	 of	 a	
functional	clock	leads	to	an	attenuated	feeding	rhythm	and	obesity.	Indeed,	obesity	in	humans	has	
been	 associated	 with	 remodelling	 of	 the	 adipocyte	 lipidome	 characterised	 by	 a	 reduction	 in	 the	
amount	of	polyunsaturated	fatty	acids	(Pietilainen	et	al.,	2011).		
	
	 In	 the	 visceral	 adipose	 tissues	 of	 C57BL/6J	 mice,	 the	 rhythmic	 expression	 of	 clock	 genes	
(Bmal1,	Per1,	Per2,	Cry1,	Cry2,	Dbp)	was	mildly	attenuated	in	obese	mice	(KK)	and	greatly	attenuated	
in	more	obese,	diabetic	(KK-Ay)	mice	(figure	1.15)	(Ando	et	al.,	2005).	Obese	diabetes	also	diminished	
the	rhythmic	expression	of	the	clock	genes	in	the	liver.	In	addition,	the	peak	level	of	Dbp,	a	first-order	
clock	controlled	gene,	in	KK	mice,	was	much	lower	than	in	C57BL/6J	mice.	Therefore,	obesity	and/or	
T2D	appear	to	affect	the	intracellular	clock	system	in	visceral	adipose	tissue.	With	regard	to	the	daily	
profiles	 of	 adipocytokine	 mRNAs,	 the	 rhythmic	 expression	 of	 adiponectin	 and	 resistin	 was	 not	
detected	in	either	KK	or	KK-Ay	mice.	The	peak	levels	of	adiponectin	and	resistin	were	significantly	lower	
in	KK	mice	than	in	the	C57BL/6J	mice,	with	levels	even	lower	in	KK-Ay	mice	than	KK	mice.	The	visfatin	
mRNA	 levels	 were	 also	 lower	 in	 KK	 and	 KK-Ay	 mice	 than	 in	 C57BL/6J	 mice,	 contrary	 to	 previous	
observations	 in	male	 KK-Ay	mice	 (Fukuhara	 et	 al.,	 2005).	 In	 humans,	work	 examined	 the	 effect	 of	
diurnal	rhythm	on	gene	expression	in	the	subcutaneous	adipose	tissue	of	overweight	to	mildly	obese,	
healthy	 individuals	 (Loboda	 et	 al.,	 2009).	 Adipose	 biopsies	 were	 taken	 in	 the	 morning,	 in	 the	
afternoon,	and	in	the	evening.	Results	indicated	that	the	diurnal	effect	dominates	the	transcriptome	
of	the	human	adipose	tissue,	with	more	than	25%	of	the	transcribed	genes	being	diurnally	regulated.	
This	was	consistent	with	observed	circadian	regulation	in	the	adipose	tissue	of	animal	models,	in	which	
up	to	50%	of	the	genes	are	under	circadian	control	(Zvonic	et	al.,	2006,	Ptitsyn	et	al.,	2007,	Zvonic	et	
al.,	2007).		
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Figure	 1.15:	 Daily	 mRNA	 expression	 profiles	 of	 clock	 genes	 and	 adipocytokines	 in	 the	 visceral	
adipose	tissues	of	C57BL/6J	mice,	obese	mice	and	obese	as	well	as	diabetic	mice.	Taken	from	Ando	
et	al.,	2005.	A	and	B:	Daily	mRNA	expression	profiles	of	clock	genes.	C:	Daily	mRNA	expression	profiles	
of	adipocytokines.	Obese	(KK)	and	obese/diabetic	(KK-Ay)	mice	were	treated	(empty	circles)	or	not	(full	
circles)	with	an	anti-diabetic	agent	(pioglitazone)	for	two	weeks.	All	data	are	means	and	SEM	of	five	
mice	at	each	time	point,	and	are	expressed	as	relative	values	to	the	lowest	values	in	control	mice	for	
each	gene.		
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C
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	 Another	study	investigated	serial	human	subcutaneous	WAT	biopsies,	collected	regularly	over	
24-h,	from	lean	individuals,	overweight/obese,	and	overweight/obese	type	2	diabetic	humans	(Otway	
et	 al.,	 2011).	 Results	presented	 significant	 temporal	 changes	of	 core	 clock	 (Per1,	Per2,	Per3,	Cry2,	
Bmal1	 and	Dbp)	 and	metabolic	 (Rev-erbα,	 receptor-interacting	 protein	 140	 (RIP	 140)	 and	 PGC1α)	
genes	in	lean	individuals.	Bmal1	rhythm	was	in	approximate	anti-phase	with	the	rhythm	of	other	clock	
genes,	 with	 no	 significant	 effect	 of	 increased	 body	 weight	 or	 type	 2	 diabetes	 on	 rhythmic	 gene	
expression	(figure	1.16).	Comparison	of	data	between	subject	groups	clearly	 indicated	that	obesity	
and	T2D	are	not	related	to	the	amplitude	of	rhythmic	WAT	gene	expression	in	humans	maintained	
under	controlled	conditions.	The	persistence	of	24-h	rhythms	in	WAT	from	patients	with	T2D	suggests	
that	the	link	between	human	circadian	and	metabolic	physiology	could	occur	outside	of	WAT,	at	least	
in	 the	 earlier	 stages	 of	 the	 disease.	 Furthermore,	 the	 circadian	 rhythmicity	 of	 adiponectin	 was	
examined,	one	of	 the	most	 clinically	 relevant	cytokines	associated	with	obesity,	 in	human	adipose	
tissue	(Gomez-Abellan	et	al.,	2010).	AT	explants	from	morbidly	obese	women	were	cultured	for	24	
hours,	and	gene	expression	of	AdipoQ,	AdipoR1	as	well	as	AdipoR2	was	analysed	using	quantitative	
real-time	polymerase	chain	reaction	(PCR).	All	genes	investigated	showed	a	circadian	rhythmicity,	and	
oscillated	accurately	as	well	as	independently	of	the	suprachiasmatic	nuclei,	in	both	the	subcutaneous	
and	 visceral	 adipose	 tissue,	
with	 adiponectin	 gene	
expressions	 fluctuating	 in	 the	
same	 phase	 as	 its	 receptors.	
Results	 also	 revealed	 that	 an	
increase	 of	 adiposity	 markers,	
and	mainly	 abdominal	 obesity	
(BMI,	body	fat	percent,	weight,	
waist	 and	 sagittal	 diameter),	
significantly	 correlated	 with	 a	
Figure	1.16:	Comparison	of	24-h	gene	expression	profiles	in	human	WAT	from	individuals	who	are	lean,	
overweight/obese,	or	overweight/obese	with	type	2	diabetes.	Taken	from	Otway	et	al.,	2011.	24-h	gene	
expression	profiles	of	 lean	(solid	line),	overweight/obese	(dashed	line)	or	overweight/obese	with	type	2	
diabetes	(dotted	line)	individuals	were	compared.	Data	are	presented	as	means	±	standard	error	(SE)	of	
n=8-11	values	and	normalised	to	glyceraldehyde	3-phosphate	dehydrogenase.	For	all	genes,	there	was	a	
significant	 (p<0.05)	 effect	of	 time	but	no	subject	group	 effect	on	gene	 expression	 (two-way	 repeated-
measures	analysis	of	variance	(ANOVA)).	With	the	exception	of	Bmal1	(p<0.01),	there	was	no	significant	
interaction	between	time	and	subject	group	on	gene	expression.	Horizontal	bars	represent	wake	(white)	
and	sleep	(black)	periods	during	the	laboratory	study.	Zeitgeber	time	0	represents	the	time	of	 lights	on	
(equivalent	to	clock	time	06.30h).	
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decrease	in	adiponectin	and	AdipoR1	as	well	as	AdipoR2	amplitude,	which	characterised	a	dampened	
rhythm.	This	situation	was	present	only	in	the	visceral	fat.	Correlation	analyses	between	the	genetic	
circadian	 oscillation	 and	 components	 of	 the	 metabolic	 syndrome	 revealed	 that	 adiposity	 and	
abdominal	obesity	correlated	with	a	decrease	in	adiponectin	and	adiponectin	receptors	AdipoR1	and	
AdipoR2	amplitude.	Visceral	fat	showed	a	trend	toward	a	phase	delay	and	dampening	of	the	mRNA	
amplitude	 of	 adiponectin	 as	 compared	 with	 subcutaneous	 fat.	 In	 a	 few	 words,	 this	 investigation	
indicated	 that	 the	mRNA	 expression	 of	 adiponectin	 and	 its	 receptors	 showed	 24-h	 rhythmicity	 in	
human	adipose	tissue	from	morbidly	obese	patients.		
		
1.6.5	Characterisation	of	the	3T3-L1	cell	line	as	a	tool	for	the	study	of	adipose	clocks	
	
	 The	3T3-L1	cell	line	is	a	well-established	pre-adipose	cell	line,	developed	from	murine	Swiss	
3T3	cells	(Green	et	al.,	1974).	3T3-L1	cells	are	derived	from	disaggregated	17-	to	19-day-old	Swiss	3T3	
mouse	 embryos,	 displaying	 a	 fibroblast-like	 morphology,	 which	 can	 acquire	 an	 adipocyte-like	
phenotype	under	appropriate	conditions	(Green	et	al.,	1974,	Green	et	al.,	1976,	Armani	et	al.,	2010).	
One	of	the	main	advantages	of	this	cell	line	is	that	it	is	easier	to	culture	and	less	costly	to	use	than	
freshly	isolated	cells,	such	as	mature	adipocytes,	even	though	freshly	isolated	cells	allow	for	various	
comparisons,	 such	 as	 the	 in	 vitro	 evaluation	 of	 different	 in	 vivo	 conditions	 (Poulos	 et	 al.,	 2010).	
Moreover,	they	can	tolerate	an	increased	number	of	passages	and	are	homogenous	in	terms	of	the	
cell	 population.	 Therefore,	 these	 cells	 provide	 a	 homogenous	 response	 following	 treatments	 and	
changes	 in	 experimental	 conditions.	 Because	 of	 this,	 3T3-L1	 cells	 have	 been	 extensively	 used	 to	
evaluate	the	effects	of	compounds	or	nutrients	on	adipogenesis,	to	establish	the	underlying	molecular	
mechanisms	of	adipogenesis	as	well	as	the	potential	application	of	various	compounds	and	nutrients	
in	the	treatment	of	obesity	(Kang	et	al.,	2016,	Lai	et	al.,	2016,	Tutino	et	al.,	2016).	Moreover,	these	
cells	have	been	used	to	describe	the	effects	of	melatonin	(Kato	et	al.,	2015),	reactive	oxygen	species	
(ROS),	or	antioxidants	(Calzadilla	et	al.,	2013)	on	adipogenic	differentiation	(Matsuo	et	al.,	2015),	and	
also,	the	role	of	some	androgens	such	as	testosterone	that	inhibit	the	adipogenic	differentiation	by	
activation	of	androgen	receptor/b-catenin/T-cell	 factor	4	 interaction	 in	3T3-L1	adipocytes	(Singh	et	
al.,	2003).		Apart	from	that,	3T3-L1	cells	have	been	useful	to	study	the	mechanisms	of	action	of	several	
compounds	(or	nutrients)	during	the	differentiation	process	previously	shown	to	inhibit	obesity	in	vivo	
(Mammi	et	al.,	2016).		
	
	 Additionally,	several	endocrine	disruptors	and	obesogenic	compounds	have	been	evaluated	
during	the	differentiation	of	3T3-L1	cells	 (Regnier	et	al.,	2015).	Different	gene	silencing	techniques	
such	 as	 small	 interfering	 RNA	 (siRNA)	 and	 short	 hairpin	 RNA	 (shRNA),	 together	 with	 different	
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transfection	procedures	(adenovirus,	lentivirus	transfection,	and	plasmid	electroporation)	have	been	
applied	 to	 study	 the	 function	 of	 different	 genes	 associated	 with	 adipogenesis	 in	 3T3-L1	 cells	
(Ramanathan	et	al.,	2012,	Ramanathan	et	al.,	2014).	In	particular,	inflammatory	pathways,	adipokine	
synthesis,	and	secretion	of	study	enzyme’s	function	have	been	investigated	through	gene	silencing	in	
adipocytes	 (An	et	al.,	2012,	Ma	et	al.,	2012,	Abdesselem	et	al.,	2016,	Lee	et	al.,	2016a,	Lien	et	al.,	
2016).	Finally,	this	cell	line	is	useful	in	the	study	of	co-cultures	and	three-dimensional	cell	cultures,	as	
well	as	diverse	studies	of	high-throughput	screening	of	compounds	(Huang	et	al.,	2013,	Turner	et	al.,	
2015).	 The	 limitations	 of	 the	 3T3-L1	 model	 are	 the	 time	 of	 initial	 subculture	 and	 the	 fact	 that	
adipogenic	differentiation	requires	at	least	two	weeks	(Student	et	al.,	1980).	Moreover,	when	3T3-L1	
cells	 become	 confluent	 or	 have	 been	 passaged	 extensively,	 they	 no	 longer	 differentiate	 into	
adipocytes;	are	difficult	to	transfect;	and	because	this	cell	line	originated	from	a	single	clone,	it	fails	to	
recapitulate	the	characteristics	of	primary	cell	culture	models	(Wolins	et	al.,	2006).				
					
		 In	 order	 to	 convert	 3T3-L1	 cells	 from	 their	 fibroblasts	 phenotype	 into	 adipocytes,	 it	 is	
necessary	to	treat	them	with	adipogenic	agents,	such	as	insulin,	DEX	and	IBMX,	which	elevates	the	
intracellular	cAMP	levels	in	the	presence	of	foetal	bovine	serum	(FBS)	(Caprio	et	al.,	2007).	This	cocktail	
activates	an	adipogenic	program,	occurring	in	two	well-defined	phases	(Farmer	2006).	The	first	phase	
is	often	referred	to	as	a	clonal	expansion,	during	which	the	stimulated	cells	immediatly	re-enter	the	
cell	 cycle	and	progress	 through	at	 least	 two	cell-cycle	divisions.	During	 this	 time,	 the	 cells	express	
specific	adipogenic	transcription	factors,	as	well	as	cell-cycle	regulators	facilitating	the	expression	of	
PPAR-γ	 and	 C/EBPα.	 Following	 this	 event,	 the	 second	 phase	 sees	 the	 committed	 cells	 undergo	 a	
terminal	differentiation	manifested	by	the	production	of	 lipid	droplets	as	well	as	the	expression	of	
multiple	metabolic	programs	characteristic	of	mature	fat	cells.	Thus,	the	established	cloned	line,	3T3-
L1,	is	a	pre-adipose	line.	When	the	cells	enter	a	resting	state,	either	in	monolayers	or	in	suspension	
culture	stabilised	with	methyl	cellulose,	 they	accumulate	 triglyceride	 fat	and	become	adipose	cells	
(Green	 et	 al.,	 1974).	 Moreover,	 Vishwanath	 et	 al.	 published	 a	 new	 method	 that	 promoted	 the	
differentiation	of	3T3-L1	pre-adipocytes	over	a	shorter	span	of	time	using	a	combination	of	DEX	and	
troglitazone	 over	 fewer	 days	 compared	 to	 the	 combination	 of	 IBMX	 and	 DEX	 with	 the	 standard	
protocol	 (Vishwanath	 et	 al.,	 2013).	 By	 using	 DEX	 and	 troglitazone,	 the	 lipid	 droplet	 accumulation	
increased	by	112%,	and	glucose	transporter	type	4	(GLUT4)	mediated	a	137%	higher	glucose	uptake	
compared	to	cells	that	were	differentiated	using	the	traditional	method.	A	high	serum	concentration	
in	 the	 culture	medium	 increases	 the	 rapidity	 and	extent	of	 the	 fat	 accumulation,	 and	 the	adipose	
conversion	 can	 be	 delayed	 indefinitely	 in	 surface	 cultures	 by	 keeping	 the	 cells	 in	 a	 growing	 state	
(Green	 et	 al.,	 1974).	 A	 year	 later	 was	 indicated	 that	 the	 large	 increase	 in	 the	 rate	 of	 triglyceride	
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synthesis	 appearing	when	 pre-adipocytes	 differentiate	 into	 adipocytes	 could	 be	measured	 by	 the	
incorporation	rate	of	 labelled	palmitate,	acetate,	and	glucose	 (Green	et	al.,	1975).	 In	a	resting	3T3	
subline	which	does	not	undergo	the	adipose	conversion,	the	rate	of	triglyceride	synthesis	from	these	
precursors	 is	very	 low,	and	similar	to	that	of	growing	3T3-L1	cells,	before	their	adipose	conversion	
begins.	As	would	be	expected	from	their	known	actions	on	tissue	adipose	cells,	lipogenic	and	lipolytic	
hormones	as	well	as	drugs	could	affect	the	rate	of	synthesis	and	accumulation	of	triglycerides	by	3T3-
L1	cells.	For	example,	insulin	markedly	increases	the	rate	of	synthesis	and	accumulation	of	triglycerides	
by	fatty	3T3-L1	cells,	and	produces	a	related	increase	in	cell	protein	content.	The	accumulation	of	fat	
in	adipose	cells	throughout	adipogenesis	can	be	quantified	and	lipid	droplets	can	be	identified	via	Oil	
Red	O	staining	(Otway	et	al.,	2009)	(section	2.6.2.2).	Lipid	droplets	were	first	observed	four	days	after	
onset	of	differentiation,	and	by	day	8	many	cells	had	large	unilocular	droplets.	Quantitative	analysis	
revealed	triglyceride	elevation	above	undifferentiated	cells	by	day	4,	followed	by	rapid	accumulation	
thereafter	(figure	1.17).	Interestingly,	Pparγ	mRNA	was	detectable	in	undifferentiated	cells,	but	was	
elevated	from	days	2	through	10.	In	contrast,	the	expression	of	Leptin	and	Glut-4	was	only	detected	
after	two	and	four	days	of	differentiation,	respectively.	
	
	
	
	
	
	
Figure	1.17:	Differentiation	of	3T3-L1	
cells.	Taken	from	Otway	et	al.,	2009.	
Pre-adipocytes	 were	 differentiated	
into	adipocytes.	At	two-day	intervals,	
cells	 were	 analysed	 by	 triglyceride	
quantification	 using	 a	 triglyceride	
assay.		
	
	
1.7	Applications	of	dielectrophoresis	potential		
	
	 Modern	biomedicine	depends	on	the	process	of	separating	and	isolating	subpopulations	of	
cells	from	a	heterogeneous	group;	be	it	for	the	identification	of	white	blood	cells	for	counting,	the	
isolation	of	circulating	tumour	cells,	the	identification	of	stem	cells	of	potential	therapeutic	use	from	
an	undifferentiated	cell	mass	(Hughes	2016).	At	present,	three	methods	of	cell	separation	dominate.	
The	simplest	uses	differences	in	density	to	fraction	cells,	most	commonly	nucleated	white	blood	cells	
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from	anucleated	red	blood	cells	(RBCs).	The	remaining	two	methods	use	more	complex	approaches;	
fluorescence-activated	cell	sorting	(FACS)	uses	fluorescent	labels	which	bind	to	molecules	within	the	
cells	of	interest.	Cells	are	then	fired	in	droplets	small	enough	to	contain	a	single	cell;	each	droplet	is	
interrogated	with	a	laser,	and	those	droplets	containing	the	fluorescent	agent	are	subject	to	an	electric	
field	which	guides	them	to	a	receptacle,	where	they	are	collected.	Those	not	containing	the	agent	
continue	to	a	waste	outlet.	A	third	separation	technique	 is	magnetic-activated	cell	sorting	(MACS),	
where	magnetic	beads	are	 covered	 in	antibodies	 raised	 to	an	antigen	present	only	on	 the	 cells	of	
interest	within	 the	heterogeneous	population.	These	cells	bind	 to	 the	beads,	and	are	 retrieved	by	
applying	 a	magnetic	 field.	 These	methods	 have	 important	 drawbacks.	Whilst	 inexpensive,	 density	
methods	lack	specificity.	Furthermore,	both	FACS	and	MACS	rely	on	the	use	of	expensive	antibodies	
with	significant	cell	losses.	There	is	hence	a	need	for	an	alternative	method	of	separation,	one	of	which	
relies	on	the	intrinsic	properties	of	the	cell	rather	than	the	use	of	expensive	labels	which	can	limit	the	
usefulness	of	cells	or	affect	their	function.	The	aim	was	also	to	be	able	to	discriminate	between	cell	
populations	 that	 the	 other	 methods	 cannot;	 for	 example,	 separating	 them	 on	 the	 basis	 of	 ion	
concentration	 in	 the	 cytoplasm,	 or	 the	 capacitance	 of	 the	 membrane.	 One	 of	 such	 method	 is	
dielectrophoresis	(DEP).	DEP	is	the	name	given	to	the	phenomenon	of	induced	motion	in	a	suspended	
particle	due	to	 its	 interaction	with	an	applied	non-uniform	electric	field	(Pohl	1951).	Differences	 in	
dielectric	behaviour	in	a	non-uniform	field	can	be	used	to	produce	selective	migration	of	single-cell	
organisms,	 for	 instance	 yeast	 cells	 (Pohl	 et	 al.,	 1966).	 The	 process	 described	 here	 is	 not	
electrophoresis,	but	dielectrophoresis.	Electrophoresis	is	the	motion	of	charged	particles	in	an	electric	
field.	Dielectrophoresis	is	the	motion	resulting	from	the	force	set	up	by	the	action	of	a	non-uniform	
electric	field	on	a	neutral	particle	(figure	1.18)	(Pohl	1951).				
	
	
Figure	 1.18:	 Comparison	 of	 dielectrophoresis	
and	 electrophoresis.	 Taken	 from	 Pohl	 et	 al.,	
1966.	 The	 direction	 of	 the	 motion	 of	 the	
charged	particle	 is	dependent	on	the	direction	
of	the	applied	field.	The	plus-charged	object	 is	
pulled	 toward	whichever	electrode	 is	negative	
(electrophoresis).	The	neutral	object	(shown	as	
a	 larger	 body)	 is	 pulled	 toward	 the	 region	 of	
highest	 field	 intensity.	 If	 the	 field	 is	 reversed,	
the	 direction	 of	 the	 induced	 dipole	 is	 also	
reversed,	 but	with	 a	 greater	 net	 force	 toward	
the	 more	 concentrated	 set	 of	 field	 charges	
(dielectrophoresis).		
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	 Any	dipole	 (induced	or	permanent)	 in	a	neutral	body	will	have	a	 finite	separation	of	equal	
amounts	of	positive	and	negative	charges	in	it	(Pohl	et	al.,	1966).	The	electric	field	will	cause	some	
degree	of	alignment	of	the	dipole	with	it.	In	a	non-uniform	(divergent)	field,	one	end	of	the	dipole	will	
be	 in	a	weaker	field	than	the	other.	A	net	force	will	result,	and	the	body	will	be	pulled	toward	the	
region	of	greatest	field	intensity	(figure	1.18).	The	direction	of	the	field	can	be	reversed	and	still	give	
rise	to	the	original	direction	of	force	on	the	polarizable	body.	As	a	consequence,	one	way	motion	takes	
place	 only	 toward	 the	 region	 of	 highest	 field	 intensity	 in	 either	 direct	 or	 alternating	 fields	 during	
dielectrophoresis,	but	not	in	electrophoresis	where	reversing	the	field	also	reverses	the	force	of	the	
charged	body	(Pohl	1951,	Pohl	et	al.,	1966).	
	
	 Dielectrophoresis	 does	 not	 require	 ionized	 particles	 but	 rather	 depends	 on	 asymmetrical	
induction	and	attraction	of	displacement	charges	within	the	particles,	and	further	that	the	resultant	
motions	 be	 different	 for	 solvent	 and	 solute	 (Pohl	 1951).	 The	 unequal	 field	 force	 acting	 on	 all	
permanent	or	induced	dipoles	causes	them	to	be	constrained	to	move	towards	the	region	of	highest	
field	density.	When	the	polarisability	of	the	suspensoid	is	greater	than	the	solvent,	the	asymmetric	
field	 forces	 accelerate	 the	 suspensoid	 particles	more	 than	 the	 solvent,	 giving	 rise	 to	 an	 increased	
concentration	of	the	suspensoid	near	the	centre	of	high	field	strength.	The	suspensoid	particles	are	
then	more	prone	to	collision	and	coagulation.	The	motion	of	the	suspensoid	under	the	influence	of	
the	 inhomogeneous	 field	 will	 be	 proportional	 to	 the	 absolute	 value	 of	 the	 electric	 field	 strength	
applied,	to	its	divergence,	and	to	the	differences	in	dielectric	constant	of	suspensoid	and	solvent.		
	
	 In	 1966,	 Pohl	 and	 his	 colleagues	 used	 high	 frequency	 non-uniform	 electric	 fields	 to	 cause	
selective	 dielectrophoresis	 of	 yeast	 cells	 in	 an	 aqueous	 medium	 (Pohl	 et	 al.,	 1966).	 Living	 cells	
separated	from	dead	ones	remained	viable	after	the	separation	process.	Key	factors	in	the	separation	
of	 living	cells	 from	stained	dead	ones	by	dielectrophoresis	appear	 to	be	 the	use	of	high-frequency	
alternating	fields,	media	of	very	low	conductivity,	and	non-uniform	electric	fields.	Furthermore,	there	
should	be	an	appreciable	difference	between	the	complex	permittivities	of	the	cells	and	the	medium.	
It	was	 reasonable	 to	attribute	 the	high	effective	electrical	permittivity	of	 the	 living	cells,	 in	part	at	
least,	to	the	known	existence	of	an	easily	distortable	electric	double	layer	across	the	cell	membrane.	
A	later	study	used	a	simple	pin-pin	electrode	system	of	platinum	and	high-frequency	alternating	fields	
in	yeast	(Pohl	et	al.,	1971).	The	collectability	of	cells	at	the	electrode	tip	was	observed,	i.e.	at	the	region	
of	highest	field	strength,	depends	upon	physical	parameters	such	as	field	strength,	field	uniformity,	
frequency,	 cell	 concentration,	 suspension	 conductivity,	 and	 time	 of	 collection.	 The	 yield	 of	 cells	
collected	is	also	observed	to	depend	upon	biological	factors	such	as	colony	age	and	thermal	treatment	
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of	 the	cells.	The	dielectrophoretic	 collection	of	yeast	cells	has	been	studied	with	 reference	 to	 two	
categories	of	variables,	physical	and	biological.	The	former	includes	field	strength,	frequency,	particle	
concentration,	 conductivity	 of	 the	 suspension,	 and	 elapsed	 time.	 The	 latter	 includes	 colony	 age,	
chemical	treatment,	and	exposure	to	heat	and	to	ultraviolet	 light.	 It	 is	thus	possible	to	subject	the	
organisms	to	a	variety	of	physical	and	chemical	circumstances	which	may	affect	the	various	cellular	
components	in	different	ways,	and	thereby	to	hope	to	isolate	the	important	mechanisms.	
	
	 Stimulation	of	 either	 B	 or	 T	 lymphocytes	 using	 specific	mitogens	 results	 in	 changes	 in	 the	
passive	electrical	properties	of	the	cell	surface	(Hu	et	al.,	1990).	These	effects	can	be	related	to	growth	
and	secretion,	and	this	was	possible	because	the	high	resolution	of	the	contra-field	electro-rotation	
method,	combined	with	the	use	of	very	 low	conductivity	media,	allowed	accurate	and	analytically-
derived	values	for	the	cell	surface	properties.	Such	properties	are	membrane	capacity,	which	indicates	
the	degree	of	membrane	ramification;	membrane	conductivity,	indicative	of	the	membrane	transport	
activity;	 and	 surface	 conductance,	 reflecting	 the	 extent	 and	 charge	 of	 the	 glycocalyx.	 In	 1992,	 a	
method	was	developed	for	studying	the	dielectrophoretic	properties	of	both	homogeneous	and	mixed	
populations	of	mammalian	cells	(Gascoyne	et	al.,	1992).	Computerized	image	analysis	was	employed	
for	the	quantification	of	the	rate	of	motion	of	cells	suspended	in	 low	conductivity	medium	as	they	
moved	under	the	influence	of	a	non-uniform	alternating	electric	field	produced	by	an	interdigitated	
electrode	 array.	 As	 expected	 for	 dielectrophoresis,	 cells	 were	 collected	 at	 highly	 inhomogeneous	
electric	 field	 regions	 of	 the	 array	 when	 the	 electrical	 polarizability	 of	 cells	 exceeded	 that	 of	 the	
suspending	medium,	or	away	from	such	regions	when	their	polarizability	was	less	than	that	of	their	
medium.	 These	 two	 specific	 behaviours	 were	 respectively	 classified	 as	 positive	 and	 negative	
dielectrophoresis.	 The	 dielectrophoretic	 characteristics	 of	 normal,	 leukaemic,	 and	 differentiation-
induced	leukaemic	mouse	erythrocytes	were	shown	to	be	significantly	different.	By	suitable	choices	
of	applied	frequency	and	cell	suspension	medium,	dielectrophoretic	separation	of	different	cell	types	
from	cell	mixtures	was	demonstrated.		
	
	 Cell	separation	having	numerous	applications	in	medicine,	biotechnology,	as	well	as	research,	
and	considering	the	fact	that	in	the	early	1990s	sorting	technologies	included	inadequate	techniques	
such	 as	 immunologic	 targets,	 receptor-ligand	 interactions	 and	 differences	 in	 cell	 density,	 it	 was	
important	 to	 be	 able	 to	 identify	 novel	 properties	 by	which	 different	 cell	 types	may	 be	 discerned	
(Becker	 et	 al.,	 1995).	 For	 this	 reason,	 dielectrophoresis	 came	 as	 a	 novel	method	 allowing	 a	 rapid	
analysis	and	producing	pure	cell	populations,	previously	difficult	to	obtain.	Cells	possessing	dissimilar	
dielectric	properties	experience	different	DEP	forces,	suggesting	two	approaches	by	which	cells	might	
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be	separated,	namely	DEP	migration	and	retention.	In	the	first	method,	different	cell	types	would	be	
caused	 to	 experience	 forces	 in	 opposite	 directions	 by	 judicious	 choice	 of	 the	 applied	 field	 and	
suspending	medium	characteristics,	as	demonstrated	on	a	microscopic	scale	(Gascoyne	et	al.,	1992,	
Wang	et	al.,	1993,	Markx	et	al.,	1994a).	The	second	scheme	would	depend	upon	DEP	entrapment	of	
cells	in	potential	energy	wells	whose	depths	depend	on	the	cellular	dielectric	properties.	By	applying	
an	 appropriate	 external	 force,	 such	 as	 fluid	 flow,	 cells	 in	 shallow	wells	would	be	 swept	 away	 and	
harvested	while	others	would	remain	held	in	place	by	the	DEP	forces.	Through	such	means	DEP	offers	
the	potential	not	only	to	discriminate	between	but	also	to	separate	different	cell	types	(Becker	et	al.,	
1995).	 Cell	 separation	 occurs	 almost	 exclusively	 by	 density	 gradient	 and	 by	 FACS/MACS	methods,	
which	 suffer	 from	 lack	 of	 specificity,	 high	 cell	 loss,	 use	 of	 labels,	 and	 high	 capital/operating	 cost	
(Faraghat	et	al.,	2017).	DEP-based	cell-separation	has	been	presented	as	a	method	using	3D	electrodes	
on	a	low-cost	disposable	chip;	where	one	cell	type	is	allowed	to	pass	through	the	chip	whilst	the	other	
is	retained	and	subsequently	recovered.	The	technique	has	a	capacity	and	throughput	comparable	to	
the	fastest	MACS	or	FACS,	requires	no	chemical	 labels	and	offers	a	significantly	 lower	cell	 loss	and	
running	costs.		
	
	 Using	DEP,	it	was	shown	that	the	dielectric	characteristics	of	cultured	breast	cancer	cells	are	
significantly	 different	 from	 those	 of	 blood	 cells,	 and	 that	 these	 differences	 can	 be	 exploited	 in	 a	
dielectric	affinity	column	to	remove	tumour	cells	from	diluted	blood	(Becker	et	al.,	1995).	A	later	work	
measured	 the	 membrane	 dielectric	 responses	 of	 human	 T-lymphocytes	 following	 mitogenic	
stimulation	(Huang	et	al.,	1999).	After	induction	of	the	cell	division	cycle,	the	cells	were	examined	at	
24-h	 intervals	 for	 up	 to	 96-h	 by	 flow	 cytometry	 to	 determine	 cell	 cycle	 distributions	 and	 by	
electroporation	 to	 evaluate	dielectric	 properties.	 The	 average	membrane	 specific	 capacitance	was	
found	to	vary	24-h	and	48-h	following	the	stimulation,	coinciding	with	the	large	alteration	in	the	cell	
cycle	distribution,	but	remained	unchanged	up	to	96-h	after	stimulation.	The	study	also	revealed	an	
increased	 complexity	 in	 cell	 membrane	 morphology	 following	 stimulation,	 suggesting	 that	 the	
observed	 change	 in	 the	 membrane	 capacitance	 was	 dominated	 by	 the	 alteration	 of	 cell	 surface	
structures.	These	data	indicated	a	correlation	between	membrane	capacitance	and	cell	cycle	phases	
reflecting	alterations	in	the	cell	plasma	membrane.	At	around	the	same	time,	the	group	presented	the	
principle	of	cell	characterisation	and	separation	by	dielectrophoretic	field-flow	fractionation	(Huang	
et	al.,	1997).	In	this	method,	an	inhomogenous	dielectrophoretic	levitation	force	acts	to	balance	the	
homogeneous	gravitational	 force,	and	provides	an	effective	mechanism	for	controlling	positions	of	
cells	and	their	corresponding	velocities	in	a	fluid	flow	profile.	The	cell	velocity	is	a	function	of	the	mean	
fluid	velocity,	the	voltage	and	frequency	of	the	signals	applied	to	the	electrodes,	and	the	cell	dielectric	
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properties.	The	validity	of	the	model	was	demonstrated	with	human	leukaemia	(HL)-60	cells,	with	the	
device	able	to	separate	the	cells	from	peripheral	blood	mononuclear	cells.	
	
	 Dielectrophoresis	was	also	employed	to	analyse	the	electrophysiological	properties	of	cortical	
human	and	mouse	neural	stem	and	progenitor	cells	(NSPCs)	(Labeed	et	al.,	2011).	It	was	revealed	that	
the	membrane	capacitance	of	the	cells	inversely	correlated	with	the	neurogenic	potential	of	the	cells.	
Inversely,	differences	in	membrane	conductance	between	NSPCs	did	not	consistently	correlate	with	
the	ability	of	the	cells	to	generate	neurons.	The	quantitative	measurement	of	cell	behaviour	in	DEP	
directly	correlated	with	neuron	generation	of	NSPCs,	 indicating	a	potential	mechanism	to	separate	
stem	 cells	 biased	 to	 particular	 differentiated	 cell	 fates.	 The	 same	 team	 also	 applied	 the	 electrical	
phenomenon	dielectrophoresis	for	detecting	apoptosis	at	very	early	stages	on	the	basis	of	changes	in	
electrophysiological	properties	(Chin	et	al.,	2006).	Here,	the	cytoplasmic	conductivity	of	K562	(human	
myelogenous	 leukaemia)	 cells	 increased	 in	 a	 persistent	manner,	 as	 early	 as	 30	minutes	 following	
exposure	to	an	apoptotic	agent.	The	method	therefore	allowed	for	a	far	more	rapid	detection	than	
existing	biochemical	marker	methods.	Thus,	DEP	is	a	technique	that	can	detect	early	events	associated	
with	the	onset	of	apoptosis	in	a	manner	which	can	be	correlated	with	other	apoptotic	events	such	as	
the	translocation	of	membrane	phospholipids	between	inner	and	outer	leaflets	(Mulhall	et	al.,	2015).	
However,	whilst	tools	for	the	study	of	apoptosis	often	focus	on	the	analysis	of	the	apoptotic	process,	
a	 greater	 part	 of	 the	 analysis	 is	 in	 the	 quantification	 of	 the	 number	 of	 cells	 undergoing	 the	
phenomenon,	in	order	to	determine	the	efficacy	of	drugs	at	different	concentrations	(Henslee	et	al.,	
2016).	Previously,	DEP	was	unable	to	achieve	this,	as	the	majority	of	DEP	analysis	methods	use	cell	
tracking	to	measure	the	force	on	a	population	of	cells.	Notably,	cells	in	late	apoptosis	tend	to	break	
into	small	particles	known	as	“apoptotic	bodies”	that	are	too	small	to	track	easily,	making	it	difficult	
to	 quantify	 how	may	 cells	 have	 entered	 this	 phase.	 Consequently,	 the	 accurate	 quantification	 of	
apoptosis	 is	essential	 in	understanding	the	function	and	performance	of	new	anti-cancer	drugs	for	
instance.	Results	suggested	that	DEP	could	be	used	as	an	effective	tool	for	quantifying	cell	death,	with	
results	comparable	to	standard	assays	such	as	trypan	blue,	flow	cytometry	and	3-(4,5-Dimethylthiazol-
2-yl)-2,5-Diphenyltetrazolium	Bromidefor	(MTT)	assay.		
	
	 Importantly,	 electrophysiological	 and	 pharmacological	 approaches	 participated	 in	 the	
discovery	that	circadian	rhythms	were	also	observed	in	isolated	mammalian	RBCs,	which	lack	nuclei,	
suggesting	the	existence	of	post-translational	cellular	clock	mechanisms	in	these	cells	(Henslee	et	al.,	
2017).	More	 specifically,	 human	 RBCs	 display	 circadian	 regulation	 of	membrane	 conductance	 and	
cytoplasmic	conductivity	depending	on	 the	cycling	of	cytoplasmic	potassium	(K+)	 levels.	Moreover,	
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using	 pharmacological	 intervention	 and	 ion	 replacement,	 it	 was	 shown	 that	 an	 inhibition	 of	 K+	
transport	abolished	RBCs	electrophysiological	rhythms.	This	suggested	that	red	blood	cells	maintained	
a	 circadian	 rhythm	 in	 membrane	 electrophysiology	 through	 a	 dynamic	 regulation	 of	 potassium	
transport,	in	the	absence	of	conventional	transcription	cycles.	
	
1.8 Aim,	objectives	and	hypotheses	
	
1.8.1	Overall	aim	
	
	 The	overall	aim	of	this	work	was	to	provide	a	broader,	clearer,	and	in-depth	study	of	circadian	
rhythms	 within	 adipose	 cells.	 We	 proposed	 three	 different	 in	 vitro	 approaches;	 metabolic,	
electrophysiological,	and	molecular,	in	the	hope	of	further	understanding	the	mechanisms	of	action	
of	adipose	circadian	clocks	on	our	physiology.	
	
1.8.2	Hypotheses	
	
Hypothesis	 1:	 In	 vitro	 utilisation	 dynamics	 of	 glucose	 in	 pre-adipose	 cells	 are	 exhibiting	 circadian	
rhythms,	as	do	utilisation	rates	of	various	other	carbon-based	sources;	predictors	of	the	development	
of	obesity,	markers	of	insulin	resistance,	and	intermediates	in	key	metabolic	pathways.	
	
Hypothesis	2:	 Electrophysiological	parameters	 reflecting	 the	cellular	morphology	and	 ionic	activity	
between	the	cell	and	its	external	environment	vary	according	to	a	circadian	manner	in	pre-adipocytes.	
	
Hypothesis	3:	3T3-L1	pre-adipocytes	and	adipocytes	possess	an	endogenous	circadian	clock	driving	
robust,	persistent,	and	anti-phasic	circadian	rhythms	in	the	activity	of	the	promoters	of	two	core	clock	
genes:	Per2	and	Bmal1.	3T3-L1	adipocytes	exhibit	a	faster	damping	rate	and	lower	amplitude	rhythms	
as	compared	to	their	pre-adipocytes	counterparts.		
	
1.8.3	Objectives	
	
Objective	 1:	 Determine,	 across	 the	 circadian	 time,	 in	 vitro	 utilisation	 dynamics	 of	 glucose	 in	 pre-
adipocytes,	 as	 well	 as	 of	 a	 various	 array	 of	 monosaccharides,	 oligosaccharides,	 polysaccharides,	
nucleosides,	alcohols,	organic	acids,	ketone	bodies	and	short	chain	fatty	acids.		
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Objective	 2:	 Evaluate	 the	 ionic	 transport	 across	 the	 membrane	 and	 on	 its	 surface,	 the	 cellular	
morphology	 as	 well	 as	 the	 free	 ionic	 concentration	 within	 the	 cytoplasm,	 at	 regular	 intervals	
throughout	the	circadian	time,	in	3T3-L1	cells.	
	
Objective	 3:	 Differentiate	 pre-adipocytes	 into	 adipocytes	 in	 order	 to	 study	 the	 effect	 of	 the	
differentiation	process	on	the	circadian	rhythmicity	in	the	activity	of	the	promoters	of	two	core	clock	
genes:	Per2	and	Bmal1;	through	the	analysis	of	the	amplitude,	period,	damping,	and	phase.	
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CHAPTER	2:	METHODS	
	
2.1	Manufacturers	
	
	 Table	 2.1	 lists	 the	 different	manufacturers	 for	 products	 described	 herein,	 as	well	 as	 their	
headquarters.	
	
Table	2.1:	List	of	manufacturers	and	their	headquarters.	
	
Manufacturer	 Location	of	headquarters	
Abcam	 Milton,	Cambridge	–	UK	
ACC	Silicones	 Wallingford,	Oxfordshire	–	UK	
Actimetrics	 Wilmette,	Illinois	–	USA	
Biolog	Technopath	 Hayward,	California	–	USA	
Bio	Rad	 Watford,	Hertfordshire	–	UK	
Corning	 Corning,	New-York	–	USA	
DEP-techonologies	 Heathfield,	East	Sussex	-	UK		
Gibco	 Carlsbad,	California	–	USA	
Labtech	 Heathfield,	East	Sussex	-	UK	
Promega	 Madison,	Wisconsin	–	USA	
Sigma-Aldrich	MERCK	 Gillingham,	Dorset	–	UK	
Thermo-Fisher	Scientific	 Waltham,	Massachusetts	–	USA	
VWR	 Radnor,	Pennsylvania	–	USA	
	
2.2	Reagents	preparation	
	
	 This	section	describes	the	procedures	followed	for	the	preparation	of	various	consumables	
used	in	this	work.		
	
2.2.1	Collagen	type	I	from	rat	tail	
	
	 From	an	initial	10mg	collagen	powder	(Sigma-Aldrich	–	C7661),	a	2.5mg/mL	stock	solution	was	
prepared	by	dissolving	the	collagen	in	0.2%	sterile	acetic	acid	(Sigma-Aldrich	–	A6283).	The	resulting	
solution	was	then	gently	stirred	at	room	temperature	for	a	period	of	1	to	3	hours,	until	the	collagen	
was	completely	dissolved.	The	collagen	solution	was	stored	in	a	refrigerator	between	2	and	8°C	for	up	
to	1	month.	
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2.2.2	Deep	Red	dye	membrane	stain	
	
	 100µL	of	Dimethyl	Sulfoxide	(DMSO,	Abcam)	was	added	to	the	Deep	Red	dye	probe	provided	
by	the	staining	kit	(Cytopainter	Cell	Plasma	Membrane	Staining	Kit,	ab219942	-	Abcam),	in	order	to	
prepare	a	500-X	Deep	Red	dye	stain	stock	solution.	This	was	mixed	by	gentle	pipetting	before	storage	
at	-20°C,	away	from	light	and	for	up	to	two	months	(if	not	used	immediately).	To	obtain	the	working	
solution,	the	500-X	stock	solution	was	thawed	at	room	temperature,	before	20µL	of	this	stock	solution	
was	mixed	to	10mL	of	the	assay	buffer,	also	provided	by	the	kit	(Abcam)	and	equilibrated	at	room	
temperature.	Cycles	of	freeze/thaw	were	avoided.	
		
2.2.3	Dexamethasone		
	
	 A	 25mg	 dexamethasone	 powder	 (Sigma-Aldrich	 –	 D4902)	was	mixed	 to	 25mL	 of	 absolute	
ethanol	 (100%,	Sigma	–	51976).	The	resulting	solution	was	gently	swirled	until	all	 the	powder	was	
dissolved.	Subsequently,	49mL	of	sterile	Dulbecco’s	Modified	Eagle’s	Medium	(DMEM,	Sigma-Aldrich	
–	D6429)	was	added	per	mL	of	the	above	ethanol	used	to	dissolve	DEX,	 in	order	to	achieve	a	final	
concentration	of	20µg/mL	(or	50µM)	of	the	stock	solution.	This	was	aliquoted	 into	1mL	Eppendorf	
supplies	before	storage	at	-20°C	for	up	to	3	months	(after	which	the	product	is	not	stable	anymore).	
The	final	working	concentration	was	of	1µM,	thus	the	stock	solution	was	diluted	50	times	in	DMEM	
growing	medium.		
	
2.2.4	Gelatine	
	
	 A	0.01%	Gelatine	solution	from	bovine	skin	type	B	(Sigma-Aldrich	–	G9391)	was	prepared	by	
mixing	 10mg	of	Gelatine	 powder	 to	 100mL	of	Milli-Q	water.	 The	 powder	was	 allowed	 to	 dissolve	
completely	via	gentle	swirl,	and	the	resulting	solution	was	used	within	three	weeks.		
	
2.2.5	Insulin	
	
	 A	1mg/mL	 insulin	 stock	 solution	was	made	by	dissolving	250µL	of	4mg/mL	 insulin	 (human	
recombinant	 in	zinc	–	Thermo-Fisher	Scientific	–	12585-014),	 into	750µL	of	DMEM	(Sigma-Aldrich).	
Aliquots	of	250µL	were	stored	at	-20°C.	
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2.2.6	3-Isobutyl-1-MethylXanthine		
	
	 100mg	of	the	initial	IBMX	powder	(Sigma-Aldrich	–	I7018)	was	dissolved	into	900µL	of	DMSO	
(Sigma-Aldrich	–	W387520),	 in	order	to	obtain	a	0.5M	stock	solution.	Aliquots	of	100µL	were	then	
made	before	storage	at	-20°C,	and	were	stable	for	at	least	3	months	in	these	conditions.		
	
2.2.7	Phosphate	Buffered	Saline	(PBS)	
	
	 One	tablet	of	PBS	(Sigma-Aldrich	–	P4417)	was	dissolved	in	200mL	of	Milli-Q	water,	resulting	
in	a	solution	of	0.01M	PBS	containing	0.0027M	of	potassium	chloride	and	0.137M	of	sodium	chloride.	
This	was	used	within	a	month.		
	
2.2.8	Poly-D-Lysine	Hydrobromide	
	
	 50mL	of	Milli-Q	water	was	added	to	5mg	of	poly-D-lysine	(Sigma-Aldrich	–	P6407)	for	a	final	
working	solution	of	0.1g/L.	This	was	prepared	in	a	50mL	falcon	tube,	and	the	working	poly-D-lysine	
solution	was	sterile	filtered	before	use.	Storage	conditions	were	at	2	to	8°C	for	a	maximum	period	of	
time	of	2	months.	
	
2.3	Cell	culture	
	
2.3.1	Overview	
	
	 The	cells	lines	used	in	this	work	were	all	stored	at	>-196°C	within	a	liquid	nitrogen	container,	
in	1.5mL	cryovials	(Sigma-Aldrich).	Each	cryovial	contained	1mL	of	cell	suspension	at	a	density	of	1.106	
cells/mL.	All	culturing	handling	was	performed	in	a	clean	laminar	flow.	Consumables	were	usually	pre-
warmed	at	37oC	in	a	water	bath	upon	usage,	unless	otherwise	stated.	
	
	 Cell	lines	containers	(plates,	dishes	and	flasks)	were	kept	in	an	incubator	set	at	37oC	with	5%	
carbon	dioxide	(CO2),	and	grown	in	culture	medium,	based	on	DMEM.	This	medium	contained	a	high	
glucose	concentration	of	4500mg/L,	and	was	supplemented	with	10%	of	FBS	 (Gibco	–	16000-036),	
2mM	 L-Glutamine	 (Gibco	 –	 25030-081,	 from	 an	 initial	 concentration	 of	 200mM),	 1%	 Antibiotic-
Antimycotic	 (Thermo-Fisher	 Scientific	 –	 15240-062)	 and	 finally	 with	 1%	 Sodium	 Pyruvate	 (Sigma-
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Aldrich	 –	 S8636).	 The	 antibiotic-antimycotic	mixture	 contained	 10.000	 units	 of	 penicillin,	 10mg	 of	
streptomycin	and	25µg	of	amphotericin	B.	
	
	 Table	2.2	below	presents	the	volumes	needed	for	each	component	in	order	to	obtain	a	total	
DMEM	medium	volume	of	500mL,	and	summarises	their	storage	conditions.	Once	the	medium	was	
completed,	50mL	of	medium	were	aliquoted	in	50mL	falcon	tubes,	stored	at	4°C,	and	used	within	a	
month.	
	
Table	2.2:	Culture	medium	composition	and	storage	conditions	for	stock	components.	
	
Component	 Associated	volume	(total	of	500mL)	 Storage	conditions	
DMEM	medium	4500mg/L	glucose	 435mL	 2	to	8°C	
FBS	 50mL	 -5	to	-30°C	
Sodium	Pyruvate	 5mL	 2	to	8°C	
Antibiotic-Antimycotic	 5mL	 -5	to	-30°C	
L-Glutamine	2mM	 5mL	 -5	to	-30°C	
	
2.3.2	3T3-L1	pre-adipose	cell	lines	
	
	 Two	different	3T3-L1	cell	lines	have	kindly	been	donated	by	the	team	of	Dr	Andrew	C.	Liu	from	
the	University	of	Memphis,	TN	–	USA,	containing	an	integrated	lentiviral	luciferase	reporter	of	either	
the	Per2	or	the	Bmal1	gene	promoter.	The	team	of	Dr	Liu	created	two	mammalian	reporter	constructs	
containing	an	expression	cassette	 in	which	the	promoter	of	a	circadian	gene	(in	this	case	Per2	and	
Bmal1)	is	fused	with	the	luciferase	gene	(Ramanathan	et	al.,	2012).	In	order	to	generate	a	lentiviral	
reporter,	 the	 team	 used	 a	 recombination-based	 Gateway	 cloning	 method	 to	 obtain	 a	 P(Per2	 or	
Bmal1)-dLuc	reporter.	The	example	of	the	cloning	method	for	the	Per2	gene	is	described	hereafter.	
	
STEP	1:	Cloning	of	the	Per2	promoter.	
	
	 A	PCR	technique	was	used	to	amplify	the	Per2	promoter	DNA	fragment	(526bp)	upstream	of	
the	 transcription	 start	 site	 from	 a	 mouse	 Per2	 BAC	 clone.	 A	 forward	 primer	 (5’-
CTCGAGCGGATTACCGAGGCTGGTCACG	 TC-3’)	 as	 well	 as	 a	 reverse	 primer	 (5’-
CTCGAGATCCCTTGCTCGGCCCGTCAC	 TTGG-3’),	 cloned	 into	 a	 pENTR5’-TOPO	 vector	 (Invitrogen)	 in	
order	to	generate	pENTR5’-P(Per2)	were	used	to	do	so.	
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STEP	2:	Cloning	of	dLuc.	
	
	 The	 dLuc	 contained	 the	 firefly	 luciferase	 gene	 and	 a	 C-terminal	 peptide	 sequence	 rich	 in	
proline	(P),	glutamic	acid	(E),	serine	(S)	and	threonine	(T)	(PEST)	for	rapid	protein	degradation.	Here	
again,	PCR	was	used	to	amplify	the	dLuc	fragment	then	cloned	into	pENTR/D-TOPO	vector	(Invitrogen)	
to	generate	pENTR/D-dLuc.	
	
STEP	3:	Construction	of	the	reporter	vector.	
	
	 The	 two	 previously	 obtained	 pENTR	 plasmids	 (pENTR5’-P(Per2)	 and	 pENTR/D-dLuc)	 were	
mixed	with	 the	 lentiviral	 destination	 vector	 pLV7-Bsd	 (blasticidin	 S	 deaminase	 resistance	 gene).	 A	
recombination	 reaction	 was	 then	 performed,	 using	 clonase,	 to	 generate	 a	 pLV7-Bsd-P(Per2)-dLuc	
reporter	as	represented	figure	2.1	below:	
			
	
	
Figure	 2.1:	 Schematic	 diagram	 representing	 the	 lentiviral	 P(Per2)-dLuc	 reporter	 construct.	 Taken	
from	Ramanathan	et	al.,	2012.	Only	the	region	for	integration	into	the	host	cell	genome	is	shown	and	
the	transcription	of	dLuc	is	under	direct	control	of	the	Per2	promoter.	A	co-expressed	Bsd	resistance	
gene	facilitates	the	selection	of	infected	cells.		
	
	 Lentiviral	particles	were	produced	using	human	embryonic	kidney	(HEK)	293T	cells	transduced	
via	calcium	phosphate	(CaPO4)/DNA	precipitation.	A	plasmid	transfection	mix	was	prepared	by	adding	
a	lentiviral	reporter	plasmid	DNA	(pLV7-Bsd-P(Per2)-dLuc)	and	3	packaging	vectors	(Gag/Pol,	Rev	and	
VSVG).	Next,	calcium	chloride	(CaCl2)	was	added	to	the	plasmid	mix,	as	well	as	a	borate	buffered	saline	
solution,	 before	 the	 DNA	 mix	 was	 incubated	 at	 room	 temperature	 for	 15	 minutes.	 Finally,	 the	
transfection	mix	 was	 added	 to	 the	 HEK293T	 cells	 drop	 by	 drop	 before	 overnight	 incubation.	 The	
medium	containing	the	transfection	mix	was	aspirated	at	16	hours	post	transfection	and	replaced	by	
DMEM	culturing	medium.	On	day	4	post-transfection,	the	medium	containing	secreted	and	infectious	
lentiviral	 particles	 was	 collected	 and	 centrifuged	 in	 order	 to	 then	 gather	 the	 virus-containing	
supernatant.	
	
	
	
	
	
		SIN-LTR											RRE												PPT													P(Per2)													dLuc																		WPRE												P(SV40)										Bsd																	SIN-LTR	
			attB4																		attB1																								attB2	
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	 3T3	cells	were	ready	to	be	infected	using	the	collected	medium	containing	the	viral	particles	
mixed	with	5µg/mL	of	polybrene	(enhancing	the	infection	efficiency).	The	cells	in	the	presence	of	the	
infectious	medium	were	incubated	overnight.	Finally,	the	clones	expressing	high	levels	of	luciferase	
and	exhibiting	circadian	properties	comparable	to	 infected	parental	cell	populations	were	selected	
using	Blastidin,	which	selects	for	stably	transduced	cells.			
	
2.3.3	 Initiation	 and	 maintenance	 of	 a	 cell	 culture:	 3T3-L1	 Per2	 and	 Bmal1	 d-Luc	 pre-
adipocytes		
	
	 A	cryovial	containing	1mL	of	the	cell	suspension	of	interest	(either	3T3-L1	Per2-dLuc	or	3T3-
L1	 Bmal1-dLuc)	 was	 removed	 from	 liquid	 nitrogen	 storage,	 and	 placed	 in	 a	 37oC	 water	 bath	 for	
approximately	 2	 minutes,	 in	 order	 for	 the	 cells	 to	 be	 thawed	 in	 a	 controlled	 manner.	 The	 cell	
suspension	was	then	quickly,	but	carefully,	transferred	to	a	15mL	falcon	tube,	and	5mL	of	culturing	
DMEM	medium	were	added	to	the	cell	suspension.	The	tube	was	centrifuged	at	200g	for	4	minutes,	
in	order	to	pellet	the	cells,	allowing	us	to	aspirate	the	supernatant	containing	cryoprotectant	agents	
from	the	freezing	medium	(DMSO	–	Sigma-Aldrich),	toxic	for	living	cells	at	prolonged	exposure.			
	
	 The	cell	pellet	was	resuspended	in	5mL	of	culture	DMEM	medium,	transferred	to	a	T25	flask	
and	subsequently	incubated	at	37°C	with	5%	CO2.	Cells	were	left	to	grow	to	reach	approximately	70-
80%	confluence,	which	typically	occurred	2	days	after	seeding	into	the	T25	flask,	at	which	point	cells	
were	split	into	T75	flasks	at	a	1:3	ratio.	Splitting	was	achieved	by	aspirating	the	cell	culture	medium	
and	washing	the	cells	once	with	4mL	of	1X-PBS	(Sigma-Aldrich).	After	washing,	2mL	of	1-X	Trypsin	–	
Ethylene	Diamine	Tetra	Acetic	Acid	(Trypsin-EDTA,	Sigma-Aldrich)	were	added	to	the	cells	in	the	flask	
by	careful	pipetting,	before	incubation	(37°C,	5%	CO2)	for	approximately	2	minutes	or	until	all	the	cells	
were	detached	from	the	bottom	of	the	flask	(this	was	checked	using	an	inversed-light	microscope).	
For	cell	detachment	assistance,	the	flasks	could	be	gently	tapped	on	the	side	of	the	bench.	Upon	full	
cell	detachment,	the	trypsin-EDTA	was	inactivated	by	addition	of	2mL	of	fresh	culture	medium	to	the	
flask,	and	the	resulting	suspension	was	gently	mixed	by	pipetting	(see	table	2.3).	The	content	of	the	
flask	(containing	the	cells)	was	transferred	into	a	15mL	falcon	tube	to	pellet	the	cells	by	centrifugation	
(200g,	 4	 minutes).	 The	 supernatant	 was	 discarded	 and	 the	 pellet	 resuspended	 in	 3mL	 of	 culture	
medium.	Three	times	1mL	of	 this	cell	 suspension	was	transferred	 into	a	T75	 flask,	which	was	then	
supplemented	with	9mL	of	culture	medium,	achieving	a	total	volume	of	10mL	(table	2.3).	Cells	were	
grown	until	they	reached	70-80%	confluence,	at	which	point	they	were	split	1:3	following	the	same	
procedure	as	mentioned	above.	The	cell	culture	medium	was	changed	every	two	days,	and	the	acidity	
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of	the	medium	was	monitored	by	ensuring	there	wasn’t	any	major	colour	change	of	the	phenol	red.	
Table	2.3	below	records	the	different	volumes	of	consumables	for	cell	passaging,	according	to	the	flask	
size.			
	
Table	2.3:	Record	of	the	different	volumes	of	consumables	for	cell	passaging	according	to	the	size	
of	the	flask.		
	
	
2.3.4	Freezing	down	cells	for	storage	
	
	 In	order	to	have	stocks	of	3T3-L1	Per2	and	Bmal1	–	dLuc	pre-adipocytes,	the	cryovials	were	
quickly	thawed	as	described	in	section	2.3.3,	and	split	into	a	T75	flask.	The	cell	passage	number	for	
this	procedure	was	then	set	to	1,	indicating	this	was	the	first	passage	done	in	our	laboratory.		When	
reaching	approximately	80%	confluence,	cells	were	split	1:10	 in	10	different	T75	flasks	as	stated	in	
section	2.3.3.	This	was	counted	as	passage	2.	Cells	were	incubated	at	37°C	and	5%	CO2	and	grown	to	
reaching	80%	confluence,	at	which	point	9	of	the	T75	flasks	were	trypsinised	and	centrifuged	(200g,	4	
minutes)	 following	the	method	described	 in	section	2.3.3.	The	supernatants	were	carefully	aspired	
and	the	pellets	were	each	resuspended	in	3.5mL	of	freezing	medium	in	order	to	make	3	aliquots	of	
1mL	 per	 T75	 flask.	 The	 freezing	 medium	 was	 composed	 of	 serum-free	 DMEM	 medium	 (SFM)	
supplemented	with	10%	DMSO,	10%	FBS	and	1%	of	an	antibiotic-antimycotic	mixture.	DMSO	was	used	
as	a	cryoprotectant	agent	in	this	process,	preventing	the	cells	from	forming	crystals,	and	could	be	kept	
as	room	temperature	when	in	storage.	The	cells	within	the	remaining	T75	flask	were	trypsinised	and	
split	 1:10	 into	 10	 T75	 flasks	 (passage	 number	 3),	which	were	 grown	 to	 80%	 confluence	 as	 stated	
previously.	In	the	same	manner,	cells	were	trypsinised	and	centrifuged	(section	2.3.3)	before	each	cell	
pellet	 was	 resuspended	 in	 freezing	 medium.	 This	 time,	 the	 cells	 contained	 in	 the	 10	 flasks	 were	
prepared	for	long-time	storage.	
	
	 All	 57	 aliquots	 containing	 cells	 in	 freezing	medium	were	 placed	 in	 isopropanol	 containers	
(Nalgene,	Mr.	Frosty	TM),	and	placed	in	a	-80oC	freezer	facilitating	a	1oC/min	cooling	rate	for	24	hours	
immediately	after	the	cells	were	mixed	to	the	freezing	medium.	The	vials	were	then	placed	in	liquid	
nitrogen	for	indefinite	storage.		
Size	of	the	flask	 Volume	of	DMEM	for	
centrifugation	
Total	volume	of	
DMEM	for	culture	
Volume	of	PBS	
for	washing	
Volume	of	
Trypsin	/	EDTA	
T25	 2mL	 5mL	 4mL	 2mL	
T75	 3mL	 10mL	 8mL	 3mL	
T150	 5mL	 18mL	 10mL	 5mL	
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2.3.5	Coating	of	cell	culture	surface	areas	
	
	 Different	 non-specific	 attachment	 factors	were	 used	 in	 this	work	 in	 order	 to	 promote	 cell	
adhesion	to	solid	surfaces.	More	specifically,	35mm	petri	dishes	used	to	grow	pre-adipocytes	to	be	
differentiated	into	adipocytes	were	pre-coated	with	either	collagen	or	gelatine	as	the	cells	become	
more	spherical	over	the	process	of	differentiation	and	therefore	are	less	adherent	to	the	bottom	of	
the	dish.	Furthermore,	96-well	plates	also	used	to	grow	pre-adipocytes	were	pre-coated	with	poly-D-
lysine	hydrobromide,	as	the	small	surface	offered	by	a	well	makes	the	cells	extremely	susceptible	to	
detachment	when,	for	instance,	a	pipetting	occurs.	
	
2.3.5.1	Collagen	coating	
	
	 Collagen	is	the	most	widely	used	extracellular	matrix	(ECM)	protein	for	cell	culture,	facilitating	
cell	attachment,	growth,	differentiation,	migration	and	tissue	morphogenesis.	Collagen	type	I	from	rat	
tail	was	here	used	for	coating	and	prepared	using	the	method	described	in	section	2.2.1.	Surface	areas	
of	35mm	(petri	dishes,	Corning)	were	pre-coated	using	collagen.	In	short,	1mL	of	the	collagen	working	
solution	was	pipetted	 into	the	35mm	dish,	and	 left	 for	a	period	of	24	hours	at	room	temperature,	
under	a	laminar	flow.	This	was	to	allow	the	collagen	to	adhere	to	the	cell	culture	dish	surface.	After	
this	period,	the	remaining	liquid	was	gently	aspirated,	and	the	dishes	were	washed	twice	using	1mL	
of	1X-PBS,	before	being	left	to	dry	for	15	minutes,	again	at	room	temperature	and	under	a	laminar	
flow.	Cells	were	immediately	added	to	the	pre-coated	dishes.	
	
2.3.5.2	Gelatine	coating	
	
	 Gelatine	was	also	used	 to	 improve	cell	 attachment,	 as	a	heterogeneous	mixture	of	water-
soluble	proteins	of	high	average	molecular	masses,	present	in	collagen.		A	solution	of	0.01%	Porcine	
gelatine	 (Sigma-Aldrich)	 in	Milli-Q	water	was	 prepared	 as	 described	 in	 section	 2.2.4.	 The	 gelatine	
solution	was	applied	to	cover	the	culture	surfaces	where	the	cells	should	grow.	In	this	project,	this	
was	again	in	35mm	petri	dishes,	requiring	1mL	of	Gelatine	0.01%	per	dish.	The	gelatine	solution	was	
left	for	24	hours	at	room	temperature	and	under	a	laminar	flow	cabinet	before	being	carefully	aspired.	
The	coated	dishes	were	then	left	to	dry	in	the	same	conditions	for	15	to	20	minutes,	before	cells	were	
added.	
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2.3.5.3	Poly-D-Lysine	hydrobromide	coating	
	
	 Poly-D-lysine	(Sigma-Aldrich)	was	used	as	an	attachment	factor	as	it	enhanced	electrostatic	
interaction	between	negatively	charged	ions	of	the	cell	membrane	and	the	culture	surface.	This	agent	
increased	the	number	of	positively	charged	sites	available	for	cell	binding.		
	
	 A	5mg	poly-D-lysine	hydrobromide	powder	of	molecular	weight	comprised	between	70.000	
and	150.000g/moL	was	prepared	(section	2.2.8).	The	culture	surfaces	were	then	coated	using	1mL	of	
poly-D-lysine	in	each	well	of	a	6-well	plate,	or	50µL	for	96-well	plates.	The	plates	were	then	manually	
rocked	gently	in	order	to	ensure	an	even	coating.	After	10	minutes,	the	solution	was	discarded	and	
the	culture	surface	was	rinsed	with	1X-PBS	(the	same	volume	as	the	coating	agent	was	used,	so	either	
1mL	or	50	µL).	The	surface	was	left	to	dry	for	at	least	2	hours	before	cell	suspensions	in	culture	medium	
could	be	introduced.		
	
2.3.6	High	concentrations	of	serum	and	circadian	gene	expression	
	
	 Throughout	this	thesis,	we	used	a	method	whereby	the	molecular	clocks	within	individual	cells	
can	be	synchronised	across	a	cell	culture	by	providing	high	serum	concentrations	(Nagoshi	et	al.,	2004,	
Welsh	 et	 al.,	 2004).	 The	protocol,	 often	 referred	 to	 as	 “serum	 shock”	or	 “serum	pulse”,	 has	been	
developed	in	1998	(Balsalobre	et	al.,	1998).	High	serum	concentrations	were	provided	by	a	culture	
medium	constituted	of	50%	FBS	and	50%	SFM,	completed	with	1%	of	antibiotic-antimycotic	(serum	
shock	medium).			
	 	
	 For	 each	 experiment	 involving	 a	 serum	 pulse,	 cells	 were	 grown	 to	 90%	 confluence.	 The	
culturing	medium	was	then	removed	before	cell	culture	surfaces	were	rinsed	using	1X-PBS	(1mL	in	
case	of	a	35mm	petri	dish,	50µL	in	96-well	plates	and	see	table	2.3	for	cell	culture	flasks).	The	serum	
shock	medium	was	then	added	to	the	cells	(2mL	in	a	35mm	dish	or	6-well	plate,	50µL	in	96-well	plates	
and	see	table	2.3	for	cell	culture	flasks)	for	a	total	of	2	hours,	before	being	replaced	by	the	culture	
DMEM	medium	(same	volumes	as	the	serum	shock	medium)	in	case	the	cells	were	not	used	directly	
following	another	wash	with	1X-PBS.	The	start-time	of	serum	shock	(the	exact	time	at	which	the	serum	
shock	medium	was	added)	was	indicated	as	CT	0,	or	0	hours	since	serum	shock,	throughout	this	thesis.		
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2.4	BIOLOGTM:	metabolic	studies	of	3T3-L1	Per2-dLuc	reporter	cells	
	
2.4.1	Generalities	
	
	 This	phenotype	microarray	technology	is	an	exclusive	platform,	able	to	focus	on	the	metabolic	
profiling	of	all	types	of	cells,	and	to	detect	critical	changes	in	energy	pathway	usage.	Typically,	cells	
are	placed	in	96-well	cell-based	assay	plates	in	the	presence	of	a	colorimetric	redox	dye	(Technopath,	
74352),	constituting	the	first	component	of	the	BIOLOGTM	platform.	Each	well	of	study	contains	an	
energy	substrate,	or	energy	source,	matching	a	specific	metabolic	pathway	of	interest.	If	the	substrate	
can	be	metabolised	(or	utilised)	by	the	cells,	nicotinamide	adenine	dinucleotide	(NADH)	is	produced	
and	this	is	detected	by	the	dye	which	will	then	become	purple.	The	amount	of	purple	is	thus	reflecting	
the	 amount	 of	 NADH	 generated	 and	 the	 amount	 of	 energy	 produced	 by	 the	 cells.	 The	 second	
component	of	the	BIOLOGTM	platform	is	an	automated	incubator	reader,	the	OMNILOGTM,	deprived	
of	CO2,	set	at	37°C,	and	equipped	with	an	analysis	software	(OMNILOGTM	data	collection,	version	2.4).	
Figure	2.2	below	illustrates	the	BIOLOGTM	platform.	
	
	
	
Figure	2.2:	BIOLOGTM	platform	from	Technopath.	Images	taken	from	https://www.biolog.com/.	On	
the	 right	 is	 shown	 the	OMNILOGTM	 incubator	 set	 at	 37°C,	where	 a	 rack	 represents	 one	 of	 the	 25	
positions	which	can	be	found	within	the	incubator.	Each	plate	 is	filled	with	cells	 in	contact	with	an	
energy	source,	and	a	colorimetric	dye	 reflecting	 the	amount	of	energy	produced	by	 the	cells	after	
utilisation	of	 the	energy	 source.	The	wells	become	more	and	more	purple	as	 the	energy	 source	 is	
utilised,	which	is	illustrated	by	the	plate	shown	on	the	left.	The	incubator	is	attached	to	a	computer	
equipped	with	an	analysis	software	for	the	recording	of	the	data.	
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	 Once	 the	 recordings	 started,	 the	 OMNILOGTM	 data	 collection	 software	 recorded	 a	 kinetic	
graph	showing	the	amount	of	colour	(or	NADH)	produced	by	the	cells	in	each	of	the	wells	versus	time,	
with	the	help	of	an	on-board	camera	located	just	behind	the	trays	containing	the	plates	within	the	
OMNILOGTM	incubator.	The	colour	development	by	the	dye,	on	a	plate	to	plate	basis,	was	recorded	
every	15	minutes,	illustrated	by	kinetic	patterns	also	representing	the	energy	produced	by	the	cells	
when	utilising	a	specific	substrate,	which	were	developing	in	as	little	as	1	to	4	hours.	Figure	2.3	below	
shows	examples	of	kinetic	patterns	recorded	by	the	OMNILOGTM	data	collection	software,	using	3T3-
L1	Per2-dLuc	cells.	In	this	case,	each	well	was	filled	with	different	carbon	sources.	
	
	
	
Figure	2.3:	Examples	of	kinetic	patterns	recorded	by	the	OMNILOGTM	data	collection	software.	A:	
Plate	equipped	with	96	substrates	is	shown	at	the	top,	where	the	colour	development	observed	was	
due	 to	 the	energy	being	produced	by	 the	 cells	 and	NADH	 released	 following	 the	utilisation	of	 the	
substrate.	At	the	bottom	are	represented	the	different	kinetic	profiles	of	OMNILOGTM	values	across	
time	for	each	substrate.	B:	This	panel	shows	a	zoom	on	the	kinetic	profile	of	one	well	representing	
one	substrate	only,	with	OMNILOGTM	values	plotted	against	the	time	of	recording.	
	
2.4.2	Measurement	of	glucose	utilisation	using	the	BIOLOGTM	technology	
	
2.4.2.1	Cell	culture	
	
	 3T3-L1	Per2-dLuc	pre-adipocytes	were	grown	following	the	method	described	previously	 in	
section	2.3.3,	using	DMEM	culturing	medium.	Cells	were	grown	in	T75	flasks	and	allowed	to	reach	80%	
confluence.	The	flasks	were	then	rinsed	with	1X-PBS	before	trypsinisation	and	centrifugation	at	200g	
and	 for	 4	minutes	 (section	 2.3.3).	 The	 supernatant	was	 carefully	 discarded,	 before	 2mL	of	DMEM	
culturing	medium	were	used	to	re-suspend	the	cellular	pellet.	10µL	of	the	resulting	cell	suspension	
A B
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was	mixed	to	another	10µL	of	0.4%	Trypan-Blue	(Sigma-Aldrich,	T8154),	before	10µL	was	inserted	into	
the	chamber	of	a	disposable	haemocytometer	 (Bio-Rad	–	1450003).	Trypan	Blue	was	used	 to	help	
detect	dead	and	dying	 cells	 in	 suspension	as	 the	dye	was	 then	able	 to	 traverse	 their	membranes,	
therefore	the	cells	were	coloured	in	blue.	Living	cells	were	left	uncoloured	as	the	trypan	blue	was	in	
this	case	unable	to	penetrate	their	membranes.	Cells	were	automatically	counted	using	an	automated	
cell	 counter	 (Bio-Rad	–	TC20TM),	which	was	also	able	 to	automatically	 check	 for	 cell	 viability	when	
detecting	Trypan	Blue	(we	accepted	a	percentage	of	living	cells	of	at	least	90%).	The	cell	density	was	
then	adjusted	to	4.105	cell/mL	using	DMEM	medium.	50µL	of	the	resulting	cell	suspension	was	inserted	
in	 a	 well	 of	 a	 blank	 BIOLOGTM	 96-well	 plate	 (figure	 2.4)	 (Technopath,	 30311),	 therefore	 not	 pre-
inoculated	with	any	energy	source,	pre-coated	with	poly-D-lysine	hydrobromide	(sections	2.2.8	and	
2.3.5.3).	In	order	to	measure	glucose	utilisation,	a	minimal	medium	was	required	not	containing	any	
carbon	sources	in	order	not	to	be	interfering	with	the	measurements.	The	medium	was	provided	by	
Biolog	 (Technopath,	 72301)	 as	 IF-M1	 and	 was	 supplemented	 with	 200mM	 L-Glutamine,	 200x	
antibiotics-antimycotics	and	5%	dialysed	FBS	 (Gibco,	A3382001),	 thus	 resulting	 in	a	medium	called	
MC-0	considered	as	the	complete	BIOLOGTM	medium.	An	illustration	of	a	BIOLOGTM	96-well	plate	is	
given	figure	2.4	below:	
	
																			
	
	
	
	
	
	
Figure	2.4:	Example	of	a	BIOLOGTM	
96-well	 plate.	 Image	 taken	 from	
https://www.biolog.com/.	
	
	
2.4.2.2	Different	glucose	concentrations	
	
	 To	measure	the	glucose	utilisation	of	3T3-L1	pre-adipocytes,	the	first	optimisation	step	was	to	
record	the	utilisation	of	various	concentrations	of	glucose,	in	order	to	determine	the	one	which	gave	
the	most	 accurate	 utilisation	within	 the	 physiological	 range.	 The	 highest	 concentration	 of	 glucose	
tested	was	4500mg/L,	as	the	concentration	of	glucose	found	in	the	DMEM	medium	used	to	culture	
the	cells.	This	concentration	was	then	diluted	through	1:2	serial	dilutions	up	until	17.58mg/L,	for	a	
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total	 of	 9	 different	 concentrations:	 4500,	 2250,	 1125,	 562.5,	 281.25,	 140.625,	 70.3125,	 35.15	 and	
17.578mg/L.	6	technical	replicates	were	recorded	for	a	total	of	3	different	biological	replicates,	for	
concentrations	ranging	between	4500mg/L	and	35.15mg/L	of	glucose.	Biological	replicates	used	cells	
grown	at	different	weeks	and	coming	from	different	initial	cryovials.	A	technical	replicate	was	simply	
a	 replicate	 of	 the	 experiment	 for	 the	 same	biological	 replicate.	 Therefore,	 in	 this	 case,	 cells	were	
cultured	at	the	same	time,	and	were	coming	from	the	same	culture	flask	as	well	as	the	same	initial	
cryovial.	A	 total	 of	 two	biological	 replicates	 (4	 technical	 replicates)	were	measured	 for	 the	 lowest	
concentration	of	glucose	(17.578mg/L).	The	same	numbers	of	negative	controls	(using	water	instead	
of	glucose)	were	done.	
	
	 Cells	were	incubated	in	DMEM	medium,	at	37°C	with	5%	CO2,	for	24	hours	after	plating	into	a	
blank	BIOLOGTM	plate	as	explained	above	(section	2.4.2.1).	After	this	period	of	24	hours,	cells	were	
fully	confluent	and	the	medium	was	then	removed.	At	this	stage,	wells	were	carefully	rinsed	with	50µL	
of	1X-PBS,	before	50µL	of	serum	shock	medium	was	added	in	each	well	for	2	hours	(section	2.3.6).	
Following	the	synchronisation	of	the	cells	circadian	rhythms,	the	wells	were	emptied	and	rinsed	with	
50µL	1X-PBS	before	being	filled	with	35µL	of	MC-0	BIOLOGTM	medium,	10µL	of	colorimetric	dye	MB	
and	 5µL	 of	 the	 appropriate	 concentration	 of	 glucose.	 Negative	 controls	 were	 done	 using	 5µL	 of	
distilled	 water	 instead	 of	 glucose,	 and	 allowed	 to	 ensure	 a	 proper	 measurement	 comparison	 of	
substrates	responses.	The	plate	was	then	ready	to	be	incubated	in	the	OMNILOGTM	device	for	a	48-
hour	 recording,	 before	 kinetic	 profiles	 were	 analysed,	 using	 the	 PM_KineticTM	 analysis	 software	
(version	1.6).	OMNILOGTM	values	were	extracted,	and	the	slopes	as	well	as	the	averaged	plateau	values	
of	 the	 kinetic	 profiles	 for	 all	 glucose	 concentrations	were	 calculated.	 The	 slopes,	 representing	 the	
utilisation	rates,	were	determined	by	the	linear	regression	through	the	accumulation	phase,	defined	
to	lie	between	the	first	value	crossing	the	20%	concentration	threshold,	and	the	first	value	after	the	
80%	concentration	threshold.	The	plateau	represented	the	maximal	utilisation	of	the	substrate,	when	
all	had	been	utilised	by	the	cells.	
	
2.4.2.3	Different	times	of	starvation	
	
	 The	 DMEM	medium	 used	 to	 culture	 the	 cells	 contained	 carbon-based	 sources,	 or	 energy	
sources	(like	glucose),	especially	coming	from	the	serum.	Because	the	aim	of	using	this	technique	was	
to	measure	utilisation	rates	of	these	specific	type	of	substrates,	a	second	optimisation	step	was	to	
place	the	cells	in	MC-0	BIOLOGTM	medium	before	recording,	which	is	deprived	of	any	carbon	sources.	
The	objective	was	for	the	cells	to	utilise	all	carbon	sources	from	their	culturing	DMEM	medium	prior	
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to	 recording,	 to	 ensure	 that	 what	 was	 measured	 were	 actual	 glucose	 utilisation	 rates	 and	 not	
utilisation	rates	of	other	energy	sources.	To	this	purpose,	cells	were	inserted	and	grown	in	a	BIOLOGTM	
96-well	plate	pre-coated	with	poly-D-lysine	(sections	2.2.8	and	2.3.5.3),	at	an	initial	density	of	4.105	
cells/mL	(see	section	2.4.2.1),	 in	exactly	the	same	way	as	mentioned	above.	Cells	were	then	serum	
shocked	for	two	hours	(section	2.3.6),	after	which	wells	were	carefully	emptied	and	rinsed.	This	time,	
50µL	of	MC-0	medium	was	added	afterwards	in	each	well.	Measurements	were	either	done	directly	
afterwards	(4	technical	replicates),	or	cells	were	incubated	(37°C,	5%	CO2)	in	MC-0	medium	for	2,	3,	4	
and	5	hours	(2	technical	replicates)	following	serum	shock	and	prior	to	recordings.	Before	inserting	
the	plate	in	the	OMNILOGTM	incubator,	wells	were	emptied	and	their	content	was	replaced	with	35µL	
of	MC-0	medium,	10µL	of	dye	MB	and	5µL	of	glucose	at	4500mg/L,	as	described	previously	in	section	
2.4.2.2.	As	mentioned	above,	negative	controls	were	also	done	in	this	case	(2	technical	replicates),	
using	5µL	of	water	instead	of	glucose	and	measured	directly	after	serum	shock.	Utilisation	rates	(slope)	
of	glucose	were	determined	as	explained	in	section	2.4.2.2	and	plotted	against	the	time	of	incubation	
of	the	cells	in	MC-0	medium	after	serum	shock.	
	
2.4.2.4	Circadian	utilisation	of	glucose	using	blank	BIOLOGTM	plates	
	
	 For	 this	 experiment,	 3T3-L1	Per2-dLuc	 pre-adipocytes	were	 grown	 in	 T75	 flasks	 and	when	
confluent,	rinsed	with	1X-PBS	upon	trypsinisation	and	centrifugation	(200g,	4	minutes)	as	explained	
in	 section	 2.3.3	 above.	 Cells	were	 then	 plated	 in	 a	 BIOLOGTM	 plate,	 pre-coated	with	 poly-D-lysine	
(sections	2.2.8	and	2.3.5.3)	at	a	density	of	4.105	cells/mL	(section	2.4.2.1).	Cells	were	incubated	for	24	
hours	at	37°C	and	5%	C02,	after	which	they	reached	near	full	confluency	and	were	ready	to	be	serum-
shocked	 for	2	hours	at	 the	appropriate	 time.	After	 serum-shock,	wells	were	carefully	emptied	and	
rinsed	with	50µL	of	1X-PBS.	50µL	of	DMEM	medium	were	then	added	to	each	well,	and	the	plate	was	
incubated	up	until	2	hours	prior	to	the	time	point.	At	this	stage,	DMEM	medium	was	carefully	pipetted	
out	before	wells	were	rinsed	with	50µL	of	1X-PBS	and	filled	with	50µL	of	MC-0	BIOLOGTM	medium.	
Cells	were	incubated	in	this	medium	for	two	hours,	after	which	the	content	of	the	wells	was	replaced	
with	35µL	of	MC-0	medium,	10µL	of	colorimetric	dye	MB	and	5µL	of	glucose	at	35.15mg/L,	or	water.	
The	 recordings	were	done	 straight	 after,	 every	3	hours,	 between	6	 and	72	hours	 following	 serum	
synchronisation	 (2<N<8	biological	 replicates).	Plates	were	 immediately	 inserted	 in	 the	OMNILOGTM	
incubator,	prior	to	the	start	of	recordings	every	15	minutes	for	at	least	48	hours,	in	order	to	make	sure	
the	kinetic	patterns	had	sufficient	time	to	develop	(section	2.4.1).	Data	were	then	extracted	using	the	
PM_KineticTM	 analysis	 software	 (version	 1.6),	 before	 utilisation	 rates	 were	 calculated	 for	 each	
biological	and	technical	replicate.	
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2.4.2.5	Statistics	
	
	 Slope	calculations	were	made	from	kinetic	profiles	of	raw	OMNILOGTM	values	obtained	by	the	
OMNILOGTM	data	collection	software.	Following	the	determination	of	the	utilisation	rates	of	various	
concentrations	of	 glucose	 (including	 the	plateau	 values)	 and	of	 4500mg/L	of	 glucose	after	 various	
incubation	times	in	MC-0	medium	prior	to	recordings,	a	one-way	ANOVA	determined	if	there	were	
any	significant	differences	in	the	data	(p-value<0.05).	If	so,	a	post-hoc	Tukey’s	multiple	comparisons	
test	was	applied,	in	order	to	see	in	between	which	concentrations	data	differed	significantly.	All	figures	
and	analyses	were	made	using	Graph-Pad	Prism	version	7.0.	
	
	 The	same	software	was	used	to	plot	baseline-subtracted	utilisation	rates	of	glucose	across	the	
circadian	time,	meaning	that	for	each	experiment	the	control	value	was	subtracted	from	the	actual	
glucose	 utilisation	 rate	 measured	 at	 a	 particular	 time	 point.	 This	 allowed	 us	 to	 obtain	 the	 true	
utilisation	dynamics.	A	cosine	curve	was	fitted	to	the	experimental	data,	against	the	null	hypothesis	
of	a	straight	line,	and	within	prediction	bands	representing	confidence	levels	of	95%	in	the	fit.		The	
equation	for	the	cosine	curve	was	the	following	(the	rules	for	initial	values	fixed	the	periodicity	to	24):	
	
	
	 	
	 As	indicated,	this	mathematical	model	allowed	the	extraction	of	various	circadian	parameters:	
the	 mesor,	 amplitude	 and	 period	 of	 the	 rhythm,	 as	 well	 as	 the	 determination	 of	 an	 R2	 value,	
representative	of	the	goodness	of	fit	of	the	cosine	curve	to	the	utilisation	dynamics	values.	A	rhythm	
was	considered	if	the	null	hypothesis	was	rejected	for	a	significant	p-value<0.05,	as	in	this	case	the	
preferred	model	 to	 fit	 the	 data	was	 a	 cosine	 curve	 indicative	 of	 a	 temporal	 variation	 in	 the	 data.	
Moreover,	the	rhythm	was	defined	as	circadian	for	a	periodicity	of	24±5	hours.		
	
2.4.3	Measurement	of	various	carbon	sources	utilisation	
	
2.4.3.1	Experimental	procedure	
	
	 For	this	experiment,	96-well	BIOLOGTM	PM-M1	plates	were	used	(Technopath,	13101).	This	
time	however,	each	well	was	pre-inoculated	with	a	negative	control	or	with	a	specific	carbon-based	
energy	source.	The	map	of	the	plate	is	illustrated	in	figure	2.5	below.	
Y=(Mesor+Amplitude*cos(((2*pi)*(X-Acrophase))/Period))	
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	 3T3-L1	Per2-dLuc	pre-adipocytes	were	grown	to	90%	confluence	 in	T75	flasks	using	DMEM	
medium,	 as	 detailed	 in	 section	 2.3.3.	 The	 aim	was	 to	measure	 the	 utilisation	 rates	 of	 the	 various	
carbon	sources	every	3	hours	between	24	and	51	hours	following	serum	shock	of	the	cells	(section	
2.3.6).	As	this	corresponds	to	a	total	of	10	time	points,	10	T75	flasks	were	grown	for	one	experimental	
replicate	(1	flask	per	time	point).	When	all	flasks	were	confluent,	the	cells	were	rinsed	with	8mL	of	1X-
PBS	(section	2.3.3)	before	being	serum	shocked	for	2	hours	using	8mL	of	serum	shock	medium	per	
flask	(section	2.3.6)	at	the	appropriate	time.	After	two	hours,	the	serum	shock	medium	was	removed	
to	be	replaced	by	normal	DMEM	culturing	medium.	Cells	were	incubated	at	37°C	with	5%	CO2	up	until	
2	hours	prior	to	the	time	point,	when	DMEM	medium	was	replaced	by	MC-0	BIOLOGTM	medium	for	a	
2-hour	starvation.	This	was	to	allow	the	carbon	sources	present	in	the	DMEM	medium	to	be	utilised.		
	
	 After	2	hours,	the	MC-0	BIOLOGTM	medium	was	aspirated	and	cells	were	rinsed	with	8mL	of	
1X-PBS,	 before	 3mL	 of	 Trypsin-EDTA	were	 added	 in	 the	 flask.	 The	 flask	was	 then	 returned	 to	 the	
incubator	 (37°C,	5%	CO2)	 for	 two	minutes.	Using	a	microscope,	 it	was	checked	 that	 the	cells	were	
NO	SUBSTRATE
MONOSACCHARIDES,	OLIGOSACCHARIDES	AND	POLYSACCHARIDES
NUCLEOSIDES
ALCOHOLS	AND	ORGANIC	ACIDS	
KETONE	BODIES	AND	SHORT	CHAIN	FATTY	ACIDS
Figure	 2.5:	Map	 of	 a	 BIOLOGTM	 PM-M1	 plate	 pre-inoculated	with	 91	 different	 carbon-based	
energy	sources	and	negative	controls.	Image	taken	from	https://www.biolog.com/.	The	different	
carbon	sources	used	 to	pre-inoculate	BIOLOGTM	PM-M1	plates	 could	be	grouped	 into	different	
categories:	no	substrates	(or	negative	controls)	represented	in	blue	on	the	map,	monosaccharides,	
oligosaccharides	and	polysaccharides	(in	orange),	nucleosides	in	brown,	alcohols	and	organic	acids	
in	green	and	finally	ketone	bodies	as	well	as	short	chain	fatty	acids	in	dark	grey.	
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detached	from	the	bottom	of	the	flask,	after	which	3mL	of	MC-0	BIOLOGTM	medium	were	mixed	to	
the	 cell	 suspension	 before	 centrifugation	 (200g,	 4	 minutes,	 section	 2.3.3).	 The	 supernatant	 was	
carefully	 discarded	 and	 the	 pellet	 re-suspended	 into	 2mL	 of	 MC-0	 medium,	 before	 cells	 were	
automatically	 counted.	 The	 cell	 density	 was	 adjusted	 to	 achieve	 a	 final	 concentration	 of	 4x105	
cells/mL,	as	described	in	section	2.4.2.1.	50µL	of	the	cell	suspension	was	then	inserted	into	every	well	
of	the	plate	using	a	multi-channelled	pipette,	and	this	was	supplemented	with	10µL	of	dye,	added	into	
every	 well	 the	 same	 way.	 Straight	 after,	 the	 plate	 was	 inserted	 into	 the	 OMNILOGTM	 device,	 for	
measurements	every	15	minutes	over	a	minimal	period	of	 time	of	48	hours.	 3	different	biological	
replicates	 of	 the	 experiments	 were	 done,	 using	 cells	 coming	 from	 different	 initial	 cryovials	 and	
cultured	at	different	days	(several	months	apart).	
	
2.4.3.2	Statistics	
	
	 Utilisation	rates	were	calculated	from	the	OMNILOGTM	values	giving	the	kinetic	profiles	of	the	
substrates	of	interest,	as	explained	in	section	2.4.2.2.	As	each	PM-M1	plate	was	containing	3	controls	
(in	positions	A1	to	A3),	the	slope	values	found	for	the	3	positions	were	averaged	before	the	resulting	
number	was	subtracted	to	every	value	found	for	the	substrates	of	the	same	plate.	The	data	obtained	
are	called	baseline-subtracted,	and	were	then	Z-scored,	before	being	plotted	across	the	circadian	time	
using	the	Graph-Pad	Prism	software	version	7.0	(section	2.4.2.5).	The	same	mathematical	model	as	
described	 in	 the	 previous	 experiment	was	 used	 to	 fit	 a	 cosine	 curve	 to	 the	 data,	 against	 the	 null	
hypothesis	of	a	straight	line.	In	case	of	temporal	variations	in	the	data,	this	hypothesis	was	rejected	
(p<0.05),	and	the	preferred	model	to	fit	the	data	was	as	cosine	curve.	Prediction	bands	were	again	
represented,	as	confidence	levels	of	95%	in	the	fit.	This	was	done	using	the	Graph-Pad	Prism	software,	
version	7.0.	
	
2.5	Dielectrophoresis	applications	
	
2.5.1	DEP	applied	to	3T3-L1	Per2-dLuc	pre-adipocytes	
	
	 Dielectrophoresis	potential	is	defined	as	a	high-throughput	electrophysiological	tool,	allowing	
the	measurement	of	the	electrical	properties	of	suspended	particles,	corresponding	in	this	work	to	
whole-cell	 suspensions	 of	 3T3-L1	 Per2-dLuc	 pre-adipocytes.	 Cells	 were	 suspended	 in	 a	 minimal	
isotonic	 sucrose	 (Sigma-Aldrich,	 S8501)	 /	 glucose	 (Sigma-Aldrich,	 G8270)	 medium	 (250/17mM;	
285mOsm.kg-1).	The	medium	was	then	supplemented	with	calcium	chloride	(CaCl2,	Sigma-Aldrich	–	
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C1016)	and	magnesium	chloride	(MgCl2,	Sigma-Aldrich	–	M8266)	in	Milli-Q	water.	Literature	advises	
respective	concentrations	of	0.1mM	and	0.25mM	(Fry	et	al.,	2012).	To	this	DEP	medium	was	gradually	
added	a	solution	of	1X-PBS	drop-by-drop,	in	order	to	adjust	the	conductivity	of	the	medium,	with	the	
help	of	a	conductivity	meter.	Cells	suspended	 in	DEP	medium	were	exposed	to	a	non-uniform	and	
alternating	 electric	 field	 (0.001-20MHz)	 generated	 by	 gold-plated	 copper	 rings	 formed	 by	 drilling	
through	 copper	 sheets,	 separated	 by	 a	 polyamide	 insulator	 forming	 a	 1mm	 diameter	 well.	 The	
electrical	field	is	presented	figure	2.6	below.	
	
	
	
Figure	2.6:	Experimental	chambers	used	to	measure	physiological	properties	of	cells	in	suspension.	
Taken	from	Fry	et	al.,	2012.	The	DEP	chamber	shows	alternating	rings	of	gold-plated	copper	electrodes	
(dark	rings)	and	insulator	(light	rings).	The	light	path	to	the	detectors	below	the	chamber	is	shown	(A).	
The	electric	 field	generated	by	gold-plated	copper	 rings,	 formed	by	drilling	 through	copper	 sheets	
separated	by	a	polyamide	insulator	generating	a	1mm	diameter	well	on	which	the	cells	were	placed,	
is	illustrated	in	panel	(B).		
	
	 The	 idea	behind	the	DEP	technique	was	 to	be	able	 to	determine	the	movement	of	cells	 in	
suspension	by	measuring	the	light	intensity	of	a	beam	directed	through	the	wells	of	the	electrical	field	
at	different	frequencies.	Our	idea	was	to	record	this	movement	on	a	cell	suspension	of	3T3-L1	Per2-
dLuc	pre-adipocytes	across	the	circadian	time,	every	4	hours	between	0	and	72	hours	(total	of	19	time	
points)	following	serum	shock	of	the	cells	(see	section	2.3.6).	The	DEP	chip	presented	in	figure	2.6	B	
was	filled	up	with	approximately	75µL	of	the	cell	suspension	at	a	density	of	1.106	cells/mL,	using	a	
needled	1mL	syringe.	It	was	important	here	to	have	an	excess	of	volume	in	order	to	make	sure	all	the	
wells	were	filled.	Furthermore,	the	density	of	1.106	cells/mL	was	used	as	too	many	cells	don’t	allow	
any	movement	within	the	well,	and	too	few	lead	to	noisy	data.	A	glass	cover-slip	(18mmx18mm)	was	
carefully	placed	on	top	of	the	wells.	The	chip	was	then	inserted	into	the	3DEP	reader	(DEP-tech,	figure	
2.7),	 in	 which	 the	 pin	 connections	 energised	 each	 well	 at	 10	 peak-to-peak	 voltage	 (Vp-p),	 with	 a	
different	frequency	applied	to	each	one	of	the	20	wells	(figure	2.7	below,	panels	A	and	B).	The	wells	
filled	with	cells	could	also	be	visualised	prior	 to	 the	start	of	 the	recording	 (figure	2.7	C),	and	were	
A B
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collectively	energised	 for	a	 total	of	30	seconds	and	on	a	 range	of	 frequencies	between	10KHz	and	
100MHz.	A	total	of	7	to	9	assays	per	sample	were	recorded,	in	order	to	make	sure	we	had	sufficient	
data	for	further	analysis.		
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	2.7:	Insertion	of	the	DEP	electrical	field	to	the	3DEP	reader	device	(DEP-tech)	and	preview	of	
the	cells.	Source:	http://deptech.com/the-deptech-3dep/.	The	DEP	chip	was	inserted	into	the	3DEP	
reader	(A	and	B),	which	imaged	the	entire	20	wells	(represented	in	panel	C,	where	the	wells	are	filled	
with	cells).	DEP	forces	were	measured	every	second	for	30	seconds;	for	each	replicate.	All	frequencies	
applied	induced	a	unique	cellular	response	in	each	well,	monitored	as	changes	in	light	intensity	around	
the	well	edge.	
	
	 A	decrease	or	increase	in	intensity	represented	a	cell	migration,	either	from	the	electrodes	or	
to	 the	electrodes,	 in	other	words	away	 from	 the	well	 centre	or	 towards	 the	well	 centre.	 This	was	
equivalent	 to	 the	DEP	 force,	 FDEP,	 exercised	on	a	particle	 (cell)	 of	 radius	 r	 (µM)	 in	 a	medium	 (DEP	
medium)	of	permittivity	es,	within	an	electric	 field	E.	The	geometry	of	 the	electrode	was	also	very	
important	as	it	produces	a	highly	non-uniform	field	to	give	a	DEP	force	overcoming	the	randomising	
A B
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effects	of	a	Brownian	motion	of	the	cells	 in	their	surrounding	medium	causing	a	movement	of	the	
particles	to	the	desired	location	(Markx	et	al.,	1994a).	
	
	 The	DEP	 force	 is	 represented	 in	 the	equation	shown	below,	with	K	 (w)	being	 the	Clausius-
Mossotti	 factor.	 In	 this	equation,	 the	r3	 (with	r	being	 the	radius	of	 the	cell)	demonstrates	 that	 the	
magnitude	of	the	DEP	force	is	proportional	to	the	cell	volume	and	to	the	electrical	local	field	gradient.	
	
			
	
	 In	DEP,	mammalian	cells	were	considered	as	a	single-shell	model	 rather	than	homogenous	
spheres,	approximated	 to	 spheres	of	 cytoplasm	 (conductivity,	sc;	permittivity,	ec)	 surrounded	by	a	
membrane	(conductivity,	smem;	permittivity,	emem).	This	single-shell	approximation	gave	a	number	of	
parameters	for	a	DEP	spectrum:	membrane	capacitance	(F/m2),	membrane	conductance	(S/m2)	and	
cytoplasm	 conductivity	 (S/m).	 The	 membrane	 capacitance	 results	 from	 the	 fact	 that	 the	 plasma	
membrane	acts	as	a	capacitor,	with	the	phospholipid	bilayer	comparable	to	a	thin	insulator	separating	
two	electrolytic	media,	the	extracellular	space	and	the	cytoplasm.	The	membrane	capacitance	is	also	
proportional	to	the	cell	surface	area	and	determines	the	membrane	time	constant,	dictating	how	fast	
the	 cell	 membrane	 potential	 responds	 to	 the	 flow	 of	 ion	 channel	 currents	 (when	 added	 to	 the	
membrane	 resistance).	 The	 membrane	 conductance	 is	 inversely	 proportional	 to	 the	 membrane	
resistance	 and	 represents	 the	 degree	 of	 permeability	 of	 the	 cellular	membrane	 to	 certain	 ions.	 It	
therefore	 gives	 information	 on	 the	 ability	 of	 the	 membrane	 to	 store	 charges.	 The	 cytoplasm	
conductivity	is	a	measure	of	the	ionic	charge	in	the	cytoplasm	moving	freely	and	contributing	to	the	
conduction.	This	parameter	is	related	to	the	sum	of	the	positive	and	negative	charges	in	the	cell.	The	
Clausius-Mossotti	 factor	 K	 (w)	 was	 represented	 as	 a	 function	 of	 the	 membrane,	 cytoplasm,	 and	
medium	conductances	and	permittivities.	A	representation	of	the	single-shell	model	is	given	figure	2.8	
below.	
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Figure	2.8:	The	single-shell	model.	Adapted	from	Das	et	
al.,	2014.	Schematic	representation	of	a	cell	of	a	radius	
R	 (µM).	 εi,	 εmem,	 εm	 and	 si,	 smem,	 sm	 represent	 the	
permittivity	 (e)	 as	 well	 as	 the	 conductivity	 (s)	 of	 the	
cytoplasm,	 the	 membrane	 and	 the	 medium	
respectively.		
	
	 The	Clausius-Mossotti	factor	is	thus	given	by	the	equation	below:  
	
	
																																	
	
	
	
	 The	variations	of	the	electric	field	frequencies	to	produce	profiles	of	cell	polarisability	gave	a	
spectrum	through	the	3DEP	analysis	software	(DEP-tech,	version	1.2.0.00),	presented	in	figures	2.9	
and	 2.10	 below.	 On	 these	 figures,	 the	 left	 part	 of	 the	 spectrum	 (low	 frequencies)	was	 related	 to	
membrane	parameters,	and	the	second	part	of	the	curve	was	linked	to	cytoplasm	parameters	(high	
frequencies).	 Through	 the	 fitting	 of	 a	 single-shell	model	 to	 DEP	 forces	 values	 across	 the	 different	
frequencies,	 the	 analysis	 software	 was	 able	 to	 automatically	 determine	 the	 effective	 membrane	
conductance	(S/m2);	representative	of	the	ionic	transport	across	the	membrane	and	on	its	surface,	
the	 effective	 membrane	 capacitance	 (F/m2);	 indicative	 of	 the	 membrane	 morphology	 and/or	
composition,	 and	 finally	 the	 cytoplasm	 conductivity	 (S/m);	 giving	 information	 on	 the	 free	 ionic	
concentration	within	the	cytoplasm.			
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Figure	 2.9:	 DEP	 spectrum	 from	 a	
single-shell	model.	The	blue	highlight	
was	 affected	 by	 the	 membrane	
conductance,	and	the	red	part	by	the	
membrane	 capacitance.	 The	 green	
part	of	 the	 spectrum	was	 influenced	
by	 the	 cytoplasm	 conductivity.	 The	
3DEP	 associated	 analysis	 software	
was	 able	 to	 reveal	 the	 mean	
electrophysiological	properties	of	cell	
suspensions	in	as	little	as	10	seconds.	
The	 DEP	 force,	 read	 on	 the	 Y	 axis,	
could	either	be	positive	(movement	of	
the	 cells	 towards	 the	 well	 edge)	 or	
negative	 (movement	 of	 the	 cells	
towards	the	well	centre),	depending	on	the	well’s	applied	frequency.		
	
	 At	low	frequencies	(less	that	1kHz),	the	DEP	behaviour	is	influenced	by	the	cell	surface	charge,	
implying	 that	 the	 effective	 polarisability	 of	 the	 cell	 is	 dominated	 by	 the	 electrical	 double	 layer	
surrounding	the	charged	cell.	The	transition	from	a	negative	to	a	positive	DEP	occurs	at	a	well-defined	
frequency,	fxo1,	called	the	first	DEP	cross-over	frequency	(figure	2.10).	The	fxo1	value	is	very	sensitive	
to	the	size	of	the	cells	studied.	Below	fxo1,	the	cell	membrane	has	a	high	resistance	and	the	DEP	force	
has	a	negative	value,	meaning	that	the	cells	are	repelled	from	regions	near	electrode	edges	where	the	
greatest	spatial	changes	of	the	electric	potential	are	generated.	Above	fxo1,	the	DEP	force	becomes	
positive	and	the	cells	are	therefore	driven	towards	the	edges	of	the	electrode.	DEP	force	values	are	
then	seen	to	plateau	to	finally	decrease.	 If	values	decrease	to	reach	negative	DEP	forces,	a	second	
cross-over	 frequency	 is	 reached.	 This	was,	 however,	 considered	 rare	 as	 the	 3DEP	 reader	was	 not	
equipped	to	go	to	frequencies	above	100MHz	(Pethig	et	al.,	2010).	Figure	2.11	below	illustrates	an	
image	analysis	of	the	wells,	taken	from	the	3DEP	analysis	software	and	representing	the	response	of	
the	cells	to	various	frequencies,	where	the	DEP	force	is	negative,	null,	or	positive.		
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Figure	 2.10:	 DEP	 response	 exhibited	 by	 a	
typical	mammalian	cell	as	a	function	of	the	
frequency	 of	 the	 applied	 electric	 field.	
Taken	 from	 Pethig	 et	 al.,	 2010.	 The	 DEP	
force	 reverses	 polarity	 at	 two	 DEP	 cross-
over	 frequencies,	 fxo1	 and	 fxo2,	
determined	by	the	various	cell	parameters	
listed	 on	 the	 figure.	 The	 determination	 of	
fxo1	 and	 cell	 diameter	 along	 with	 the	
conductivity	 of	 the	 suspending	 solution	
provide	 a	 measure	 of	 the	 cell	 membrane	
capacitance.	 Direct	measurements	 of	 fxo2	
have	not	yet	been	clearly	reported,	as	such	
high	frequencies	are	often	not	supported	by	
the	3DEP	reader	device.		
	
	
													
	
Figure	2.11:	 Image	anaysis	of	the	wells.	
The	 first	 wells	 (blue	 section)	 represent	
the	 lowest	 frequencies	 where	 the	 DEP	
force	 is	 negative,	 therefore	 cells	 are	
migrating	 towards	 the	wells	 centre.	 For	
the	 well	 in	 orange,	 the	 cells	 are	 not	
moving	either	towards	the	well	centre	or	
edge,	and	therefore	the	DEP	force	is	null.	
In	green,	the	wells	pictured	show	that	the	
cells	are	moving	towards	the	edges	of	the	
wells,	 corresponding	 to	 a	 positive	 DEP	
force.		
	 	
	 The	value	of	fxo	defines	the	frequency	at	which	the	dielectric	properties	of	a	cell	exactly	match	
those	of	the	surrounding	suspending	solution,	and	in	this	case	the	cells	do	not	experience	any	DEP	
force.	This	condition	is	given	by	the	following	equation:	
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	 With	σ	and	ε	representing	the	conductivity	and	permittivity	values,	and	the	suffices	“c”	and	
“s”	referring	to	the	cell	and	the	surrounding	solution,	respectively.	Furthermore,	adopting	established	
relationships	concerning	the	dielectric	properties	of	cells,	the	equation	can	be	simplified	(Pethig	et	al.,	
2005)	in	the	form	of:	
	
 
 
 
	
	
	
	 R	is	the	cell	radius,	Cm	and	G*m	are	the	specific	capacitance	and	total	effective	conductance	
per	unit	area	of	the	cell	membrane,	respectively.	The	total	effective	conductance	G*m	comprises	two	
main	components,	given	by:	
	
	
	
	
	
	 Where	Gm	is	the	conductance	associated	with	the	transport	of	ions	through	pores	across	the	
membrane	 and	 Kms	 is	 the	membrane	 surface	 conductance	 of	 the	membrane	 associated	 with	 the	
electrical	double	layer	surrounding	the	cell.		
	
	 G*m	can	be	neglected	for	the	solution	conductivity	G*m	<<	4σs/r.	This	inequality	holds	for	
the	solution	conductivity	and	cell	radii	values,	and	an	approximation	of	the	membrane	capacitance	is	
given	by	the	following	equation:	
	
	
	 	
	
	
	 	
	 In	 order	 to	 obtain	 the	 initial	 robust	 negative	 DEP	 force	 values	 described	 earlier	 (at	 low	
frequencies),	the	initial	cross-over	frequency,	a	stable	plateau	phase	and	a	final	decrease	in	the	DEP	
force	at	high	 frequencies,	 it	was	 critical	 to	optimise	 the	DEP	medium	composition.	As	 the	plateau	
phase	was	mainly	affected	by	 the	presence,	or	absence,	of	CaCl2	and	MgCl2,	both	conditions	were	
tested.	 Furthermore,	 the	 presence	 of	 negative	 and	 positive	 values	 of	 DEP	 force	 at	 different	
frequencies	is	a	function	of	medium	conductivity.	For	this	reason,	we	also	tested	different	medium	
conductivities:	 10mS/m,	 45mS/m	 (used	 for	 RBCs	 in	 our	 laboratory),	 55mS/m	 and	 65mS/m.	 This	
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allowed	 to	 minimise	 the	 interference	 with	 the	 DEP	 response,	 as	 the	 conductivity	 of	 the	 DMEM	
culturing	medium	 is	way	higher	 than	 the	medium	conductivity	 required	 for	DEP.	The	 literature	on	
human	 RBCs,	 for	 instance,	 used	 a	 DEP	 medium	 with	 a	 conductivity	 of	 0.043S/m,	 whereas	 the	
conductivity	of	the	DMEM	medium	is	established	to	be	of	approximately	1.5S/m	(Henslee	et	al.,	2017).	
As	 mentioned	 earlier,	 the	 medium	 conductivity	 was	 adjusted	 with	 1X-PBS	 and	 the	 help	 of	 a	
conductivity	metre.	3T3-L1	Per2-dLuc	pre-adipocytes	were	grown	to	reaching	80-90%	confluence	in	
T75	 flasks.	 The	 flasks	were	 rinsed	with	 1X-PBS,	 trypsinised	 and	 centrifuged	 at	 200g	 for	 4	minutes	
according	to	the	protocol	described	in	section	2.3.3.	The	supernatant	was	discarded	and	the	pellet	
carefully	 resuspended	 in	 2mL	 of	 DMEM	medium	 before	 10µL	 were	 pipetted	 out	 to	 be	 mixed	 to	
another	10µL	of	Trypan	Blue	(section	2.4.2.1).	10µL	of	the	resulting	suspension	was	inserted	in	the	
chamber	of	a	disposable	haemocytometer	 (C-Chip	–	Labtech	–	DHC-N01).	Cells	were	then	counted	
manually	 under	 a	 microscope.	 The	 cell	 density	 was	 adjusted	 to	 2.105	 cells/mL	 by	 adding	 the	
appropriate	volume	of	DMEM	culturing	medium.	1mL	of	the	cell	suspension	was	placed	into	the	well	
of	a	6-well	plate	(35mm),	and	1mL	of	DMEM	medium	was	added	for	a	total	volume	of	2mL.		
	
	 The	plates	were	incubated	(37°C,	5%	CO2)	for	48	hours	in	order	for	the	cells	to	reach	near	full	
confluency	(approximately	5.105	cells	per	well).	After	48	hours,	cells	were	serum	shocked	for	2	hours	
(section	2.3.6),	before	the	wells	were	washed	with	1mL	of	1X-PBS	and	trypsinised	using	1mL	of	Trypsin-
EDTA.	The	content	of	2	wells	(approximately	1.106	cells/mL)	was	mixed	before	2mL	of	DMEM	culturing	
medium	was	added	to	the	suspension.	Cells	were	centrifuged	at	200g	for	4	minutes,	after	which	the	
cell	 pellets	 were	 resuspended	 in	 the	 appropriate	 DEP	 medium	 (5mL).	 Cell	 suspensions	 were	
centrifuged	 again	 (200g,	 4	 minutes),	 before	 pellets	 were	 resuspended	 in	 1mL	 of	 the	 same	 DEP	
medium.	This	was	transferred	to	sterile	Eppendorf	1.5mL	supplies,	before	approximately	75µL	of	the	
cell	suspension	was	gently	withdrawn	from	the	Eppendorf	tube	with	a	needled	syringe	of	the	same	
type	to	fill	 the	chip’s	20	wells	simultaneously.	This	chip	was	cleaned	with	70%	ethanol	followed	by	
water,	and	finally	rinsed	using	the	appropriate	DEP	medium	before	cells	were	inserted.	The	electrical	
field	was	then	placed	into	the	reader	(DEP-tech,	figure	2.7),	in	which	the	pin	connections	energised	
each	well	at	10	Vp-p	with	a	different	frequency	applied	to	each	one	of	the	20	wells	(figure	2.11).	The	
wells	were	collectively	energised	 for	a	 total	of	30	seconds	and	on	a	 range	of	 frequencies	between	
10KHz	and	100MHz.	For	each	condition	(presence	or	not	of	CaCl2	and	MgCl2	and	different	medium	
conductivities),	a	total	of	7	to	9	assays	were	recorded.	
	
	 After	 optimisation	 of	 the	 DEP	 medium	 composition,	 the	 technique	 was	 used	 across	 the	
circadian	time	following	a	similar	procedure.	Briefly,	cells	were	grown	to	confluence	in	T75	flasks	and	
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trypsinised	before	centrifugation	(section	2.3.3).	Cells	were	transferred	into	6-well	plates	at	a	density	
of	2.105	cells/mL,	following	the	protocol	described	just	above,	before	a	48-hour	incubation	after	which	
they	reached	full	confluence.	Cells	were	serum	shocked	for	2	hours	at	the	appropriate	time	(section	
2.3.6).	The	idea	was	then	to	measure	DEP	between	0	and	72	hours	following	this	serum	shock,	every	
4	hours.	The	serum	shock	medium	was	replaced	with	DMEM	culturing	medium	and	incubated	at	37°C	
with	5%	CO2	until	the	time	point.	The	medium	within	2	wells	was	carefully	removed,	the	cells	were	
rinsed	with	1mL	of	1X-PBS	and	trypsinised.	The	content	of	the	two	wells	was	mixed	together	before	
centrifugation	 with	 DMEM	medium	 (section	 2.3.3).	 The	 pellet	 was	 resuspended	 into	 1mL	 of	 DEP	
medium	supplemented	with	MgCl2	and	CaCl2	at	55mS/m,	before	the	cell	suspension	was	transferred	
in	a	1.5mL	Eppendorf	tube.	Recordings	were	done	immediately	after,	with	7	to	9	technical	replicates	
measured	every	time.	In	between	each	recording,	the	DEP	chips	were	always	rinsed	with	DEP	medium.	
In	between	time	points,	chips	were	cleaned	with	70%	ethanol,	in	order	to	keep	the	chip	free	of	debris	
and	dead	cells	from	previous	work,	and	distilled	water.		
	
	 In	terms	of	analysis,	the	3DEP	analysis	software	was	used	to	load	the	DEP	forces	values	against	
the	frequency.	Usually,	for	the	data	resulting	from	the	same	experimental	replicate,	at	least	3	technical	
replicates	were	loaded	together	(out	of	the	7	to	9	replicates	recorded).	A	single-shell	model	was	then	
fit	to	the	DEP	forces	values.	If	too	few	replicates	were	entered	(i.e.	1	or	2	spectrum(a),	there	were	not	
enough	DEP	force	values	to	appropriately	reflect	the	DEP	response	of	the	cells	when	testing	different	
DEP	medium	compositions	or	at	a	specific	time	point.	An	insertion	of	too	many	data	points,	however,	
could	easily	have	biased	 the	determination	of	 the	membrane	capacitance,	 conductance	as	well	 as	
cytoplasm	 conductivity,	 with	 a	 great	 chance	 of	 obtaining	 noisy	 data.	 The	 cell	 properties	 were	
automatically	given	as	the	following:	cytoplasm	conductivity	(S/m),	the	cytoplasm	permittivity	(e),	the	
specific	membrane	 conductance	 in	 S/m2,	 the	 specific	membrane	 capacitance	 (F/m2),	 the	medium	
conductivity	(S/m)	and	permittivity	(e)	as	well	as	the	cell	radius	(µm).	The	relative	medium	permittivity	
and	conductivity,	the	relative	cytoplasm	permittivity	as	well	as	the	cell	radius	were	fixed.	For	the	cell	
radius,	pictures	of	the	cells	in	suspension	in	DEP	medium	were	taken	before	each	of	the	recordings.	In	
order	to	do	so,	10µL	of	the	final	1mL	cell	suspension	(density	of	1.106	cells/mL)	in	DEP	medium	was	
pipetted	out	and	transferred	into	the	chamber	of	a	disposable	haemocytometer	(Labtech).	Pictures	
were	taken	using	a	microscope	(Nikon	TMS-F)	adapted	to	a	digital	camera	(Nikon,	COOLPIX990)	and	
via	the	Dolphin	Imaging	software	version	8.0.	The	diameter	of	50	different	cells	was	then	determined	
using	ImageJ	version	2.0	and	averaged,	before	being	divided	by	2,	to	transfer	diameter	to	radius.	The	
value	was	then	inserted	into	the	software	prior	to	analysis.	The	medium	permittivity	was	fixed	at	78e		
and	the	conductivity	at	0.055S/m.	For	all	parameters	taken	into	consideration	by	the	software	(fixed	
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or	not	fixed),	a	range	constraint	was	set	so	that	the	results	were	only	allowed	to	vary	within	that	range	
(1	 to	 50µM	 for	 the	 cell	 radius,	 0.001	 to	 0.1	 S/m	 for	 the	 cytoplasm	 conductivity,	 10	 to	 80	 for	 the	
cytoplasm	permittivity,	0.1	to	25000S/m2	for	the	membrane	conductance,	0.001	to	0.1F/m2	for	the	
membrane	capacitance,	0.0001	to	1.5S/m	for	the	medium	conductivity	and	30	to	100	for	the	relative	
medium	permittivity).	Furthermore,	initial	starting	point	values	were	entered	prior	to	each	analysis	at	
0.2S/m	for	the	cytoplasm	conductivity,	4500S/m2	for	the	membrane	conductance	and	0.01F/m2	for	
the	membrane	capacitance.	These	values	were	chosen	as	a	representation	of	the	results	obtained	on	
unsynchronised	cells:	a	total	of	3	biological	replicates	were	done	on	3T3-L1	Per2-dLuc	pre-adipocytes	
which	were	not	subjected	to	serum	shock,	measured	at	various	times	throughout	the	day.	DEP	force	
values	 at	 each	 frequency	 could	be	 extracted	onto	 excel,	which	 also	 specified	 the	presence	of	 any	
outliers	in	the	data	(often	the	result	of	the	presence	of	an	air	bubble	in	the	well).	These	outliers	were	
manually	removed	from	the	data	set,	manually	from	the	analysis	software.	
	
2.5.2	Confocal	analysis	of	3T3-L1	Per2-dLuc	reporters	stained	across	the	circadian	time	
	
2.5.2.1	Growing	cells	on	glass	cover-slips	
	
	 The	 first	 step	of	 this	experiment	was	 to	clean	some	22mmx22mm	glass	cover-slips	using	a	
solution	containing	70%	ethanol	and	10%	sodium	hydroxide	(NaOH).	Once	the	cleaning	buffer	was	
prepared,	an	appropriate	volume	of	the	solution	was	placed	in	a	beaker	in	which	the	cover-slips	were	
placed.	The	beaker	was	placed	on	an	orbital	shaker	for	a	2-hour	gentle	mix.	After	2	hours,	the	solution	
was	disposed	of	and	one	cover-slip	was	placed	in	the	centre	of	a	6-well	plate	well,	employing	tweezers,	
in	a	sterile	laminar	flow	cabinet.	The	cover-slips	were	then	rinsed	2	times,	by	placing	1mL	of	1X-PBS	in	
the	well.	Once	the	PBS	from	the	last	rinse	was	discarded,	the	plates	were	left	for	30	minutes	under	
ultraviolet	(U.V)	light	for	sterilisation,	after	which	they	were	put	in	an	incubator,	for	a	total	of	2	hours,	
in	order	for	the	wells	to	dry.	During	this	process,	 it	was	advised	to	touch	the	cover-slips	as	little	as	
possible.	When	 the	cleaning	of	 the	cover-slips	was	done,	 the	wells	were	 ready	 to	be	coated	using	
1mL/well	 of	 Poly-D-Lysine	 hydrobromide	 following	 the	 protocols	 described	 in	 sections	 2.2.8	 and	
2.3.5.3.		
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2.5.2.2	Fixation	and	staining	of	3T3-L1	Per2-dLuc	reporters	across	the	circadian	time	
	
	 The	cells	were	grown	 in	T75	 flasks	 to	 reaching	approximately	80%	confluence,	after	which	
they	were	 trypsinised	 and	 centrifuged	at	 200g	 for	 4	minutes	 (section	2.3.3).	 The	 supernatant	was	
disposed	 of	 and	 the	 pellet	 re-suspended	 in	 6mL	 of	 DMEM	 medium.	 1mL	 of	 the	 resulting	 cell	
suspension	was	then	placed	in	a	well	of	a	6-well	plate,	equipped	with	a	cover-slip	(section	2.5.2.1),	
supplemented	with	another	1mL	of	DMEM	growing	medium	for	a	total	of	2mL.		
	
	 The	 plates	 were	 then	 incubated	 at	 37°C	 and	 5%	 CO2	 and	 the	 cells	 left	 to	 grow	 for	
approximately	48	hours.	The	cells	were	then	serum	shocked	for	two	hours	at	the	appropriate	time	
using	the	method	described	in	section	2.3.6.	3	biological	replicates	were	done	where	the	cells	were	
grown	at	different	times	(different	weeks)	from	different	initial	cryovials.	For	each	of	those	replicates,	
I	did	a	total	of	8	time	points	from	24	to	52	hours	and	1	following	the	serum	shock	synchronisation	of	
the	cells,	every	4	hours.	At	the	appropriate	time	point,	the	culturing	medium	was	removed	and	the	
cells	were	very	carefully	rinsed	using	1mL	of	1X-PBS.	The	PBS	was	discarded	and	replaced	by	2mL	of	
4%	Formalin	(Sigma-Aldrich,	F8775).	This	was	to	fix	the	cells	in	order	to	halt	their	decomposition	and	
maintain	cellular	proteins	intact,	as	well	as	the	subcellular	structures	in	place.	The	initial	stock	of	40%	
Formalin	was	diluted	1:10	in	1X-PBS,	and	2mL	was	added	to	the	well.	The	cells	were	then	incubated	in	
Formalin	for	10-20	minutes	at	room	temperature.	After	20	minutes,	wells	were	rinsed	twice	with	1mL	
1X-PBS,	in	order	to	remove	any	fixation	reagents.	2mL	of	1X-PBS	were	then	added	to	the	well	after	
which	the	plates	were	stored	at	4°C	for	up	to	1	month,	wrapped	in	an	aluminium	foil	to	protect	the	
cells	from	light.	At	the	last	moment	possible	upon	confocal	microscopy	observation	and	analysis,	in	
order	to	avoid	any	fading	of	the	signal,	the	cells	were	stained	for	the	nuclei,	the	cytoskeleton	and	the	
membrane.	 In	 order	 to	 optimise	 the	 quality	 of	 the	 result,	 the	 cells	 were	 either	 stained	 for	 the	
membrane	or	the	cytoskeleton.	In	both	cases,	a	nuclei	stain	was	performed.	As	a	result,	2	wells	were	
considered	per	time	point,	where	in	the	first	one	cells	were	stained	for	the	cytoskeleton	and	nuclei,	
and	in	the	other	for	the	membrane	and	the	nuclei	(repeated	for	every	biological	replicates).			
	 	
	 In	case	of	a	cytoskeleton	staining,	the	cells	were	first	permeabilised	in	order	to	perforate	the	
cellular	membrane	and	allow	the	staining	to	cross	this	barrier.	This	was	completed	by	adding	2mL	of	
TritonTM	 X-100	 0.2%	 (Sigma-Aldrich,	 T8787)	 in	 each	 well.	 The	 cells	 were	 then	 incubated	 at	 room	
temperature	 for	15	minutes,	protected	 from	 light.	The	 solution	was	gently	discarded	and	 the	well	
rinsed	twice	with	1mL	of	1X-PBS.	2mL	of	1X-PBS	were	then	placed	in	the	well,	with	5	drops	of	Actin-
Green	 488	 (Thermo-Fisher	 Scientific,	 R37110).	 The	 cells	 were	 incubated	 once	 again	 at	 room	
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temperature	and	protected	from	light	for	30	minutes,	after	which	were	inserted	5	drops	of	NucBlue	
Fixed	Cell	Ready	Probes	Reagent	(Thermo-Fisher	Scientific,	R37605)	to	the	well	for	10	minutes.	The	
solution	was	aspirated	before	the	well	was	rinsed	twice	using	1mL	1X-PBS.	2mL	of	1X-PBS	were	then	
inserted	to	the	well	upon	mounting	of	the	cover-slip	on	a	glass	slide	before	microscopy	studies.	
	
	 For	membrane	staining,	the	cells	didn’t	need	to	be	permeabilised	so	they	were	directly	stained	
using	Abcam	Cell	Plasma	Membrane	Staining	Kit	Deep	Red	(ab219942).	The	kit	came	with	a	solution	
of	DMSO	(via	containing	200µL	of	DMSO),	of	which	100µL	were	taken	after	the	vial	was	warmed	for	a	
few	minutes	(approximately	10	minutes)	until	thawed,	at	37°C	in	a	water	bath.	This	was	pipetted	in	
the	vial	containing	the	Deep	Red	dye,	and	mixed	by	pipetting	up	and	down	in	order	to	prepare	a	500X	
Deep	Red	dye	stain	stock	solution.	This	solution	could	be	stored	at	-20°C	protected	from	light,	if	not	
used	in	one	assay,	but	repeated	cycles	of	freeze-thaw	needed	to	be	avoided.	The	Deep	Red	dye	stock	
solution	then	needed	to	be	used	within	2	months.	Upon	staining,	20µL	of	the	Deep	Red	dye	stain	stock	
solution	was	mixed	to	5mL	of	assay	buffer	(50mL	also	provided	by	the	kit),	ready	to	use	as	supplied	
after	being	equilibrated	at	room	temperature.	2mL	of	this	working	solution	of	Deep	Red	dye	stain	was	
then	 placed	 in	 the	well	 after	 the	 cells	were	 rinsed	 once	with	 1mL	of	 1X-PBS.	 The	 cells	were	 then	
incubated	at	37°C	and	5%	CO2	for	30	minutes,	protected	from	light.	The	dye-loading	solution	was	then	
aspired	carefully	before	 the	cells	were	 rinsed	once	with	1mL	of	1X-PBS.	2mL	of	1X-PBS	were	 then	
placed	in	the	well,	mixed	with	5	drops	of	NucBlue	Fixed	Cell	Ready	Probes	Reagent	(Thermo-Fisher	
Scientific),	used	once	again	to	stain	the	nuclei.	After	a	10-20	minutes	incubation	at	room	temperature,	
the	cells	were	rinsed	twice	with	1mL	1X-PBS,	after	which	2mL	of	1X-PBS	were	placed	in	the	well	upon	
observation	of	the	cells	using	a	confocal	microscope	(Nikon	A1M	Ti-Eclipse).	Importantly,	if	samples	
were	not	analysed	directly	after	staining,	the	plates	were	carefully	wrapped	in	foil	and	placed	in	the	
fridge	at	4°C	for	no	longer	than	3	days	so	as	not	to	affect	the	quality	of	the	stain.		
	
	 Upon	observation	using	a	confocal	microscope,	the	cover	slip	was	taken	out	of	the	plate	and	
mounted	in	the	centre	of	a	microscope	glass	slide	(Thermo-Fisher	Scientific,	76x26mm	–	AGL4242)	on	
the	opposite	side,	meaning	that	the	cells	are	directly	in	contact	with	the	slide.	Before	mounting,	the	
cover	 slip	was	gently	put	 sideways	on	a	 tissue	 so	 the	 remaining	PBS	could	be	absorbed.	Once	 the	
coverslip	was	placed	on	the	slide,	nail	varnish	was	used	to	seal	the	coverslip	to	the	microscope	slide.	
This	was	then	left	to	dry	for	a	few	minutes	before	observation.			
	
	 If	the	cells	were	stained	for	the	membrane,	they	were	observed	using	a	cyanine	5	(Cy5)	filter	
set	(excitation/emission=640/660nm).	For	the	cytoskeleton,	a	fluorescence	isothiocyanate	(FITC)	filter	
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set	(excitation/emission=495/518nm)	was	used,	and	for	the	nucleus	a	4’,6-diamidino-2-phenylindole	
(DAPI)	(excitation/emission=360/460nm)	filter	set	was	applied.	Each	sample	was	observed	using	an	
objective	of	magnification	x60	covered	with	immersion	oil	(Sigma-Aldrich,	56822).	The	objective	was	
then	to	zoom	on	a	specific	cell,	still	using	the	x60	magnification.	As	it	was	important	to	study	cells	in	
an	un-biased	way,	random	coordinates	corresponding	to	random	positions	within	the	cover-slip	were	
set	up	by	the	measurement	software	linked	to	the	confocal	microscope	(NIS-Elements	version	4.6).	
For	 each	 position,	 a	 picture	was	 taken,	 representing	 the	 full	 field	 of	 view	observed.	 Then,	 on	 the	
condition	that	the	cell	was	isolated	from	other	cells	and	was	fully	shown	by	the	field	of	view,	a	zoom	
was	made	on	one	specific	cell,	after	which	another	capture	was	taken.		
	
	 The	next	step	was	to	zoom	in	and	out	of	the	cell,	in	order	to	obtain	the	bottom	and	the	top	of	
the	cell.	A	Z-stack	was	done	for	a	total	of	50	slices	taken	from	the	top	to	the	bottom	of	the	cell.	All	the	
cells	meeting	the	measurements	criteria	were	analysed	in	the	full	field	of	view.	At	least	10	cells	were	
measured	in	total	for	each	time	point,	each	biological	replicate,	and	each	staining	type	(membrane	
and	cytoskeleton).	To	obtain	this	number	of	cells,	as	much	field	of	views	as	necessary	could	be	used.	
The	 z-stack	 results	 then	allowed	 the	determination	of	 several	parameters	 related	 to	 the	 cells:	 the	
volume,	 the	 sphericity	 coefficient,	 the	 diameter	 and	 the	 surface	 of	 the	 cell,	 via	 the	 3D	 object	
measurement	module	within	 the	NIS-Elements	AR	software,	version	4.6.	Furthermore,	parameters	
related	to	the	orientation	of	the	cell	such	as	the	pitch,	elongation,	orientation	and	intensity	among	
others	can	be	extracted	from	the	software	(see	appendix	3).	All	measurements	for	these	parameters	
were	averaged	from	the	10	or	more	cells	studied	in	each	condition.	The	standard	deviation	(SD)	and	
standard	error	of	the	mean	were	also	calculated	for	each	time	point	and	each	biological	replicate.	The	
data	were	then	plotted	across	the	circadian	time	before	statistics	were	done.	
	
2.5.3	Statistics	
	
	 For	each	time	point,	the	membrane	capacitance,	conductance	and	cytoplasmic	conductivity	
obtained	were	plotted	across	the	circadian	time,	each	biological	replicate	considered,	and	a	cosine	
curve	was	fitted	to	the	data.	This	was	done	against	the	null	hypothesis	of	a	straight	line.	A	p-value	was	
then	given,	which	 if	significant	 (p<0.05)	revealed	a	temporal	variation	 in	the	data.	 In	this	case,	 the	
hypothesis	of	a	straight	line	was	rejected	for	a	preferred	model	of	a	cosine	curve	to	fit	the	data.	A	total	
of	n=5	experimental	replicates	were	recorded	between	0	and	20	hours	following	serum	shock	of	the	
cells,	n=6	between	24	and	48	hours	and	n=1	between	52	and	72	hours.	All	graphs	and	analysis	were	
made	using	Graph-Pad	Prism	version	7.0.	The	tool	used	to	test	the	null	hypothesis	of	a	straight	line	
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against	a	cosine	curve	to	fit	the	data	was	a	non-linear	regression	fit,	and	the	equation	of	the	cosine	
curve	can	be	found	is	detailed	in	section	2.4.2.5.	
	
	 For	 the	 confocal	 microscopy,	 the	 same	 tool	 was	 used:	 data	 for	 the	 cytoskeleton	 and	
membrane	staining	of	all	parameters	analysed	by	the	software	(NIS-Elements	AR	v4.6)	were	plotted	
against	the	circadian	time	using	Graph-Pad	Prism	version	7.0.	For	each	parameter,	a	cosine	curve	was	
fitted	to	the	data	the	same	way,	against	the	null	hypothesis	of	a	straight	line.	The	p-value	gave	us	the	
preferred	model	to	fit	the	experimental	data,	either	a	cosine	curve	(if	significant	p-value)	or	a	straight	
line	(non-significant	p-value).	To	confirm	the	results,	a	one-way	ANOVA	was	also	done	for	comparison	
of	 p-values	 between	 the	 two	 types	 of	 analysis,	 using	Graph-Pad	 Prism	 version	 7.0.	 A	 total	 of	 n=3	
different	experimental	replicates	were	considered	for	this	work.	Whether	the	preferred	model	to	fit	
the	data	was	a	straight	line	or	a	cosine	curve,	this	was	presented	within	a	95%	confidence	interval.	If	
the	preferred	model	was	a	cosine	curve,	 the	amplitude,	period,	acrophase	and	mesor	values	were	
extracted.	A	circadian	rhythm	was	considered	if	the	periodicity	was	of	24±5	hours.	R2	values,	indicating	
the	quality	of	the	fit	of	the	model	to	the	experimental	data,	could	also	be	obtained.		
	
2.6	Bioluminescence	recording	of	circadian	gene	expression	
	
2.6.1	Bioluminescence	recording	of	3T3-L1	Per2	and	Bmal1	–	dLuc	pre-adipocytes	
	
	 For	 this	 experiment,	 3T3-L1	 pre-adipocytes	 containing	 either	 the	 Per2::dLuc	 or	 the	
Bmal1::dLuc	reporter	constructs	(section	2.3.2)	were	taken	from	liquid	nitrogen	storage,	and	cultured	
as	described	in	section	2.3.3.	When	reaching	80%	confluence,	cells	were	pelleted	and	resuspended	in	
2mL	of	culture	DMEM	medium	(section	2.3.3).	For	the	purpose	of	bioluminescence	recording,	cells	
were	 first	 washed	 (using	 1X-PBS)	 and	 trypsinised	 as	 described	 in	 section	 2.3.3.	 Cells	 were	 then	
centrifuged	at	200g	for	4	minutes,	after	which	the	pellet	was	resuspended	in	6mL	of	DMEM	medium.	
10µL	of	the	resulting	cell	suspension	was	pipetted	out,	and	mixed	to	10µL	of	0.4%	Trypan	Blue	(section	
2.4.2.1).	 10µL	 of	 the	 resulting	 cell	 suspension	 was	 pipetted	 into	 a	 disposable	 haemocytometer	
(Labtech),	before	living	cells	(defined	as	those	that	do	not	take	up	the	impermeable	Trypan	Blue	dye)	
were	counted	manually	under	a	microscope	(section	2.5.1).	After	counting,	the	cell	density	within	the	
suspension	 was	 adjusted	 to	 2.105	 cells/mL,	 in	 DMEM	 culture	 medium.	 Subsequently,	 1mL	 of	 the	
resulting	 suspension	was	 transferred	 into	35mm	petri-dishes,	pre-coated	with	 collagen	or	gelatine	
(see	 sections	 2.2.1,	 2.2.4,	 2.3.5.1	 and	 2.3.5.2)	 (John	 et	 al.,	 1977).	 Another	 1mL	 of	 DMEM	 culture	
medium	was	added	to	the	dish,	making	a	total	volume	of	2mL.	
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	 Upon	 reaching	 near	 100%	 confluency	 (estimated	 to	 correspond	 to	 approximately	 1.106	
cells/mL),	which	typically	occurred	48	hours	after	plating,	a	serum	shock	(as	described	in	section	2.3.6)	
was	used	to	synchronise	the	molecular	circadian	clocks	between	the	cells	of	an	individual	dish.	The	
total	 volume	of	 serum	shock	medium	was	of	 2mL	per	dish.	 The	 real-time	bioluminescence	 signals	
reporting	the	activity	of	the	Per2	or	Bmal1	promoter	could	then	be	measured.	This	required	luciferin,	
substrate	of	the	luciferase	enzyme.	As	a	result,	2	hours	after	initiation	of	the	serum	shock,	the	serum	
shock	medium	was	removed	before	35mm	dishes	were	rinsed	using	1mL	of	1X-PBS.	A	medium	suitable	
for	the	bioluminescence	recording	device	(Lumicycle,	Actimetrics)	was	immediately	added	to	the	cells	
at	 a	 volume	 of	 2mL	 per	 dish.	 This	 bioluminescence	medium	was	 based	 on	 a	 DMEM	medium	 not	
containing	any	phenol	red	(Gibco	–	21063-029)	supplemented	with	10%	FBS,	1%	antibiotic-antimycotic	
and	1%	sodium	pyruvate.	The	absence	of	phenol	red	was	required,	as	this	dye	could	interfere	with	
bioluminescence	 recordings.	 Importantly,	 the	bioluminescence	medium	was	also	supplemented	by	
0.1mM	luciferin	(1µL/mL	–	Promega	E6551).	Finally,	the	dishes	were	sealed	using	a	40mm	diameter	
cover	glass	(VWR),	glued	to	the	dish	using	a	translucent	grease	(ACC	Silicones	–	SGM494).		
	
	 To	record	circadian	rhythms	of	bioluminescence,	the	35mm	dishes	were	immediately	placed	
in	a	luminometer	device	constructed	for	this	purpose	(version	2.31,	Actimetrics).	This	machine	was	a	
light-tight	box	containing	4	photomultiplier	tubes	(PMTs)	and	a	turntable	with	32	slots	for	the	35mm	
culture	dishes.	This	turntable	rotated	four	dishes	at	a	time	into	position	under	the	PMTs,	and	the	real-
time	bioluminescence	of	each	dish	was	measured	 for	approximately	70	seconds,	at	 intervals	of	10	
minutes.	Once	 the	 recordings	 are	 done	 for	 one	 position,	 the	 turntable	 automatically	 rotates,	 and	
another	 position	 comes	 under	 the	 PMTs.	 Importantly,	 the	 4	 PMTs	 tubes	 are	 analogue-digital	
converting	photon-counting	sensors	selected	for	high	sensitivity	in	the	green	portion	of	the	spectrum	
at	which	luciferase	emits	light.	Bioluminescence	rhythms	were	usually	recorded	for	3	to	10	days.	As	
the	quality	of	the	trace	could	be	seen	on	the	computer	attached	to	the	Lumicycle,	the	recording	was	
stopped	if	the	rhythms	were	shown	to	dampen	to	flatness	rapidly.	The	LumiCycle	is	shown	in	figure	
2.12	below.	
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Figure	2.12:	LumiCycle	device	from	Actimetrics.		
		
	 Bioluminescence	was	recorded	in	real-time,	and	exported	to	the	Lumicycle	analysis	software	
(version	2.53,	Actimetrics)	as	raw	photon	counts	(photons/sec).	Due	to	high	transient	luminescence	
upon	medium	change,	the	first	cycle	was	excluded	for	rhythm	analysis	(Ramanathan	et	al.,	2014).	The	
analysis	program	then	allowed	us	to	export	baseline-subtracted	data	calculated	on	a	24-hour	running	
window,	to	which	was	fitted	a	cosine	curve.	Four	free	variables	were	determined:	period,	amplitude,	
damping	 and	 phase.	 These	 values	were	 determined	 using	 an	 iterative	 process	 in	which	 the	 least-
square	best	fit	model	method	was	used.	The	software	also	reported	a	goodness	of	fit	value,	showing	
how	well	the	model	of	the	sine	wave	represented	the	data,	based	on	the	overall	variance	between	
the	two.	The	literature	estimated	that	for	rhythms	persisting	over	time,	a	goodness-of-fitness	superior	
or	equal	to	90%	was	achieved	(Liu	et	al.,	2007b),	and	in	our	case	we	accepted	a	goodness	of	fit	>85%,	
as	a	few	successful	traces	were	found	
to	 have	 a	 goodness	 of	 fit	 comprised	
between	 85	 and	 90%.	 The	 circadian	
parameters	 represented	 on	 a	 wave	
are	 illustrated	 in	 the	 following	 figure	
2.13.		
	
	
	
Figure	2.13:	Description	and	analysis	
of	 a	 circadian	 rhythm.	 Taken	 from	
Benavides	et	al.,	1998.	
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2.6.2	Differentiation	of	3T3-L1	pre-adipocytes	
	
2.6.2.1	 General	 protocol	 for	 the	 differentiation	 of	 3T3-L1	 Per2	 and	 Bmal1	 –	 dLuc	 pre-
adipocytes		
	
	 A	cell	suspension	of	3T3-L1	Per2	or	Bmal1	–	dLuc	pre-adipocytes	was	cultured	in	T75	flasks.	
Upon	experiment,	the	cells	were	washed	after	removal	of	the	growing	medium	and	trypsinised	(see	
details	of	the	full	protocol	in	section	2.3.3).	After	centrifugation,	the	supernatant	was	discarded	and	
the	pellet	resuspended	in	2mL	of	growing	DMEM	medium.	The	cell	density	was	then	adjusted	to	2.105	
cells/mL	after	manual	cell	counting,	following	the	method	described	in	section	2.6.1.	1mL	of	the	cell	
suspension	was	placed	in	a	35mm	dish	(John	et	al.,	1977)	pre-coated	with	either	collagen	or	gelatine	
(see	 sections	 2.2.1,	 2.2.4,	 2.3.5.1	 and	 2.3.5.2),	 supplemented	with	 1mL	of	 normal	DMEM	growing	
medium.	The	cells	were	then	 left	 to	grow	until	 reaching	near	 full	confluence	and	the	medium	was	
changed	every	two	days.	
	
	 In	order	to	enable	cell	growth	arrest	prior	to	experiment,	the	experiment	started	at	two	days	
post-confluence	(day	0),	when	the	differentiation	was	 initiated.	The	differentiation	was	 induced	by	
supplementing	a	complete	growth	culture	medium	with	0.5mM	of	IBMX	(Sigma-Aldrich,	section	2.2.6),	
1µM	of	DEX	(Sigma-Aldrich,	section	2.2.3)	and	10µg/mL	of	insulin	(Thermo-Fisher	Scientific,	section	
2.2.5).	Two	days	after	adding	 the	3-component	cocktail	used	 for	adipogenic	 induction	 (day	2),	 the	
culture	medium	within	the	dishes	was	removed	by	pipetting	and	the	cells	were	carefully	washed	using	
1mL	of	1X-PBS.	As	 the	cells	already	started	to	differentiate,	 they	became	rounder	as	 lipid	droplets	
were	appearing,	making	them	more	susceptible	to	detachment	from	the	culture	surface.	This	is	why	
it	was	crucial	to	always	manipulate	them	with	care	and	ensure	all	cell	culture	surfaces	were	pre-coated	
prior	 to	 the	 initiation	of	 the	differentiation.	A	new	culture	medium	was	 then	 inserted	 (2mL),	 only	
containing	insulin	(10µg/mL)	as	a	supplement	to	a	complete	DMEM	growth	medium.	The	cells	were	
kept	in	this	medium	for	two	days,	after	which	at	day	4	the	culture	medium	was	replaced	with	a	normal	
DMEM	growing	medium	(section	2.3.1)	without	any	further	supplements.	From	this	point	onwards,	
the	 culturing	 medium	 was	 replaced	 every	 two	 days	 until	 approximately	 80%	 of	 the	 cells	 were	
differentiated	into	adipocytes.	The	differentiation	process	of	these	3T3-L1	reporter	cells	was	usually	
observed	to	take	up	to	15	days.	
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2.6.2.2	Confirmation	of	differentiation	
	
	 To	 assess	 the	 success	 of	 the	 differentiation	 of	 pre-adipocytes	 into	 adipocytes	 in	 vitro,	
triglycerides	(mostly	present	in	the	vacuoles	of	mature	adipocytes)	were	stained	using	an	Oil	Red	O	
staining.	 This	 method	 would	 typically	 confirm	 the	 presence	 of	 lipid	 droplets	 observed	 in	 mature	
adipocytes	(Li	et	al.,	2013,	Wu	et	al.,	2017).	Cell	culture	medium	was	removed	from	the	35mm	petri	
dish	and	replaced	with	2.4mL	of	formalin	10%	containing	37%	formaldehyde,	13%	methanol	and	50%	
distilled	sterile	water	in	1X-PBS.	This	solution	was	discarded	immediately.	The	same	amount	of	this	
10%	formalin	solution	in	1X-PBS	was	added	again	for	incubation	at	room	temperature	during	an	hour	
in	order	to	fix	the	cells.	At	this	stage,	the	samples	were	ready	to	be	analysed.	In	the	case	of	a	non-
immediate	analysis,	the	samples	were	stored	protected	from	light	and	airtight	for	a	maximum	of	two	
days	at	room	temperature.	In	this	case,	the	plates	were	wrapped	in	parafilm	and	covered	with	silver	
foil.	When	the	analysis	was	ready	to	be	done,	the	formalin	solution	was	carefully	removed	before	the	
cells	were	washed	twice	with	1mL	of	60%	ethanol	and	twice	with	1mL	of	distilled	water.	At	this	point,	
the	morphology	was	captured	using	a	digital	camera	(coolPIX990,	Nikon)	attached	to	a	microscope	
(TMS,	Nikon).	For	the	staining,	1mL	of	an	Oil	Red	O	solution	(0.18%)	was	added	to	each	well	of	interest	
for	a	total	of	10	minutes	at	room	temperature.		
	
	 A	saturated	stock	solution	of	0.3%	Oil	Red	O	was	made	up	by	adding	0.3g	of	Oil	Red	O	powder	
(Sigma-Aldrich	–	1320-06-5)	to	100mL	of	isopropanol.	To	obtain	a	0.18%	working	solution,	6mL	of	the	
above	stock	solution	was	added	to	4mL	of	sterile	distilled	water	(60:40	volume	ratio).	The	obtained	
solution	was	allowed	to	stand	at	room	temperature	under	laminar	flow	for	20	minutes,	and	was	then	
sterile	filtered	through	a	0.22µM	filter.	After	10	minutes,	the	Oil	Red	O	was	removed	and	the	cells	
washed	carefully	with	distilled	water	(1mL)	three	times.	1mL	of	distilled	water	was	added	to	each	well	
and	remained	in	the	dish	for	microscopy	observation.	The	stained	fatty	acids	were	photographed	as	
described	earlier	on	and	the	success	of	the	differentiation	was	studied.	Pictures	of	morphology	and	
staining	were	taken	regularly	throughout	the	differentiation	process	every	two	days	from	the	initiation	
of	 the	differentiation,	using	the	same	digital	camera	(coolPIX990,	Nikon)	attached	to	a	microscope	
(TMS,	Nikon).	
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2.6.3	Statistics	
	
	 For	each	successful	trace	of	bioluminescence,	with	a	goodness	of	fit	>85%	and	presenting	a	
persistent	 rhythm	 with	 a	 periodicity	 of	 24±5	 hours,	 a	 cosine	 curve	 was	 automatically	 fit	 by	 the	
LumiCycle	analysis	software	to	the	baseline-subtracted	data,	and	the	period,	amplitude,	damping	and	
phase	 were	 extracted.	 A	 two-way	 ANOVA	 was	 used	 in	 order	 to	 know	 whether	 there	 were	 any	
significant	differences	between	the	differentiation	state	and	the	gene	studied.	Furthermore,	a	one-
way	ANOVA	was	done	to	test	any	significant	differences	between	the	groups,	therefore	between	any	
gene	of	interest	or	any	differentiation	state.	This	for	a	total	of	n=10	for	both	cell	lines	of	adipocytes,	
n=40	for	3T3-L1	Per2-dLuc	pre-adipocytes	and	n=31	for	3T3-L1	Bmal1-dLuc	pre-adipocytes.		
	
	 The	phase	was	analysed	using	the	number	cruncher	statistical	system	(NCSS)	version	11.0.	A	
Rayleigh	test	was	performed	in	order	to	determine	whether	the	distribution	of	the	angles	was	uniform	
(null	hypothesis,	Ho,	or	unimodal).	A	directional	vector	was	also	built	 in	order	to	point	towards	the	
average	 phase,	 for	 each	 cell	 line	 and	 differentiation	 state.	 A	 p-value<0.05	 was	 significant,	 and	
indicated	a	unimodal	distribution	of	the	angles.	
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CHAPTER	3	
	
CIRCADIAN	DYNAMICS	OF	UTILISATION	IN	AN	ARRAY	
OF	CARBON-BASED	ENERGY	SOURCES	IN	PRE-
ADIPOCYTES	IN	VITRO	
	
3.1	Introduction	
	
	 Over	 the	 past	 several	 decades,	 it	 has	 become	 clear	 that	 a	 plethora	 of	 cyclic	
behaviours	 (such	 as	 eating	 and	 sleeping),	 as	well	 as	 physiological	 and	metabolic	 processes	 exhibit	
oscillations	with	a	period	of	about	a	day	(Sassone-Corsi	2014).	These	circadian	rhythms	have	been	
observed	across	a	variety	of	organisms,	 including	 fungi,	 insects,	plants,	cyanobacteria,	vertebrates,	
and	mammals.	These	circadian	rhythms	are	thought	to	be	the	internal	representation	of	one	of	the	
most	ancient	feature	of	our	environment:	the	rotation	of	Earth	around	its	axis,	leading	to	the	24-hour	
daylight-darkness	cycles	(Reppert	et	al.,	2001,	Schibler	et	al.,	2002).	Circadian	rhythms	are	driven	by	
internal	clocks,	which	allow	anticipation	of	these	environmental	light-dark	cycles,	greatly	benefitting	
the	maintenance	of	physiology,	behaviour	and	metabolism	(Marcheva	et	al.,	2013).	In	recent	years,	it	
has	 become	 clear	 that	 one	 of	 the	main	 functions	 of	 tissue-specific	 circadian	 clocks	 is	 to	maintain	
appropriate	 alignment	 of	 the	 timing	 of	 internal	metabolic	 cycles	 relative	 to	 the	 sleep-wake	 cycle,	
enabling	organisms	to	anticipate	changes	 in	 the	daily	energetic	environment	 tied	 to	 the	rising	and	
setting	of	the	sun.	
	
	 Recent	 insights	 into	 circadian	 timing	 of	 metabolism	 include	 the	 discovery	 that	 biological	
rhythms	are	sustained	by	a	genetically	encoded	transcription-translation	network	that	functions	as	a	
molecular	oscillator	with	near	24-h	precision	in	most	tissues	(Marcheva	et	al.,	2013).	Indeed,	these	
tissue-specific	mammalian	clocks	drive	the	timing	of	metabolic	homeostasis	across	a	broad	range	of	
behavioural	and	physiological	processes	related	to	metabolism,	including	the	timing	of	eating,	glucose	
and	lipid	metabolism,	endocrine	hormone	secretion	and	body	temperature	(figure	3.1)	(Panda	et	al.,	
2002b,	Reppert	et	al.,	2002).	The	impact	of	circadian	timing	on	human	metabolic	health	has	begun	to	
emerge	through	observational	population	studies	 in	 individuals	subjected	to	sleep	restriction,	shift	
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work	and	 jet	 travel.	Additionally,	 clinical	 investigations	 revealed	pathophysiologic	consequences	of	
circadian	disruption	on	metabolic	function	(i.e.	glucose	homeostasis,	obesity,	T2D),	as	well	as	more	
general	 health	 issues	 such	 as	 cognitive	 function,	 psychiatric	 disorders,	 cancer	 and	 inflammation	
(Reppert	et	al.,	2002,	Bechtold	et	al.,	2010).		
	
	
	
Figure	 3.1:	 Rhythmicity	 of	 metabolic	
processes	 according	 to	 the	 time	 of	 day.	
Taken	 from	 Bass	 et	 al.,	 2010.	 Circadian	
clock	 coordinates	 appropriate	 metabolic	
responses	within	 the	 light-dark	cycle,	and	
enhances	 energetic	 efficiency	 through	
temporal	 separation	 of	 anabolic	 and	
catabolic	 reactions	 in	 peripheral	 tissues.	
Circadian	 misalignment,	 which	 occurs	
during	 sleep	 disruption,	 shift	 work	 and	
dietary	alterations,	disrupts	the	integration	
of	circadian	and	metabolic	systems,	leading	
to	adverse	metabolic	health	effects.	
	
	
	 Some	 of	 the	 first	 evidence	 for	 the	 involvement	 of	 adipose-specific	 circadian	 rhythms	 in	
metabolic	 homeostasis	 stems	 from	 observations	 that	 disturbances	 in	 circadian	 rhythms	 of	 the	
adipokines	leptin	may	be	unhealthy	(Kim	et	al.,	2015).	This	adipocyte-derived	circulating	hormone	acts	
to	suppress	appetite	and	regulates	metabolism,	and	is	therefore	extremely	important	in	obesity	(Froy	
et	al.,	2018).	Leptin	exhibits	striking	circadian	patterns	in	both	gene	expression	and	protein	secretion;	
with	peaks	during	the	sleep	phase	in	humans	(Kalra	et	al.,	2003).	Neither	altering	feeding	time	nor	
adrenalectomy	 affected	 the	 rhythmicity	 of	 leptin	 release,	 however	 an	 ablation	 of	 the	main	 light-
entrainable	clock	in	the	SCN	of	the	hypothalamus	eliminated	leptin	circadian	rhythmicity	in	rodents,	
suggesting	that	the	central	circadian	clock	drives	the	circadian	timing	of	leptin	expression	(Kalsbeek	et	
al.,	2001).	Differences	in	circadian	pattern	of	leptin	secretion	between	obese	and	non-obese	subjects	
were	seen;	with	lean	subjects	presenting	elevated	leptin	levels	in	the	evening	(peak)	with	low	levels	
at	 around	 noon	 (through),	 whilst	 the	 noon	 values	were	 higher	 than	 the	morning	 values	 in	 obese	
individuals	 (Radic	 et	 al.,	 2003).	 This	 difference	 was	 probably	 caused	 by	 an	 enlarged	 volume	 of	
subcutaneous	fat	tissue	in	obese	people.	In	lean	subjects,	a	normal	volume	of	subcutaneous	fat	and	
leptin	 secretion	 enable	 the	 influence	 of	 other	 physiological	 factors,	 such	 as	 insulin,	 on	 the	 daily	
dynamics	of	blood	leptin	levels	(Kolaczynski	et	al.,	1996,	Malmstrom	et	al.,	1996,	Ryan	et	al.,	1996).			
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	 Obesity	causes	have	been	linked	to	a	circadian	misalignment,	whereby	circadian	desynchrony	
affects	the	expression	profiles	of	leptin,	adiponectin	and	other	fat-derived	cytokines	(Kern	et	al.,	2003,	
Moran	et	al.,	2003,	Wisse	2004,	Caer	et	al.,	2017).	However,	it	was	not	until	2006	that	a	comprehensive	
analysis	 of	 the	 circadian	 clock	machinery	 in	mouse	 adipose	depots	was	 undertaken	 (Zvonic	 et	 al.,	
2006).	Robust	and	coordinated	expression	of	circadian	clock	genes	(i.e.	Bmal1,	Per1-3	and	Cry1-2)	as	
well	 as	 clock	 controlled	 downstream	 genes	 (i.e.	Dbp,	Rev-erbα,	Rev-erbβ	 and	 Id2)	 in	murine	 BAT,	
eWAT,	 and	 iWAT	 were	 observed,	 with	 patterns	 similar	 to	 the	 liver	 and	 blood	 serum	markers	 of	
circadian	 function.	A	mistimed,	 temporally	 restricted	 feeding	paradigm	 in	mice	was	also	 shown	 to	
cause	a	coordinated	phase	shift	in	the	circadian	expression	of	major	oscillator	genes	in	adipose	tissues,	
showing	that	the	adipose	clock	can	be	entrained	to	feeding	patterns.	In	a	human	forced	desynchrony	
protocol,	Scheer	and	colleagues	then	demonstrated	that	a	misalignment	between	eating	and	sleeping	
led	to	a	significant	decrease	in	leptin,	and	increase	in	circulating	insulin	as	well	as	glucose	(Scheer	et	
al.,	2009).	This	circadian	misalignment	also	caused	postprandial	glucose	responses	in	a	range	that	is	
typical	 of	 a	pre-diabetic	 state.	 These	 findings	demonstrated	 the	adverse	metabolic	 implications	of	
circadian	misalignment	on	adipose	tissue	function,	as	is	often	seen	with	jetlag	and	chronical	shift	work.	
The	importance	of	maintaining	a	good	metabolic	homeostasis	in	adipose	tissue	is	partly	illustrated	by	
the	 fact	 that	 an	 excessive	 accumulation	 of	 lipids	 can	 lead	 to	 lipotoxicity,	 cell	 dysfunction	 and	
alterations	in	metabolic	pathways;	both	in	adipose	tissue	and	other	peripheral	organs	such	as	liver,	
heart,	pancreas	and	muscle	(Saponaro	et	al.,	2015).	The	causes	for	lipotoxicity	are	not	only	a	high	fat	
diet	but	also	adipogenesis,	adipose	tissue	insulin	resistance	and	excessive	lipolysis.	Such	accumulation	
of	 lipids	 is	recognised	as	a	risk	 factor	 for	the	development	of	metabolic	disorders,	such	as	obesity,	
diabetes,	fatty	liver	disease	and	cardiovascular	diseases.		
	
	 The	 circadian	 control	 of	 glucose	 homeostasis	 is	 now	 well	 documented,	 but	 a	 better	
understanding	 of	 the	 associated	 circadian	 molecular	 mechanisms	 is	 needed.	 Plasma	 glucose	
homeostasis,	in	normal	conditions,	is	achieved	through	a	tightly	controlled	balance	between	glucose	
delivery	(from	the	liver	in	the	post-absorptive	state	and	the	gut	in	the	post-prandial	state)	and	glucose	
utilisation	(Van	Cauter	et	al.,	1997).	Insulin	plays	a	key	role	in	this	process,	by	inhibiting	hepatic	glucose	
production	and	stimulating	glucose	uptake	by	insulin-sensitive	tissues	(mainly	the	skeletal	muscle	and	
adipose	tissue).	Therefore,	insulin	signalling	is	key	to	adipose	lipogenesis.	Human	insulin	secretion	is	
a	complex	oscillatory	process,	including	rapid	pulses	recurring	every	10	to	15	minutes,	superimposed	
on	slower	oscillations	with	periods	in	the	range	of	90-120	minutes	(Lang	et	al.,	1979,	Shapiro	et	al.,	
1988).	 The	 counter-regulatory	 hormones,	 mainly	 glucagon,	 catecholamines,	 cortisol	 and	 growth	
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hormone,	are	able	to	increase	blood	glucose	concentrations	by	stimulating	hepatic	glucose	production	
and/or	inhibiting	glucose	uptake	by	adipose	and	other	tissues	(Van	Cauter	et	al.,	1997).		
	
	 The	next	result	of	 the	tight	control	of	glucose	delivery	and	utilisation	 is	 that	blood	glucose	
levels	oscillate	in	a	circadian	manner,	peaking	before	the	start	of	the	active	period	in	humans	(Bolli	et	
al.,	1984,	Arslanian	et	al.,	1990),	alongside	many	hormones	closely	implicated	in	metabolism,	such	as	
glucagon	 (Ruiter	 et	 al.,	 2003),	 insulin	 (La	 Fleur	 et	 al.,	 1999),	 corticosterone	 (De	Boer	 et	 al.,	 1987),	
adiponectin	(Ando	et	al.,	2005),	leptin	and	ghrelin	(Ahima	et	al.,	1998,	Bodosi	et	al.,	2004).	In	line	with	
this,	are	the	observations	that	in	the	evening,	glucose	tolerance	is	diminished	and	the	plasma	insulin	
response	 is	delayed;	 therefore	an	evening	meal	or	glucose	 ingestion	result	 in	a	greater	 increase	 in	
plasma	glucose	concentrations	 in	 the	evening	 in	comparison	 to	 the	morning	 (Lee	et	al.,	1992,	Van	
Cauter	et	al.,	1992,	Morgan	et	al.,	1999,	Saad	et	al.,	2012).	Indeed,	it	was	shown	that	glucose	tolerance	
(Bowen	 et	al.,	 1967,	 Jarrett	 et	al.,	 1969,	 Jarrett	 et	al.,	 1970)	and	 insulin	 secretion/action	vary	 in	a	
diurnal	fashion	throughout	the	day	(Jarrett	et	al.,	1972,	Carroll	et	al.,	1973).	Oral	glucose	tolerance	is	
impaired	in	the	evening	compared	to	morning	hours,	due	to	the	combined	effects	of	reduced	insulin	
sensitivity	and	insulin	secretion	at	night	(Roberts	1964,	Gibson	et	al.,	1972,	Van	Cauter	et	al.,	1997).	
In	1999	was	established	that	the	basal	concentrations	of	glucose	were	directly	controlled	by	the	SCN,	
independently	of	its	influence	on	feeding	activity	(La	Fleur	et	al.,	1999).	To	add	to	the	evidence	of	a	
direct	role	for	the	circadian	clock	in	glucose	homeostasis,	SCN-ablated	rats	and	degeneration	of	the	
autonomic	 tract	 linking	 the	SCN	to	 the	 liver	displayed	 loss	of	24-h	glucose	rhythms	(la	Fleur	et	al.,	
2001,	Cailotto	et	al.,	2005).	Additionally,	researchers	worked	on	SCN-intact	and	lesioned	rats	to	find	
an	increased	glucose	uptake	at	the	beginning	of	the	activity	period	followed	by	a	gradual	decrease	at	
the	end	of	the	activity	period	(la	Fleur	et	al.,	2001).	Lesioning	the	SCN	resulted	in	the	suppression	of	
the	daily	variations	in	insulin	sensitivity	and	glucose	uptake,	with	an	enhancement	in	glucose	tolerance	
which	could	not	be	explained	by	greater	insulin	sensitivity	and	insulin	responses.	This	suggested	a	role	
for	the	SCN	in	 insulin-independent	glucose	uptake.	 In	addition,	circadian	rhythms	in	 leptin,	glucose	
tolerance	and	plasma	glucose	were	able	to	be	regulated	by	the	SCN	through	humoral	and/or	neural	
signals	 to	the	white	adipose	tissue,	 the	pancreas,	 the	heart,	 the	adrenal	cortex	as	well	as	 the	 liver	
(Buijs	et	al.,	2006b).	
	
	 Studies	in	both	rodents	and	humans	suggested	that	a	loss	of	circadian	rhythmicity	of	glucose	
metabolism	may	contribute	to	the	development	of	metabolic	disorders	such	as	type	2	diabetes,	as	
rhythms	of	insulin	secretion,	glucose	tolerance,	and	corticosterone	release	are	diminished	in	diabetic	
rats	and	in	patients	with	T2D	(Oster	et	al.,	1988,	Shimomura	et	al.,	1990,	Van	Cauter	et	al.,	1997).	Early	
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studies	examined	 the	 response	of	male	 subjects	 to	a	 standardised	oral	glucose	 load,	administered	
once	in	the	morning	and	once	in	the	afternoon,	and	found	an	inverse	relationship	between	the	degree	
of	obesity	and	the	decrease	in	glucose	tolerance	from	morning	to	afternoon	(Jarrett	et	al.,	1970).	In	
obese	and	non-obese	children,	an	oral	glucose	tolerance	test	(OGTT)	exposed	a	significant	drop	in	the	
insulin/glucose	ratio	in	the	afternoon	for	non-obese	children,	whereas	this	ratio	remained	high	in	the	
obese	 group,	 the	 latter	 of	 which	 showed	 no	 significant	 changes	 in	 this	 response	 during	 the	 day	
(Desjeux	et	al.,	1982).	A	separate	study	revealed	that	obese	subjects	showed	no	morning	to	evening	
variation	in	glucose	tolerance	in	contrast	to	lean	controls,	with	no	decline	in	insulin	sensitivity	in	the	
afternoon	and	a	decline	 in	β-cell	 responsiveness	 to	glucose	 in	 the	 later	part	of	 the	day	 (Lee	et	al.,	
1992).	Abnormalities	in	the	daytime	profiles	of	glucose	tolerance	and	insulin	secretion	in	obesity	were	
further	demonstrated	in	subjects	receiving	a	continuous	intravenous	glucose	infusion	(Van	Cauter	et	
al.,	1994).	Lean	subjects	presented	a	decline	in	glucose	tolerance	toward	the	end	of	the	day,	whereas	
plasma	glucose	levels	remained	stable	in	obese	subjects	across	the	day.	This	in	spite	of	a	decrease	in	
insulin	 secretion	 rate	 (ISR),	 indicating	 an	 improved	 glucose	 tolerance	 as	 the	 day	 progresses.	
Additionally,	a	disruption	of	circadian	insulin	secretion	was	associated	with	a	reduced	glucose	uptake	
in	first-degree	relatives	of	T2D	patients	(Boden	et	al.,	1999).	
	 	
	 Links	between	circadian	and	adipose	physiology	at	 the	molecular	 level,	with	many	mutant	
mouse	lines	with	genetic	lesions	of	clock	or	clock-related	genes	exhibiting	abnormal	lipid	processing	
(Johnston	et	al.,	2009).	C57BL/6J	mice	expressing	the	dominant	negative	allele	Clock∆19	display	many	
symptoms	of	metabolic	syndrome,	such	as	adipocyte	hypertrophy,	hyperlipidaemia,	hyperglycaemia,	
hyperleptinaemia	and	hypoinsulinaemia	(Turek	et	al.,	2005).	Moreover,	adult	Bmal1-/-	mice	exhibit	a	
reduction	of	fat	and	other	tissues,	which	however	could	be	the	result	of	premature	ageing,	rather	than	
an	abnormal	adipose	physiology	(Kondratov	et	al.,	2006).	 In	rodents,	variants	of	Bmal1,	Npas2	and	
Per2	have	been	associated	to	hypertension,	glucose	dysregulation	and	other	components	of	metabolic	
syndrome	(Woon	et	al.,	2007,	Englund	et	al.,	2009).	Other	clear	evidence	for	the	circadian	control	of	
metabolism	 is	 provided	 by	 the	 observation	 that	 mice	 carrying	 a	 knockout	 for	 helix-loop-helix	
transcriptional	repressor	rhythmically	expressed	in	many	tissues,	Id2,	had	altered	circadian	expression	
profiles	of	liver	genes,	including	those	involved	in	lipid	metabolism	(Mathew	et	al.,	2013).	These	mice	
also	presented	disrupted	daily	and	circadian	rhythms	of	 feeding	and	 locomotor	activity,	consumed	
higher	amounts	of	food	relative	to	body	mass	and	displayed	less	weight	gain.	Id2-/-		females	had	smaller	
adipocytes,	 indicative	of	a	sexual-dimorphic	programming	of	adipogenesis.	The	glucose	uptake	was	
increased	by	skeletal	muscle	and	BAT	 in	male	 Id2-/-	mice	 (revealed	by	 fluorodeoxyglucose-positron	
emission	tomography	(FDG-PET)	analysis),	and	an	increased	glucose	tolerance	and	insulin	sensitivity	
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were	observed	 (exacerbated	 in	older	 animals).	 The	 intramuscular	 triacylglycerol	 and	diacylglycerol	
were	also	reduced.	This	implied	an	increased	glucose	metabolism	and	thermogenesis	in	these	tissues,	
and	indicated	a	role	for	ID2	as	a	regulator	of	glucose	and	lipid	metabolism,	as	well	as	in	the	circadian	
control	 of	 feeding/locomotor	 behaviour.	 The	 study	 also	 contributed	 to	 the	 understanding	 of	 the	
development	of	obesity	and	diabetes,	particularly	in	shift	work	where	the	incidence	of	such	metabolic	
disorders	 is	 elevated.	A	 study	using	 radiolabelled	 18F-fluorodeoxyglucose	 (18F-FDG)	was	 the	 first	 to	
show	circadian	rhythms	in	glucose	uptake	in	brown	adipose	tissue	of	C57BL/6J	mice	(figure	3.2)	(van	
der	Veen	et	al.,	2012b).	The	same	authors	demonstrated	that	these	rhythms	exhibit	different	peak	
times	of	glucose	uptake	than	brain	and	heart	(van	der	Veen	et	al.,	2012a).	Interestingly,	BAT	has	gained	
increased	attention	over	recent	years	as	being	involved	in	metabolic	phenotypes	and	obesity,	where	
BAT,	 as	 observed	 by	 PET	 analysis,	 negatively	 correlates	 with	 obesity	 and	 age.	 Therefore,	 the	
observation	 of	 a	 24-hour	 rhythm	 in	 glucose	 uptake	 in	 iBAT	makes	 this	 tissue	 a	 candidate	 site	 of	
interaction	between	metabolic	and	circadian	systems.	A	few	years	later,	glycaemic	excursions	and	BAT	
thermogenic	 responses	 in	 human	 brown	 adipocytes,	 BAT	 explants,	 and	 healthy	 adults	 were	
characterised,	revealing	their	circadian	coupling	in	vivo	and	in	vitro,	orchestrated	by	UCP1,	GLUT4	and	
REV-ERBα	biorhythms	(Lee	et	al.,	2016b).	These	data	uncovered	a	potential	crosstalk	between	glucose	
regulatory	pathways	and	BAT,	encouraging	the	search	for	BAT	harnessing	strategies	in	therapeutics.	
Using	the	same	PET	technology,	recent	work	in	obese	rats	presented	a	decrease	in	the	basal	levels	of	
glucose	uptake	 in	all	 tissues.	A	similar	 trend	was	observed	 in	diet-induced	obese	mice;	but	only	 in	
WAT,	while	BAT	showed	increments	in	the	basal	glucose	uptake	(Ishino	et	al.,	2017).		
	
Figure	 3.2:	 Time-of-day	 specific	 variation	 of	 FDG	
uptake	 in	 iBAT.	 Taken	 from	 van	 der	 Veen	 et	 al.,	
2012b.	Individual	values	of	the	average	voxel	value	in	
the	 iBAT	 are	plotted	 against	 time	of	measurement.	
Values	for	FDG	uptake	in	those	animals	that	are	part	
of	 the	 group	 measured	 around	 the	 dark	 to	 light	
transition	 (ZT	 0/24),	 but	 fall	 in	 the	 light	 phase,	 are	
plotted	both	early	in	the	light	phase	and	after	the	end	
of	the	dark	phase.	Cosinor	fitting	of	the	data	predicts	
a	peak	phase	of	FDG	uptake	at	ZT	9.3	and	a	through	
at	 ZT	21.3.	 **P<0.01	 against	 ZT	0	 and	18.	 The	 grey	
area	 indicates	 the	 dark	 phase	 of	 the	 24-hours	 LD	
cycle.	 The	 data	 did	 not	 show	 any	 effects	 of	 age,	
gender,	 iBAT	 volume,	 and	 body	 mass	 on	 average	
voxel	value	FDG	uptake	(P’s>0.05).	
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	 It	 is	 thus	 clear	 that	 adipose	 tissue	 plays	 an	 important	 role	 in	 maintaining	 metabolic	
homeostasis,	and	that	mistiming	circadian	rhythms	in	adipose	metabolism	contribute	to	the	negative	
health	 consequences	 of	 shift	work.	 However,	 to	 the	 best	 of	 our	 knowledge,	 literature	 on	 glucose	
utilisation	 in	 adipose	 tissue	 itself	 is	 relatively	 limited,	 and	 insights	 into	 the	 circadian	 timing	 of	
utilisation	of	other	carbon-based	energy	sources	by	adipose	tissue	is	almost	completely	lacking.	This	
is	a	striking	gap	in	our	knowledge,	considering	that	we	know	most	metabolic	processes	to	be	under	
circadian	 regulation	 –	 not	 just	 glucose	 utilisation	 –	 and	 that	 these	 processes	 are	 also	 involved	 in	
important	metabolic	cellular	pathways	associated	with	energy	homeostasis,	such	as	the	Krebs	cycle	
or	glycolysis.	In	this	chapter,	we	therefore	set	out	to	investigate	utilisation	rates	of	glucose	by	3T3-L1	
pre-adipocytes	 in	 vitro,	 across	 the	 circadian	 time.	We	 employed	 a	 novel	 approach	 by	 designing	 a	
circadian	use	of	a	metabolic	phenotype	microarray	 (the	BIOLOGTM	platform),	and	for	the	first	 time	
showed	vast	circadian	regulation	of	metabolism	in	a	panel	of	more	than	90	different	carbon-based	
energy	sources	in	pre-adipocytes.	
	
3.2	Aim,	hypothesis	and	objectives	
	
3.2.1	Aim	
	
	 In	vitro	utilisation	dynamics	of	glucose	in	pre-adipose	cells	are	exhibiting	circadian	rhythms,	
as	 do	 utilisation	 rates	 of	 various	 other	 carbon-based	 sources;	 predictors	 of	 the	 development	 of	
obesity,	markers	of	insulin	resistance,	and	intermediates	in	key	metabolic	pathways.	
	
3.2.2	Hypothesis	
	
	 This	study	will	 test	the	hypothesis	that	 in	vitro	utilisation	dynamics	of	91	different	
energy	sources	(including	glucose)	in	pre-adipose	cells	(3T3-L1)	exhibit	circadian	rhythms.	
	
3.2.3	Objectives	
	
Global	objective:	Determine,	across	the	circadian	time,	in	vitro	utilisation	dynamics	of	glucose	in	pre-
adipocytes,	as	well	as	an	array	of	monosaccharides,	oligosaccharides,	polysaccharides,	nucleosides,	
alcohols,	organic	acids,	ketone	bodies	and	short	chain	fatty	acids.	
	
127	
	
Specific	 objective	 1:	 Optimise	 the	 use	 of	 the	 BIOLOGTM	 metabolic	 phenotyping	 technology	 for	
establishing	temporal	patterns	in	energy	sources	utilisation	dynamics,	using	glucose	as	a	well-known	
established	marker	of	circadian	rhythms	in	oxidative	metabolism.			
	
Specific	objective	2:	Validate	the	BIOLOGTM	approach,	by	confirming	the	circadian	pattern	of	glucose	
utilisation	in	3T3-L1	cells	in	vitro,	between	6	and	72	hours	following	serum	synchronisation,	through	
the	investigation	of	real-time	redox	build-up	dynamics.	
	
Specific	objective	3:	Determine,	for	the	first	time,	the	circadian	patterns	of	utilisation	of	a	panel	of	91	
carbon-based	sources	in	3T3-L1	cells	in	vitro	between	24	and	51	hours	after	serum	shock,	and	align	
these	patterns	to	glucose	utilisation	rates	obtained	previously.		
	
3.3	Methods	
	
	 Oxidative	utilisation	rates	were	measured	using	the	phenotype	microarray	BIOLOGTM	platform	
(figure	2.2),	which	employs	a	colorimetric	 redox	assay	as	a	universal	 reporter	of	 cell	 respiration	 in	
vitro.	 When	 the	 3T3-L1	 cells	 are	 cultured	 in	 a	 medium	 containing	 a	 single	 carbon-based	 energy	
substrate,	NADH	 is	produced,	during	 the	oxidative	utilisation	of	 this	energy	 source.	 The	BIOLOGTM	
platform	then	extrapolates	the	amount	of	NADH	generated	from	the	change	of	the	colorimetric	dye,	
which	is	used	as	a	molecular	proxy	for	the	amount	of	energy	generated	by	the	cells	when	metabolising	
the	single	substrate	offered	in	the	medium.	Colorimetric	changes	in	the	dye	(dye	MB	-	Technopath)	
were	recorded	in	the	OMNILOGTM	incubator,	equipped	with	an	optical	sensor	connected	to	the	data	
collection	 software	 (OMNILOGTM	 version	 2.4)	 which	 allowed	 the	 quantification	 of	 this	 energy	
produced	by	the	cells	when	utilising	the	substrate	of	 interest.	Measurements	were	taken	every	15	
minutes,	generating	a	temporal	kinetic	profile	of	energy	utilisation	(figure	2.3).	
	
Objective	1:	
	
	 3T3-L1	pre-adipocytes	were	grown	in	T75	flasks	up	until	reaching	90%	confluency.	The	flasks	
were	 then	 rinsed	using	1X-PBS,	before	 the	cells	were	 trypsinised	and	centrifuged	according	 to	 the	
protocol	described	in	section	2.3.3.	After	centrifugation,	the	pellet	was	carefully	resuspended	in	1mL	
of	DMEM	medium,	cells	were	automatically	counted,	and	the	cell	suspension	was	diluted	to	reach	a	
density	of	4.105	cells/mL	(section	2.4.2.1).	50µL	of	the	cell	suspension	was	added	to	each	well	of	the	
plate,	which	was	pre-coated	with	 the	non-metabolisable	poly-D-lysine	matrix,	 in	order	 to	 facilitate	
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adhesion	(sections	2.2.8	and	2.3.5.3).	After	exactly	24	hours,	 the	cells	had	reached	full	confluency,	
were	adherent,	and	ready	to	be	serum	treated	for	2	hours	(for	synchronisation	of	the	circadian	clocks	
between	 cells,	 see	 section	 2.3.6).	 After	 these	 2	 hours,	 cells	 were	 rinsed	 with	 1X-PBS	 and	 then	
supplemented	with	35µL	of	BIOLOGTM	minimal	MC-0	medium,	deprived	of	any	carbon	sources,	and	
5µL	of	the	various	concentrations	of	glucose.	This	was	completed	to	a	total	volume	of	50µL	by	adding	
10µL	of	colorimetric	dye	MB.	Negative	controls	consisted	of	samples	in	which	5µL	of	sterile	distilled	
water	replaced	the	glucose.	The	plates	were	immediately	incubated	in	the	OMNILOGTM	device,	where	
utilisation	dynamics	where	measured	every	15	minutes	for	at	least	48	hours	and	up	to	96	hours.		
	
	 A	range	of	different	glucose	concentrations	(from	17.58mg/L	to	4500mg/L)	were	tested.	For	
each	concentration,	three	biological	replicates	(cells	cultured	from	different	flasks	and	different	initial	
cryovials,	at	different	times),	with	two	technical	replicates	(cells	coming	from	the	same	flask	and	same	
initial	cryovial	cultured	on	the	same	day)	per	biological	replicate	were	measured,	including	the	same	
number	of	 replicates	of	negative	controls	 (except	 for	17.58mg/L,	where	only	2	 technical	 replicates	
were	 measured	 for	 one	 biological	 replicate).	 The	 OMNILOGTM	 incubator	 was	 set	 to	 record	 the	
cumulative	redox	build-up	by	means	of	the	NADH-driven	discoloration	of	the	dye,	 indicative	of	the	
total	 amount	 of	 energy	 generated	 by	 the	 cells	 when	 utilising	 glucose.	 Communication	 with	 the	
company	 that	 developed	 this	 technology	 (Technopath)	 indicated	 that	 the	 utilisation	 patterns	
developed	in	as	little	to	1	to	4	hours,	after	which	OMNILOGTM	values	reached	a	plateau.	This	plateau	
could	be	the	consequence	of	the	substrate	being	completely	utilised	by	the	cells,	or	a	saturation	of	
the	colorimetric	dye.	We	 found	 that	 the	plateau	was	 typically	 reached	after	2	hours	with	glucose,	
independent	of	the	concentration	offered	(figure	2.3).	Glucose	utilisation	measures	(in	arbitrary	units)	
were	then	reported	by	the	PM_KineticTM	analysis	software	(version	1.6)	and	exported	to	excel.	We	
then	determined	the	slope	of	the	 linear	regression	through	the	accumulation	phase,	defined	to	 lie	
between	 the	 first	 value	 crossing	 the	 20%	 utilisation	 threshold,	 and	 the	 first	 value	 after	 the	 80%	
utilisation	threshold.		These	values	represent	the	“rate	of	utilisation”	at	a	specific	time	point.	We	also	
determined	the	averaged	plateau	values	of	the	same	kinetic	profiles.		
	
	 We	then	aimed	at	finding	to	which	degree	the	metabolism	in	the	3T3-L1	cells	was	based	on	
the	substrate	we	offered,	rather	than	any	other	energy	sources	present	within	the	cells,	remaining	
from	previous	DMEM	culturing	medium.	To	this	end,	we	starved	the	cells	for	0,	2,	3,	4	and	5	hours	
after	 serum	 shock,	 in	 a	 minimal	MC-0	 BIOLOGTM	medium	 that	 did	 not	 contain	 any	 carbon-based	
sources,	 prior	 to	measuring	 glucose	utilisation	 as	 described	 above.	We	optimised	 the	 “starvation”	
period,	such	that	the	cells	had	metabolised	all	remaining	carbon	sources	before	being	offered	the	test	
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carbon	 source	 in	 the	 medium.	 Therefore,	 after	 serum	 shock,	 cells	 were	 incubated	 with	 50µL	 of	
substrate-free	MC-0	medium	for	0,	2,	3,	4	and	5	hours	(2	technical	replicates,	1	biological	replicate),	
before	 the	BIOLOGTM	medium	was	 supplemented	with	4500mg/L	of	glucose	 (or	water,	2	 technical	
replicates	 and	 1	 biological	 replicate)	 as	 well	 as	 colorimetric	 dye.	 The	 full	 method	 is	 described	 in	
sections	2.4.2.2	and	2.4.2.3.		
	
Objective	2:	
	
	 We	next	set	out	to	validate	our	approach	by	obtaining	measurements	of	circadian	rhythms	in	
glucose	 utilisation	 in	 our	 set-up,	 and	 to	 compare	 the	 results	 against	 published	 data	 using	 other	
techniques.	It	was	also	necessary	to	confirm	that	the	cellular	morphology,	in	an	incubator	where	the	
air	was	not	supplemented	with	any	CO2	as	was	the	case	in	the	OMNILOGTM	incubator,	did	not	change	
over	time.	For	this	part	of	the	work,	the	method	was	the	same	as	described	just	above,	where	90%	
confluent	cells	from	a	T75	flask	were	transferred	into	a	BIOLOGTM	96-well	plate	(section	2.3.3)	pre-
coated	with	poly-D-lysine	(sections	2.2.8	and	2.3.5.3)	at	a	density	of	4.105	cells/mL	(section	2.4.2.1).	
Cells	were	then	incubated	for	24	hours,	after	which	they	were	serum	shocked	for	2	hours,	according	
to	 the	protocol	described	 in	 section	2.3.6.	 From	6	 to	57	hours	 after	 serum-shock	 synchronisation,	
photomicrographs	 were	 taken	 every	 3	 hours	 at	 a	 magnification	 of	 10,	 using	 a	 digital	 camera	
(coolPix990)	attached	to	a	microscope	(TMS,	Nikon).	Prior	to	each	time	point,	cells	were	incubated	for	
two	hours	in	50µL	of	BIOLOGTM	medium	(37°C	with	CO2),	mimicking	the	proposed	sampling	schedule.	
This	was	then	replaced	by	50µL	of	fresh	BIOLOGTM	medium.	From	this	point,	cells	were	returned	to	an	
incubator	 where	 any	 CO2	 alimentation	 had	 been	 cut	 (still	 at	 37°C),	 prior	 to	 assessment	 of	 cell	
morphology	at	the	appropriate	time	point.		
	
	 Our	next	objective	was	to	establish	the	circadian	patterns	of	glucose	utilisation	by	3T3-L1	pre-
adipocytes	in	vitro,	between	6	and	72	hours	following	serum	synchronisation.	Here	again,	cells	were	
grown	in	T75	flasks	up	until	reaching	90%	confluence.	The	flasks	were	then	rinsed	using	1X-PBS,	before	
cells	were	trypsinised	and	centrifuged	(section	2.3.3).	After	centrifugation,	the	pellet	was	resuspended	
in	 1mL	 of	 DMEM	 medium,	 the	 cells	 were	 automatically	 counted	 prior	 to	 a	 dilution	 of	 the	 cell	
suspension	to	a	density	of	4.105	cells/mL	(section	2.4.2.1).	Cells	were	plated	in	a	blank	BIOLOGTM	96-
well	plate	pre-coated	with	poly-D-lysine	(sections	2.2.8	and	2.3.5.3),	and	incubated	for	24	hours	at	
37°C	and	with	5%	CO2,	after	which	they	reached	full	confluency.	Cells	were	then	exposed	to	a	serum-
shock	(section	2.3.6)	before	incubation	in	50µL	of	DMEM	medium.	Every	3	hours	between	6	and	72	
hours	following	this	serum	synchronisation,	2<n<8	biological	replicates	(different	flasks	at	4	different	
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days)	of	cells	were	starved	for	2	hours	and	placed	in	MC-0	microscope	(TMS,	Nikon).	Prior	to	each	time	
point,	cells	were	incubated	for	two	hours	in	35µL	of	BIOLOGTM	medium,	10µL	glucose	(or	water)	and	
5µL	of	dye	before	recordings	in	the	OMNILOGTM	incubator.	The	full	method	description	can	be	found	
in	section	2.4.2.4.		
	
Objective	3:	
	
	 The	final	objective	of	this	chapter	was	to	determine	circadian	profiles	of	utilisation	of	91	pre-
defined	carbon	sources,	between	24	and	51	hours	after	serum	shock.	This	period	was	chosen	based	
on	the	glucose	utilisation	profile	obtained	earlier,	showing	a	full	circadian	cycle,	including	a	peak	and	
a	trough	across	this	time	frame.	We	now	used	the	commercially	available	PM-M1	plates	(Technopath),	
designed	 for	 use	 as	metabolic	 phenotyping	 of	mammalian	 cells.	 These	 plates	 included	 3	 negative	
controls,	 and	 all	 other	 sources	 were	 carbon-based	 (figure	 2.5).	 The	 inclusion	 of	 α-D-Glucose	 also	
allowed	us	to	validate	our	approach,	by	comparing	utilisation	patterns	against	those	achieved	in	the	
previous	objective	and	the	literature.	A	total	of	3	biological	replicates	were	done,	on	three	separate	
occasions	(several	months	apart).	In	this	case,	cells	were	grown	in	T75	flasks	up	until	reaching	90%	
confluency	after	approximately	48	hours.	To	be	able	to	have	sufficient	amounts	of	cells	to	fill	a	plate,	
a	full	T75	flask	was	required	for	each	time	point	(and	each	biological	replicate)	to	fill	the	96-well	plate.	
As	before,	cells	were	serum	shocked	for	two	hours	(section	2.3.6),	after	which	they	were	returned	to	
incubation	in	DMEM	medium	containing	4500mg/L	of	glucose.	2	hours	prior	to	each	time	point,	cells	
were	starved	using	minimal	MC-0	BIOLOGTM	medium	before	trypsinisation	and	centrifugation	(200g,	
4	 minutes,	 section	 2.3.3).	 The	 pellet	 was	 then	 carefully	 resuspended	 in	 2mL	 of	 MC-0	 BIOLOGTM	
medium,	before	cell	density	was	adjusted	to	4.105	cells/mL	following	automated	cell	counting	(section	
2.4.2.1).	50µL	of	the	cell	suspension	were	then	rapidly	pipetted	into	each	well	of	the	plate,	followed	
by	 10µL	 of	 dye	 MB	 (using	 a	 multi-channel	 pipette).	 The	 plate	 was	 immediatly	 inserted	 in	 the	
OMNILOGTM	incubator	for	measurements.	The	full	method	is	described	in	section	2.4.3.		
	
3.4	Statistics	
	
	 All	graphs	and	analyses	were	prepared	using	Graph-Pad	Prism	version	7.0.	For	optimisation	
steps,	statistics	were	performed	using	a	one-way	ANOVA	in	order	to	test	any	significant	differences	in	
the	data	 (p-value<0.05).	 If	 the	main	effect	was	significant,	post-hoc	pairwise	comparisons	 (Tukey’s	
multiple	comparisons	test)	were	applied.		
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	 Principal	component	analyses	(PCAs)	were	undertaken	in	Simca	(version	13.0.3.0,	Umetric).	
All	samples	falling	outside	of	the	Hotelling’s	95%	confidence	of	the	first	2	principal	components	were	
deemed	as	outliers.		
	
	 The	 utilisation	 rates	 of	 glucose	 and	 other	 carbon	 sources	were	 plotted	 against	 time	 since	
serum	shock,	to	which	a	cosine	curve	was	fitted.	The	validity	of	the	cosine	fit	was	tested	against	the	
null	hypothesis	that	a	straight	line	described	the	data	better.	For	all	significant	cosine	fits,	the	period,	
amplitude,	acrophase	and	mesor	were	reported,	and	only	cosine	fits	with	periods	between	19	and	29	
hours	(24±5	hours)	were	accepted	as	circadian	rhythms.	The	heat-map	of	utilisation	rates	were	made	
using	Mat-Lab	(version	9.3).	Statistics	are	detailed	in	sections	2.4.2.5	and	2.4.3.2.	
	
	 Interpretation	of	 the	 results	of	 this	 chapter	 in	 terms	of	metabolic	ontogeny	 related	 to	 the	
development	 of	 obesity	 and	 diabetes	 was	 undertaken	 using	 the	 validated	 online	 MetaboAnalyst	
(https://www.metaboanalyst.ca)	platform.	Firstly,	metabolite	set	enrichment	analyses	(MESAs)	were	
done	in	order	to	identify	biologically	meaningful	enrichments	in	metabolite	subsets,	identified	through	
cluster	analyses	of	the	utilisation	time-series	as	depicted	in	the	heat-map.	The	full	list	of	compounds	
used	to	pre-coat	the	PM-M1	plates	was	used	as	a	reference	library	for	our	experiments,	rather	than	
the	whole	metabolome.	We	then	undertook	over-representation	analyses	(ORAs),	to	test	 if	certain	
groups	 of	 metabolites	 were	 represented	 more	 often	 than	 expected	 by	 chance	 within	 a	 given	
metabolite	 list.	 Here,	 the	 most	 common	 approach	 to	 test	 this	 statistically	 was	 by	 using	 the	
hypergeometric	test	or	Fisher’s	exact	test	to	calculate	the	probability	of	seeing	at	least	a	particular	
number	of	metabolites	containing	the	biological	term	of	interest	in	the	given	compound	list.	Finally,	
we	 employed	 pathway	 analysis	 within	 MetaboAnalyst	 to	 look	 for	 enrichment	 of	 specific	 Kyoto	
encyclopaedia	of	genes	and	genomes	(KEGG)	metabolic	pathways	for	each	cluster.		
	
3.5	Results	
	
3.5.1	Utilisation	of	different	concentrations	of	glucose	by	3T3-L1	pre-adipocytes		
	
	 The	 first	 objective	 of	 the	 study	 was	 to	 optimise	 the	 BIOLOGTM	 metabolic	 phenotyping	
technology,	 for	 establishing	 circadian	 rhythms	 in	 carbon-based	 sources	 utilisation	 dynamics,	 using	
glucose.	To	do	so,	it	was	first	necessary	to	find	a	suitable	concentration	at	which	the	slope	value	of	
the	NADH	build-up	kinetic	curve	was	impacted.	We	measured	utilisation	rates	by	pre-adipocytes	that	
were	 incubated	 in	 the	 OMNILOGTM	 device,	 supplied	 with	 medium	 containing	 a	 range	 of	 glucose	
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concentrations	 from	 17.58mg/L	 to	 4500mg/L	 (the	 highest	 concentration	 is	 the	 saturating	
concentration	of	glucose	present	in	the	commercial	DMEM	culturing	medium,	with	the	mean	normal	
blood	glucose	level	in	humans	being	of	1000mg/L).	In	all	cases,	the	utilisation	rates	of	glucose	were	
higher	than	those	of	the	negative	controls	(see	figure	3.3),	confirming	that	glucose	in	the	medium	was	
being	utilised	by	the	cells.	The	utilisation	rates	of	glucose	differed	significantly	between	cells	cultured	
on	different	glucose	concentrations	(p-value<0.05,	one-way	ANOVA),	suggesting	that	different	glucose	
concentrations	were	associated	with	different	utilisation	dynamics.		
	
	
	
Figure	 3.3:	 Initial	 glucose	 utilisation	 rates	 at	 various	 concentrations	 of	medium	 glucose	 by	 pre-
adipocytes.	Cells	were	 incubated	 in	 a	medium	 containing	 a	 range	 of	 glucose	 concentrations	 from	
17.58mg/L	(left)	to	4500mg/L	(right).	For	all	concentrations,	3	biological	replicates	(n=3)	were	tested,	
except	for	17.58mg/L	where	2	biological	replicates	(n=2)	were	measured	(all	represented	in	blue	on	
the	graph).	For	each	biological	replicate,	2	technical	replicates	were	done	(n=2).	Negative	controls	(no	
glucose)	were	also	included,	for	which	glucose	was	replaced	by	water	(in	orange	on	the	graph).	The	
various	concentrations	of	glucose	are	represented	on	a	logarithmic	axis	(X	axis).	A	one-way	ANOVA	
considering	 all	 replicates	 (n=6	 for	 all	 concentrations	 except	 for	 17.58mg/L	where	 n=4)	 revealed	 a	
significant	effect	of	glucose	concentrations	on	utilisation	rates	(p=0.0008).	
	
	 A	post-hoc	comparison	of	the	different	concentrations	(see	table	3.1)	indicated	that	significant	
differences	 in	 the	utilisation	 rates	of	glucose	were	apparent	at	 lower	glucose	concentrations	only,	
especially	 between	 35.16mg/L	 and	 140.63mg/L	 of	 glucose,	 as	 well	 as	 between	 281.25mg/L	 and	
17.58mg/mL	 of	 glucose.	 Utilisation	 rates	 at	 this	 lowest	 concentration	 of	 17.58mg/L	 were	 also	
significantly	different	from	140.63mg/L	and	70.31mg/L	of	glucose.	Based	on	these	results,	we	made	
the	decision	 to	 continue	all	 further	work	with	 a	 concentration	of	 35.16mg/L	of	 glucose.	 The	main	
reasons	for	this	were	that	the	corresponding	kinetic	profiles	at	this	concentration	were	at	the	centre	
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of	the	linear	phase	of	the	increasing	rate,	allowing	for	both	increases	and	decreases	un	utilisation	due	
to	circadian	timing.	
	
Table	3.1:	Results	of	the	Tukey’s	multiple	comparisons	test	for	the	utilisation	rates	of	the	various	
concentrations	of	 glucose	 tested.	 “N.S”	 indicates	no	 significant	differences	 in	utilisation	dynamics	
between	 two	 different	 concentrations	 of	 glucose,	with	 “p<0.05”	 denoting	 a	 significant	 difference.	
Values	were	considered	significantly	different	for	a	p-value<0.05.	
	
	 The	plateau	values	in	utilisation	seen	2	to	3	hours	after	the	linear	utilisation	phase	obtained	
for	the	different	concentrations	of	glucose	are	plotted	in	figure	3.4.	Whilst	the	variations	in	plateau	
values	 for	 the	 different	 concentrations	 appeared	 low,	 significant	 differences	 were	 found	 (p-
value<0.05).	However,	the	post-hoc	multiple	comparisons	test	only	identified	significant	differences	
between	 the	 lowest	 and	 highest	 concentrations	 tested,	 as	 well	 as	 between	 17.58mg/L	 and	
281.25mg/L	of	glucose	(table	3.2).	We	therefore	considered	that	the	plateau	value	was	not	affected	
by	the	concentration	of	glucose	tested.		
	
Table	3.2:	Results	of	 the	Tukey’s	multiple	comparisons	test	 for	 the	plateau	values	of	 the	various	
concentrations	of	 glucose	 tested.	 “N.S”	 indicates	no	 significant	differences	 in	utilisation	dynamics	
between	 two	 different	 concentrations	 of	 glucose,	with	 “p<0.05”	 denoting	 a	 significant	 difference.	
Values	were	considered	significantly	different	for	a	p-value<0.05.	
 
Glucose	concentration	
(mg/L)	
4500	 2250	 1125	 562.5	 281.25	 140.63	 70.31	 35.16	 17.58	
4500	 	 N.S		 N.S		 N.S		 N.S		 N.S		 N.S		 N.S		 N.S		
2250	 N.S		 		 N.S		 N.S		 N.S		 N.S		 N.S		 N.S		 N.S		
1125	 N.S		 N.S		 	 N.S		 N.S		 N.S		 N.S		 N.S		 N.S		
562.5	 N.S		 N.S		 N.S		 	 N.S		 N.S		 N.S		 N.S		 N.S		
281.25	 N.S		 N.S		 N.S		 N.S		 	 N.S		 N.S		 N.S		 P<0.05	
140.63	 N.S		 N.S		 N.S		 N.S		 N.S		 		 N.S		 P<0.05	 P<0.05	
70.31	 N.S		 N.S		 N.S		 N.S		 N.S		 N.S		 		 N.S		 P<0.05	
35.16	 N.S		 N.S		 N.S		 N.S		 N.S		 P<0.05	 N.S		 		 		
17.58	 N.S		 N.S		 N.S		 N.S		 P<0.05	 P<0.05	 P<0.05	 N.S		 N.S		
Glucose	
concentration	(mg/L)	
4500	 2250	 1125	 562.5	 281.25	 140.63	 70.31	 35.16	 17.58	
4500	 	 N.S		 N.S		 N.S		 N.S		 N.S		 N.S		 N.S		 P<0.05	
2250	 N.S		 	 N.S		 N.S		 N.S		 N.S		 N.S		 N.S		 N.S		
1125	 N.S		 N.S		 	 N.S		 N.S		 N.S		 N.S		 N.S		 N.S		
562.5	 N.S		 N.S		 N.S		 	 N.S		 N.S		 N.S		 N.S		 N.S		
281.25	 N.S		 N.S		 N.S		 N.S		 	 N.S		 N.S		 N.S		 P<0.05	
140.63	 N.S		 N.S		 N.S		 N.S		 N.S		 	 N.S		 N.S		 N.S		
70.31	 N.S		 N.S		 N.S		 N.S		 N.S		 N.S		 	 N.S		 N.S		
35.16	 N.S		 N.S		 N.S		 N.S		 N.S		 N.S		 N.S		 	 N.S		
17.58	 P<0.05	 N.S		 N.S		 N.S		 P<0.05	 N.S		 N.S		 N.S		 	
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Figure	 3.4:	 Total	 utilisation	 of	 glucose	 as	 represented	 by	 the	 plateau	 phase	 using	 different	
concentrations.	 Plateau	 values	 were	 determined	 from	 kinetic	 profiles	 and	 plotted	 for	 each	
concentration	of	glucose	tested,	from	17.58mg/L	(left)	to	4500mg/L	(right).	For	all	concentrations,	3	
biological	 replicates	 were	 tested	 (n=3),	 except	 for	 17.58mg/L	 where	 2	 biological	 replicates	 were	
measured	 (n=2).	 For	 each	 biological	 replicate,	 2	 technical	 replicates	 (n=2)	 were	 obtained	 (all	
represented	 in	 blue	 on	 the	 graph).	 For	 every	 glucose	 concentrations,	 negative	 controls	were	 also	
recorded,	for	which	glucose	was	replaced	by	water	(indicated	in	orange	on	the	graph).	The	various	
concentrations	 of	 glucose	 are	 here	 represented	 on	 a	 logarithmic	 axis	 (X	 axis).	 A	 one-way	 ANOVA	
considering	 all	 replicates	 (n=6	 for	 all	 concentrations	 except	 for	 17.58mg/L	where	 n=4)	 revealed	 a	
significant	effect	of	glucose	concentrations	on	the	plateau	of	the	kinetic	profiles	(p=0.0091). 
	
3.5.2	Effect	of	different	starvation	times	on	glucose	utilisation	rates	by	pre-adipocytes	
	
	 After	establishing	the	optimal	medium	glucose	concentration,	we	set	out	to	determine	the	
most	favourable	pre-measure	starvation	times.	In	our	approach,	cells	were	starved	for	0,	2,	3,	4	or	5	
hours	 (1	 biological	 replicate	 and	 2	 technical	 replicates	 for	 each	 starvation	 condition),	 in	 medium	
deprived	of	 any	 energy	 sources,	 following	 a	 2-hour	 serum	 shock	 (figure	 3.5).	 Pre-adipocytes	were	
incubated	in	OMNILOGTM	medium	and	exposed	to	the	highest	concentration	of	glucose	(4500mg/L),	
in	order	to	evaluate	the	effect	of	starvation	on	utilisation	dynamics	of	a	maximal	concentration	of	the	
substrate.	Furthermore,	slope	values	differed	significantly	between	the	different	starvation	times,	as	
revealed	by	 a	one-way	ANOVA	 (p<0.0001).	 	 A	post-hoc	 comparisons	 test	 indicated	 that	 almost	 all	
utilisation	rates	differed	between	each	time	point	 (see	 table	3.3);	but	only	 looking	at	comparisons	
between	adjacent	time	points,	it	emerges	that	a	2-hour	starvation	significantly	reduces	the	production	
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of	NADH,	with	a	further	hour	of	starvation	(3	hours)	not	significantly	altering	this	utilisation	rate.	As	
there	were	no	significant	differences	in	the	utilisation	rates	of	glucose	after	a	2-	or	3-hour	incubation	
in	MC-0	medium,	and	we	did	not	want	to	compromise	the	physiology	and	morphology	of	the	cells	by	
placing	 them	without	 energy	 sources	 for	 a	 longer	 time	 (starvation	of	 4	 or	 5	 hours),	we	made	 the	
decision	to	pursue	further	work	using	a	2-hour	incubation	of	the	cells	in	minimal	MC-0	medium,	prior	
to	recording	of	utilisation	dynamics.		
	
	
Figure	3.5:	Different	starvation	times	in	MC-
0	 medium	 of	 3T3-L1	 pre-adipocytes	 using	
4500mg/L	of	glucose.	Cells	were	incubated	in	
MC-0	 BIOLOGTM	medium	 for	 0,	 2,	 3,	 4	 or	 5	
hours,	 from	 left	 to	 right,	 following	 serum	
shock.	 Utilisation	 rates	 of	 4500mg/L	 of	
glucose	 were	 recorded	 (n=2	 technical	
replicates	 represented	 in	blue	 in	 the	graph,	
for	 n=1	 biological	 replicate)	 immediately	
after.	 Negative	 controls	 were	 subtracted	
from	 each	 actual	 utilisation	 rate	 value	 to	
obtain	true	utilisation	dynamics	data.	A	one-
way	 ANOVA,	 all	 replicates	 considered,	
revealed	a	significant	effect	of	the	starvation	
time	(p<0.0001).	
	
Table	3.3:	Results	of	the	Tukey’s	multiple	comparisons	test	for	utilisation	rates	of	glucose	obtained	
after	cells	were	 incubated	for	various	periods	of	time	 in	minimal	MC-0	BIOLOGTM	medium.	“N.S”	
indicates	no	 significant	differences	 in	utilisation	dynamics	between	 two	different	 starvation	 times,	
with	“p<0.05”	denoting	a	significant	difference.	Values	were	considered	significantly	different	for	a	p-
value<0.05.	
	
Time	of	starvation	(hours	
after	serum	shock) 
0 2 3 4 5 
0 	 P<0.05 P<0.05 P<0.05 P<0.05 
2 P<0.05 	 N.S	 P<0.05 P<0.05 
3 P<0.05 N.S	 	 P<0.05 P<0.05 
4 P<0.05 P<0.05 P<0.05 	 N.S	 
5 P<0.05 P<0.05 P<0.05 N.S	 	 
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3.5.3	Cellular	morphology	throughout	time	
	
	 To	ensure	that	cells	remained	morphologically	healthy	over	prolonged	periods	in	our	setup,	
we	optically	 and	 regularly	 documented	 this	morphology	 for	 a	 period	of	 57	hours	 following	 serum	
shock.	Cells	were	serum	shocked	and	incubated	in	MC-0	medium	containing	35.16mg/L	of	glucose,	
without	any	influx	of	CO2,	exactly	replicating	experimental	conditions	in	the	OMNILOGTM	incubator.	
The	morphology	of	the	cells	was	reported	every	three	hours	between	6	and	57	hours	following	the	
serum	shock	procedure	(one	picture	per	time	point),	using	photomicrographs	at	a	magnification	x10.	
Figure	3.6	shows	representative	images	of	the	cellular	phenotype,	revealing	that	the	morphology	as	
well	 as	 the	 density	 of	 the	 cells	 remained	 unchanged	 across	 time	 based	 on	 general	 knowledge	 of	
adipose	cell	morphology	and	the	comparisons	of	the	pictures	at	the	different	time	points.		
	
	
	
Figure	 3.6:	 Representative	 photomicrographs	 of	 pre-adipocytes	 taken	 every	 3	 hours,	 starting	 6	
hours	 following	serum	shock.	Photomicrographs	of	3T3-L1	pre-adipocytes	captured	after	different	
incubation	times	in	an	incubator	deprived	of	any	influx	of	CO2,	every	3	hours	between	6	and	57	hours	
(times	are	indicated	at	the	top	left	of	each	photomicrograph)	following	serum	synchronisation	of	the	
cells.	Pictures	were	taken	using	a	magnification	x10,	and	a	scale	bar	represented	a	length	of	75µM	
(bottom	left	of	the	graph).		
75μM
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3.5.4	 Glucose	 utilisation	 of	 3T3-L1	 pre-adipocytes	 between	 6	 and	 72	 hours	 following	
synchronisation	of	the	cells	circadian	clocks	
	
	 We	had	now	optimised	our	approach	for	measuring	temporal	dynamics	in	glucose	utilisation,	
and	 thus	aimed	 to	measure	glucose	utilisation	dynamics	by	3T3-L1	pre-adipocytes	over	3	days	 (72	
hours).	Glucose	utilisation	rates	were	plotted	against	 time,	every	3	hours	between	6	and	72	hours	
after	serum	shock	(figure	3.7),	and	fitted	with	a	cosine	curve.	Our	statistical	approach	confirmed	that	
a	 cosine	model	 was	 a	 better	 fit	 to	 the	 data	 as	 compared	 to	 a	 straight	 line	 (p<0.05),	 indicating	 a	
temporal	variation	in	the	glucose	utilisation	rates.	Cosinor	analysis	described	3	consecutive	cycles	with	
a	period	of	23.32	hours	(table	3.4),	with	peaks	around	12,	36	and	60	hours	(approximately)	following	
serum	 shock.	 Utilisation	 rates	 of	 glucose	 were	 plotted	 as	 absolute	 utilisation	 dynamics	 (control-
subtracted	values).	From	the	cosine	fit,	we	also	extracted	the	mesor	(187.7),	amplitude	(36.03)	and	
acrophase	 (36.07	 hours).	 The	 mesor	 and	 amplitude	 are	 expressed	 in	 arbitrary	 units.	 This	 fit	 was	
successful	in	describing	53%	of	the	variation	(R2=0.53),	and	most	loss	of	accurate	fitting	is	caused	by	
the	sharp	peak,	which	do	not	follow	a	sinusoidal	waveform.		
	
	
	
	
	
	
		
	
	
	
	
	
	
	
	
Figure	 3.7:	 Circadian	 pattern	 of	 glucose	 utilisation	 dynamics	measured	 in	 3T3-L1	 pre-adipocytes	
using	blank	BIOLOGTM	plates.	Glucose	utilisation	rates	of	3T3-L1	pre-adipocytes	were	measured	every	
3	 hours,	 between	 6	 and	 72	 hours	 following	 a	 2-hour	 serum	 shock;	 for	 a	 concentration	 of	
glucose=35.16mg/L.	 3	 circadian	 cycles	 were	 observed,	 for	 a	 total	 of	 2<n<8	 biological	 replicates	
(4<n<16	technical	replicates,	 indicated	in	blue	on	the	graph).	A	cosine	curve	was	fitted	to	the	data	
within	a	95%	confidence	interval	(represented	by	the	black	dashed	lines).		Considering	all	replicates,	a	
significant	p-value	 revealed	 that	 the	cosine	 fit	model	was	preferred,	as	opposed	 to	a	 straight	 line,	
indicating	temporal	variations	in	the	data	(p<0.0001).		
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Table	3.4:	 Circadian	parameters	 and	R2	 value	of	 glucose	utilisation	 rates	using	blank	plates.	The	
mesor,	amplitude	and	R2	values	are	expressed	in	arbitrary	units.	
	
Mesor	 187.7	
Amplitude	 36.03	
Acrophase	(hours)	 36.07	
Period	(hours)	 23.32	
R2	 0.53	
P-value	 <0.0001	
	
3.5.5	Circadian	patterns	of	utilisation	of	a	panel	of	carbon	sources	measured	in	vitro	in	3T3-
L1	pre-adipocytes,	between	24	and	51	hours	after	serum	shock	
	
	 Finally,	we	set	out	to	measure	utilisation	rates	of	a	panel	of	different	carbon-based	substrates	
(figure	2.5).	We	confirmed	that	the	blank	control	samples	did	not	exhibit	any	variation	over	time	(one-
way	ANOVA,	P<0.05),	and	that	the	linear	fit	was	preferred	over	the	cosine	fit	(see	figure	3.8).	We	thus	
expressed	all	utilisation	rates	as	control-subtracted	and	normalised.	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	3.8:	Negative	control	values	across	the	circadian	time.	For	each	biological	replicate	(total	of	
n=3)	and	time	point	measured	every	3	hours	between	24	and	51	hours	following	serum	shock,	a	total	
of	n=3	technical	replicates	are	indicated	on	the	graph	by	the	blue	dots.	A	cosine	curve	was	fitted	to	
the	data	against	the	null	hypothesis	of	a	straight	line.	In	this	case,	no	temporal	variations	in	the	data	
were	found,	and	the	preferred	model	was	the	simpler	straight	line,	when	considering	all	n=9	replicates	
per	time	point.	
	
	 A	principal	component	analysis	was	carried	out	on	all	samples	combined,	to	investigate	any	
potential	outliers	in	the	data;	which	were	plotted	against	their	first	and	second	principal	components	
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(figure	3.9	A).	All	the	samples	fell	within	the	Hotelling’s	95%	confidence	interval	of	both	components,	
attesting	that	there	were	indeed	no	outliers	in	our	data.	The	primary	principal	component	was	then	
plotted	 against	 the	 time	 of	 sampling	 (between	 24	 and	 51	 hours	 after	 serum	 shock,	 figure	 3.9	 B),	
revealing	that	the	primary	variation	in	the	data	exhibited	a	circadian	rhythm.	The	loading	scatter	plot	
of	the	PCA	is	shown	in	figure	3.10,	and	indicated	two	aspects	of	the	data.	The	first	aspect	was	that	the	
three	wells	filled	with	α-D-Glucose,	in	each	PM-M1	plate	independently,	showed	very	similar	loading,	
attesting	 the	 reproducibility	 of	 the	 data	 (indicated	 by	 the	 red	 dots	 on	 the	 graph).	 Secondly,	 this	
principal	component	analysis	exposed	clustering	of	the	model	loading	of	utilisation	rates	of	carbon-
based	 sources,	which	are	biochemically	 related.	 Indeed,	on	 the	graph	can	be	observed	number	of	
carbon-based	substrates	close	to	each	other,	especially	on	the	bottom	left	of	the	figure.	This	suggested	
that	specific,	functional	substrate	groups	were	utilised	in	the	same	manner.				
	
	
																																										
Figure	3.9:	Principal	component	analysis	on	all	samples,	recorded	every	3	hours	between	24	and	51	
hours	 following	 serum	 synchronisation	 of	 the	 cells.	A:	No	 outliers	 in	 the	 data	were	 found	when	
running	a	principal	component	analysis,	with	all	samples	falling	within	the	95%	confidence	interval	of	
the	first	and	second	principal	components.	B:	The	primary	principal	component	was	plotted	against	
the	time,	revealing	that	the	primary	level	of	variation	was	a	circadian	waveform.		
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Figure	 3.10:	 PCA	 analysis	 across	 the	 different	 energy	 substrates	 of	 interest,	 all	 time	 points	 and	
experimental	 replicates	 considered.	 The	 principal	 component	 analysis	 presented	 above	 has	 been	
done	 considering	 the	 91	 different	 carbon	 sources	 (indicated	 in	 green	 on	 the	 graph)	 averaged	
throughout	the	different	time	points	and	replicates,	revealing	a	few	clusters	of	substrates	grouped	
together.	 This	 graph	 also	 shows	 that	 the	 three	 wells	 coated	 with	 α-D-Glucose	 had	 very	 similar	
coordinates	between	the	3	biological	replicates	done	and	across	the	circadian	time.	They	are	shown	
by	the	red	dots	on	the	figure	(bottom	left	corner).	
	
	 All	technical	(n=3)	and	biological	(n=3)	replicates	of	α-D-Glucose	exhibited	the	same	utilisation	
patterns	between	24	and	51	hours	after	serum	synchronisation	of	the	cells	(figure	3.11).	A	cosine	curve	
was	 found	 to	 describe	 the	 24-hour	 utilisation	 rate	 profile	 better	 than	 a	 straight	 line	 (p<0.05),	
confirming	our	previous	finding	of	circadian	variations	in	the	utilisation	rates	of	glucose.	We	confirmed	
that	α-D-Glucose	was	utilised	in	a	circadian	fashion	with	a	period	of	19.41	hours,	an	acrophase	of	34.83	
hours,	a	mesor	of	209.5,	an	amplitude	of	31.21	and	an	R2	value	of	0.	74	(all	arbitrary	units,	table	3.5).	
The	 peak	 phase	 of	 utilisation	 at	 34.83	 hours	 in	 this	 protocol	 is	 similar	 to	 that	 found	 in	 the	 initial	
experiment	 (36.07	 hours,	 figure	 3.7	 and	 table	 3.4;	 indicated	 by	 a	 black	 line	 in	 figure	 3.11).	 The	
amplitude	and	mesor	values	were	also	very	similar	between	both	protocols	(36.03	versus	31.21	and	
187.7	versus	209.5,	respectively).		
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Figure	3.11:	Circadian	utilisation	rates	of	α-D-Glucose	measured	in	3T3-L1	pre-adipocytes	using	PM-
M1	BIOLOGTM	plates.	Slope	calculations	for	α-D-Glucose	were	calculated	across	the	time	points,	and	
the	data	for	all	3	different	biological	replicates	(n=3	technical	replicates	per	biological	replicate)	were	
plotted	every	three	hours	between	24	and	51	hours	after	serum	shock	of	the	cells	(each	represented	
by	a	blue	dot	on	the	graph).	Data	(all	replicates	considered)	were	analysed	by	fitting	a	cosine	wave	
against	the	null	hypothesis	of	a	straight	line.	In	this	case,	the	cosine	curve	was	the	preferred	model	to	
fit	the	data,	built	here	in	a	95%	confidence	interval	(black	dashed	lines),	as	the	p-value	was	<0.0001.	
The	vertical	black	line	indicates	the	acrophase	value	of	glucose	utilisation	rate	obtained	in	the	previous	
experiment	using	blank	BIOLOGTM	plates.		
	
Table	3.5:	Circadian	parameters	and	R2	value	of	glucose	utilisation	rates	using	PM-M1	plates.	The	
mesor,	amplitude	and	R2	values	are	expressed	in	arbitrary	units.	
	
Mesor	 209.5	
Amplitude	 31.21	
Acrophase	(hours)	 34.83	
Period	(hours)	 19.41	
R2	 0.74	
P-value	 <0.0001	
	
	 We	next	compared	the	temporal	expression	profiles	of	all	91	different	substrates	(expressed	
as	normalised	utilisation	through	subtraction	of	negative	controls).	The	temporal	profiles	of	all	carbon-
based	source	utilisation	rates	are	shown	as	Z-scored	in	figure	3.12.	A	total	of	64	(out	of	91,	70.33%)	
different	carbon	sources	were	exhibiting	circadian	utilisation	dynamics	across	the	circadian	time,	as	
evidenced	by	the	preference	of	a	cosinor	fit	over	a	straight	line	(p<0.05).	We	were	then	able	to	group	
all	the	various	carbon-based	sources	into	3	clusters,	according	to	the	timing	of	their	peak	utilisation	
rates	(figures	3.11	and	3.15).	Cluster	1	was	constituted	of	51	substrates	(79.69%)	whose	utilisation	
rates	were	circadian	with	an	acrophase	ranging	between	approximately	33	and	36	hours	 following	
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24 27 30 33 36 39 42 45 48 51
0
5
150
175
200
225
250
275
Ut
ili
sa
tio
n	
ra
te
	(s
lo
pe
	th
ro
ug
h	
ar
bi
tr
ar
y	O
M
NI
LO
GT
M
va
lu
es
)
142	
	
serum	 shock	 (including	α-D-Glucose).	 Cluster	 2	 grouped	 12	 carbon-based	 sources	 (18.75%)	with	 a	
circadian	utilisation	sharing	an	acrophase	close	to	45	hours	after	synchronisation;	 therefore	out	of	
phase	in	comparison	to	the	first	cluster.	Finally,	27	energy	sources	(29.67%)	were	found	to	have	non-
circadian	profiles	of	utilisation	rates	(cluster	3),	as	well	as	the	negative	controls.	The	null	hypothesis	
of	a	straight	line	was	in	this	case	accepted	(p>0.05).	One	compound	(1.56%),	D-Cellobiose,	was	utilised	
in	a	circadian	 fashion	but	was	not	peaking	at	a	similar	or	anti-phasic	 time	as	compared	to	glucose	
(acrophase	of	26.55	hours,	periodicity	of	25.16	hours),	and	was	therefore	not	included	in	any	cluster	
but	considered	as	a	rhythmic	cluster	of	 its	own.	Clusters	1,	2	and	3	are	 indicated	on	the	heat-map	
(figure	3.12)	by	the	black	braces.	
	
Figure	3.12:	Heat-map	indicating	the	slope	utilisation	rates	of	all	carbon-based	sources	used	to	coat		
PM-M1	 plates	 across	 the	 circadian	 time.	 The	 red	 colour	 indicates	where	 slope	 values	 (utilisation	
dynamics)	were	the	highest	across	the	different	energy	sources.	This	heat-map	reveals	an	important	
cluster	between	approximately	33	and	36	hours	following	serum	shock	of	the	cells	(cluster	1),	with	
another	after	45	hours	(cluster	2).	A	third	cluster	was	identified,	where	the	energy	sources	did	not	
present	 a	 circadian	 utilisation	 (cluster	 3).	One	 rhythmic	 carbon	 source	 had	 an	 acrophase	of	 26.55	
hours,	which	did	not	match	that	of	the	two	other	rhythmic	clusters	previously	defined	(D-Cellobiose,	
at	the	top	of	the	metabolites	list).	All	clusters	are	indicated	on	the	heat-map	by	the	black	braces	on	
the	right-hand	side.	
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	 Cluster	1:	Figure	3.13	presents	examples	of	4	different	carbon	sources,	one	for	each	biological	
category	 of	 substrates	 represented	 on	 the	 PM-M1	 plate	 (saccharides,	 nucleosides,	 alcohols	 and	
organic	acids,	ketone	bodies	and	short	chain	fatty	acids	–	see	details	in	figure	2.5).	Substrates	have	a	
peak	utilisation	rate	close	to	33	hours	(table	3.6),	very	similar	to	that	of	α-D-Glucose	(figures	3.7	and	
3.11,	 tables	 3.4	 and	3.5).	 Table	 3.6	 also	 revealed	periodicities	 comprised	between	20.4	 and	24.66	
hours,	 therefore	close	to	the	expected	24-hour	periodicity	of	a	circadian	rhythm.	Amplitudes	were	
evaluated	between	14.39	and	33.08,	with	quite	similar	values	between	the	four	examples.	We	finally	
identified	mesors	varying	in	a	significant	manner	(between	20.79	and	98.18),	with	R2	values	ranging	
between	 0.62	 and	 0.79	 (arbitrary	 units).	 Data	 are	 summarised	 in	 table	 3.9	 with	 amplitudes,	
acrophases,	mesors,	periods,	and	R2	values	listed	for	all	carbon-based	sources	studied.		
	
	
	
Figure	3.13:	Examples	of	carbon-based	sources	from	BIOLOGTM	PM-M1	plates	utilised	in	a	circadian	
manner	with	an	acrophase	close	to	33	hours	after	serum	shock.	This	figure	presents	the	utilisation	
dynamics	 of	 Dextrin,	 Inosine,	 α-Hydroxy-Butyric	 acid	 and	 Pyruvic	 acid,	 between	 24	 and	 51	 hours	
following	synchronisation,	indicated	by	the	blue	dots	on	the	graphs	for	n=3	biological	replicates	(n=1	
technical	replicate	per	biological	replicate).	Dextrin,	Inosine,	α-Hydroxy-Butyric	acid	and	Pyruvic	acid	
were	grouped	in	the	same	cluster	as	presenting	a	very	similar	acrophase	(close	to	33	hours	following	
serum	shock	of	the	cells).	A	cosine	curve	was	fitted	to	the	data,	all	replicates	considered,	within	a	95%	
confidence	interval	(represented	by	the	black	dashed	lines).	
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Table	3.6:	Summary	of	circadian	parameters	and	R2	values	of	Dextrin,	 Inosine,	α-Hydroxy-Butyric	
acid	and	Pyruvic	acid	utilisation	rates.	The	mesor,	amplitude	and	R2	values	are	expressed	in	arbitrary	
units.	
	
	
	
	
	 Cluster	2:	the	same	protocol	as	for	cluster	1	was	followed.	Four	examples	are	illustrated	in	
figure	3.14.	In	this	case,	peak	utilisation	rates	were	found	between	43.78	and	44.89	hours.	Amplitudes	
were	close	between	the	4	substrates,	as	varying	only	between	10.96	and	16.2.	Mesor	values	were	
ranging	between	12.97	and	60.51	(arbitrary	units,	table	3.7).	The	periods	were	comprised	between	
19.66	 and	 25.7	 hours	 (therefore	 in	 line	 with	 the	 approximate	 24-hour	 periodicity	 of	 a	 circadian	
rhythm).	R2	values	were	fluctuating	between	0.5	and	0.56	(arbitrary	units).	Data	are	summarised	in	
table	 3.9	 with	 amplitudes,	 acrophases,	mesors,	 periods,	 and	 R2	 values	 listed	 for	 all	 carbon-based	
sources	studied.		
	
Figure	3.14:	Examples	of	carbon-based	sources	from	BIOLOGTM	PM-M1	plates	utilised	in	a	circadian	
manner	with	an	acrophase	close	to	45	hours	after	serum	shock.	This	figure	presents	the	utilisation	
of	 D-Glucose-6-Phosphate,	 L-Fucose,	 D,L-β-Hydroxy-Butyric	 acid	 and	 D,L-α-Glycerol-Phosphate,	
between	24	and	51	hours	 following	synchronisation	 (results	are	 indicated	by	 the	blue	dots	on	 the	
graph).	All	four	substrates	were	presenting	their	highest	slope	values	45	hours	after	serum	shock,	and	
were	 grouped	 as	 a	 result	 into	 the	 same	 cluster.	 3	 biological	 replicates	 were	 done	 (n=1	 technical	
replicate	per	biological	replicate),	and	a	cosine	curve	was	fitted	to	the	data	(all	replicates	considered)	
within	a	95%	confidence	interval	(black	dashed	lines).	
PARAMETER	 Dextrin	 Inosine	 α-Hydroxy-Butyric	acid	 Pyruvic	acid	
Mesor	 45.81	 98.18	 20.79	 55.19	
Amplitude	 21.49	 33.08	 14.39	 29.5	
Acrophase	(hours)	 36.17	 33.94	 33.31	 33.91	
D-Glucose-6-Phosphate L-Fucose
D,L-β-Hydroxy-Butyric	Acid D,L-α-Glycerol-Phosphate
U
ti
lis
at
io
n	
ra
te
	(s
lo
pe
	th
ro
ug
h	
ar
bi
tr
ar
y	
O
M
N
IL
O
G
TM
va
lu
es
)
U
ti
lis
at
io
n	
ra
te
	(s
lo
pe
	th
ro
ug
h	
ar
bi
tr
ar
y	
O
M
N
IL
O
G
TM
va
lu
es
)
CT	(hours	after	serum	shock) CT	(hours	after	serum	shock)
24 27 30 33 36 39 42 45 48 51
0
10
20
30
40
50
60
24 27 30 33 36 39 42 45 48 51
0
5
30
40
50
60
70
80
90
100
24 27 30 33 36 39 42 45 48 51
-10
0
10
20
30
40
50
24 27 30 33 36 39 42 45 48 51
-10
0
10
20
30
40
145	
	
Table	3.7:	Summary	of	circadian	parameters	and	R2	values	of	D-Glucose-6-Phosphate,	L-Fucose,	D,L-
β-Hydroxy-Butyric	acid	and	D,L-α-Glycerol-Phosphate	utilisation	rates.	The	mesor,	amplitude	and	R2	
values	are	expressed	in	arbitrary	units.	
	
	 Cluster	3:	Lastly,	examples	of	non-circadian	utilisation	rates	time	series	examples	are	shown	
in	figure	3.15.	The	preferred	model	to	fit	the	data	was	therefore	a	straight	line,	as	the	null	hypothesis	
could	not	be	rejected	(p>0.05).	Data	are	summarised	in	table	3.9	with	amplitudes,	acrophases,	mesors,	
periods,	and	R2	values	listed	for	all	carbon-based	sources	studied.	The	utilisation	profiles	of	all	other	
carbon-based	sources	not	illustrated	in	this	chapter	are	presented	in	appendix	1.		
	
Figure	3.15:	Examples	of	carbon-
based	 sources	 from	 BIOLOGTM	
PM-M1	 plates	 utilised	 in	 an	
arrhythmic	 manner.	 Utilisation	
dynamics	 of	 Myo-Inositol,	 D-
Glucuronic	 acid,	 γ-Amino-N-
Butyric	 acid	 and	 Citric	 acid	were	
measured	every	3	hours	between	
24	and	51	hours	following	serum	
shock	of	the	cells,	after	which	the	
slope	values	were	plotted	against	
the	 circadian	 time.	 The	
experiment	 was	 replicated	 3	
times	 (n=3	 biological	 replicates,	
n=1	 technical	 replicate	 per	
biological	 replicate),	 with	 results	
indicated	by	the	blue	dots	on	the	
graphs.	A	cosine	curve	was	fitted	
to	the	data	against	a	straight	line,	
all	 replicates	 considered.	 The	
preferred	 model	 to	 fit	 the	 data	
was	a	straight	line,	and	thus	the	data	remained	unchanged	across	time.	Accordingly,	p-values	were	
either	not	calculated	by	the	software	or	not	significant	(p>0.05).		
	
	
	 D-Glucose-6-
Phosphate	
L-Fucose	 D,L-β-Hydroxy-Butyric	
acid	
D,L-α-Glycerol-Phosphate	
Mesor	 60.51	 17.4	 23.47	 12.97	
Amplitude	 16.2	 13.12	 13.95	 10.96	
Acrophase	(hours)	 43.78	 44.23	 44.89	 44.39	
Period	(hours)	 25.7	 23.62	 19.66	 20.81	
R2	 0.56	 0.51	 0.56	 0.5	
P-value	 0.0002	 0.0002	 <0.0001	 0.0001	
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	 Mean	utilisation	rate	time	series	of	all	carbon	sources	constituting	the	3	clusters	are	plotted	
in	 figure	 3.16.	Means	were	 calculated	 over	 Z-scored	 values	 of	 all	 biological	 replicates	 and	plotted	
against	 the	 circadian	 time.	 For	 the	 first	 cluster,	we	 confirmed	 that	 the	 preferred	model	 to	 fit	 the	
averaged	 data	 was	 a	 cosine	 curve	 (p<0.05),	 indicating	 the	 circadian	 temporal	 variation	 in	 the	
substrates	of	this	cluster.	The	period	of	the	averaged	circadian	profile	was	evaluated	at	20.23	hours.	
Furthermore,	we	 confirmed	 an	 acrophase	 close	 to	 33	 hours	 (33.89	 hours)	 as	 seen	 in	 table	 3.8	 A.	
Strikingly,	the	addition	of	the	second	cluster	comprised	of	carbon	sources	with	utilisation	rates	that	
peaked	44.18	hours	on	average	following	serum	shock,	revealed	a	clear	anti-phase	with	the	first	group.	
In	the	case	of	this	second	cluster,	we	again	were	able	to	confirm	that	a	cosine	curve	was	the	preferred	
model	to	fit	the	data	(p<0.05),	with	a	mean	period	of	22.64	hours	(table	3.8	B).	For	the	last	cluster,	no	
significant	variations	in	the	utilisation	rates	were	found	across	the	time	points,	as	in	this	case	the	data	
were	most	appropriately	modelled	by	a	straight	 line	(p>0.05).	Finally,	the	phase	distribution	of	the	
peaks	of	utilisation	rates	(for	the	three	rhythmic	clusters)	are	shown	in	figure	3.17.	The	three	rhythmic	
clusters	are	each	discernible	as	cluster	of	high	accumulation	at,	or	around,	 the	peak	phase	of	 that	
specific	cluster.	This	also	confirmed	the	anti-phase	between	clusters	1	and	2,	whose	utilisation	rates	
peaked	after	approximately	33	hours	and	45	hours	following	serum	shock,	as	their	phase	distributions	
were	pointing	towards	opposite	directions.		
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	3.16:	Z-scored	data	of	the	clusters	1,	2	and	3	grouped	together.	This	graph	shows	the	averaged	
Z-scored	data	within	each	time	point	and	all	replicates	(biological	and	technical),	considered	for	every	
substrate	of	the	3	different	clusters.	The	mean	values	of	utilisation	dynamics	are	represented	by	a	
circle	for	the	cluster	1	(in	orange),	a	square	for	cluster	2	(in	blue)	and	a	triangle	for	cluster	3	(in	green).	
The	highest	mean	value	for	cluster	1	was	found	33	hours	(approximately)	after	serum	shock	of	the	
cells,	whereas	 it	was	after	45	hours	(approximately)	 for	cluster	2.	The	two	clusters	then	presented	
anti-phasic	circadian	rhythms.	The	last	cluster,	number	3,	consisted	of	carbon	sources	utilised	in	an	
arrhythmic	manner,	and	values	were	not	presenting	any	temporal	variations	over	time.		
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Table	3.8:	Summary	of	circadian	parameters	and	
R2	 values	 obtained	 between	 the	 two	 main	
rhythmic	 clusters.	 Rhythmic	 clusters	 grouped	
carbon	sources	whose	utilisation	rates	peaked	at	
around	 33	 hours	 (A,	 cluster	 1)	 or	 45	 hours	 (B,	
cluster	 2)	 following	 serum	 shock.	 The	 mesor,	
amplitude	 and	 R2	 values	 are	 expressed	 in	
arbitrary	units.		
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	3.17:	Peak	acrophase	distribution	in	utilisation	dynamics	of	91	different	carbon-based	energy	
substrates.	
A
B
Mesor 0.01
Amplitude 1.031
Acrophase	(hours) 33.89
Period	(hours) 20.23
R2 0.65
P-value <0.001 
Mesor -0.06 
Amplitude 1.004
Acrophase	(hours) 44.18
Period	(hours) 22.64
R2 0.62
P-value <0.001 
A
B
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OVERLEAF:	Table	3.9:	Summary	of	circadian	parameters	and	R2	values	obtained	for	each	carbon-
based	source	constitutive	of	the	PM-M1	plate.	The	mesor,	amplitude	and	R2	values	are	expressed	in	
arbitrary	units.	
	
Name	of	the	substrate Category Rhythmic? Amplitude Mesor AMPLITUDE/MESOR	(relative	amplitude) Acrophase Period R2	 P-value
D-CELLOBIOSE Monosaccharides,	oligosaccharides	and	polysaccharides YES 13.86 24.94 0.56 26.55 25.16 0.52 <0.0001
2,3-BUTANEDIOL Ketone	bodies	and	short	chain	fatty	acids YES 14.69 16.41 0.9 32.2 20.68 0.55 <0.0001
PALATINOSE Monosaccharides,	oligosaccharides	and	polysaccharides YES 12.46 24.75 0.5 32.48 19.09 0.68 <0.0001
ADONITOL Monosaccharides,	oligosaccharides	and	polysaccharides YES 18.39 26 0.71 32.57 22.04 0.53 <0.0001
HEXANOIC	ACID Ketone	bodies	and	short	chain	fatty	acids YES 15.91 20.83 0.76 32.62 20.8 0.6 <0.0001
D-MANNITOL Monosaccharides,	oligosaccharides	and	polysaccharides YES 12.59 16.39 0.77 32.84 20.76 0.39 0.0018
MESO-TARTARIC	ACID Alcohols	and	organic	acids YES 13.61 16.38 0.83 32.89 19.55 0.68 <0.0001
MELIBIONIC	ACID Monosaccharides,	oligosaccharides	and	polysaccharides YES 17.07 24.04 0.71 33.05 19.76 0.62 <0.0001
D-MALTOSE Monosaccharides,	oligosaccharides	and	polysaccharides YES 13.91 30.6 0.45 33.06 18.78 0.69 <0.0001
MONO-METHYL	SUCCINATE Alcohols	and	organic	acids YES 12.72 17.96 0.71 33.08 19.56 0.4 0.0013
L-ARABINOSE Monosaccharides,	oligosaccharides	and	polysaccharides YES 14.36 21.76 0.66 33.12 15.41 0.52 <0.0001
SUCCINAMIC	ACID Alcohols	and	organic	acids YES 17.66 19.25 0.92 33.13 23.01 0.64 <0.0001
CHONDROITIN-6-SULFATE Monosaccharides,	oligosaccharides	and	polysaccharides YES 15.64 19.03 0.82 33.18 20.89 0.52 <0.0001
L-MALIC	ACID Alcohols	and	organic	acids YES 14.17 17.23 0.82 33.2 19.95 0.61 <0.0001
α-HYDROXY-BUTYRIC	ACID Ketone	bodies	and	short	chain	fatty	acids YES 14.39 20.79 0.69 33.31 20.4 0.62 <0.0001
α-D-LACTOSE Monosaccharides,	oligosaccharides	and	polysaccharides YES 12.07 17.35 0.7 33.35 15.53 0.45 0.0005
ETHANOLAMINE Alcohols	and	organic	acids YES 19.75 19.64 1.01 33.42 21.18 0.68 <0.0001
URIDINE Nucleosides YES 16.6 19.37 0.86 33.44 20.86 0.67 <0.0001
STACHYOSE Monosaccharides,	oligosaccharides	and	polysaccharides YES 4.99 10.14 0.49 33.47 12.82 0.21 0.0499
PROPIONIC	ACID Ketone	bodies	and	short	chain	fatty	acids YES 14.97 17.74 0.84 33.53 20.27 0.67 <0.0001
β-METHYL-D-XYLOPYRANOSIDE Monosaccharides,	oligosaccharides	and	polysaccharides YES 15.16 20.3 0.75 33.62 20.34 0.53 <0.0001
D-FRUCTOSE-6-PHOSPHATE Monosaccharides,	oligosaccharides	and	polysaccharides YES 11.81 25.31 0.47 33.63 18.95 0.67 <0.0001
MALTITOL Monosaccharides,	oligosaccharides	and	polysaccharides YES 15.55 21.66 0.72 33.64 19.97 0.54 <0.0001
D-MELIBIOSE Monosaccharides,	oligosaccharides	and	polysaccharides YES 17.65 23.51 0.75 33.64 19.85 0.49 0.0002
α-KETO-BUTYRIC	ACID Ketone	bodies	and	short	chain	fatty	acids YES 15.67 27.91 0.56 33.64 18.41 0.73 <0.0001
D-SORBITOL Monosaccharides,	oligosaccharides	and	polysaccharides YES 18.34 18.96 0.97 33.71 20.49 0.65 <0.0001
D-FRUCTOSE Monosaccharides,	oligosaccharides	and	polysaccharides YES 15.31 26.34 0.58 33.75 21.31 0.58 <0.0001
SUCROSE Monosaccharides,	oligosaccharides	and	polysaccharides YES 14.24 14.12 1.01 33.79 20.5 0.58 <0.0001
ACETOACETIC	ACID Ketone	bodies	and	short	chain	fatty	acids YES 22.54 31.38 0.72 33.79 19.41 0.76 <0.0001
BUTYRIC	ACID Ketone	bodies	and	short	chain	fatty	acids YES 21.89 23.78 0.92 33.83 22.94 0.73 <0.0001
XYLITOL Monosaccharides,	oligosaccharides	and	polysaccharides YES 16.73 20.32 0.82 33.84 21.4 0.65 <0.0001
D-LACTITOL Monosaccharides,	oligosaccharides	and	polysaccharides YES 15.32 14.49 1.06 33.87 19.62 0.62 <0.0001
PYRUVIC	ACID Alcohols	and	organic	acids YES 29.5 55.19 0.53 33.91 21.29 0.71 <0.0001
N-ACETYL-D-GLUCOSAMINE Monosaccharides,	oligosaccharides	and	polysaccharides YES 16.15 20.32 0.79 33.93 20.73 0.56 <0.0001
INOSINE Nucleosides YES 33.08 98.18 0.34 33.94 20.5 0.76 <0.0001
L-SORBOSE Monosaccharides,	oligosaccharides	and	polysaccharides YES 12.15 30.17 0.4 34 19.72 0.6 <0.0001
β-GENTIOBIOSE Monosaccharides,	oligosaccharides	and	polysaccharides YES 18.37 19.68 0.93 34.1 19.16 0.58 <0.0001
α-METHYL-D-MANNOSIDE Monosaccharides,	oligosaccharides	and	polysaccharides YES 16.52 19.93 0.83 34.13 20.91 0.56 <0.0001
D-TURANOSE Monosaccharides,	oligosaccharides	and	polysaccharides YES 15.47 21.43 0.72 34.16 19.62 0.54 <0.0001
D,L-LACTIC	ACID Alcohols	and	organic	acids YES 21.22 47.23 0.45 34.27 20.02 0.61 <0.0001
N-ACETYL-NEURAMINIC	ACID Monosaccharides,	oligosaccharides	and	polysaccharides YES 17.34 18.86 0.92 34.28 21.68 0.68 <0.0001
LACTULOSE Monosaccharides,	oligosaccharides	and	polysaccharides YES 8.57 13.73 0.62 34.34 19.24 0.41 0.0016
THYMIDINE Nucleosides YES 16.01 17.49 0.92 34.37 20 0.65 <0.0001
β-METHYL-D-GLUCOSIDE Monosaccharides,	oligosaccharides	and	polysaccharides YES 17.86 18.15 0.98 34.38 21.03 0.63 <0.0001
ADENOSINE Nucleosides YES 34.37 90.21 0.38 34.39 20.09 0.74 <0.0001
MALTOTRIOSE Monosaccharides,	oligosaccharides	and	polysaccharides YES 16.23 32.51 0.5 34.65 21.42 0.59 <0.0001
α-D-GLUCOSE Monosaccharides,	oligosaccharides	and	polysaccharides YES 31.21 209.5 0.15 34.83 19.41 0.74 <0.0001
GLYCOGEN Monosaccharides,	oligosaccharides	and	polysaccharides YES 10.58 29.15 0.36 35.02 18.96 0.41 0.0016
α-D-GLUCOSE-1-PHOSPHATE Monosaccharides,	oligosaccharides	and	polysaccharides YES 7.55 26.32 0.29 35.45 18.92 0.46 0.0042
D-MANNOSE Monosaccharides,	oligosaccharides	and	polysaccharides YES 39.05 206 0.19 36.07 19.23 0.75 <0.0001
DEXTRIN Monosaccharides,	oligosaccharides	and	polysaccharides YES 21.49 45.81 0.47 36.17 24.66 0.79 <0.0001
MANNAN Monosaccharides,	oligosaccharides	and	polysaccharides YES 13.79 19.72 0.7 36.81 19.44 0.53 <0.0001
α-CYCLODEXTRIN Monosaccharides,	oligosaccharides	and	polysaccharides YES 19.16 24.53 0.78 41.54 26.3 0.75 <0.0001
L-GLUCOSE Monosaccharides,	oligosaccharides	and	polysaccharides YES 15.21 17.3 0.88 43.68 24.4 0.56 <0.0001
D-GLUCOSE-6-PHOSPHATE Monosaccharides,	oligosaccharides	and	polysaccharides YES 16.2 60.51 0.27 43.78 25.7 0.56 0.0002
α-METHYL-D-GALACTOSIDE Monosaccharides,	oligosaccharides	and	polysaccharides YES 6.09 15.73 0.39 43.99 20.84 0.32 0.0074
L-FUCOSE Monosaccharides,	oligosaccharides	and	polysaccharides YES 13.12 17.4 0.75 44.23 23.62 0.51 0.0002
METHYL	PYRUVATE Alcohols	and	organic	acids YES 12.41 15.23 0.81 44.3 21.75 0.46 0.0004
D,L-α-GLYCEROL-PHOSPHATE Alcohols	and	organic	acids YES 10.96 12.97 0.85 44.39 20.81 0.5 0.0001
3-O-METHYL-D-GLUCOSE Monosaccharides,	oligosaccharides	and	polysaccharides YES 17.91 17.54 1.02 44.41 24.08 0.77 <0.0001
MESO-ERYTHRITOL Monosaccharides,	oligosaccharides	and	polysaccharides YES 14.36 12.45 1.15 44.47 23 0.55 <0.0001
PECTIN Monosaccharides,	oligosaccharides	and	polysaccharides YES 17.88 30.68 0.58 44.78 21.06 0.73 <0.0001
D,L-β-HYDROXY-BUTYRIC	ACID Ketone	bodies	and	short	chain	fatty	acids YES 13.95 23.47 0.59 44.89 19.66 0.56 <0.0001
METHYL	D-LACTATE Alcohols	and	organic	acids YES 14.5 14.52 1 45.2 20.1 0.58 <0.0001
CITRIC	ACID Alcohols	and	organic	acids NO N.A N.A N.A N.A N.A N.A N.A
GLYCEROL Alcohols	and	organic	acids NO N.A N.A N.A N.A N.A N.A N.A
L-RHAMNOSE Monosaccharides,	oligosaccharides	and	polysaccharides NO N.A N.A N.A N.A N.A N.A N.A
D-TREHALOSE Monosaccharides,	oligosaccharides	and	polysaccharides NO N.A N.A N.A N.A N.A N.A N.A
γ-HYDROXY-BUTYRIC	ACID Ketone	bodies	and	short	chain	fatty	acids NO N.A N.A N.A N.A N.A N.A N.A
TRICARBALLYLIC	ACID Alcohols	and	organic	acids NO N.A N.A N.A N.A N.A N.A N.A
D-GLUCOSAMINIC	ACID Monosaccharides,	oligosaccharides	and	polysaccharides NO N.A N.A N.A N.A N.A N.A N.A
D-FUCOSE Monosaccharides,	oligosaccharides	and	polysaccharides NO N.A N.A N.A N.A N.A N.A N.A
3-HYDROXY-2-BUTANONE Ketone	bodies	and	short	chain	fatty	acids NO N.A N.A N.A N.A N.A N.A N.A
MYO-INOSITOL Monosaccharides,	oligosaccharides	and	polysaccharides NO N.A N.A N.A N.A N.A N.A N.A
D-ARABINOSE Monosaccharides,	oligosaccharides	and	polysaccharides NO N.A N.A N.A N.A N.A N.A N.A
α-METHYL-D-GLUCOSIDE Monosaccharides,	oligosaccharides	and	polysaccharides NO N.A N.A N.A N.A N.A N.A N.A
D-GALACTOSE Monosaccharides,	oligosaccharides	and	polysaccharides NO N.A N.A N.A N.A N.A N.A N.A
PROPYLENE	GLYCOL Alcohols	and	organic	acids NO N.A N.A N.A N.A N.A N.A N.A
β-METHYL-D-GALACTOSIDE Monosaccharides,	oligosaccharides	and	polysaccharides NO N.A N.A N.A N.A N.A N.A N.A
α-KETO-GLUTARIC	ACID Alcohols	and	organic	acids NO N.A N.A N.A N.A N.A N.A N.A
ACETIC	ACID Ketone	bodies	and	short	chain	fatty	acids NO N.A N.A N.A N.A N.A N.A N.A
D-SALICIN Monosaccharides,	oligosaccharides	and	polysaccharides NO N.A N.A N.A N.A N.A N.A N.A
SUCCINIC	ACID Alcohols	and	organic	acids NO N.A N.A N.A N.A N.A N.A N.A
D-TAGATOSE Monosaccharides,	oligosaccharides	and	polysaccharides NO N.A N.A N.A N.A N.A N.A N.A
γ-AMINO-N-BUTYRIC	ACID Ketone	bodies	and	short	chain	fatty	acids NO N.A N.A N.A N.A N.A N.A N.A
D-MALIC	ACID Alcohols	and	organic	acids NO N.A N.A N.A N.A N.A N.A N.A
N-ACETYL-β-D-MANNOSAMINE Monosaccharides,	oligosaccharides	and	polysaccharides NO N.A N.A N.A N.A N.A N.A N.A
D-MELEZITOSE Monosaccharides,	oligosaccharides	and	polysaccharides NO N.A N.A N.A N.A N.A N.A N.A
SEDOHEPTULOSAN Monosaccharides,	oligosaccharides	and	polysaccharides NO N.A N.A N.A N.A N.A N.A N.A
D-GLUCURONIC	ACID	 Monosaccharides,	oligosaccharides	and	polysaccharides NO N.A N.A N.A N.A N.A N.A N.A
D-RAFFINOSE Monosaccharides,	oligosaccharides	and	polysaccharides NO N.A N.A N.A N.A N.A N.A N.A
NEGATIVE	CONTROL No	substrate NO N.A N.A N.A N.A N.A N.A N.A
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3.5.6	Enrichment	and	pathway	analyses		
	
3.5.6.1	Enrichment	analyses	in	MetaboAnalyst	
	
	 To	investigate	the	aspects	of	metabolism	associated	with	the	different	clusters	of	substrates	
identified	in	the	preceding	experiments,	we	first	identified	whether	the	clusters	were	enriched	for	any	
specific	metabolic	process.	For	cluster	1,	the	enrichment	analysis	revealed	no	significant	enrichment	
(p>0.05).	The	list	of	the	most	enriched,	non-significant	processes	included	glycolysis,	lactose	synthesis,	
and	metabolism	of	butyrate,	selenoamino	acid,	methionine,	pyrimidine	as	well	as	purine	(figure	3.18).	
The	 ORA	 confirmed	 that	 the	 probability	 of	 seeing	 at	 least	 a	 particular	 number	 of	 metabolites	
containing	 the	 biological	 term	 of	 interest	 in	 the	 given	 compound	 list	 was	 the	 highest	 for	 these	
particular	pathways,	as	the	p-values	were	the	lowest	(table	3.10).		
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	 3.18:	 Metabolite	 sets	 enrichment	 overview	 after	 analysis	 of	 the	 first	 cluster.	 Glycolysis,	
lactose	 synthesis,	 butyrate,	 selenoamino	 acid,	 methionine,	 pyrimidine	 and	 purine	 metabolism,	
pentose	 phosphate	 pathway	 and	 beta	 oxidation	 of	 very	 long	 chain	 fatty	 acids	 were	 identified	 as	
represented	more	often	 than	expected	by	chance	within	a	given	metabolite	 list	 (full	 list	of	 carbon	
sources	used	in	the	PM-M1	plates).		
150	
	
Table	3.10:	Results	from	over-representation	analysis	of	the	first	cluster.	
	
Compound	 Total	 Expected	 Hits	 Raw	p	
Glycolysis	 4	 3.91	 4	 9.15E-01	
Butyrate	Metabolism	 3	 2.94	 3	 9.36E-01	
Lactose	Synthesis	 3	 2.94	 3	 9.36E-01	
Selenoamino	Acid	Metabolism	 2	 1.96	 2	 9.57E-01	
Methionine	Metabolism	 2	 1.96	 2	 9.57E-01	
Pyrimidine	Metabolism	 2	 1.96	 2	 9.57E-01	
Purine	Metabolism	 2	 1.96	 2	 9.57E-01	
Pentose	Phosphate	Pathway	 1	 0.98	 1	 9.79E-01	
Beta	Oxidation	of	Very	Long	Chain	Fatty	Acids	 1	 0.98	 1	 9.79E-01	
Betaine	Metabolism	 1	 0.98	 1	 9.79E-01	
Threonine	and	2-Oxobutanoate	Degradation	 1	 0.98	 1	 9.79E-01	
Homocysteine	Degradation	 1	 0.98	 1	 9.79E-01	
Pyruvaldehyde	Degradation	 1	 0.98	 1	 9.79E-01	
Vitamin	K	Metabolism	 1	 0.98	 1	 9.79E-01	
Mitochondrial	Beta-Oxidation	of	Short	Chain	
Saturated	Fatty	Acids	
1	 0.98	 1	 9.79E-01	
Phosphatidylcholine	Biosynthesis	 1	 0.98	 1	 9.79E-01	
Phosphatidylethanolamine	Biosynthesis	 1	 0.98	 1	 9.79E-01	
Glycine	and	Serine	Metabolism	 3	 2.94	 2	 1.00E+00	
Tyrosine	Metabolism	 2	 1.96	 1	 1.00E+00	
Phenylalanine	and	Tyrosine	Metabolism	 2	 1.96	 1	 1.00E+00	
Ammonia	Recycling	 3	 2.94	 2	 1.00E+00	
Nucleotide	Sugars	Metabolism	 2	 1.96	 1	 1.00E+00	
Cysteine	Metabolism	 2	 1.96	 1	 1.00E+00	
Propanoate	Metabolism	 4	 3.91	 3	 1.00E+00	
Arginine	and	Proline	Metabolism	 2	 1.96	 1	 1.00E+00	
Phospholipid	Biosynthesis	 2	 1.96	 1	 1.00E+00	
Oxidation	of	Branched	Chain	Fatty	Acids	 2	 1.96	 1	 1.00E+00	
Valine,	Leucine	and	Isoleucine	Degradation	 3	 2.94	 2	 1.00E+00	
Sphingolipid	Metabolism	 2	 1.96	 1	 1.00E+00	
Galactose	Metabolism	 14	 13.7	 10	 1.00E+00	
Amino	Sugar	Metabolism	 7	 6.85	 5	 1.00E+00	
Alanine	Metabolism	 2	 1.96	 1	 1.00E+00	
Citric	Acid	Cycle	 5	 4.89	 3	 1.00E+00	
Starch	and	Sucrose	Metabolism	 7	 6.85	 6	 1.00E+00	
Urea	Cycle	 2	 1.96	 1	 1.00E+00	
Pyruvate	Metabolism	 5	 4.89	 3	 1.00E+00	
Fructose	and	Mannose	Degradation	 5	 4.89	 4	 1.00E+00	
Aspartate	Metabolism	 3	 2.94	 1	 1.00E+00	
Ketone	Body	Metabolism	 3	 2.94	 2	 1.00E+00	
Glutamate	Metabolism	 5	 4.89	 3	 1.00E+00	
Glucose-Alanine	Cycle	 3	 2.94	 2	 1.00E+00	
Gluconeogenesis	 6	 5.87	 5	 1.00E+00	
Mitochondrial	Electron	Transport	Chain	 2	 1.96	 1	 1.00E+00	
Phytanic	Acid	Peroxisomal	Oxidation	 2	 1.96	 1	 1.00E+00	
Fatty	Acid	Biosynthesis	 4	 3.91	 3	 1.00E+00	
Lactose	Degradation	 3	 2.94	 2	 1.00E+00	
Carnitine	Synthesis	 2	 1.96	 1	 1.00E+00	
Transfer	of	Acetyl	Groups	into	Mitochondria	 4	 3.91	 3	 1.00E+00	
Warburg	Effect	 8	 7.83	 6	 1.00E+00	
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Likewise,	enrichment	analysis	of	the	second	cluster	did	not	identify	a	significant	enrichment,	
although	some	processes	were	borderline	significant	(see	figure	3.19).	A	strong	enrichment	was	seen	
for	processes	such	as	the	glucose-alanine	cycle,	glycolysis,	transfer	of	acetyl	groups	into	mitochondria,	
glycerol	phosphate	shuttle,	pyruvaldehyde	degradation,	de	novo	triacylglycerol	biosynthesis	as	well	as	
cardiolipin	biosynthesis.	These	pathways	are	presented	in	table	3.11.		
	
	
	
Figure	 3.19:	Metabolite	 sets	 enrichment	 overview	 after	 analysis	 of	 the	 second	 cluster.	Glucose-
alanine	 cycle,	 glycolysis,	 transfer	 of	 acetyl	 groups	 into	 mitochondria,	 glycerol	 phosphate	 shuttle,	
pyruvaldehyde	degradation,	de	novo	 triacylglycerol	 biosynthesis	 as	well	 as	 cardiolipin	biosynthesis	
were	identified	as	represented	more	often	than	expected	by	chance	within	a	given	metabolite	list	(full	
list	of	carbon	sources	used	in	the	PM-M1	plates).	
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Table	3.11:	Results	from	over-representation	analysis	of	the	second	cluster.	
	
Compound	 Total	 Expected	 Hits	 Raw	p	
Glucose-Alanine	Cycle	 3	 0.57	 2	 8.95E-02	
Glycolysis	 4	 0.77	 2	 1.60E-01	
Transfer	of	Acetyl	Groups	into	Mitochondria	 4	 0.77	 2	 1.60E-01	
Glycerol	Phosphate	Shuttle	 1	 0.19	 1	 1.91E-01	
Pyruvaldehyde	Degradation	 1	 0.19	 1	 1.91E-01	
De	Novo	Triacylglycerol	Biosynthesis	 1	 0.19	 1	 1.91E-01	
Cardiolipin	Biosynthesis	 1	 0.19	 1	 1.91E-01	
Gluconeogenesis	 6	 1.15	 2	 3.22E-01	
Cysteine	Metabolism	 2	 0.38	 1	 3.50E-01	
Phospholipid	Biosynthesis		 2	 0.38	 1	 3.50E-01	
Sphingolipid	Metabolism		 2	 0.38	 1	 3.50E-01	
Glycerolipid	Metabolism		 2	 0.38	 1	 3.50E-01	
Alanine	Metabolism		 2	 0.38	 1	 3.50E-01	
Urea	Cycle	 2	 0.38	 1	 3.50E-01	
Mitochondrial	Electron	Transport	Chain	 2	 0.38	 1	 3.50E-01	
Glycine	and	Serine	Metabolism	 3	 0.57	 1	 4.80E-01	
Ammonia	Recycling	 3	 0.57	 1	 4.80E-01	
Ketone	Body	Metabolism	 3	 0.57	 1	 4.80E-01	
Lactose	Synthesis		 3	 0.57	 1	 4.80E-01	
Lactose	Degradation		 3	 0.57	 1	 4.80E-01	
Warburg	Effect		 8	 1.53	 2	 4.83E-01	
Citric	Acid	Cycle	 5	 0.96	 1	 6.73E-01	
Pyruvate	Metabolism	 5	 0.96	 1	 6.73E-01	
Fructose	and	Mannose	Degradation	 5	 0.96	 1	 6.73E-01	
Glutamate	Metabolism	 5	 0.96	 1	 6.73E-01	
Amino	Sugar	Metabolism	 7	 1.34	 1	 7.99E-01	
Galactose	Metabolism	 14	 2.68	 1	 9.72E-01	
	
	 For	the	last	cluster,	with	carbon	sources	presenting	arrhythmic	utilisation	dynamics,	it	was	the	
inositol,	 arginine	 and	 proline	 metabolism,	 oxidation	 of	 branched	 chain	 fatty	 acids,	 phytanic	 acid	
peroxisomal	oxidation	and	carnitine	synthesis	which	were	represented	more	often	than	expected	by	
chance	within	the	given	metabolite	(figure	3.20),	with	the	ORA	identifying	these	pathways	with	the	
lowest	 p-values	 and	 therefore	 the	 highest	 probability	 of	 seeing	 at	 least	 a	 particular	 number	 of	
metabolites	 containing	 the	 biological	 term	 of	 interest	 in	 the	 given	 compound	 list	 (the	 full	 carbon	
sources	list,	table	3.12).					
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Figure	3.20:	Metabolite	sets	enrichment	overview	after	analysis	of	the	third	cluster.	Inositol,	arginine	
and	proline	metabolism,	oxidation	of	branched	chain	fatty	acids,	phytanic	acid	peroxisomal	oxidation	
and	carnitine	synthesis	were	identified	as	represented	more	often	than	expected	by	chance	within	a	
given	metabolite	list	(full	list	of	carbon	sources	used	in	the	PM-M1	plates).	
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Table	3.12:	Results	from	over-representation	analysis	of	the	third	cluster.	
	
Compound	 Total	 Expected	 Hits	 Raw	p	
Inositol	Metabolism	 2	 1.11	 2	 3.01E-01	
Arginine	and	Proline	Metabolism	 2	 1.11	 2	 3.01E-01	
Oxidation	of	Branched	Chain	Fatty	Acids	 2	 1.11	 2	 3.01E-01	
Phytanic	Acid	Peroxisomal	Oxidation		 2	 1.11	 2	 3.01E-01	
Carnitine	Synthesis		 2	 1.11	 2	 3.01E-01	
Beta-Alanine	Metabolism	 1	 0.55	 1	 5.53E-01	
Lysine	Degradation	 1	 0.55	 1	 5.53E-01	
Tryptophan	Metabolism	 1	 0.55	 1	 5.53E-01	
Malate-Aspartate	Shuttle		 1	 0.55	 1	 5.53E-01	
Ethanol	Degradation		 1	 0.55	 1	 5.53E-01	
Inositol	Phosphate	Metabolism	 1	 0.55	 1	 5.53E-01	
Phosphatidylinositol	Phosphate	Metabolism	 1	 0.55	 1	 5.53E-01	
Trehalose	Degradation	 1	 0.55	 1	 5.53E-01	
Valine,	Leucine	and	Isoleucine	Degradation	 3	 1.66	 2	 5.81E-01	
Aspartate	Metabolism	 3	 1.66	 2	 5.81E-01	
Citric	Acid	Cycle	 5	 2.77	 3	 6.03E-01	
Glutamate	Metabolism		 5	 2.77	 3	 6.03E-01	
Tyrosine	Metabolism	 2	 1.11	 1	 8.06E-01	
Phenylalanine	and	Tyrosine	Metabolism	 2	 1.11	 1	 8.06E-01	
Nucleotide	Sugars	Metabolism	 2	 1.11	 1	 8.06E-01	
Cysteine	Metabolism		 2	 1.11	 1	 8.06E-01	
Sphingolipid	Metabolism		 2	 1.11	 1	 8.06E-01	
Glycerolipid	Metabolism	 2	 1.11	 1	 8.06E-01	
Alanine	Metabolism	 2	 1.11	 1	 8.06E-01	
Urea	Cycle	 2	 1.11	 1	 8.06E-01	
Mitochondrial	Electron	Transport	Chain	 2	 1.11	 1	 8.06E-01	
Pyruvate	Metabolism	 5	 2.77	 2	 8.85E-01	
Glycine	and	Serine	Metabolism		 3	 1.66	 1	 9.18E-01	
Ammonia	Recycling		 3	 1.66	 1	 9.18E-01	
Ketone	Body	Metabolism	 3	 1.66	 1	 9.18E-01	
Butyrate	Metabolism	 3	 1.66	 1	 9.18E-01	
Glucose-Alanine	Cycle		 3	 1.66	 1	 9.18E-01	
Lactose	Degradation	 3	 1.66	 1	 9.18E-01	
Warburg	Effect	 8	 4.43	 3	 9.34E-01	
Propanoate	Metabolism	 4	 2.21	 1	 9.66E-01	
Fatty	Acid	Biosynthesis		 4	 2.21	 1	 9.66E-01	
Transfer	of	Acetyl	Groups	into	Mitochondria	 4	 2.21	 1	 9.66E-01	
Amino	Sugar	Metabolism		 7	 3.87	 2	 9.76E-01	
Gluconeogenesis	 6	 3.32	 1	 9.95E-01	
Galactose	Metabolism	 14	 7.74	 4	 9.97E-01	
Starch	and	Sucrose	Metabolism	 7	 3.87	 1	 9.98E-01	
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3.5.6.2	Pathway	analyses	
	
For	the	first	cluster,	the	propanoate	metabolism	pathway	was	identified	with	the	lowest	p-
value	and	no	impact	(figure	3.21).	In	this	pathway	were	found	succinic	and	propionic	acid	as	well	as	2-
hydroxybutyric	acid	and	2-ketobutyric	acid.	The	purine	metabolism	pathway	had	a	very	small	impact	
but	a	higher	p-value;	with	inosine	and	adenosine.	The	figure	shows	that	the	cysteine	and	methionine	
metabolism	had	a	higher	impact	but	the	same	p-value	as	the	purine	metabolism	(pyruvic	acid	and	2-
ketobutyric	 acid	 were	 found	 in	 this	 pathway).	 Always	 with	 the	 same	 p-value	 but	 an	 even	 more	
important	impact	was	the	pyrimidine	metabolism	(uridine	and	thymidine).	Among	the	list	of	carbon	
sources	belonging	to	this	cluster,	the	acetoacetic	acid	was	implicated	in	the	synthesis	and	degradation	
of	ketone	bodies	which	had	the	highest	impact	and	one	of	the	highest	p-values.		
	
	
	
Figure	 3.21:	 Summary	 of	 pathway	 analysis	 for	 the	 first	 cluster.	Propanoate	metabolism	 had	 the	
lowest	p-value	and	impact,	followed	by	purine	metabolism,	cysteine	and	methionine	metabolism	as	
well	 as	 pyrimidine	metabolism,	 which	 were	 sharing	 a	 higher	 p-value	 and	 increasing	 impacts.	 The	
synthesis	and	degradation	of	ketone	bodies	was	found	to	have	the	biggest	impact	and	highest	p-value.	
The	node	colour	is	based	on	the	p-value	and	the	node	radius	on	the	impact	pathway	value.		
	
	 For	 the	second	cluster,	 the	glycine,	serine	and	threonine	metabolism	as	well	as	 the	valine,	
leucine	 and	 isoleucine	 biosynthesis	 had	 the	 lowest	 p-value	 and	 no	 impact,	 with	 the	 pyruvic	 acid	
involved	 in	 this	 pathway	 (figure	 3.22).	 With	 the	 same	 p-value	 but	 a	 higher	 impact,	 the	 pentose	
Propanoate metabolism
Purine	metabolism
Cysteine	and	Methionine	metabolism
Pyrimidine	metabolism
Pyruvate	metabolism
Krebbs cycle
Pentose	and	glucuronate interconversions
Glycolysis	or	Gluconeogenesis
Synthesis	and	degradation	of	ketone	bodies
Galactose	metabolism
Starch	and	sucrose	metabolism
Butanoate	metabolism
Glycine,	Serine	and	Threonine	+	Tyrosine	metabolism
Aminoacyl-tRNA biosynthesis
Valine,	Leucine	and	Isoleucine	degradation	and	biosynthesis
Fructose	and	Mannose	metabolism
Alanine,	Aspartate	and	Glutamate	metabolism
Glyoxylate and	Dicarboxylate metabolism
Glycerophospholipd metabolism
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phosphate	pathway	was	also	identified,	and	the	carbon	source	of	our	cluster	involved	in	this	pathway	
was	 also	 the	 pyruvic	 acid.	 The	 glycolysis	 or	 gluconeogenesis	was	 found	with	 a	 higher	 p-value	 and	
impact	(glucose-6-phosphate	as	well	as	pyruvic	acid).	On	figure	3.22	were	also	seen	the	synthesis	and	
degradation	 of	 ketone	 bodies	 ((R)-3-Hydroxybutyric	 acid)	 and	 butanoate	 metabolism	 ((R)-3-
Hydroxybutyric	 acid	 and	 pyruvic	 acid),	 each	with	 no	 impact	 and	 higher	 p-values	 as	 the	 pathways	
previously	described.	With	the	same	p-value	as	the	synthesis	and	degradation	of	ketone	bodies,	we	
found	a	higher	 impact	 for	 the	cysteine	and	methionine	metabolism	(pyruvic	acid),	 followed	by	the	
glycerophospholipid	 metabolism	 (glycerol-3-phosphate).	 Amino	 sugar	 and	 nucleotide	 sugar	
metabolism	 had	 an	 even	 more	 important	 impact	 and	 a	 higher	 p-value	 (L-Fucose	 and	 Glucose-6-
Phosphate).	The	starch	and	sucrose	metabolism	pathway	was	identified	as	having	the	highest	impact	
and	 p-value	 as	 the	 pathways	 previously	 described,	 where	 we	 found	 D-Glucose	 and	 Glucose-6-
Phosphate).	On	the	figure	was	also	indicated	that	the	pyruvate	metabolism	pathway	had	the	highest	
p-value	with	 an	 impact	 slightly	 lower	 than	 the	 starch	 and	 sucrose	metabolism	 pathway,	with	 the	
pyruvic	acid	involved	in	this	signalisation	cascade.		
	
	
	
Figure	 3.22:	 Summary	 of	 pathway	 analysis	 for	 the	 second	 cluster.	Glycine,	 serine	 and	 threonine	
metabolism	as	well	as	valine,	leucine	and	isoleucine	biosynthesis	pathways	had	the	lowest	p-value	and	
impact,	 followed	 by	 the	 pentose	 phosphate	 pathway	 (same	 p-value	 but	 higher	 impact)	 and	 the	
glycolysis	or	gluconeogenesis,	which	presented	a	higher	 impact	and	higher	p-value.	The	starch	and	
sucrose	metabolism	was	identified	as	having	the	highest	impact	and	a	high	p-value.	For	the	pyruvate	
metabolism	pathway,	the	impact	was	slightly	lower	with	a	higher	p-value.	The	node	colour	is	based	
on	the	p-value	and	the	node	radius	on	the	impact	pathway	value.	
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Galactose	metabolism
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	 The	pathway	analysis	results	for	the	last	and	third	cluster	are	presented	in	figure	3.23.	We	can	
see	 that	 the	ascorbate	and	aldarate	metabolism	had	 the	highest	 impact	and	 lowest	p-value	 (Myo-
Inositol	and	D-Glucuronic	acid),	with	the	inositol	phosphate	metabolism	having	a	lower	impact	but	a	
similar	p-value	(same	compounds	involved).	D-Glutamine	and	D-Glutamate	metabolism	(oxoglutaric	
acid)	as	well	as	arginine	and	proline	metabolism	(γ-Aminobutyric	acid)	both	had	the	same	p-value,	
higher	than	the	previously	identified	pathways.	Their	impact	was,	however,	low.	The	Krebs	cycle	(citric	
acid)	as	well	as	alanine,	aspartate	and	glutamate	metabolism	(γ-Aminobutyric	acid,	succinic	acid	and	
oxoglutaric	acid)	had	a	slightly	higher	p-value	similar	between	both	groups,	and	a	higher	impact	than	
D-Glutamine,	 D-Glutamate,	 arginine	 and	 proline	metabolism.	With	 a	 similar	 p-value	 and	 a	 higher	
impact	was	 identified	the	glycerolipid	metabolism	pathway,	which	 involved	glycerol	and	propylene	
glycol.	The	glyoxylate	and	dicarboxylate	metabolism	(citric	acid)	also	had	an	important	impact,	with	a	
higher	 p-value	 than	 seen	 for	 the	 other	 pathways	 presented	 here.	 The	 complete	 pathways,	 with	
compounds	presented	as	their	KEGG	identification	number,	are	represented	in	appendix	2.	
	
	
	
Figure	3.23:	Summary	of	pathway	analysis	for	the	third	cluster.	Ascorbate	and	aldarate	metabolism,	
as	well	as	inositol	phosphate	metabolism,	had	the	lowest	p-values	with	the	former	having	the	highest	
impact	of	 the	cluster.	The	Krebs	cycle	had	an	 important	 impact	with	a	higher	p-value,	 followed	by	
alanine,	 aspartate	 and	 glutamate	 metabolism	 then	 glycerolipid	 metabolism	 (same	 p-value	 but	
increasingly	higher	impact).	The	glyoxylate	and	dicarboxylate	metabolism	pathway	was	identified	as	
having	the	highest	p-value	and	impact	of	the	series.	The	node	colour	is	based	on	the	p-value	and	the	
node	radius	on	the	impact	pathway	value.					
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3.6	Discussion	and	concluding	remarks	
	
Using	our	novel	approach,	we	exposed	widespread	circadian	rhythmicity	in	energy	utilisation	
in	 3T3-L1	 pre-adipocytes	 in	 vitro.	 Out	 of	 the	 91	 different	 carbon	 energy	 sources	 investigated,	we	
showed	that	64	sources	(70%)	exhibit	clear	circadian	utilisation	patterns,	which	could	be	divided	in	
two	phase-clusters.	The	first	and	larger	cluster	(51	substrates)	included	α-D-Glucose	and	showed	peak	
utilisation	between	33-36	hours	after	serum	shock,	in	line	with	the	existing	literature	(Feneberg	et	al.,	
2004).	A	second	cluster	showed	12	carbon	sources	exhibiting	peaks	of	utilisation	anti-phasic	to	the	
peak	of	glucose	utilisation,	around	45	hours	after	serum	shock.	To	our	knowledge,	this	is	the	first	large-
panel	 screen	 of	 circadian	 rhythms	 in	 energy	 utilisation	 in	 any	 cell	 type,	 and	 these	 findings	 clearly	
indicate	that	using	glucose	utilisation	patterns	as	a	phase	marker	proxy	for	all	circadian	metabolism	
within	pre-adipocytes	–	and	 likely	other	 cell	 types	–	 is	 a	 simplified	view	which	does	not	 recognise	
diversity	 in	 the	 circadian	 timing	 of	 different	 metabolic	 pathways.	 Published	 work	 on	 3T3-L1	
adipocytes,	 liver	 and	 colon	 cells	 measured	 glucose	 utilisation,	 employing	 the	 same	 type	 of	 assay	
(Bochner	et	al.,	2011).	These	authors,	 like	us,	found	a	high	utilisation	of	glucose,	and	revealed	that	
glucose	was	not	the	only	relevant	energy	source	used	by	these	cell	types.		
		
In	vivo,	glucose	utilisation	was	first	measured	in	the	early	1980s,	in	the	rat,	monkey	and	cat,	
using	the	14C-labeled	deoxy-glucose	technique	(Schwartz	et	al.,	1983).	This	study	revealed	that	 the	
SCN	metabolic	activity	in	all	species	was	endogenously	rhythmic,	with	high	levels	during	the	subjective	
daylight	portion	of	the	24-h	day.	This	suggested	similar	biochemical	processes	underlying	the	activity	
of	circadian	clocks	in	mammals	with	a	different	diurnality,	suggesting	a	timing	of	glucose	utilisation	
driven	 by	 the	 internal	 clock,	 rather	 than	 the	 behavioural	 sleep-wake	 pattern.	 These	 results	 were	
confirmed	two	decades	later	in	mice,	through	the	use	of	another	radiolabelled	glucose	molecule,	FDG	
micro-PET	(van	der	Veen	et	al.,	2012a).	The	same	year,	it	was	demonstrated	that	18F-FDG	uptake	in	
iBAT	 of	 mice	 was	 out	 of	 phase	 with	 the	 SCN	 (van	 der	 Veen	 et	 al.,	 2012b).	 Importantly,	 BAT	 has	
increasingly	gained	attention	over	recent	years	as	being	involved	in	metabolic	processes	and	obesity,	
where	BAT,	as	observed	by	PET	analyses,	negatively	correlates	with	obesity	and	age	(Himms-Hagen	
1979,	Cypess	et	al.,	2009).	It	has	been	shown	that	a	24-hour	profile	of	iBAT	glucose	uptake	could	be	
generated	by	 signals	 from	 the	ANS	and	plasma	hormones	 (Amir	 et	 al.,	 1989,	 Cannon	 et	 al.,	 2004,	
Stephens	et	al.,	2011),	and	here	we	demonstrated	that	adipose	glucose	utilisation	was	also	rhythmic	
in	vitro,	in	the	absence	of	autonomic	inputs,	suggesting	a	direct	role	for	the	cellular	circadian	clock.		
	
Such	 an	 intrinsic	 drive	 of	 glucose	 utilisation	 was	 confirmed	 in	 a	 study	 showing	 circadian	
rhythms	 of	 glucose	 uptake	 in	 primary	muscle	 and	 fat	 cells	 (Feneberg	 et	 al.,	 2004),	 although	 they	
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measured	 glucose	 uptake,	which	 precedes	 the	 actual	 utilisation	measured	 here.	 Interestingly,	 the	
authors	showed	that	2-deoxy-D-(1-3H)	glucose	(2-DG)	uptake	over	48	hours	 in	fat	cells	displayed	a	
circadian	rhythm	in	control	rats,	markedly	perturbed	in	diabetic	animals.	Indeed,	it	has	been	suggested	
that	 circadian	 regulation	 ensures	 the	 proper	 temporal	 orchestration	 of	metabolic	 processes	 upon	
physiological	conditions,	and	that	a	loss	of	circadian	rhythmicity	through	gene	knockout	is	associated	
with	disturbed	metabolic	homeostasis,	leading	to	obese	or	other	metabolic	phenotypes	(Englund	et	
al.,	2009,	Kondratov	et	al.,	2006,	Turek	et	al.,	2005,	Woon	et	al.,	2007).	Moreover,	 the	 factor	 that	
dominates	in	obesity	is	the	permanent	elevation	of	plasma	FFAs	and	the	predominant	utilisation	of	
lipids	by	the	muscle,	generating	a	diminution	of	glucose	uptake,	and	therefore	of	insulin	resistance	
(Felber	et	al.,	2002).	The	rise	in	insulin	secretion	appears	to	be	a	compensatory	mechanism	responding	
to	 the	 increased	 levels	 of	 circulating	 glucose,	 whilst	 the	 fall	 in	 insulin	 secretion	 occurs	 as	 a	 late	
phenomenon.	Work	 demonstrated	 that	 individuals	with	 impaired	 glucose	 tolerance	 (IGT)	 have	 an	
impaired	insulin	secretion,	with	evidence	that	impaired	pancreatic	beta	cell	function	would	precede	
the	onset	of	glucose	intolerance	(Mitrakou	et	al.,	1992,	Polonsky	et	al.,	1996).	
	
In	the	same	vein,	circadian	misalignment	lead	to	increased	risks	of	metabolic	disruptions	in	
rodents	and	humans	(Kalsbeek	et	al.,	2014,	Maury	et	al.,	2014,	Dibner	et	al.,	2015,	Perelis	et	al.,	2015,	
Perelis	 et	 al.,	 2016,	 Kiehn	 et	 al.,	 2017).	 Accumulating	 epidemiological	 evidence	 has	 indicated	 that	
circadian	disturbances	in	the	forms	of	shift	work	(Suwazono	et	al.,	2009,	Pan	et	al.,	2011),	late	meal	
timing	(Mattson	et	al.,	2014),	 late	chronotype	(Reutrakul	et	al.,	2014),	social	 jet-lag	(Parsons	et	al.,	
2015)	and	sleep	 loss	 (Nedeltcheva	et	al.,	2014)	are	associated	with	 increased	risks	of	T2D.	Further	
confirmation	 of	 a	 causal	 role	 of	 circadian	 disruption	 in	 the	 increased	 risk	 for	 T2D	 is	 provided	 by	
experimental	studies	showing	that	circadian	disruption	leads	to	impaired	glucose	controls	in	healthy	
participants	 (Morris	 et	 al.,	 2012).	 Circadian	 rhythms	 in	 blood	 glucose	 levels	 are	 associated	 with	
circadian	variation	in	the	insulin	response,	probably	secondary	to	changes	in	the	pancreatic	beta	cell	
sensitivity	to	glucose	(Aparicio	et	al.,	1974).	Studies	also	showed	an	impairment	in	glucose	tolerance	
occurring	 in	the	 latter	part	of	the	day	(Roberts	1964,	Keen	1966,	Bowen	et	al.,	1967,	Jarrett	et	al.,	
1969,	 Jarrett	 et	 al.,	 1970,	 Ben-Dyke	 1971,	 Carroll	 et	 al.,	 1973).	 Interestingly,	 the	 reduced	 glucose	
tolerance	 in	the	evening	was	not	simply	due	to	differences	 in	preceding	food	 intake	(Carroll	et	al.,	
1973).	Indeed,	it	is	now	accepted	that	oral	glucose,	intravenous	glucose	infusions	and	identical	meals	
all	result	in	a	significantly	higher	elevation	of	plasma	glucose	(lower	glucose	tolerance)	in	the	evening	
than	in	the	morning	(Van	Cauter	et	al.,	1997).	A	decreased	glucose	tolerance	is	a	risk	factor	for	and	
diagnostic	measure	of	T2D.	In	healthy,	normoglycaemic	individuals,	glucose	tolerance	in	response	to	
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an	identical	meal	 is	relatively	 impaired	in	the	evening	and	night,	as	compared	to	the	morning	(Van	
Cauter	et	al.,	1992).	
	
	 Circulating	blood	glucose	is	the	main	source	for	peripheral	glucose	rhythms,	with	the	principal	
glucose	transporters	in	fat	and	muscle	cells	being	GLUT1	and	4	(Fischer	et	al.,	1997).	About	90%	of	
GLUT4	is	located	in	intracellular	vesicles,	which	are	translocated	to	the	cell	surface	under	the	influence	
of	 insulin,	 among	 others	 (Shepherd	 et	 al.,	 1999),	 whereas	 GLUT1	 is	 located	 primarily	 on	 the	 cell	
surface.	An	inhibition	of	these	transporters	then	understandably	leads	to	a	complete	abolishment	of	
the	circadian	rhythm	of	2-DG	uptake.	What	was	then	hypothesised	by	Feneberg	and	colleagues	was	a	
relationship	between	Per1	expression	and	the	circadian	pattern	of	glucose	uptake.	Indeed,	the	protein	
kinase	 C	 and	 its	 isoforms	 are	 crucial	 for	 the	 action	 of	 insulin	 (Braiman	 et	 al.,	 1999,	 Farese	 2002,	
Nishitani	et	al.,	2002).	Additionally,	PKC	can	trigger	a	transient	surge	of	Per1	transcription	and	elicit	
rhythmic	 gene	 expression	 in	 Rat-1	 fibroblasts	 (Balsalobre	 et	 al.,	 2000b).	 The	 action	 of	 a	 potent	
inhibitor	of	PKC	did	not	lead	to	an	abolishment	of	the	circadian	pattern	of	glucose	uptake	under	basal	
and	insulin	stimulated	conditions,	but	inhibited	insulin-stimulated	glucose	uptake.	Therefore,	it	was	
concluded	that	the	role	of	PKC	is	not	pivotal	for	the	circadian	pattern	of	glucose	uptake,	but	that	Per1	
could	 play	 a	 potential	 role	 (Feneberg	 et	 al.,	 2004).	 It	 should	 be	 noted	 that	 these	 results	 came	 to	
contradict	 earlier	 work	 published	 in	 1996,	 describing	 that	 after	 insulin	 administration,	 GLUT4	
containing	vesicles	fused	with	the	plasma	membrane	and	delivered	the	transporter	to	its	site	of	action	
(Boden	et	al.,	1996).	As	a	result,	the	content	of	GLUT4	at	the	cellular	membrane	increases	and	the	
glucose	uptake	by	 the	cells	 is	 significantly	elevated.	Authors	 showed	 that	a	disruption	of	 circadian	
insulin	secretion	was	associated	with	a	reduced	glucose	uptake	 in	relatives	of	patients	with	type	2	
diabetes.	Normal	subjects,	however,	presented	circadian	cycles	of	insulin	secretion	and	plasma	insulin	
levels,	rising	in	the	early	morning	and	declining	during	the	night.	There	is	thus	accumulating	evidence	
that	 altered	 glucose	 homeostasis	 in	 shift	 work,	 obesity	 and	 diabetes	 involved	 adipose	 tissues.	
However,	a	main	gap	 in	our	knowledge	 is	 the	potential	 circadian	utilisation	of	other	carbon-based	
sources,	and	 the	 impact	of	a	 circadian	misalignment	on	 these	profiles.	Here,	we	showed	circadian	
variations	in	the	utilisation	of	64	other	carbon-based	sources,	with	different	peak	timings.	One	of	the	
substrates	 that	 exhibited	 circadian	utilisation,	 peaking	 in	 phase	with	α-D-Glucose,	was	α-Hydroxy-
Butyric	 acid	 (or	 α-hydroxybutyrate).	 α-Hydroxy-Butyric	 acid	 was	 identified	 as	 an	 early	marker	 for	
insulin	resistance	and	impaired	glucose	regulation	(Gall	et	al.,	2010),	with	the	underlying	biochemical	
mechanisms	 potentially	 involving	 an	 increased	 lipid	 oxidation	 and	 oxidative	 stress.	 It	 is	 becoming	
evident	 that	 plasma	 metabolites	 that	 distinguish	 isolated	 impaired	 glucose	 tolerance	 (iIGT)	 from	
isolated	impaired	fasting	glucose	(iIFG)	may	be	useful	biomarkers	to	predict	IGT,	a	high-risk	state	for	
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the	 development	 of	 type	 2	 diabetes.	 Targeted	 metabolomics	 with	 23	 metabolites	 previously	
associated	with	dysglycaemia	was	performed,	with	plasma	samples	from	subjects	without	diabetes	
(Cobb	et	al.,	2016).	Confirming	the	previous	study,	α-Hydroxy-Butyric	acid	was	reported	as	strongly	
associated	with	iIGT,	and	shown	to	be	a	selective	biomarker	of	iIGT	(independent	of	age,	sex,	BMI	and	
fasting	 glucose).	 This	 biomarker	 could	 then	be	used	 in	 predictive	models	 to	 identify	 subjects	with	
impaired	glucose	tolerance	without	performing	an	OGTT.	Among	the	substrates	tested,	mono-methyl	
succinate	was	also	found,	revealed	to	be	a	potent	insulin	secretagogue,	like	leucine	(MacDonald	et	al.,	
1989).	 Indeed,	 both	 released	 about	 one-third	 to	 one-half	 as	 much	 insulin	 as	 a	 near-maximal	 to	
maximal	insulinotropic	glucose	concentration.	As	observed	earlier,	mono-methyl	succinate	was	also	
shown	to	be	utilised	in	a	circadian	manner	by	pre-adipocytes	in	our	study;	with	a	peak-time	similar	to	
that	of	glucose.	Other	carbon	sources	studied	included	short	chain	fatty	acids	such	as	propionic	acid,	
butyric	 acid,	 and	 acetic	 acid.	 Butyrate,	 propionate	 and	 acetate	 all	 protected	 against	 diet-induced	
obesity	 and	 insulin	 resistance	 in	 mice	 (Lin	 et	 al.,	 2012).	 Butyrate	 and	 propionic	 acid	 were	 more	
effective	than	acetate.	In	our	case,	acetic	acid	was	not	utilised	in	any	circadian	manner,	contrary	to	
propionic	acid	which	presented	circadian	utilisation	dynamics	similar	to	that	of	glucose.	
	
	 Whilst	 the	 general	 enrichment	 analysis	 (MetaboAnalyst)	 of	 our	 clusters	 was	 inconclusive	
(likely	due	 to	 the	 relative	 low	number	of	only	91	carbon-based	sources	overall),	pathway	analyses	
highlighted	several	pathways	specifically	impacted	by	the	substrates	in	the	respective	clusters.	A	key	
pathway	 that	 shows	 is	 pyruvate	 metabolism:	 looking	 at	 pyruvate	 and	 acetate	 metabolism	 in	
hereditary	obesity-diabetes	syndrome	in	mice	revealed	that	obese	mice	do	not	catabolise	acetate	at	
the	same	rate	as	the	non-obese	animals	(Guggenheim	et	al.,	1952).	Acetate,	which	escapes	oxidation,	
is	to	a	large	degree	transformed	into	synthesised	fatty	acids,	and	comparison	of	the	pyruvate	oxidation	
curves	of	non-obese	mice	furnishes	evidence	in	vivo	of	a	block	in	carbohydrate	metabolism	in	diabetes	
below	 the	 pyruvate	 stage.	 This	 correlated	with	 later	work	 suggesting	 a	 defect	 in	 the	 oxidation	 of	
pyruvic	acid	as	a	cause	of	obesity	(Pennington	1954).	Furthermore,	pyruvate	consumption	reduces	the	
weight	 gain	 and	 food-conversion	 efficiency	 of	 obese	 Zucker	 rats,	 in	 part	 by	 increasing	 the	 resting	
metabolic	rate	and	fatty	acid	oxidation	(Cortez	et	al.,	1991).	In	our	study	in	pre-adipocytes,	pyruvic	
acid	was	utilised	in	a	circadian	fashion	and	with	a	similar	peak	utilisation	phase	as	glucose.	This	was	
also	 the	case	of	adenosine,	 for	which	a	daily	cyclic	 response	had	already	been	observed	 in	 the	rat	
blood	 (Chagoya	 de	 Sanchez	 et	 al.,	 1983).	 Similarly,	 we	 found	 a	 circadian	 rhythmicity	 in	 inosine	
utilisation	 rates	by	pre-adipocytes	 (peak	 similar	 to	 that	of	glucose),	with	 the	 same	study	 revealing	
inosine	levels	elevated	during	the	day	and	low	at	night.	In	addition,	it	was	indicated	that	the	decrease	
in	purine	catabolism	coincides	with	a	decrease	in	inosine	and	an	increase	in	adenosine.	Importantly,	
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it	was	shown	that	in	adipocytes,	acetoacetic	acid	and	succinamic	acid	(whose	utilisation	rates	peaked	
in	phase	with	glucose	in	our	study)	resulted	in	some	of	the	greatest	increases	in	dye	reduction	when	
using	the	same	approach	as	us;	in	accordance	with	our	results.		
	
In	the	second	cluster,	the	pentose	phosphate	pathway	was	impacted.	Interestingly,	it	has	been	
shown	that	genetic	and	pharmacological	inhibition	of	the	pentose	phosphate	pathway	prolongs	the	
period	 of	 circadian	 rhythms	 in	 human	 cells,	 mouse	 tissues,	 and	 fruit	 flies;	 and	 that	 the	 pentose	
phosphate	 pathway	 regulates	 circadian	 rhythms	 via	 nicotinamide	 adenine	 dinucleotide	 phosphate	
(NADPH)	metabolism,	suggesting	a	pivotal	role	for	NADPH	availability	in	circadian	timekeeping	(Rey	et	
al.,	2016).	Similarly,	glycolysis,	a	pathway	of	glucose	metabolism,	critically	regulates	insulin	secretion	
and	metabolic	functions	of	various	cells	(Guo	et	al.,	2012b).	Therefore,	targeting	key	metabolic	and	
regulatory	enzymes	to	enhance	glycolysis	may	offer	viable	approaches	for	the	treatment	of	diabetes.	
In	line	with	this,	glucose-6-phosphatase	was	shown	to	be	involved	in	the	action	of	insulin	to	control	
hepatic	glucose	production	(Gardner	et	al.,	1993).	The	Krebs	cycle	function	is	elevated	in	the	pathology	
of	diet-induced	hepatic	insulin	resistance	and	fatty	liver	(Satapati	et	al.,	2012).	Lipid	accumulation	and	
loss	of	insulin	action	results	in	elevated	oxidative	pathways	of	the	hepatic	Krebs	cycle,	with	elevated	
gluconeogenesis	from	the	Krebs	cycle	precursors	elevated.	An	increased	Krebs	cycle	flux	is	also	likely	
incited	by	a	dysfunctional	mitochondrial	respiration,	especially	during	later	stages	of	hepatic	insulin	
resistance.	Static	metabolic	analyses	showed	that	glutamate	(pathway	highly	represented	with	a	high	
impact	in	the	third	cluster)	and	constitutive	metabolites	of	the	Krebs	cycle	were	increased	in	the	WAT	
of	obese	mice	(ob/ob)	and	diet-induced	obesity	mice	but	not	in	the	liver	or	skeletal	muscle	of	these	
obese	mice	(Nagao	et	al.,	2017).	In	vivo	metabolic	turnover	analyses	demonstrated	that	these	glucose-
derived	metabolites	were	dynamically	and	specifically	produced	in	obese	WAT	compared	with	lean	
WAT.	This	second	cluster	of	energy	substrates	that	exhibits	utilisation	peaks	out-of-phase	with	α-D-
Glucose	includes	L-Glucose	and	D-Glucose-6-phosphate,	intermediates	of	the	glycolysis.	Among	this	
cluster	was	also	found	methyl	pyruvate,	another	component	of	the	glycolysis	but	also	of	the	Krebs	
cycle.	This	agent	was	proposed	to	have	therapeutic	benefit	in	the	treatment	of	diabetes	(Dukes	et	al.,	
1998).	For	this	substrate,	evidence	was	provided	that	the	insulinotropic	action	of	methyl	pyruvate	was	
mainly	 a	 consequence	 of	 a	 direct	 inhibition	 of	 adenosine	 triphosphate	 (ATP)-sensitive	 potassium	
channels,	rather	than	an	indirect	effect	via	augmented	ATP	production	due	to	its	metabolism	(Dufer	
et	al.,	2002).	This	was	of	particular	relevance,	since	steps	preceding	the	closure	of	these	ATP-sensitive	
potassium	channels	may	be	disturbed	in	T2DM.	
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In	the	third	cluster	of	carbon	sources	that	did	not	shown	circadian	rhythms	in	utilisation,	the	inositol	
phosphate	metabolism	was	highly	impacted	in	the	pathway	analysis.	We	found	that	in	pre-adipocytes,	
myo-inositol	was	not	utilised	in	a	circadian	or	rhythmic	manner.	A	study	shows	that	inositol,	via	myo-
inositol	among	others,	participates	in	both	insulin	signalling	and	glucose	metabolism	by	influencing	
distinct	pathways	(Bevilacqua	et	al.,	2018).	Indeed,	clinical	data	supports	the	beneficial	effects	exerted	
by	 inositol	 by	 reducing	 glycaemia	 levels	 and	 hyperinsulinemia	 and	 buffering	 negative	 effects	 of	
sustained	 insulin	 stimulation	 upon	 the	 adipose	 tissue	 and	 endocrine	 system.	 Another	 high-impact	
pathway	found	within	the	third	cluster	was	the	glycerolipid	metabolism.	It	is	well-known	that	lipolysis	
is	an	integral	part	of	the	glycerolipid/free	fatty	acid	cycle,	with	work	showing	that	alterations	in	the	
glycerolipid/FFAs	 cycling	 are	 involved	 in	 the	 pathogenesis	 of	 T2D,	 obesity	 and	 cancer.	 The	 two	
substrates	of	our	study	that	were	involved	in	this	pathway,	glycerol	and	propylene	glycol,	were	not	
found	to	be	utilised	by	pre-adipocytes	in	a	circadian	fashion,	however.	An	important	consideration	in	
assessing	the	limitation	of	our	study,	is	that	when	considering	all	91	different	carbon	sources	analysed,	
the	majority	of	them	were	widely	used	in	the	food	industry	as	thickeners,	sweeteners	or	stabilizers,	
on	 top	 of	 being	 key	 intermediates	 in	 key	metabolic	 pathways.	 Secondly,	 the	 over-representation	
analyses	in	MetaboAnalyst	indicated	the	impact	of	the	Warburg	effect	in	our	results.	This	effect	refers	
to	the	observation	in	oncology	that	even	in	aerobic	conditions,	cancer	cells	tend	to	favour	metabolism	
via	glycolysis,	rather	than	the	much	more	efficient	oxidative	phosphorylation	pathway	(preference	of	
most	other	cells	of	the	body).	Furthermore,	literature	indicates	that	the	Warburg	effect	with	aerobic	
glycolysis	 efficiently	 produced	 ATP	 synthesis	 and	 consequently	 promotes	 cell	 proliferation,	 by	
reprogramming	metabolism	 in	 order	 to	 increase	 glucose	 uptake	 and	 stimulate	 lactate	 production	
(Warburg	1956)				
	
Concluding	remarks	
	
	 The	 work	 undertaken	 here	 provided	 an	 important,	 although	 preliminary,	 insight	 into	 the	
circadian	utilisation	of	91	carbon-based	sources,	for	many	of	which	only	very	limited	information	is	
available	in	terms	of	their	circadian	utilisation	patterns	and	their	role	in	the	maintenance	of	circadian	
energy	homeostasis.	We	identified	two	clusters	of	carbon-based	sources	whose	utilisation	rates	were	
rhythmic,	and	in	anti-phase	from	each	other,	including	several	substrates	involved	in	key	metabolic	
pathways	such	as	the	Krebs	cycle	and	glycolysis.	As	a	next	step,	it	will	be	important	to	link	the	peak	of	
utilisation	rate	of	these	particular	sources	to	the	actual	biological	time	in	vivo,	providing	real-world	
insight	 into	differential	energy	source	utilisation.	 It	will	also	be	key	to	 investigate	for	each	of	these	
metabolites	whether	utilisation	timing	is	driven	directly	by	the	molecular	circadian	clock,	or	indirectly	
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through	their	sequential	position	in	key	metabolic	pathways.	In	the	long	term,	it	will	indeed	be	critical	
to	investigate	these	rhythms,	as	well	as	the	changes	in	their	utilisation	rates	as	a	result	of	a	circadian	
desynchrony.	 Initial	studies	 in	vitro	could	involve	experiments	of	co-cultured	adipocytes	with	other	
cell	types	that	provide	substrates	in	a	circadian	fashion.	This	would	require	either	culturing	two	types	
of	cells	in	a	same	dish,	or	on	separate	dishes	but	taking	the	culture	medium	of	the	first	cell	line	to	feed	
the	second	cell	line	and	vice	versa.	Further	ahead,	we	could	consider	animal	and	human	studies,	in	
which	the	utilisation	of	the	carbon-based	sources	are	measured	in	shift	work	protocols.		
	
		 In	summary,	these	data	provided	an	initial	validation	to	further	pursue	both	qualitative	and	
quantitative	approaches	to	assess	the	ability	of	adipose	tissue	to	metabolise	not	only	glucose,	but	a	
full	 array	 of	 energy	 sources	 potentially	 differentially	 affected	 by	 shift	 work.	 As	 such,	 one	 level	 of	
“circadian	 desynchrony”	 that	 may	 result	 from	 shift	 work	 could	 be	 within-cell	 misalignment	 of	
utilisation	of	different	energy	sources,	leading	to	disturbed	metabolic	homeostasis	at	the	cellular	level.		
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CHAPTER	4	
	
CIRCADIAN	RHYTHMS	IN	MEMBRANE	CAPACITANCE	
OF	PRE-ADIPOCYTES	REVEALED	BY	
DIELECTROPHORESIS	ARE	NOT	ASSOCIATED	WITH	
VARIATIONS	IN	CELLULAR	MORPHOLOGY	
	
4.1	Introduction	
	
	 Since	 it	 was	 first	 described	 by	 Pohl	 (Pohl	 1951,	 Pohl	 1958,	 Pohl	 1978),	 DEP	 on	 biological	
particles	 has	 received	 a	 renewed	 attention	 as	 an	 attractive	 technology	 for	 precise	 particle	
manipulation	in	a	variety	of	micro-bioprocesses	over	the	past	20	years.	DEP	is	similar	to	underlying	
the	processes	of	electrophoresis,	but	uses	more	complex	electric	field	conditions,	in	order	to	induce	
particle	 motion	 (dependent	 on	 the	 particles’	 electrophysiology)	 (figure	 1.18).	 Dielectrophoretic	
phenomena	occur	when	free-floating	particles	are	exposed	to	a	non-uniform	electrical	 field,	which	
results	in	their	polarisation,	according	to	their	dielectric	properties	(Pohl	1951).		If	the	electric	field	is	
non-uniform,	the	electrostatic	forces	at	each	pole	of	the	particle	are	unbalanced,	creating	a	net	force	
(Pohl,	 1958,	 Pohl,	 1978).	 The	 electric	 field	 is	 defined	 by	 a	 high-frequency	 alternating	 polarity,	
generated	by	a	simple	pin-pin	electrode	of	platinum,	of	a	size	between	that	of	a	postage	stamp	and	a	
credit	card	(Hughes	2002).	Unlike	electrophoresis,	where	motion	depends	solely	on	the	charge	of	the	
particle	(and	thus	only	charged	particles	will	exhibit	a	net	force),	the	velocity	and	direction	of	cellular	
motion	in	DEP	are	dependent	on	the	electrophysiological	properties;	in	the	case	of	a	cell,	the	various	
cellular	compartments,	and	the	frequency	of	the	applied	electric	field	(Pohl	1958,	Pohl	1978).		
	
	 A	 number	 of	 force	 transducers	 developed	 through	 the	 last	 few	 decades	 were	 applied	 to	
microfluidic	devices	and	used	to	manipulate	micro-particles	by	non-inertial	forces	including	DEP	force,	
leading	to	successful	microchip	designs	for	particle	and	cell	separation	(Tsutsui	et	al.,	2009).	The	DEP	
chip,	equipped	with	20	different	wells	(figure	2.6	B),	can	host	particles	in	suspension	(in	our	case	pre-
adipocytes,	represented	in	figure	2.7	C).	Under	a	highly	non-uniform	electric	field,	polarizable	particles	
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experience	a	 force	 in	 the	direction	along	 (positive	DEP)	or	against	 (negative	DEP)	 the	electric	 field	
gradient	 depending	 on	 their	 dielectric	 properties.	Whether	 a	 particle	 exhibits	 positive	 or	 negative	
dielectrophoresis	 is	 then	 dependent	 on	 its	 polarizability,	 relative	 to	 its	 surrounding	 medium.	
Differences	in	the	quantity	of	induced	charge	at	the	interface	between	particle	and	medium	lead	to	
dipoles	oriented	counter	to	the	applied	field	(positive	dielectrophoresis)	where	the	polarisability	of	
the	particle	is	more	than	that	of	the	medium,	or	in	the	same	direction	as	the	applied	field	(negative	
dielectrophoresis)	where	it	is	less	(Hughes	2002).	
	
	 Whilst	dielectrophoresis	is	applicable	to	particles	on	a	broad	range	of	scales	(from	nanometre	
to	millimetre),	its	main	application	over	the	last	five	decades	has	been	in	the	study	of	particles	in	the	
micrometre	scale,	particularly	eukaryotic	cells	(Nikolic-Jaric	et	al.,	2012).		At	certain	frequencies,	the	
sign	and	the	magnitude	of	the	DEP	force	are	sensitive	to	the	ionic	composition	of	the	biological	cell,	
and	this	is	directly	related	to	the	metabolism	and	physiological	properties	of	the	cells.	Consequently,	
this	 provides	 a	 way	 to	 successfully	 identify	 cells.	 At	 higher	 frequencies,	 the	 influence	 of	 ionic	
composition	is	minimal	and	instead,	the	permittivity	(reflecting	the	cell	type)	governs	the	detected	
signal.	Using	a	combination	of	cell	responses	from	two	distinct	frequency	regimes	allows	for	detection	
of	 subtle	 modifications	 in	 the	 electronic	 signatures	 of	 the	 cells,	 ultimately	 providing	 a	 powerful	
technique	 for	 discriminating	 between	 subpopulations	 of	 cells	 (characterised	 by	 different	 ionic	
composition)	within	a	large	population	of	similar	cells.	
	
	 DEP	 can	also	be	used	 to	assess	 the	polarizability	of	bacteria	or	 viruses,	which	allowed	 the	
distinction	between	different	types	of	bacteria,	for	instance	(Markx	et	al.,	1996).	In	this	case,	there	
was	an	entrapment	of	bacteria	from	a	fluid	of	relatively	 low	conductivity,	passing	through	the	DEP	
chamber	over	a	period	of	 time,	with	the	microelectrodes	energised	so	as	to	retain	the	bacteria	by	
positive	dielectrophoresis.	For	an	electrical	signal	of	constant	magnitude	and	frequency	applied	to	the	
microelectrodes,	 the	conductivity	at	which	the	bacterial	cells	are	released	from	the	electrodes	will	
depend	on	the	bacterial	particle	conductivity	and	size,	and	the	fluid	flow	rate.	Additionally,	there	is	
considerable	 interest	 in	 isolating	 umbilical	 cord	 blood	 34	 positive	 (CD34+)	 cell	 population	 from	
leukemic	patients	undergoing	peripheral	blood	stem	cell	harvests	(Stephens	et	al.,	1996).	Techniques	
using	antibodies	specific	to	the	CD34+	surface	markers	involve	disturbance	of	the	cell	surface,	are	time	
consuming	and	relatively	expensive.	Therefore,	DEP	was	used	to	separate	CD34+	cells	from	peripheral	
blood	stem	cell	harvest	samples	containing	an	untreated	natural	mixed	cell	population,	by	exploiting	
differences	in	the	inherent	dielectric	properties	of	the	various	cell	types.	DEP	allowed	a	fast	and	non-
invasive	 separation,	 and	 was	 also	 simple	 to	 operate.	 Another	 example	 is	 the	 rapid	 and	 efficient	
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separation	of	viable	and	non-viable	yeast	cells	(Markx	et	al.,	1994b).	In	this	case,	known	mixtures	of	
viable	 and	 heat-treated	 cells	 of	 Saccharomyces	 cerevisiae	 were	 separated	 and	 selectively	 isolated	
using	 positive	 and	 negative	 dielectrophoretic	 forces,	 generated	 by	 microelectrodes	 in	 a	 small	
chamber.	From	analyses	of	the	dielectrophoretic	and	electro-rotational	behaviour	of	yeast	cells,	it	was	
demonstrated	that	the	cytoplasmic	membrane	conductivity	of	the	cells	increased	on	heat	treatment	
by	 a	 factor	 of	 >600,	 alongside	 an	 approximate	 30	 times	 decrease	 in	 the	 internal	 cell	 conductivity	
(Huang	et	al.,	1992,	Markx	et	al.,	1994b).	To	discover	whether	human	leukocyte	subpopulations	might	
be	 separable	 by	 such	 methods,	 the	 dielectric	 characteristics	 of	 the	 four	 main	 leukocyte	
subpopulations,	 namely,	 B-	 and	 T-lymphocytes,	 monocytes,	 and	 granulocytes,	 were	measured	 by	
electro-rotation	(Yang	et	al.,	1999).	The	subpopulations	were	derived	from	human	peripheral	blood	
by	MACS,	and	 the	quality	of	 the	 cell	 fractions	was	 checked	by	 flow	cytometry.	Data	 revealed	 that	
dielectrophoretic	 cell	 sorters	 should	 have	 the	 ability	 to	 discriminate	 between,	 and	 to	 separate,	
leukocyte	subpopulations	under	appropriate	conditions.		
	 	 	
	 The	relevance	and	potential	of	this	low-cost	and	high-throughput	technique	(Faraghat	et	al.,	
2017)	in	physiology	is	vast,	and	has	provided	many	insights	in	various	areas	of	biological	research.	For	
example,	DEP	was	used	to	examine	a	panel	of	Michigan	Cancer	Foundation-7	(MCF-7)	cell	lines	(breast	
cancer	cells	lines)	comprising	parental	MCF-7	cells	and	multidrug	resistant	(MDR)	derivatives	(Coley	et	
al.,	2007).	Authors	demonstrated	significant	changes	in	the	cytoplasmic	conductivity	of	all	MDR	cell	
lines	relative	to	the	parent	line	and	to	each	other,	allowing	to	propose	a	model	based	on	biophysical	
factors	 that	 can	 explain	MDR.	 Thus,	 it	was	 suggested	 that	 the	 technique	of	DEP	may	be	useful	 in	
identifying	 populations	 of	 tumour	 cells	 with	 differing	 cell	 sensitivities	 on	 the	 basis	 of	 cytoplasmic	
conductivity	 measurements.	 Examples	 of	 DEP	 applications	 in	 delineating	 cell	 electrophysiological	
properties	 also	 included	 the	 observation	 that	 human	 breast	 cancer	 cells	 had	 a	 mean	 plasma	
membrane	specific	capacitance	over	twice	the	value	observed	for	resting	T-lymphocytes	(Gascoyne	et	
al.,	1997).	This	study	demonstrated	the	use	of	differential	DEP	forces	for	the	separation	of	several	
different	cancerous	cell	types	from	blood	in	a	dielectric	affinity	column.	Additionally,	DEP	enabled	the	
evaluation	 of	 the	 relative	 contributions	 of	 chloride	 (Cl-),	 K+	 and	 Ca2+	 ions	 to	 the	 cytoplasmic	
conductivities	of	drug	sensitive	and	resistant	myelogenous	leukemic	(K562)	cells	in	order	to	determine	
the	contributions	of	individual	ion	channel	activity	in	mediating	MDR	in	cancer	(Duncan	et	al.,	2008).	
Comparisons	between	drug	sensitive	(K562)	and	doxorubicin	(chemotherapy	drug)	resistant	leukemic	
(K562AR)	cancer	cells	revealed	that	whilst	K+	and	Ca2+	levels	were	extremely	similar,	levels	of	Cl-	were	
elevated	 up	 to	 three	 times	 in	 the	 resistant	 line,	 implying	 an	 increased	 chloride	 channel	 activity	
(Duncan	 et	 al.,	 2008).	 Importantly,	 other	 work	measured	 the	 cytoplasmic	 resistivity	 in	 atrial	 cells	
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through	DEP	 (Fry	 et	 al.,	 2012).	 Here,	 DEP	 experiments	 demonstrated	 the	 importance	 of	 including	
divalent	cations	(Ca2+	and	magnesium	(Mg2+))	in	the	suspension	medium,	as	their	omission	reduced	
cell	 integrity	 by	 lowering	 membrane	 resistivity	 and	 increasing	 cytoplasm	 resistivity.	 Accurate	
measurements	of	cytoplasmic	resistivity	are	essential	to	develop	quantitative	computational	models	
determining	the	key	factors	contributing	to	the	development	of	cardiac	arrhythmias.		
	
	 Dielectrophoretic	 collection	 methods	 allow	 the	 determination	 of	 large	 number	 of	 cells	
simultaneously,	 and	 cytoplasmic	 conductivity	 is	 a	 significant	marker	 of	 cell	 state,	 particularly	with	
respect	to	membrane	hyperpolarisation,	or	depolarisation,	after	necrosis	(Broche	et	al.,	2005).	Other	
factors	 influencing	 dielectric	 properties	 of	 a	 bio-particle	 are	 the	 surface	 charge,	 the	 membrane	
capacitance	and	the	membrane	conductivity.	If	drugs	such	as	antibiotics	change	any	of	these	factors,	
the	 dielectric	 properties	 of	 the	 cells	 change	 and	 can	 be	 detected.	 This	 change	 can	 be	 used	 to	
distinguish	between	cells	that	are	resistant	or	sensitive	to	a	drug,	for	example.	Dielectric	parameters	
of	the	cell	membrane	and	cytoplasm	are	derived	by	fitting	the	single-shell	mathematical	model	to	DEP	
forces,	measured	at	different	frequencies	of	alternating	polarity	of	the	electrical	field	(see	figures	2.8,	
2.9,	 2.10,	 2.11	 and	 section	 2.5.1)	 (Gimsa	 et	 al.,	 1991,	 Gascoyne	 et	 al.,	 1994,	 Huang	 et	 al.,	 1996).	
Measurements	 of	 the	 morphological	 changes	 that	 occur	 for	 cells	 undergoing	 cell	 death	 through	
chemically	 induced	apoptosis	were	 reported,	employing	DEP	 (Pethig	 et	al.,	 2007).	 The	parameters	
recorded	were	cell	size	and	the	electric	field	frequency	at	which	the	dielectric	properties	of	each	cell	
exactly	matched	 those	 of	 the	 surrounding	 electrolyte	 (DEP	 cross-over	 frequency).	 Determinations	
were	then	made	of	the	membrane	capacitance,	which	in	turn	enabled	changes	occurring	in	membrane	
surface	 features	 and	 the	 ionic	 porosity	 of	 the	 membrane	 to	 be	 monitored.	 Additionally,	 studies	
showed	 alterations	 in	 cell	 membrane	 capacitance	 and	 conductance	 during	 apoptosis	 progression	
(Wang	et	al.,	2002).	Indeed,	the	apparent	cell-specific	membrane	capacitance	decreased	as	apoptosis	
progressed,	 and	 changes	 in	 membrane	 conductance	 occurred	 later	 than	 the	 changes	 seen	 in	
membrane	capacitance.	There	was	a	60%	increase	in	membrane	conductance	observed	4	hours	after	
induction	 of	 apoptosis,	 which	 could	 be	 due	 to	 membrane	 alterations	 (Mower	 et	 al.,	 1994)	 and	
increased	 field-dependent	 ion	 migration	 through	 ion	 channels	 during	 apoptosis,	 rather	 than	 the	
permeabilisation	of	the	cells	(Wang	et	al.,	2002).	The	magnitude	of	the	membrane	capacitance	can	be	
taken	 as	 a	 measure	 of	 the	 total	 surface	 area	 of	 the	 cell	 (Pethig	 et	 al.,	 2005).	 Furthermore,	 the	
membrane	 conductance	 comprises	 two	 main	 components,	 namely	 the	 conductance	 across	 the	
membrane	associated	with	ion	flux	through	membrane	pores	and	ion	channels,	together	with	ionic	
conduction	parallel	to	the	membrane	surface	associated	with	the	electrical	double	layer	induced	by	
the	net	negative	 charge	 carried	by	 all	 cells.	 Lastly,	 simplifying	 assumptions	 can	be	used	 to	extract	
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useful	data	from	the	DEP	collection	spectra,	hence	determining	the	properties	of	multiple	populations	
of	cells	within	a	sample	(Broche	et	al.,	2005).	Specifically,	the	observation	of	the	frequencies	of	onset	
of	dielectric	dispersion	allows	the	identification	and	enumeration	of	populations	of	cells	according	to	
cytoplasmic	conductivity,	with	particular	 relevance	 to	 the	determination	of	 the	action	of	drugs	 for	
high-throughput	screening	applications.		
	
	 Work	published	applying	DEP	on	human	erythrocytes	in	vitro	showed	that	the	addition	of	an	
ionophore	changed	the	dielectric	properties	of	the	cells	(Gimsa	et	al.,	1994).	The	biological	relevance	
of	this	lies	in	the	ionophore-membrane	interaction,	which	causes	cell	shrinkage,	leading	to	a	decrease	
in	the	internal	conductivity	that	is	not	only	caused	by	ion	loss	but	also,	to	a	large	extent,	by	a	strong	
increase	of	hindrance	because	of	shrinkage	(Gimsa	et	al.,	1994,	Griffith	et	al.,	1998).	In	the	last	years,	
DEP	 has	 permitted	 the	 determination	 of	 a	 rhythmic	 K+	 transport	 regulating	 the	 circadian	 clock	 in	
human	 RBCs	 (Henslee	 et	 al.,	 2017).	 Indeed,	 it	 was	 shown	 that	 human	 RBCs	 display	 a	 circadian	
regulation	of	membrane	conductance	and	cytoplasmic	conductivity,	that	depends	on	the	cycling	of	
cytoplasmic	 K+	 levels.	 Using	 pharmacological	 intervention	 as	well	 as	 ion	 replacement,	 researchers	
revealed	that	an	inhibition	of	K+	transport	abolished	RBCs	electrophysiological	rhythms.	This	study	was	
the	 first	major	 contribution	of	DEP	 technology	 to	 the	 field	of	 chronobiology.	 The	particular	 added	
value	 of	 DEP	 to	 this	 area	 lies	 in	 the	 fact	 that	 red	 blood	 cells	 are	 a-nucleated,	 and	 therefore	 the	
identification	 of	 circadian	 rhythms	 could	 not	 be	 measured	 as,	 or	 driven	 by,	 the	 transcription-
translation	 circadian	 clock	 found	 in	 (almost	 all)	 nucleated	mammalian	 cells.	 Indeed,	 the	 circadian	
regulation	of	processes	such	as	metabolism,	redox	balance,	and	proteasomal	degradation	persist	in	
naturally	anucleate,	isolated	human	and	mouse	RBCs,	suggesting	that	gene	expression	cycles	are	not	
essential	 for	 some	 form	of	molecular	 clockwork	 to	persist.	 Results	 indicated	 that	RBCs	maintain	 a	
circadian	rhythm	in	membrane	electrophysiology	through	dynamic	regulations	of	K+	transport,	in	the	
absence	of	conventional	transcription	cycles.		
	
	 We	here	 set	 to	apply	 the	 same	DEP	approach	 to	 investigate	whether	 circadian	 changes	 in	
electrophysiological	properties,	similar	to	those	seen	in	erythrocytes	(Henslee	et	al.,	2017),	could	be	
observed	in	pre-adipocytes.	Dielectrophoresis	potential	has	indeed	been	used	on	adipose	stem	cells	
(ASCs),	allowing	the	determination	of	their	dielectric	and	electro-kinetic	properties,	to	compare	these	
attributes	with	another	cell	type,	bone-marrow	mesenchymal	stromal	cells	(BM-MSCs)	(El-Badawy	et	
al.,	2016).	However,	to	date,	DEP	has	not	been	used	on	adipose	cells	(or	many	other	cell	types	for	that	
matter)	 to	determine	 their	electrophysiological	properties	across	 the	circadian	 time.	We	therefore	
used	 this	 tool	 to	 interrogate	 potential	 circadian	 changes	 in	 electrophysiological	 aspects	 of	 pre-
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adipocytes,	 namely	 in	 the	 ionic	 transport	 across	 the	membrane	and	on	 its	 surface,	 also	 known	as	
membrane	conductance;	 the	cellular	morphology	and/or	composition	 (reflected	by	 the	membrane	
capacitance);	 as	 well	 as	 the	 sum	 of	 the	 positive	 and	 negative	 charges	 in	 the	 cell	 (cytoplasmic	
conductivity).	We	next	aimed	to	relate	these	DEP	measures	to	changes	in	cellular	morphology	across	
the	circadian	time,	using	a	conventional	approach:	confocal	microscopy.	
	
4.2	Aim,	hypothesis	and	objectives	
	
4.2.1	Aim	
	
	 The	aim	of	this	work	was	to	establish	circadian	rhythms	in	membrane	capacitance,	membrane	
conductance	and	cytoplasmic	conductivity	of	pre-adipocytes	using	the	DEP	technology,	and	to	relate	
any	rhythms	in	these	measures	to	changes	in	cell	morphology	over	time	using	confocal	microscopy.		
	
4.2.2	Hypothesis			
	
	 Electrophysiological	parameters	reflecting	the	cellular	morphology	and	ionic	activity	between	
the	cell	and	its	external	environment	vary	in	a	circadian	manner	in	pre-adipocytes.	
	
4.2.3	Objectives	
	
Specific	objective	1:	Optimise	 the	DEP	 technology	method	 for	use	 in	pre-adipocytes,	 specifically	 in	
terms	of	medium	conductivity.		
	
Specific	objective	2:	Evaluate	the	ionic	transport	across	the	membrane	and	on	its	surface,	the	cellular	
morphology	 as	 well	 as	 the	 free	 ionic	 concentration	 within	 the	 cytoplasm,	 at	 regular	 intervals	
throughout	the	circadian	time,	in	3T3-L1	cells.	
	
Specific	objective	3:	Use	confocal	microscopy	to	associate	circadian	changes	in	DEP-derived	measures	
with	variations	of	cellular	morphology,	namely	cell	volume,	diameter,	sphericity	and	surface.	
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4.3	Methods	
	
4.3.1	DEP	applied	on	3T3-L1	Per2-dLuc	pre-adipocytes	
	
	 The	first	objective	of	this	project	was	to	optimise	the	composition	of	the	DEP	medium,	with	a	
view	 of	 maximising	 the	 fit	 of	 the	 single-shell	 model	 to	 the	 DEP	 forces	 measured	 at	 different	
frequencies	 of	 changes	 in	 polarity.	 An	 optimal	 medium	 was	 defined	 as	 a	 medium	 in	 which	 DEP	
measures	achieved:	
	
- Robust	negative	values	at	low	frequencies	known	as	“initial	negativity”.	
- An	initial	cross-over	frequency	(fxo1),	at	which	cells	experienced	zero	DEP	force	and	exhibited	
no	movement.	
- An	increase	in	the	DEP	force,	as	frequencies	become	greater,	to	positive	values	after	the	initial	
cross-over	frequency.	
- A	stable	plateau	phase	in	which	DEP	measures	do	not	change	with	 increasing	frequency	of	
polarity	changes	following	the	initial	rise	of	DEP	force.		
- A	final	decrease	in	the	DEP	force	at	high	frequencies	of	polarity	changes,	which	can	ultimately	
become	negative	after	reaching	a	second	cross-over	frequency	(fxo2).	
	
	 Fitting	of	the	single-shell	model	to	the	measures	of	DEP	forces	at	different	frequencies,	and	
especially	the	plateau	phase,	is	mainly	affected	by	the	presence,	or	absence,	of	CaCl2	and	MgCl2	in	the	
DEP	 medium.	 Therefore,	 the	 concentration	 of	 these	 “ions”	 or	 “salts”	 was	 varied.	 Moreover,	 the	
presence	of	negative	and	positive	values	of	DEP	force	at	different	frequencies	in	polarity	changes	is	a	
function	of	medium	conductivity.	If	the	medium	conductivity	is	too	high,	the	positive	DEP	force	values	
cannot	be	reached,	and	inversely,	a	too	low	medium	conductivity	can	lead	to	an	absence	of	negative	
DEP	force	values.	We	therefore	tested	media	with	and	without	0.1mM	CaCl2	and	0.25mM	MgCl2,	and	
of	 different	 conductivities	 (10,	 45,	 55	 and	 65mS/m).	 These	 various	 medium	 conductivities	 were	
measured	using	a	conductivity	meter,	and	adjusted	with	1X-PBS	and/or	DEP	medium.	1X-PBS	has	a	
high	 conductivity	 of	 1500-2000mS/m,	 and	 was	 therefore	 employed	 to	 increase	 the	 medium	
conductivity.	 If	the	conductivity	needed	to	be	lowered,	more	DEP	medium	(of	a	 lower	conductivity	
than	1X-PBS)	was	added.		
	
	 3T3-L1	Per2-dLuc	pre-adipocytes	were	grown	in	T75	flasks,	as	outlined	in	section	2.3.3	of	the	
methods	chapter,	until	reaching	approximately	80%	confluence.	At	this	point,	cells	where	washed	with	
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1X-PBS,	trypsinised,	and	pelleted	after	centrifugation	at	200g	(4	minutes,	details	in	section	2.3.3).	The	
pellet	was	then	resuspended	in	2mL	of	DMEM	medium,	before	the	cell	density	was	adjusted	to	2.105	
cells/mL	 (counted	 using	 a	 disposable	 haemocytometer,	 Labtech	 -	 see	 section	 2.5.1).	 1mL	 of	 the	
resulting	cell	suspension	was	transferred	in	a	well	of	a	6-well	plate,	supplemented	by	1mL	of	DMEM	
medium.	Cells	were	subsequently	incubated	at	37°C	with	5%	CO2	for	48	hours,	after	which	they	had	
adhered	to	the	bottom	of	the	wells,	and	reached	near	full	confluency.	At	this	point,	the	cell	density	
was	 estimated	 at	 5.105	 cells/mL,	 based	 on	 cell	 counting	 of	 pre-adipocytes	 in	 a	 confluent	 35mm	
diameter	well.	The	circadian	clocks	of	the	cells	were	then	synchronised	using	a	2-hour	serum	shock	
(described	in	section	2.3.6).	For	measuring	DEP	forces,	the	cells	contained	in	2	wells	were	trypsinised	
and	centrifuged	(200g,	4	minutes)	in	DMEM	medium	(section	2.3.3)	in	order	to	have	a	cell	density	of	
1.106	cells/mL.	From	previous	experience,	a	higher	density	led	to	an	impossible	cell	movement	within	
the	wells	of	the	DEP	chip	due	to	a	too	high	number	of	cells,	and	inversely	a	lower	density	led	to	noisy	
data	as	too	less	cells	were	considered	in	the	recordings.	The	pellet	of	these	two	wells	combined	was	
then	re-suspended	in	the	appropriate	DEP	medium	(with	varying	concentrations	of	CaCl2	and	MgCl2	
as	 well	 as	 different	 conductivities),	 before	 another	 centrifugation	 step	 (4	 minutes,	 200g)	 was	
undertaken.	Finally,	the	pellet	was	re-suspended	in	1mL	of	DEP	medium,	and	transferred	to	a	1.5mL	
Eppendorf	tube	after	a	careful	mix.	
	
	 DEP	 forces	 at	 different	 frequency	 ranges	 were	 measured	 using	 the	 3DEP	 reader	 device	
(DEPtech,	figure	2.7	B).	To	achieve	this,	the	DEP	chip	was	rinsed	with	the	appropriate	DEP	medium	
using	a	needled	syringe,	and	the	wells	of	the	chip	were	subsequently	filled	by	approximately	75µL	of	
the	cell	suspension	following	the	same	method.	To	ensure	that	the	20	wells	of	the	chip	were	all	fully	
charged	 with	 cells,	 an	 excess	 of	 cell	 suspension	 was	 left,	 before	 a	 squared	 glass	 cover-slip	
(18mmx18mm)	was	 used	 to	 cover	 the	wells.	 The	 chip	was	 then	 inserted	 to	 the	 3DEP	 reader,	 for	
recording	of	DEP	forces	at	increasing	frequencies	of	polarity	changes,	during	30	seconds.	With	1mL	of	
cell	suspension,	a	total	of	7	to	9	technical	replicates	of	DEP	force	measurements	could	be	recorded,	
out	 of	 which	 3	 to	 5	 were	 plotted	 together	 to	 fit	 the	 single-shell	 model	 before	 extraction	 of	 the	
electrophysiological	 parameters.	We	 chose	 this	 replicate	 inclusion	 range	 as	 less	 than	 3	 recordings	
(spectra)	put	 together	 is	not	enough	 for	 the	 fit	of	 the	 single-shell	model	 to	 reflect	 an	appropriate	
average	within	the	data,	and	thus	optimal	electrophysiolgical	behaviour.	On	the	other	hand,	too	many	
recordings	could	lead	to	too	many	data	points	and	potentially	noisy	data,	again	interfering	with	the	
final	results.	Analysis	was	undertaken	via	the	3DEP	analysis	software	(DEPtech,	version	1.2.0.00).		
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	 The	comparison	of	the	DEP	forces	measured,	and	the	single-shell	model	fits	to	these	forces	
for	pre-adipocytes	recorded	in	a	medium	with	or	without	ions,	exposed	different	dynamics	and	model	
fits.	In	both	cases,	we	observed	an	initial	negativity	in	DEP	force	before	the	fxo1	cross-over	frequency	
was	 reached.	These	negative	DEP	 forces	did	not	differ	between	cells	measured	 in	 the	presence	or	
absence	of	ions	in	the	medium,	and	in	both	cases	the	cross-over	frequency	was	approximately	of	the	
same	value	(between	33	and	50	kHz)	(figure	4.1).	Interestingly,	the	mean	plateau	values	were	higher	
in	cells	measured	in	a	medium	containing	CaCl2	and	MgCl2,	reaching	a	mean	relative	DEP	force	of	0.4	
to	0.6	against	0.2	(arbitrary	units)	without	ions	(figure	4.2).	When	measuring	DEP	forces	of	cells	in	a	
medium	containing	CaCl2	and	MgCl2,	the	values	were	seen	to	plateau	between	polarity	changes	at	0.1	
to	10MHz.	In	a	medium	without	ions,	the	plateau	phase	was	“unstable”,	as	presenting	a	convex	shape	
rather	 than	 a	 plateau	 (figure	 4.2).	 Taking	 these	 findings	 into	 account,	 also	 considering	 that	 the	
presence	of	CaCl2	and	MgCl2	led	to	a	higher	R2	value	of	the	single-shell	model	fit	to	the	DEP	forces	of	
0.95	instead	of	0.85,	we	decided	that	the	optimal	approach	was	to	use	a	DEP	medium	supplemented	
with	CaCl2	and	MgCl2	for	our	main	experiments.	The	full	method	description	is	detailed	in	section	2.5.1.	
	
	
	
Figure	4.1:	DEP	spectra	recorded	on	3T3-L1	Per2-dLuc	cells	with	and	without	MgCl2	and	CaCl2.	This	
figure	shows	the	DEP	response	of	3T3-L1	Per2-dLuc	pre-adipocytes	suspended	with	(A)	or	without	(B)	
MgCl2	 and	 CaCl2.	 The	 two	 spectra	 represent	 results	 of	 DEP	 force	 (relative,	 without	 units)	 plotted	
against	the	different	frequencies	applied	to	the	chip	wells	by	the	reader	(in	Hz,	logarithmic	scale).		
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Figure	4.2:	3T3-L1	Per2-dLuc	DEP	spectra	of	3	technical	replicates	loaded	together	with	and	without	
ions.	3	technical	 replicates	 (n=3)	representing	the	DEP	response	of	3T3-L1	pre-adipocytes	 in	a	DEP	
medium	supplemented	(A)	or	deprived	(B)	of	MgCl2	and	CaCl2	were	 loaded	together.	A	model	was	
automatically	fitted	to	the	experimental	data	after	outliers	(defined	by	excel)	were	manually	removed,	
in	order	to	obtain	the	R2	value,	and	compare	it	between	the	two	conditions.	R2	values	were	evaluated	
at	0.95	with	ions	(A)	and	0.85	without	(B).	
	 	
	 The	second	part	of	the	optimisation	of	the	method	was	to	assess	the	effect	of	various	medium	
conductivities:	10mS/m,	43mS/m,	55mS/m	and	65ms/m	on	the	fit	of	the	single-shell	model	to	the	DEP	
forces	measured.	At	10mS/m,	no	initial	negative	DEP	force	values	were	observed,	indicative	that	this	
medium	conductivity	was	 too	 low	 (see	 figure	4.3	A).	The	consequence	of	 the	absence	of	an	 initial	
negativity	is	that	the	membrane	capacitance	and	conductance	cannot	be	determined	appropriately	
from	the	single-shell	model	fitted	to	the	data	(figures	2.9	and	2.10,	section	2.5.1).	The	remaining	three	
conductivities:	43mS/m,	55mS/m	and	65mS/m,	all	resulted	in	DEP	force	measurements	to	which	we	
could	successfully	fit	a	single-shell	model	of	appropriate	shape	(figure	4.3	B,	C	and	D	respectively).	
Indeed,	negative	DEP	forces	were	recorded	at	low	frequencies	in	polarity	changes,	and	were	then	seen	
to	increase	so	as	to	reach	the	null	DEP	force	(fxo1	frequency).	At	higher	frequencies,	DEP	force	values	
progressively	raised,	to	plateau	and	finally	decrease.	For	a	medium	conductivity	of	43mS/m	(figure	4.3	
B),	the	cross-over	frequency	was	reached	only	after	the	second	lowest	frequency	(15kHZ),	and	this	
early	cross-over	led	to	a	suboptimal	fit	of	the	single-shell	model.	At	this	conductivity,	the	initial	DEP	
forces	before	the	first	cross-over	frequency	were	also	quite	high	(as	reaching	only	-0.06	maximum).	
Moreover,	the	plateau	values	of	DEP	forces	were	low,	as	averaged	between	DEP	forces	of	0.05	and	
0.15	only.	This	suggested	that	the	medium	conductivity	was,	once	again,	too	low.	At	60mS/m	(figure	
4.3	D),	the	plateau	values	were	of	higher	DEP	forces,	as	averaging	at	approximately	0.5,	and	the	initial	
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negative	values	lower	(reaching	-0.5),	as	compared	to	10mS/m.	However,	the	rate	of	increase	in	DEP	
force	following	the	initial	negativity	was	too	slow.	Furthermore,	DEP	forces	values	were	not	decreasing	
as	 noticeably	 as	 the	other	 examples,	which	meant	 that	 the	 cytoplasmic	 conductivity	 could	not	 be	
determined	 appropriately	 from	 the	 single-shell	 model	 fit.	 This	 was	 indicative	 that	 the	 medium	
conductivity	was,	in	this	case,	too	high.	When	measured	in	medium	with	a	conductivity	of	55mS/m	
(figure	4.3	C),	the	initial	negative	DEP	force	values	were	starting	at	between	-0.4	and	-0.2,	which	was	
lower	 than	at	43mS/m.	Furthermore,	data	points	were	 found	to	plateau	at	a	DEP	 force	comprised	
between	 0.4	 and	 0.6	 (therefore	 higher	 than	 at	 43mS/m),	 and	 in	 line	 with	 the	 example	 spectrum	
presented	 in	 figure	 2.9.	 The	 R2	 values	 (summarised	 in	 table	 4.1	 and	 expressed	 in	 arbitrary	 units)	
confirmed	that	the	best	fit	of	the	DEP	forces	to	the	single-shell	model	was	for	a	medium	conductivity	
of	55mS/m	 (0.94	against	0.83	 for	10mS/m,	0.86	 for	43mS/m	and	0.89	 for	65mS/m).	A	medium	of	
55mS.m-1	was	therefore	chosen	for	future	work.	Additionally,	we	found	that	for	all	media	tested,	the	
DEP	forces	often	decreased	at	high	frequencies	after	the	plateau,	but	without	reaching	the	second	
cross-over	frequency	(fxo2,	when	the	DEP	force	value	become	negative	once	again).	This	meant	that	
we	could	not	accurately	infer	the	cytoplasmic	permittivity	from	the	shell	model	for	our	experiments	
with	pre-adipocytes.	These	optimisation	steps	were	only	performed	once,	explaining	the	absence	of	
standard	deviations	and	standard	errors	of	the	mean.		
	
	
	
	
	
	
	
	
	
Figure	4.3:	DEP	response	of	3T3-
L1	 Per2-dLuc	 cells	 to	 various	
medium	 conductivities.	 Cells	
were	 resuspended	 in	 DEP	
medium	 containing	 MgCl2	 and	
CaCl2,	 and	 adjusted	 to	 various	
conductivities:	 10mS/m	 (A),	
43mS/m	 (B),	 55mS/m	 (C)	 and	
65mS/m	 (D).	 3	 to	 5	 technical	
replicates	 (3<n<5)	 were	 loaded	
on	 top	 of	 each	 other,	 before	
fitting	 the	 single-shell	 model	 to	
the	 data	 and	 extracting	 the	 R2	
values,	 after	 removal	of	outliers.	
A B
C D
176	
	
Table	4.1:	Summary	of	the	R2	values	for	DEP	media	of	10,	43,	55	and	65mS/m.	R2	values	are	expressed	
in	arbitrary	units.	
	
MEDIUM	CONDUCTIVITY	 10mS/m	 43mS/m	 55mS/m	 65mS/m	
R2	 0.83	 0.86	 0.94	 0.89	
	
	 Once	we	 had	 optimised	 the	 DEP	medium	 composition	 and	 conductivity	 for	 use	with	 pre-
adipocytes,	the	next	objective	was	to	record	the	DEP	forces	at	varying	frequencies	in	polarity	changes	
across	the	circadian	cycle.	3T3-L1	Per2-dLuc	pre-adipose	cells,	from	liquid	nitrogen	stock,	were	grown	
to	80%	confluence	 in	T75	 flasks	 (section	2.3.3),	 and	plated	 into	6-well	 plates	 at	 a	density	of	2.105	
cells/mL	 (section	 2.5.1).	 After	 a	 48-hour	 incubation	 (37°C,	 5%	 CO2),	 cells	 were	 estimated	 to	 have	
reached	a	density	of	5.105	cells/mL.	A	2-hour	serum	shock	was	then	applied	to	the	wells	(section	2.3.6	
of	the	methods	chapter).	Cells	were	prepared	for	DEP	measurements	every	4	hours	between	4	and	72	
hours	following	the	serum	shock.	
	
	 Prior	 to	 recording,	 the	cells	of	2	wells	were	carefully	washed	using	1mL	of	1X-PBS.	1mL	of	
Trypsin-EDTA	 was	 added	 into	 each	 well	 for	 cell	 detachment.	 After	 trypsinisation,	 1mL	 of	 DMEM	
medium	was	inserted	in	each	well	to	stop	the	trypsinisation	reaction,	before	the	content	of	the	two	
wells	was	combined	and	centrifuged	(200g,	4	minutes	-	section	2.3.3).	The	supernatant	was	discarded,	
and	the	pellet	resuspended	in	5mL	of	DEP	medium	at	55mS.m-1	supplemented	with	0.1mM	CaCl2	and	
0.25mM	 MgCl2,	 before	 another	 centrifugation	 (200g,	 4	 minutes).	 The	 resulting	 cell	 pellet	 was	
resuspended	in	1mL	of	the	same	DEP	medium.	At	this	stage,	10µL	of	the	cell	suspension	was	inserted	
into	the	chamber	of	a	disposable	haemocytometer	(Labtech),	and	photomicrographs	of	the	cells	were	
taken	for	radius	determination	(50	cells	per	sample	were	analysed,	using	ImageJ	version	2.0).	The	cells	
were	transferred	to	the	DEP	chip,	using	a	needled	syringe,	and	DEP	forces	were	recorded	using	the	
3DEP	reader	the	same	way	as	explained	earlier	in	this	section.	For	each	time	point,	a	total	of	1	to	6	
biological	replicates	were	measured,	with	7	to	9	recordings	(technical	replicates)	made	at	every	time	
point	and	experimental	 replicate.	As	explained	previously,	only	3	 to	5	of	 these	technical	 replicates	
were	loaded	together	for	analysis	before	fitting	the	single-shell	model	and	the	membrane	capacitance,	
conductance,	and	cytoplasmic	conductivity	of	the	cells	were	inferred	from	the	model,	using	the	3DEP	
analysis	software	(3DEP,	version	1.2.0.00).	The	full	method	description	is	detailed	in	section	2.5.1.	All	
graphs	were	made	using	Graph-Pad	Prism,	version	7.0.		
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4.3.2	Confocal	microscopy	
	
	 3T3-L1	Per2-dLuc	pre-adipocytes	were	grown	in	T75	flasks	using	normal	growing	medium,	at	
37°C	and	5%	CO2.	When	reaching	80-90%	confluence,	cells	were	rinsed	using	1X-PBS,	before	being	
trypsinised	 (section	 2.3.3).	 The	 resulting	 cell	 suspension	was	 then	mixed	 to	DMEM	medium	upon	
centrifugation	(4	minutes	at	200g,	section	2.3.3),	after	which	the	pellet	was	resuspended	in	2mL	of	
DMEM	medium.	The	cell	density	was	adjusted	to	2.105	cells/mL,	using	a	disposable	haemocytometer	
(section	2.5.1),	before	cells	were	transferred	into	a	6-well	plate,	where	each	well	was	equipped	with	
a	glass	cover-slip	(22mmx22mm)	to	allow	a	better	resolution	for	later	imaging	of	the	samples.	Prior	to	
the	insertion	of	the	cells	in	the	plate,	cover-slips	were	washed	and	sterilised	(section	2.5.2.1),	before	
pre-coating	with	poly-D-Lysine,	to	ensure	cell	adherence	(sections	2.2.8	and	2.3.5.3).	Once	plated,	the	
cells	were	left	for	24	hours,	after	which	they	were	approximately	60%	confluent.	It	was	important	for	
the	cells	not	to	become	too	confluent	as	the	aim	was	to	image	single	cells.	Pre-adipocytes	were	then	
serum	shocked	for	2	hours	(section	2.3.6).	The	medium	was	discarded	and	the	wells	rinsed	using	1mL	
of	1X-PBS,	replaced	with	2mL	of	DMEM	medium.	Every	4	hours	between	24	and	52	hours	after	serum	
shock,	cells	were	fixed	using	4%	formalin	(see	section	2.5.2.2).	Plates	containing	fixed	cells	were	stored	
at	4°C	wrapped	in	foil.		
	
	 Within	 a	 month	 following	 this	 procedure,	 cells	 were	 stained	 for	 either	 nuclear	 and	
cytoskeleton	markers,	or	nuclear	and	membrane	markers.	A	DAPI	stain	was	used	for	the	nuclei,	Actin	
Green	for	the	cytoskeleton	and	a	Deep	Red	dye	staining	kit	for	the	membrane	(section	2.5.2.2).	Cells	
were	imaged	immediately	upon	staining,	or	stored	at	4°C	in	2mL	of	1X-PBS	for	a	maximum	period	of	
48	hours	before	confocal	analysis,	in	order	to	preserve	high-intensity	staining	signals,	with	the	plate	
wrapped	in	foil	for	light	protection.	Before	imaging,	the	cover-slips	containing	the	stained	cells	were	
carefully	placed	in	the	centre	of	a	glass	slide	(76mmx26mm),	with	the	side	of	the	cover-slip	containing	
the	cells	placed	against	the	glass	side.		
	
	 Confocal	 imaging	 was	 done	 using	 a	 Nikon	 A1M	 Ti-Eclipse	 microscope,	 adapted	 to	 a	
measurement	software	(NIS-Elements	AR	version	4.6).	The	slide	was	placed	so	the	centre	of	the	cover-
slip	 was	 in	 the	 middle	 of	 the	 light	 path	 of	 the	 microscope.	 Using	 an	 automated	 approach,	 the	
measurement	software	defined	random	coordinates	across	the	cover-slip.	At	every	coordinate	and	
using	the	magnification	x60	of	the	microscope,	a	full	field	of	view	was	first	captured.	We	then	zoomed	
in	on	each	isolated	cell	that	was	completely	represented	within	the	field	of	view.	For	every	cell	meeting	
these	criteria,	we	acquired	 top	 to	bottom	z-stack	of	 images	consisting	of	50	slices	 taken	across	an	
178	
	
individual	cell.	We	counted	all	isolated	cells	at	the	randomly	chosen	location	and	moved	to	the	next	
coordinate	until	at	 least	10	different	cells	(technical	replicates)	were	analysed.	Using	the	3D	object	
measurement	module	within	the	NIS-Elements	AR	software,	parameters	such	as	the	cellular	volume,	
diameter,	sphericity	and	surface	area	were	extracted.	The	full	description	of	the	methods	can	be	found	
in	section	2.5.2.		
	
4.4	Statistics		
	
	 For	DEP,	variations	in	all	measures	of	cell	radii	were	assessed	using	a	one-way	ANOVA	(Graph-
Pad	prism	version	7.0).	Significant	variations	 in	 the	data	were	 indicated	by	a	p-value<0.05.	For	 the	
membrane	 capacitance	 and	 conductance	 as	 well	 as	 the	 cytoplasmic	 conductivity	 and	 parameters	
extracted	from	confocal	analysis,	a	cosine	curve	was	fitted	to	the	data	plotted	across	the	circadian	
time.	This	was	done	against	the	null	hypothesis	of	a	straight	line.	A	significant	p-value	(<0.05)	revealed	
a	 temporal	 variation	 in	 the	 data.	 In	 this	 case,	 the	 hypothesis	 of	 a	 straight	 line	was	 rejected	 for	 a	
preferred	 model	 of	 a	 cosine	 curve	 (Graph-Pad	 Prism	 version	 7.0).	 The	 tool	 used	 to	 test	 the	 null	
hypothesis	of	a	straight	line	against	a	cosine	curve	to	fit	the	data	was	a	non-linear	regression	fit,	and	
the	equation	of	the	cosine	curve	can	be	found	is	detailed	in	section	2.4.2.5.	From	this	equation	were	
extracted	the	amplitude,	the	mesor,	the	period,	the	acrophase	and	a	R2	value.	A	circadian	rhythm	was	
considered	for	a	periodicity	of	24±5	hours.	Additionally,	a	one-way	ANOVA	was	done	for	the	volume,	
surface,	diameter	and	sphericity	values	measured	using	confocal	microscopy	across	the	circadian	time,	
in	order	to	compare	the	two	types	of	analyses	and	make	sure	both	led	to	the	same	results.		
	
4.5	Results		
	
4.5.1	Circadian	 time	 series	of	DEP	 forces,	 shell-model	predicted	measures	of	membrane	
capacitance,	conductance	and	cytoplasmic	conductivity	
	
	 The	cell	radii	of	pre-adipocytes	measured	for	each	sample,	at	every	time	point,	showed	no	
significant	 variation	 over	 time	 (one-way	 ANOVA,	 p>0.05).	 Radii	 were	measured	 on	 a	 total	 of	 n=5	
biological	replicates	between	0	and	20	hours,	n=6	between	24	and	48	hours,	and	n=1	between	52	and	
72	hours	following	serum	shock	(figure	4.4).		
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Figure	 4.4:	 Cell	 radii	 averaged	 values	 across	 the	 circadian	 time.	 For	 each	 biological	 replicate	
measured	 and	 time	 point,	 radii	 values	 were	 averaged	 on	 a	 total	 of	 50	 cells,	 and	 the	 value	 was	
represented	on	the	graph	by	the	different	symbol.	A	total	of	n=5	biological	replicates	between	0	and	
20	hours	following	serum	shock,	n=6	biological	replicates	between	24	and	48	hours	after	serum	shock,	
and	n=1	biological	replicate	between	52	and	72	hours	post	synchronisation	were	considered.	A	one-
way	ANOVA,	all	replicates	taken	into	consideration,	indicated	no	significant	variation	in	the	data,	as	
p=0.0728.	
	
	 To	 be	 able	 to	 fit	 a	 single-shell	model	 to	 the	DEP	 forces	 obtained	 on	 those	 same	 samples,	
allowing	the	determination	of	the	membrane	capacitance	(F/m2),	conductance	(S/m2)	and	cytoplasmic	
conductivity	(S/m),	these	cell	radii	needed	to	be	entered	into	the	equation	of	the	single-shell	model.		
	
	 The	 membrane	 capacitance	 showed	 a	 significant	 variation	 over	 time,	 as	 revealed	 by	 a	
significant	 p-value	 obtained	 after	 fit	 of	 a	 cosine	 curve	 to	 the	 experimental	 data,	 against	 the	 null	
hypothesis	of	a	straight	line	(p<0.05	versus	linear	regression,	see	figure	4.5).	The	preferred	model	to	
fit	the	results	was	therefore	a	cosine	curve,	with	a	period	of	25.23	hours,	close	to	the	expected	24-
hour	period	expected	for	a	circadian	rhythm	(see	table	4.2	for	statistics).	Clear	troughs	were	observed	
at	8,	32,	and	60	hours	following	serum	shock,	also	in	line	with	a	circadian	oscillation.	
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Figure	4.5:	Membrane	capacitance	of	3T3-L1	Per2-dLuc	pre-adipocytes	recorded	using	DEP	across	
the	circadian	time.	The	fitting	of	a	cosine	curve	in	a	95%	confidence	interval	revealed	a	significant	p-
value	(p=	0.0006),	and	confirmed	that	the	preferred	model	to	fit	the	data	was	a	cosine	curve	rather	
than	a	straight	line.	Dashed	lines	are	a	95%	confidence	in	the	fit	of	the	cosine	curve.	The	control	value	
(measured	on	unsynchronised	cells),	on	average,	was	evaluated	at	0.013F/m2,	indicated	by	the	dotted	
black	horizontal	line	on	the	figure.		N=	5	between	4	and	20	hours,	6	between	24	and	48	hours,	and	1	
between	52	and	72	hours	after	serum	shock.		
	
Table	 4.2:	 Summary	 of	 circadian	 parameters	 and	 R2	 value	 extracted	 from	 the	 analysis	 of	 the	
membrane	capacitance.	R2	value	is	expressed	in	arbitrary	units.	
	
	
	
	
	
	
	
	 The	membrane	 conductance	 also	presented	 temporal	 variations	 (figure	4.6,	 p<0.05	 versus	
linear	regression).	The	period	of	the	cosine	fit,	which	was	then	the	preferred	model	to	fit	the	data,	
was	of	14.6	hours	(<24	hours),	characteristic	of	an	ultradian	rhythm	(see	table	4.3	for	statistics).			
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Figure	4.6:	Membrane	conductance	of	3T3-L1	Per2-dLuc	pre-adipocytes	recorded	using	DEP	across	
the	circadian	time.	A	cosine	curve	was	fitted	to	the	data,	in	a	95%	confidence	interval	(represented	
by	 the	 dashed	 lines	 on	 the	 graph).	 	 A	 significant	 p-value	 (p<0.0001)	was	 indicative	 of	 a	 temporal	
variation	 in	 the	 data.	 The	 averaged	 control	 value	 was	 3020.24S/m2,	 shown	 on	 the	 graph	 by	 the	
horizontal	dotted	line.	N=	5	between	4	and	20	hours,	6	between	24	and	48	hours,	and	1	between	52	
and	72	hours	after	serum	shock.		
	
Table	 4.3:	 Summary	 of	 circadian	 parameters	 and	 R2	 value	 extracted	 from	 the	 analysis	 of	 the	
membrane	conductance.	R2	value	is	expressed	in	arbitrary	units.	
																					
Mesor	(S/m2)	 5328	
Amplitude	(S/m2)	 -1179	
Acrophase	(hours)	 22.45	
Period	(hours)	 14.6	
R2	 0.26	
	
	
	 Time	series	analysis	of	the	cytoplasmic	conductivity	indicated	that	the	preferred	model	to	fit	
the	data	was	a	straight	line	rather	than	a	cosine	curve	(as	p>0.05).	We	therefore	concluded	that	these	
measured	exhibited	no	temporal	variations	(see	figure	4.7).		
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Figure	4.7:	Cytoplasmic	conductivity	of	3T3-L1	Per2-dLuc	pre-adipocytes	recorded	using	DEP	across	
the	circadian	time.	A	cosine	curve	was	fitted	to	the	data	against	the	null	hypothesis	of	a	straight	line.	
In	this	case,	no	temporal	variations	were	detected	and	therefore	the	preferred	model	was	a	straight	
line.	The	null	hypothesis	was	not	rejected	(p>0.05).	The	averaged	control	value	was	0.126,	shown	by	
the	black	horizontal	dotted	line	on	the	figure.	N=	5	between	4	and	20	hours,	6	between	24	and	48	
hours,	and	1	between	52	and	72	hours	after	serum	shock.		
	
	 Table	 4.4	 presents	 an	 average	 of	 all	 parameters	 studied	 at	 each	 time	 point,	 between	 all	
biological	replicates	analysed.	The	most	striking	feature	observed	was	the	difference	of	a	factor	10	
between	 the	 lowest	values	 (troughs)	of	membrane	capacitance	after	8,	32	and	60	hours	 following	
serum	shock,	and	the	rest	of	the	time	points.		
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Table	 4.4:	 Averaged	 values	 of	 membrane	 capacitance,	 membrane	 conductance	 and	 cytoplasm	
conductivity	between	4	and	72	hours	following	serum	shock	of	the	cells.	
	
	
Time	after	serum	
shock	(hours)	
Membrane	
capacitance	(F/m2)	
Membrane	
conductance	(S/m2)	
Cytoplasm	
conductivity	(S/m)	
4	 0.019	 6213.78	 0.135	
8	 0.002	 4236.995	 0.144	
12	 0.018	 5745.804	 0.188	
16	 0.024	 6098.883	 0.147	
20	 0.017	 5334.354	 0.168	
24	 0.014	 4461.479	 0.179	
28	 0.014	 6766.054	 0.16	
32	 0.004	 5115.47	 0.233	
36	 0.019	 1891.977	 0.192	
30	 0.015	 4702.852	 0.177	
44	 0.023	 6203.565	 0.186	
48	 0.017	 6419.196	 0.208	
52	 0.017	 5811.314	 0.188	
56	 0.01	 6569.677	 0.206	
60	 0.001	 5015.357	 0.166	
64	 0.023	 7983.859	 0.141	
68	 0.018	 7576.746	 0.175	
72	 0.036	 4749.098	 0.171	
	
4.5.2	Confocal	microscopy	
	
	 Literature	has	suggested	that	measurements	of	membrane	protein	concentration,	as	 in	 ion	
channel	or	ionic	conductance	density,	are	often	normalised	by	membrane	capacitance	(exhibiting	a	
circadian	rhythm	in	our	DEP	measures	on	pre-adipocytes),	which	is	proportional	to	the	surface	area,	
to	express	changes	independently	from	cell	surface	variations	(Golowasch	et	al.,	2009).	 In	practical	
terms,	for	cells,	the	membrane	capacitance	is	related	to	the	size	of	the	cell	(the	larger	the	cell,	the	
more	 lipid	membrane	 there	 is,	 and	 the	 larger	 the	 cell’s	 capacitance	 will	 be).	 For	 this	 reason,	 we	
investigated	 cellular	 morphology	 using	 confocal	 microscopy,	 with	 a	 view	 of	 measuring	 temporal	
variations	in	membrane	or	cytoskeleton	morphology.	This	was	done	every	4	hours	between	24	and	52	
hours	after	synchronisation.	We	chose	this	 timespan	because	 it	excludes	any	 immediate	effects	of	
serum	 shock,	 and	 includes	 at	 least	 one	 peak	 and	 through	 in	 the	 temporal	 patterns	 of	 changes	 in	
membrane	 capacitance	 (figure	 4.5).	 Examples	 of	 confocal	 imaging	 of	 nuclear,	 membrane	 and	
cytoskeleton	staining	in	pre-adipocytes	are	shown	in	figure	4.8	(full	microscopic	view)	and	4.9	(single-
cell	imaging).	 	
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Figure	4.8:	Full	field	of	view	of	3T3-L1	Per2-dLuc	cells	pictured	at	random	coordinates	via	confocal	
microscopy.	Panel	A	illustrates	cells	stained	for	nucleus	(in	blue)	and	cytoskeleton	(in	green).	The	red	
colour	shown	in	panel	B	represents	the	membrane	stain,	and	the	blue	the	nuclear	stain.	 	For	each	
staining	 condition,	 two	 examples	 are	 illustrated	 (left	 and	 right).	 Photographs	 were	 taken	 using	 a	
magnification	x60.		
	
	
Figure	 4.9:	 Single-cell	 imaging	 of	 3T3-L1	 Per2-dLuc	 pre-adipocytes.	 The	 cells	 were	 stained	 for	
cytoskeleton	(green,	A)	or	for	the	membrane	(red,	B).	In	all	cases,	the	nuclei	were	stained	in	blue.	For	
each	staining	condition,	two	different	cells	are	represented	as	different	examples,	obtained	after	Z-
stack.	Photographs	were	taken	using	a	magnification	x60.		
A
B
A
B
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	 The	 cell	 morphology	 measures	 computed	 from	 cells	 stained	 for	 the	 cytoskeleton	 and	
membrane	are	derived	from	separate	technical	replicates	of	the	same	biological	samples.	Indeed,	we	
could	not	stain	for	both	in	the	same	sample,	due	to	dye	restrictions.	The	mean	cell	volume	extracted	
from	the	cytoskeleton	stain	ranged	from	2215.24µM3	to	4320.74µM3,	and	that	from	the	membrane	
stain	was	very	similar,	ranging	from	2465.73µM3	to	4228.76µM3	(figure	4.10).	A	summary	of	all	mean,	
standard	deviation	and	standard	error	of	the	mean	values	is	presented	table	4.5	(all	averaged	between	
technical	 and	 biological	 replicates).	 Neither	 volume	measurements	 exhibited	 significant	 variations	
over	time	(one-way	ANOVA,	p-values>0.05,	see	table	4.6),	and	consequently	the	preferred	model	to	
fit	the	data	was	a	straight	line	as	opposed	to	a	cosine	wave.		
	
	 The	surface	values	approximated	from	cells	stained	for	the	cytoskeleton	and	membrane	did	
not	display	any	temporal	variations.	This	was	indicated	by	a	one-way	ANOVA	(p>0.05),	but	also	after	
fit	of	a	cosine	curve	to	the	data	against	a	straight	line	(p>0.05	versus	linear	regression),	the	latter	being	
the	 preferred	 model	 as	 shown	 in	 figure	 4.11.	 On	 average,	 all	 biological	 and	 technical	 replicates	
considered,	 the	 surface	 ranged	 from	1435.01µM2	to	2091.58µM2	 for	 the	membrane,	and	between	
1757.79µM2	 to	 2511.34µM2	 for	 the	 cytoskeleton	 (figure	 4.11).	 The	 averaged	 means,	 standard	
deviations	and	standard	errors	of	the	mean	(between	all	replicates)	are	represented	in	table	4.5.	The	
summary	of	 the	p-values	can	be	found	 in	table	4.6.	The	volume	and	the	surface	were	also	plotted	
together,	which	demonstrated	that	both	parameters	were	varying	alongside	each	other	across	time,	
and	therefore	data	were	proportional	to	each	other	(figure	4.12).	
	
	
Figure	4.10:	Cell	volume	estimate	based	on	cytoskeleton	and	membrane	stains.	The	volume	of	the	
cytoskeleton	(A)	and	membrane	(B)	stain	of	3T3-L1	Per2-dLuc	was	measured	every	4	hours	between	
24	 and	 52	 hours	 following	 serum	 shock.	 Blue	 dots	 on	 the	 graphs	 indicated	 the	 various	 biological	
replicates	done	at	each	time	point	(n=3),	and	represented	an	average	of	all	technical	replicates	(n≥10).	
A	cosine	curve	was	fitted	to	the	data	(all	replicates	considered)	against	the	null	hypothesis	of	a	straight	
line,	revealing	no	significant	variations	in	the	data,	for	both	the	membrane	and	the	cytoskeleton	(p-
value>0.05).	This	was	confirmed	by	a	one-way	ANOVA.		 	
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Figure	4.11:	Cell	surface	evaluation	based	on	cytoskeleton	and	membrane	stains.	Panel	(A)	shows	
the	surface	of	the	cytoskeleton	stain	and	panel	(B)	the	surface	of	the	membrane	stain,	plotted	against	
the	circadian	time.	A	one-way	ANOVA	was	done	and	another	step	of	analysis	fitted	a	cosine	curve	to	
the	data	against	the	null	hypothesis	of	a	straight	line,	in	order	to	confirm	the	presence,	or	not,	of	any	
circadian	rhythm	(all	replicates	considered).	In	both	cases,	the	preferred	model	was	a	straight	line,	as	
there	 were	 no	 temporal	 variations	 in	 the	 data	 (p>0.05).	 The	 different	 biological	 replicates	 are	
represented	in	the	graph	by	the	full	circles	(n=3)	and	were	calculated	as	a	mean	between	all	technical	
replicates	(n≥10).		
	
	
	
	
Figure	4.12:	Averaged	surface	values	plotted	against	the	averaged	volume	values.	Values	obtained	
for	the	volume	and	the	surface	were	averaged	between	each	biological	(n=3)	and	technical	replicate	
(n≥10)	 and	 plotted	 against	 each	 other.	 This	 for	 both	 staining	 conditions:	 cytoskeleton	 (A)	 and	
membrane	(B).			
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	 The	diameter	computed	from	cells	stained	for	the	cytoskeleton	and	membrane	stains,	did	not	
exhibit	any	variations	over	time,	as	revealed	by	a	one-way	ANOVA	(p-values>0.05).	Additionally,	the	
most	relevant	model	to	fit	the	data	was	a	straight	line	when	tested	against	a	cosine	curve,	which	also	
confirmed	 that	 the	 data	 remained	 invariant	with	 time	 (p-values>0.05).	 The	means,	 SDs	 and	 SEMs	
values	are	indicated	in	table	4.5	and	all	p-values	are	summarised	in	table	4.6.	On	average,	all	biological	
and	 technical	 replicates	 considered,	 the	 diameter	 ranged	 from	 15.81µM	 to	 20.16µM	 for	 the	
membrane,	and	between	16.33µM	to	19.64µM	for	the	cytoskeleton	(figure	4.13).	Interestingly,	this	
was	in	line	with	the	results	obtained	for	the	cell	radii	in	figure	4.4,	which	varied	between	14.036µM	
and	23.86	µM.		
	
Figure	4.13:	Cell	diameter	approximate	based	on	cytoskeleton	and	membrane	stainings.	Panel	(A)	
shows	the	diameter	of	the	cytoskeleton	stain	and	panel	(B)	of	the	membrane	stain,	plotted	against	
the	 circadian	 time.	 A	 straight	 line	 was	 found	 to	 be	 the	 preferred	model	 to	 fit	 the	 data	 (p>0.05),	
indicating	no	significant	differences	in	the	results.	This	was	confirmed	by	a	one-way	ANOVA.	Values	
are	represented	as	averages	between	3	biological	replicates	(full	blue	circles	on	the	graph,	n=3)	and	
technical	replicates	(n≥10).	All	replicates	were	considered	for	statistical	analyses.	
	 	
	 Lastly,	we	found	no	significant	variations	in	sphericity,	reflecting	the	cellular	shape,	across	the	
circadian	time.	Both	a	one-way	ANOVA	and	a	cosine	fit	to	the	data	against	a	straight	line	confirmed	
this	result	(p>0.05).	The	preferred	model	to	fit	the	data	was,	as	a	result,	a	straight	line	(figure	4.14).	
The	mean	sphericity	values,	calculated	between	all	replicates,	differed	in	a	range	from	0.52µM	and	
0.67µM	(membrane)	and	between	0.48µM	and	0.59µM	(cytoskeleton).	The	averaged	SDs,	SEMs,	and	
means	are	 indicated	in	table	4.5.	The	summary	of	the	p-values	can	be	found	in	table	4.6.	All	other	
parameters	 analysed	 by	 the	 NIS-Elements	measurement	 software,	 and	 related	 to	 cell	 orientation	
rather	than	cellular	morphology	are	presented	in	appendix	2.	
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Figure	4.14:	Cellular	sphericity	evaluated	based	on	cytoskeleton	and	membrane	stainings.	Panel	(A)	
represents	 the	 values	 for	 the	 cytoskeleton	 stain	 and	 (B)	 for	 the	membrane	 stain.	 The	 3	 biological	
replicates	(n=3)	done	at	each	time	points	and	indicated	by	the	full	blue	circles	on	the	graphs,	were	
calculated	as	means	of	all	 technical	replicates	(n≥10).	A	one-way	ANOVA	was	done	for	analysis	 (all	
replicates	 considered),	 and	 a	 cosine	 curve	was	 fitted	 to	 the	 data	 against	 the	 null	 hypothesis	 of	 a	
straight	line.	In	each	case,	the	preferred	model	was	a	straight	line	as	the	data	were	not	varying	in	a	
circadian	fashion	(p>0.05).	
	
Table	 4.5:	 Averaged	 means,	 standard	 deviations	 and	 standard	 errors	 for	 the	 volume,	 surface,	
diameter	and	sphericity	of	pre-adipocytes	estimated	based	on	membrane	and	cytoskeleton	stains.	
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Mean 3061.33 3128.62 4320.74 3701.72 2215.24 2653.63 3662.32 3080.57 2766.19 4024.52 2683.87 4228.76 3386.08 2875.23 2551.42 2465.73
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Table	4.6:	P-values	obtained	after	one-way	ANOVA	and	 fit	of	a	cosine	curve	 for	each	parameter	
extracted	from	the	NIS-Elements	analysis	software.	
	
PARAMETER	 P-value	ANOVA	 P-value	cosine	fit	
	 MEMBRANE	 CYTOSKELETON	 MEMBRANE	 CYTOSKELETON	
VOLUME	 0.3218	 0.416	 0.9981	 0.077	
SURFACE	 0.1131	 0.4132	 0.0586	 0.298	
SPHERICITY	 0.7476	 0.9509	 0.3689	 0.7904	
DIAMETER	 0.3252	 0.5102	 0.9912	 0.1127	
	
4.6	Discussion	
	
	 In	this	chapter,	we	successfully	measured	dielectrophoretic	properties	of	pre-adipocytes.	For	
the	first	time,	we	indicated	a	biological	rhythmicity	in	membrane	capacitance	and	conductance,	which	
were	clearly	visible	as	peak-to-trough	changes.	Strikingly,	we	did	not	confirm	that	these	changes	were	
associated	with	rhythms	in	cellular	morphology,	despite	literature	stating	that	membrane	capacitance	
is	proportional	 to	 the	 cell	 surface	area	 (Golowasch	 et	al.,	 2009).	 The	membrane	 conductance	was	
previously	shown	as	circadian	in	RBCs	(Henslee	et	al.,	2017)	and	neurons	(Michel	et	al.,	1993),	and	this	
was	 a	 pioneering	 study	 demonstrating	 temporal	 variations	 in	 adipose	 cells	 (in	 this	 case	 pre-
adipocytes).		
	
	 Given	that	this	was	the	first	time	DEP	was	applied	on	pre-adipocytes,	optimisation	steps	were	
first	essential	in	order	to	be	able	to	judge	how	well	these	cells	were	responding	to	dielectrophoresis,	
in	 comparison	 to	pre-defined	expectations.	 This	especially	 concerned	 the	medium	conductivity,	of	
particular	 relevance	 for	 these	 types	 of	 experiments	 as	 greatly	 affecting	 the	 quality	 of	 the	 cellular	
response	 to	 DEP.	 Indeed,	 for	 cardiac	muscle	 cells	 (HL-1)	 was	 used	 a	medium	 of	 2.5mS/m	 and	 of	
10mS/m	 for	RBCs	 (Henslee	 et	al.,	 2017).	Additionally,	prior	work	demonstrated	 the	 importance	of	
including	divalent	cations	in	the	suspension	medium	when	using	DEP,	as	their	omission	reduced	cell	
integrity	(Fry	et	al.,	2012).	Therefore,	our	DEP	medium	was	supplemented	with	CaCl2	and	MgCl2,	for	a	
conductivity	adjusted	to	55mS/m.	We	also	indicated	that	on	average,	the	radii	of	the	cells	were	not	
varying	 in	 a	 significant	 manner	 across	 the	 circadian	 cycle.	 These	 were	 important	 preliminary	
experiments	that	enabled	us	to	apply	our	approach	to	adipose	circadian	biology.	 Indeed,	dielectric	
properties	of	cells	depend	on	their	cell	type	and	physiological	status.	For	example,	MDA-231	human	
breast	cancer	cells	were	found	to	have	a	mean	plasma	membrane	specific	capacitance	of	26mF/m2,	
more	than	double	the	value	(11mF/m2)	observed	for	resting	T-lymphocytes	(Gascoyne	et	al.,	1997).	
Thus,	 cells	 having	 different	 dielectric	 characteristics	 will	 experience	 differential	 DEP	 forces	 when	
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subjected	to	an	electrical	field,	and	so	evaluating	the	dielectric	behaviour	of	the	cells	of	interest	is	of	
importance.		
	
	 We	 validated	 the	hypothesis	 that	 the	membrane	 capacitance	of	 the	 cells	was	 exhibiting	 a	
circadian	rhythmicity,	with	clear	troughs	after	approximately	8,	32	and	60	hours	following	the	serum	
shock.	Strikingly,	the	membrane	capacitance	values	for	the	troughs	were	10	times	lower	than	all	other	
values.	The	periodicity	of	the	rhythm	was	revealed	to	be	of	25.23	hours,	thus	very	close	to	24	hours,	
approximate	 periodicity	 of	 a	 circadian	 rhythm.	 This	 parameter	 was	 shorter	 for	 the	 membrane	
conductance,	 as	 evaluated	 at	 16.6	 hours,	 indicating	 an	 ultradian	 rhythm.	 Lastly,	 we	 rejected	 the	
hypothesis	of	the	presence	of	a	circadian	rhythm	in	the	cytoplasmic	conductivity,	as	data	were	not	
exhibiting	any	temporal	variations.	The	use	of	dielectrophoresis	potential	on	adipose	cells	across	the	
circadian	time	was	very	novel,	and	has	not	been	previously	published.	In	2016,	one	study	used	DEP	on	
adipose	stem	cells	to	compare	their	dielectric	and	electro-kinetic	properties	to	BM-MSCs	(El-Badawy	
et	al.,	2016).	Analysis	of	the	electro-kinetic	properties	showed	that	ASCs	displayed	different	traveling	
wave	velocity	and	rotational	speed	compared	to	BM-MSCs.	 Interestingly,	ASCs	seem	to	develop	an	
adaptive	response	when	exposed	to	repeated	electric	field	stimulation.	This	contributed	to	prove	a	
potential	superior	potency	of	ASCs	in	comparison	to	BM-MSCs	as	a	source	of	stem	cells.	Moreover,	
patch-clamp	revealed	that	 in	vitro	differentiated	adipocytes	derived	from	vascular	ASCs	exhibited	a	
higher	 membrane	 capacitance	 compared	 to	 subcutaneous	 ASCs	 (Baglioni	 et	 al.,	 2012).	 At	 the	
differentiated	 adipose	 state,	 results	 were	 inversed:	 the	 membrane	 capacitance	 was	 higher	 in	
subcutaneous	 adipocytes	 in	 comparison	 to	 visceral	 adipocytes.	 The	 membrane	 conductance	 was	
higher	for	adipose	stem	cells	and	differentiated	adipocytes	at	the	visceral	level,	in	comparison	to	their	
subcutaneous	counterparts.		
	
	 In	addition,	since	the	introduction	of	the	idea	of	a	dielectrophoretic	force	by	Pohl	in	1951	(Pohl	
1951),	DEP	has	mainly	been	used	to	separate	different	cell	types	(Gascoyne	et	al.,	1997),	 including	
viable	 versus	 non-viable	 cells	 (Huang	 et	 al.,	 1992).	 The	 interests	 on	 the	 technique	 has	 also	 been	
towards	its	effectiveness	and	low-cost	(Faraghat	et	al.,	2017).	The	investigation	of	circadian	changes	
via	DEP	has	only	been	previously	reported	in	erythrocytes,	in	which	circadian	changes	in	membrane	
conductance	 and	 cytoplasmic	 conductivity	 were	 associated	 with	 changes	 in	 rhythmic	 potassium	
transport	regulating	the	circadian	clock	in	human	red	blood	cells	(Henslee	et	al.,	2017).	The	authors	
also	suggested	that	a	rhythmic	regulation	of	transmembrane	ion	transport	in	RBCs	may	contribute	to,	
or	at	 least	 influence,	mechanism(s)	determining	the	period	of	oscillation.	Thus	far,	a	rhythm	in	the	
abundance	of	peroxiredoxin	proteins	has	served	as	the	primary	reporter	for	circadian	timekeeping	in	
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RBCs.	 In	 human	 RBCs,	 it	 was	 found	 that	 peroxiredoxins,	 highly	 conserved	 antioxidant	 proteins,	
undergo	 redox	cycles	with	a	periodicity	of	approximately	24	hours	persisting	 for	many	days	under	
constant	 conditions	 (O'Neill	 et	 al.,	 2011).	 The	 rhythms	 were	 entrainable	 and	 temperature-
compensated,	 both	 key	 features	 of	 circadian	 rhythms.	 Peroxiredoxin	 circadian	 rhythms	were	 also	
found	 in	 mouse	 NIH3T3	 fibroblasts	 and	 MEFs.	 Additionally,	 circadian	 cycles	 of	 post-translational	
modification	 of	 peroxiredoxin	 have	 previously	 been	 reported	 in	mouse	 liver	 (Reddy	 et	 al.,	 2006).	
Moreover,	circadian	regulation	of	transmembrane	ion	transport,	whose	initial	discovery	predates	the	
identification	of	clock	genes	(Hartman	et	al.,	1976,	Njus	et	al.,	1976,	Nitabach	et	al.,	2005),	has	become	
the	subject	of	renewed	interest.	This	in	light	of	observations	that	cellular	Mg2+	and	K+	transport	exhibit	
circadian	rhythms	in	several	mammalian	cell	types,	as	well	as	in	algae	and	fungal	cells,	suggestive	of	a	
circadian	function	with	greater	evolutionary	conservation	than	any	known	clock	gene	(Feeney	et	al.,	
2016a,	Whitt	et	al.,	2016).	
	
	 In	 adipocytes,	 the	 presence	 of	 circadian	 rhythms	 could	 be	 explained	 by	 the	 generation	 of	
transcriptional-translational	feedback	loops	at	the	nuclear	level.	The	fact	that	the	biological	rhythms	
observed	 in	membrane	 electrophysiology	 could	 not	 be	 associated	with	 circadian	 variations	 of	 cell	
surface,	 volume,	 sphericity	 and	 diameter	 (as	 approximated	 through	 cytoskeleton	 and	 membrane	
stains	via	confocal	microscopy),	means	that	these	rhythms	could	be	related	to	other	properties	of	the	
cell.	 For	 instance,	Golowasch	 and	 co-workers	 explained	 that	measurements	 of	membrane	 protein	
concentration,	as	 in	 ion	channel	or	 ionic	conductance	density,	are	often	normalised	by	membrane	
capacitance	 (Golowasch	 et	 al.,	 2009).	 Therefore,	 methods	 allowing	 such	 measurements	 could	
enlighten	 changes	 observed	 in	 membrane	 capacitance	 within	 our	 pre-adipocytes.	 Furthermore,	
dielectrophoresis	 potential	 is	 a	measure	 of	 ionic	 flows	 from	 the	 intracellular	 compartment	 to	 the	
external	environment,	and	therefore	a	circadian	rhythm	in	membrane	conductance,	capacitance	or	
cytoplasmic	conductivity	could	be	explained	by	rhythmic	ion	transport	across	the	membrane.	It	would	
then	be	necessary	to	study	the	ionic	output	and	quantify	the	ions,	in	order	to	ultimately	know	which	
ion	channels	are	affecting	the	dielectric	parameters	related	to	pre-adipose	cells.	To	do	so,	a	technique	
of	 scanning	 electron	microscopy	 (SEM)	 could	 be	 used,	 which	 for	 years	 has	 provided	 insights	 into	
cellular	morphology	(Keller	et	al.,	1977).	Another	technique	which	could	be	utilised	for	future	work	is	
inductively	coupled	plasma	mass	spectrometry	(ICPMS),	to	quantify	the	ions.	Using	this	method,	ions	
are	dispersed	in	the	mass	analyser	based	on	their	mass-to-charge	ratio.	Rhythmic	transport	of	K+	over	
the	cell	membrane	has	previously	been	observed	(Njus	et	al.,	1974),	and	was	suggested	to	be	driven	
by	the	activity	of	a	circadian	clock,	driving	associated	changes	in	membrane	properties	arising	from	a	
feedback	between	ion	transport	proteins	and	ion	concentrations	(specifically	potassium).	Njus	et	al.	
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indicated	 that	 the	 biological	 clock	 may	 be	 a	 feedback	 system	 involving	 ions	 and	 ions-transport	
channels.	 This	 was	 also	 confirmed	 two	 years	 later,	 where	 the	 model	 was	 tested	 through	 the	
measurement	 of	 the	 concentration	 of	 potassium	 ions	 in	 the	 external	medium	 of	 human	 RBCs	 by	
means	of	 flame	photometry	 (Hartman	 et	al.,	 1976).	The	same	study	 revealed	circadian	changes	 in	
membrane	properties	of	human	RBCs	cultured	in	vitro	using	a	fluorescent	probe.	
	 	
	 Interestingly,	our	results	in	pre-adipocytes	contrast	with	findings	in	erythrocytes	(Henslee	et	
al.,	2017),	in	that	we	did	not	find	a	circadian	regulation	in	cytoplasmic	conductivity,	but	in	membrane	
capacitance.	Furthermore,	membrane	conductance	was	circadian	in	RBCs,	and	appeared	ultradian	in	
adipose	 cells.	 A	 variation	 in	 membrane	 capacitance	 has	 been	 suggested	 to	 mean	 different	
concentrations	of	protein	at	the	membrane	surface,	and	a	difference	in	the	speed	at	which	the	cell	
membrane	 potential	 responds	 to	 flow	 of	 ion	 channel	 currents.	 In	 our	 experiments,	 membrane	
capacitance	 was	 shown	 to	 present	 the	 most	 profound	 variation	 in	 amplitude,	 as	 the	 membrane	
capacitance	value	of	the	troughs	was	10	times	less	than	that	of	the	peaks.	Differences	in	dielectrical	
properties	between	erythrocytes	and	pre-adipocytes	is	a	clear	demonstration	that	different	cell	types	
exhibit	 different	 dielectric	 makeups.	 Additionally,	 the	 fact	 that	 we	 found	 a	 circadian	 rhythm	 in	
membrane	 capacitance	 that	 could	 not	 be	 explained	 by	 changes	 in	 cellular	 morphology	 through	
confocal	microscopy	was	in	line	with	the	emerging	idea	that	membrane	capacitance	was	more	than	
just	related	to	the	cellular	morphology,	and	could	also	be	linked	to	chemical	compounds	located	at	
the	membrane,	as	well	as	 to	a	quantity	of	 ions	decreasing	or	 increasing	at	various	 time	points.	To	
support	this	notion,	it	was	recently	specified	that	cell	surface	N-Glycans	impacted	electrophysiological	
properties	and	the	fate	potential	of	neural	stem	cells	(Yale	et	al.,	2018).	It	was	shown	that	enhancing	
highly	branched	N-Glycans	on	neural	stem	and	progenitor	cells	significantly	increased	the	membrane	
capacitance	leading	to	the	generation	of	more	astrocytes	at	the	expense	of	neurons	with	no	effect	on	
cell	 size,	 viability	 or	 proliferation	 (which	 we	 also	 found	 in	 pre-adipocytes).	 It	 could	 therefore	 be	
interesting	 to	 replicate	 this	 type	of	 study	at	 the	adipose	 tissue	 level,	 and	more	 specifically	 in	pre-
adipose	cells,	in	order	to	be	able	to	better	understand	our	results.	
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CHAPTER	5	
	
ANAYSIS	OF	CIRCADIAN	RHYTHM	PARAMETERS	IN	
CULTURED	PRE-ADIPOCYTES	AND	ADIPOCYTES	
	
5.1	Introduction	
	
	 The	 mammalian	 circadian	 system	 is	 a	 complex	 hierarchical	 temporal	 network	 organised	
around	an	ensemble	of	uniquely	coupled	cells	comprising	the	principal	circadian	pacemaker	 in	 the	
SCN	 of	 the	 hypothalamus	 (Lowrey	 et	 al.,	 2011).	 This	 central	 clock	 is	 entrained	 each	 day	 by	 the	
environmental	 LD	 cycle	 and	 transmits	 synchronising	 cues	 to	 cell-autonomous	 oscillators	 in	 tissues	
throughout	 the	body.	Within	cells	of	 the	central	pacemaker	and	peripheral	 tissues,	 the	underlying	
molecular	 mechanism	 by	 which	 oscillations	 in	 gene	 expression	 occur	 involves	 interconnected	
feedback	loops	of	transcription	and	translation.	At	the	level	of	individual	tissues,	thousands	of	genes	
are	brought	to	unique	phases	through	the	actions	of	local	transcription/translation-based	feedback	
oscillator	and	systemic	cues	(Buhr	et	al.,	2013).	In	this	molecular	clock,	the	proteins	CLOCK	and	BMAL1	
cause	 the	 transcription	 of	 genes	 which	 ultimately	 feedback	 and	 inhibit	 CLOCK	 and	 BMAL1	
transcriptional	activity.	Interestingly,	there	are	also	other	molecular	circadian	oscillators	which	can	act	
independently	of	 the	 transcription-based	 clock.	 Furthermore,	 rodent	models	 can	also	be	a	 tool	 to	
identify	 exposures	 and	 agents	 inducing	 or	 preventing	 a	 circadian	 disruption,	 although	 these	
experiments	require	a	large	number	of	animals	(Fang	et	al.,	2017).	In	vivo	studies	also	necessitated	
significant	resources	and	infrastructure,	and	researchers	to	work	at	night.	There	is	thus	an	urgent	need	
for	 a	 cell	 type	 appropriate	 in	 vitro	 system	 to	 screen	 for	 environmental	 circadian	 disruptors	 and	
enhancers	 in	cell	types	from	different	organs	and	disease	states.	Vectors	were	constructed,	driving	
the	transcription	of	the	destabilised	luciferase	in	eukaryotic	cells	under	the	control	of	the	human	Per2	
gene	 promoter.	 In	 this	 case,	 the	 circadian	 reporter	 construct	 was	 stably	 transfected	 into	 human	
mammary	epithelial	cells,	and	circadian	responsive	reporter	cells	were	selected	to	develop	the	in	vitro	
bioluminescence	assay.	
	
	 Luciferase	reporters	introduced	into	cells	via	transient	transfection	(Ueda	et	al.,	2005,	Sato	et	
al.,	2006,	Ukai-Tadenuma	et	al.,	2011)	or	stable	transduction	(Brown	et	al.,	2005,	Liu	et	al.,	2007b,	
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Hirota	et	al.,	2008,	Zhang	et	al.,	2009)	have	been	used	to	monitor	cell-autonomous	circadian	rhythms	
of	gene	expression.	The	lentiviral	vector	system	is	superior	to	traditional	methods,	such	as	transient	
transfection	and	germline	transmission,	because	of	its	efficiency	and	versatility,	permitting	an	efficient	
delivery	and	stable	integration	into	the	host	genome	of	both	dividing	and	non-dividing	cells	(Tiscornia	
et	al.,	2006).	Once	a	reporter	cell	line	is	established,	the	dynamics	of	clock	function	can	be	examined	
through	 bioluminescence	 recording	 (Ramanathan	 et	 al.,	 2012).	 In	 vitro,	 3T3	mouse	 fibroblast	 and	
U2OS	human	osteosarcoma	cells	were	used	as	models.	Luciferase	was	first	 introduced	 in	real-time	
luminescence	monitoring	of	gene	expression	rhythms	in	plants	and	cyanobacteria	(Millar	et	al.,	1992,	
Kondo	et	al.,	1993),	and	luminescence	reporter	techniques	have	since	become	a	powerful	tool	in	non-
invasive	assays	of	circadian	oscillations	 (Yamazaki	et	al.,	2005),	 to	measure	real-time	expression	of	
circadian	and	circadian	output	genes,	as	well	as	the	protein	dynamic	of	the	circadian	genes.	Moreover,	
this	method	has	faithfully	monitored	the	rhythms	of	circadian	genes	in	the	fly	(Brandes	et	al.,	1996),	
mouse	(Geusz	et	al.,	1997,	Asai	et	al.,	2001,	Wilsbacher	et	al.,	2002,	Yoo	et	al.,	2004),	rat	(Yamazaki	et	
al.,	2000)	and	fungi	(Morgan	et	al.,	2003),	as	well	as	in	immortalised	cell	lines	driven	from	the	rat	(Ueda	
et	al.,	2002,	Izumo	et	al.,	2003),	zebrafish	(Vallone	et	al.,	2004),	and	human	(Maronde	et	al.,	2003).	
	
	 A	study	published	a	decade	ago	expected	that	 luminescence	reporting	with	an	organotypic	
culture	will	become	a	powerful	system	for	circadian	studies	(Yamazaki	et	al.,	2005).	SCN	explants	were	
maintained	for	up	to	681	days	 in	vitro,	with	a	well-maintained	organisation.	This	work	showed	that	
the	oscillation	of	Per1::Luc	activity	continued,	with	an	initial	phase	in	culture	which	could	be	used	to	
estimate	the	in	vivo	phase.	Tissues	taken	from	adult	and	aged	animals	can	be	cultured,	and	therefore	
tissue	cultured	shortly	after	in	vivo	treatments	can	be	used	to	measure	the	effect	of	the	treatments	
on	circadian	organisation.		Furthermore,	immortalized	cells,	as	well	as	primary	cell	cultures,	can	be	
used	for	drug	screening	and	molecular	analysis	(with	a	transfected	reporter	construct),	through	the	
use	 of	 bioluminescence	 analysis.	 Real-time	 analysis	 of	 gene	 expression	 was	 also	 used	 to	 reveal	
synchronised	rhythms	of	clock	gene	transcription	across	hundreds	of	neurons	within	the	mammalian	
SCN	in	organotypic	slice	culture	(Yamaguchi	et	al.,	2003).	This	study	was	published	on	mice	neurons,	
and	demonstrated	robust	and	synchronous	oscillations	of	Per1-Luc	bioluminescence	in	the	SCN	slice	
culture.	 Interestingly,	 mice	 carrying	 impaired	 Cryptochrome	 genes	 (Cry1	 and	 Cry2),	 indispensable	
components	of	the	core	clock	loop,	presented	a	complete	behavioural	arrhythmicity	with	a	constant	
cellular	bioluminescence,	rather	than	the	overt	synchronous	rhythm	detected	in	wild	type	animals.	
This	demonstrated	that	the	arrhythmicity	observed	in	the	animal	and	across	the	SCN	network	after	
genetic	 disruption	 of	 core	 clock	 loop	 was	 not	 due	 to	 desynchrony	 across	 an	 otherwise	 rhythmic	
population,	but	rather	arose	from	cessation	of	the	individual	cellular	oscillators.		
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	 Further	investigation	of	the	organisation	of	a	mammalian	circadian	system	was	done	in	2000,	
through	the	construction	of	a	transgenic	rat	line,	in	which	luciferase	is	rhythmically	expressed	under	
the	control	of	the	mouse	Per1	promoter	(Yamazaki	et	al.,	2000).	Light	emission	from	cultured	SCN	of	
these	rats	was	robustly	as	well	as	invariably	rhythmic,	and	persisted	for	up	to	32	days	in	vitro.	In	the	
liver,	the	lung,	and	the	skeletal	muscle,	circadian	rhythms	were	also	expressed,	which	damped	after	
two	to	seven	cycles,	also	in	vitro.	In	response	to	advances	and	delays	of	the	environmental	light	cycle,	
the	 circadian	 rhythm	 of	 light	 emission	 from	 the	 SCN	 shifted	more	 rapidly	 that	 did	 the	 rhythm	 of	
locomotor	behaviour	or	the	rhythms	in	peripheral	tissues.	More	recently,	bioluminescence	reporters	
were	used	to	monitor	the	circadian	rhythms	of	the	expression	of	clock	genes	Per1	and	Bmal1	within	
the	SCN	of	freely	moving	mice,	and	researchers	found	that	the	rate	of	phase	shifts	induced	by	a	single	
light	pulse	was	different	in	the	two	rhythms	(Ono	et	al.,	2017).	Indeed,	the	Per1-Luc	rhythm	was	phase-
delayed	instantaneously	by	the	light	presented	at	the	subjective	evening	in	parallel	with	the	activity	
onset	of	behavioural	rhythm,	whereas	the	Bmal1-Luc	rhythm	was	phase-delayed	gradually,	similar	to	
the	activity	onset.	These	findings	indicate	that	the	expressions	of	two	key	clock	genes,	Per1	and	Bmal1,	
are	regulated	in	the	SCN	in	such	a	way	that	they	may	adopt	different	phases	and	free-running	periods	
relative	to	each	other,	and	that	they	are	respectively	associated	with	the	expression	of	activity	onset	
and	offset.	
	
	 Another	 investigation	 on	 Rat-1	 fibroblasts	 transfected	 with	 a	 Bmal1::Luc	 plasmid	 utilised	
bioluminescence	 imaging	 to	monitor	 single-cell	 circadian	 rhythms	of	 clock	gene	expression	 for	1-2	
weeks	 (Welsh	 et	 al.,	 2004).	 It	 was	 found	 that	 single	 fibroblasts	 could	 oscillate	 robustly	 and	
independently,	 with	 undiminished	 amplitude	 and	 diverse	 circadian	 periods.	 These	 experiments	
demonstrated	 that	 individual	 fibroblast	cells	were	capable	of	 functioning	as	 independently	phased	
circadian	 oscillators	 self-sustained	 for	 many	 days	 in	 vitro.	 Later,	 real-time	 recording	 of	
bioluminescence	emitted	by	hepatocytes	expressing	circadian	luciferase	reporter	genes	was	described	
in	freely	moving	mice	(Saini	et	al.,	2013).	Additionally,	liver	cells	were	transduced	with	an	adenoviral	
vector	harbouring	a	Bmal1-Luciferase	reporter	gene	via	tail	vein	injection.	The	monitoring	of	circadian	
liver	gene	expression	revealed	that	hepatocyte	oscillators	of	SCN-lesioned	mice	synchronised	more	
rapidly	 to	 feeding	 cycles	 than	 hepatocyte	 clocks	 of	 intact	 mice.	 Hence,	 the	 SCN	 uses	 signalling	
pathways	that	counteract	those	of	feeding	rhythms	when	their	phase	is	in	conflict	with	its	own.											
		
	 An	 important	 published	 work	 from	 the	 team	 of	 Andrew	 Liu	 in	 Memphis	 reported	
establishment	 and	 genetic	 characterisation	 of	 three	 cell-autonomous	 mouse	 clock	 models:	 3T3	
fibroblasts	(reference	model),	3T3-L1	adipocytes	(cells	kindly	offered	to	us	for	this	thesis)	and	MMH-
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D3	hepatocytes	(Ramanathan	et	al.,	2014).	Each	model	was	genetically	tractable	and	had	an	integrated	
luciferase	reporter,	displaying	persistent,	high	amplitude	rhythms	with	high	temporal	resolution.	This	
allowed	longitudinal	luminescence	recording	of	rhythmic	clock	gene	expression	using	an	inexpensive	
off-the-shelf	microplate	reader.		Researchers	also	validated	these	new	models	by	generating	a	library	
of	 shRNAs	 against	 a	 panel	 of	 known	 clock	 genes,	 in	 order	 to	 evaluate	 their	 impact	 on	 circadian	
rhythms.	The	shRNA	knockdown	efficiency	was	tested	for	13	clock	genes.	Specifically,	knockdown	of	
Bmal1	or	Clock	resulted	in	rapid	damping	or	arrhythmicity,	Cry1	knockdown	lead	to	low	amplitude	or	
rapid	damping	depending	on	the	knockdown	efficiency,	whereas	a	Cry2	knockdown	lengthened	the	
period	and	increased	the	rhythm’s	amplitude.	The	aim	was	then	for	us	to	show	that	we	were	also	able	
to	replicate	those	persistent	bioluminescence	rhythms	in	vitro,	and	to	confirm	that	the	rhythms	were	
anti-phasic	between	two	cells	lines	transduced	with	the	promoter	of	two	different	clock	genes:	Per2	
and	Bmal1	(3T3-L1	Per2-dLuc	and	3T3-L1	Bmal1-dLuc).	Two	types	of	coating	(collagen	and	gelatine)	
were	 tested	 in	 order	 to	 evaluate	 whether	 it	 could	 have	 a	 potential	 effect	 on	 the	 traces	 and	 the	
corresponding	circadian	parameters.	Amplitude,	period,	damping	and	phase	were	compared	between	
pre-adipocytes	and	their	differentiated	adipocytes	counterparts,	which	allowed	us	to	study	the	effects	
of	differentiation	on	the	rhythms	parameters.			
	
5.2	Aim,	hypotheses	and	objective	
	
5.2.1	Aim	
	
	 The	aim	of	this	study	was	to	confirm	the	literature	on	3T3-L1	Per2	and	Bmal1	–	dLuc	adipocytes	
showing	 that	 these	 reporters	 exhibit	 high-amplitude	 and	 persistent	 rhythms,	 with	 anti-phasic	
activities	of	the	two	promoters	(Bmal1	and	Per2).	We	aimed	at	confirming	these	results	in	their	pre-
adipocytes	 counterparts,	 and	 highlight	 potential	 differences	 in	 circadian	 parameters	 between	 the	
different	cell	lines	and	differentiation	states.	
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5.2.2	Hypotheses	
	
Hypothesis	1:	3T3-L1	pre-adipocytes	and	adipocytes	possess	an	endogenous	circadian	clock	driving	
robust,	persistent,	and	anti-phasic	circadian	rhythms	in	the	activity	of	the	promoters	of	two	core	clock	
genes:	Per2	and	Bmal1.	
	
Hypothesis	2:	3T3-L1	adipocytes	will	exhibit	rhythms	of	lower	amplitude	and	with	a	faster	damping	
rate	compared	to	their	pre-adipocytes	counterparts.		
	
5.2.3	Objective	
	
	 Differentiate	pre-adipocytes	into	adipocytes,	in	order	to	study	the	effect	of	the	differentiation	
process	on	the	circadian	rhythmicity	in	the	activity	of	the	promoters	of	two	core	clock	genes:	Per2	and	
Bmal1;	through	the	analysis	of	the	amplitude,	period,	damping,	and	phase.	
	
5.3	Methods	
	
	 Two	3T3-L1	cell	lines	were	used,	as	reporter	cells	generated	via	lentiviral	transduction	of	either	
Per2-dLuc	or	Bmal1-dLuc	according	to	the	protocol	described	in	section	2.3.2	and	in	Ramanathan	et	
al.,	2012.		
	
	 The	first	hypothesis	of	study	was	that	3T3-L1	pre-adipocytes	possess	an	endogenous	circadian	
clock	driving	robust,	persistent,	and	anti-phasic	circadian	rhythms	in	the	activity	of	the	promoters	of	
two	core	clock	genes:	Per2	and	Bmal1.	To	answer	this	question,	cells	were	grown	in	T75	flasks.	When	
reaching	 90%	 confluence,	 cells	 were	 washed	with	 1X-PBS	 before	 trypsinisation.	 The	 resulting	 cell	
suspension	was	then	centrifuged	during	4	minutes	at	200g	(section	2.3.3),	before	the	cell	pellet	was	
resuspended	in	growing	medium	at	a	ratio	of	2.105	cells/mL.	To	obtain	the	appropriate	cell	density,	
the	pellet	resulting	from	the	centrifugation	was	resuspended	in	2mL	of	DMEM	culture	medium,	after	
which	10µL	of	the	resulting	suspension	were	mixed	with	10µL	of	Trypan	Blue	before	automated	cell	
count	(sections	2.4.2.1	and	2.5.1).	Once	diluted	to	the	correct	density,	1mL	of	the	cell	suspension	was	
placed	in	35mm	dishes	with	1mL	of	normal	DMEM	growing	medium,	before	incubation	(37°C,	5%	CO2).	
The	wells	were	pre-coated	with	either	collagen	(sections	2.2.1	and	2.3.5.1)	or	gelatine	(sections	2.2.4	
and	2.3.5.2),	to	test	for	any	effects	of	the	coating	type	on	cell	adhesion	and	differentiation.	
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	 Cells	 were	 left	 to	 reach	 full	 confluency	 during	 48	 hours,	 after	 which	 the	 growing	 culture	
medium	was	removed	and	replaced	by	2mL	of	serum	shock	medium	for	2	hours	(see	section	2.3.6).	
The	serum	shock	medium	was	then	replaced	by	a	counting	medium	deprived	of	phenol	red,	so	as	not	
to	interfere	with	future	bioluminescence	recordings,	and	supplemented	with	luciferin.	The	plates	were	
sealed	and	inserted	immediately	in	a	LumiCycle	luminometer	(figure	2.12,	version	2.31,	Actimetrics),	
where	photons	will	be	counted	as	the	D-Luciferin	added	to	the	counting	medium	reacted	with	the	
firefly	luciferase	to	produce	light	following	the	reaction	shown	figure	5.1	below.	
	
Figure	5.1:	Reaction	of	D-Luciferin	with	 the	 firefly	 luciferase	 to	produce	bioluminescence.	 Image	
taken	from	https://ccb.ucsd.edu/the-bioclock-studio/index.html.	Living	organisms	are	able	to	convert	
chemical	 energy	 into	 light.	 Light	 result	 from	 the	 oxidation	 of	 an	 organic	 substrate	 (D-luciferin)	
catalysed	by	an	enzyme	called	a	luciferase.	This	enzyme-mediated	reaction	also	involves	a	molecular	
oxygen	and	involved	the	production	of	an	electronically	excited	state	of	the	bioluminescence	product	
oxyluciferin.		
	
	 The	luminometer	was	kept	inside	a	standard	tissue	culture	incubator	at	36-37°C	without	CO2.	
Bioluminescence	from	each	dish	was	continuously	recorded	with	a	PMT	for	approximately	70	seconds	
and	at	 intervals	of	 10	minutes,	 generally	 for	 5	 to	10	days.	 The	 raw	data,	 in	 counts/seconds,	were	
plotted	against	the	time	(in	days)	after	serum	shock	(Lumicycle	measurement	software	version	2.31,	
Actimetrics).	 For	 the	 analysis	 of	 the	 rhythm	parameters,	we	used	 the	 LumiCycle	Analysis	 program	
(version	2.53),	which	automatically	compensates	for	baseline	shifts	and	signal	attenuation	over	the	
course	of	the	trial.	The	dominant	circadian	period	and	phase	(both	in	hours)	could	then	be	extracted,	
through	an	automated	equation	after	 fit	of	a	sine	wave	(damped)	to	the	baseline-subtracted	data,	
alongside	 the	 amplitude	 (in	 counts/sec).	 The	 fist	 cycle	 was	 excluded	 due	 to	 high	 transient	
luminescence	upon	medium	change,	and	because	it	is	believed	that	it	could	result	from	the	effects	of	
the	 serum	 shock.	 Indeed,	 a	 serum	 shock	 induces	 circadian	 gene	 expression	 in	mammalian	 tissue	
culture	cells	(Balsalobre	et	al.,	1998)	but	its	effects	dissipate	after	the	first	cycle	to	leave	the	intrinsic	
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cellular	 rhythms	 to	 dominate,	 which	 are	 the	 one	 we	 wanted	 to	 analyse.	 A	 circadian	 rhythm	was	
considered	for	a	goodness	of	fit	>	80%	and	a	periodicity	of	24±5	hours	(section	2.4.1).		
	
	 Further	hypotheses	of	this	work	were	that	differentiated	3T3-L1	adipocytes	also	possess	an	
endogenous	circadian	clock	driving	robust,	persistent,	and	anti-phasic	circadian	rhythms	in	the	activity	
of	 the	 promoters	 of	 two	 core	 clock	 genes:	 Per2	 and	 Bmal1,	 and	 that	 adipocytes	 exhibit	 a	 faster	
damping	rate	and	lower	amplitude	rhythms	as	compared	to	their	pre-adipocytes	counterparts.	To	test	
this,	3T3-L1	Per2	and	Bmal1	–	dLuc	were	cultured	 in	T75	flasks	and	plated	onto	35mm	dishes	pre-
coated	with	collagen	or	gelatine	in	exactly	the	same	way	as	described	above	and	following	the	protocol	
described	in	section	2.3.3.	At	this	stage,	cells	were	incubated	at	37°C	and	5%	CO2	for	48	hours,	after	
which	 full	 confluency	was	 reached.	 After	 another	 48	 hours,	 pre-adipocytes	 of	 each	 cell	 line	were	
differentiated	using	a	cocktail	of	hormones	and	drugs	having	a	role	in	the	activation	of	adipogenesis:	
insulin,	IBMX	and	DEX.	The	differentiation	was	induced	by	supplementing	a	complete	growth	culture	
medium	with	 0.5mM	of	 IBMX	 (section	 2.2.6),	 1µM	of	 DEX	 (section	 2.2.3)	 and	 10µg/mL	 of	 insulin	
(section	2.2.5).	Cells	were	left	to	incubate	for	48	hours	in	this	medium,	after	which	it	was	replaced	
with	a	DMEM	culture	medium	supplemented	only	with	insulin	(10µg/mL)	for	another	48	hours.	From	
this	point	onwards,	medium	was	replaced	with	a	normal	DMEM	culture	medium	changed	every	two	
days	up	until	an	advanced	stage	of	differentiation,	where	most	cells	had	accumulated	large	unilocular	
droplets	(usually	reached	after	15	days	of	incubation)	(figure	1.17,	Otway	et	al.,	2009).	The	success	of	
the	 differentiation	 was	 checked	 with	 the	 help	 of	 an	 Oil	 Red	 O	 solution	 0.3%	 staining	 lipid	 and	
triglyceride	contents.	When	pre-adipocytes	differentiate	into	adipocytes,	lipid	droplets	start	to	form	
and	cells	adopt	a	more	spherical	morphology.	The	Oil	Red	O	was	able	to	stain	those	lipid	droplets	and	
therefore	to	highlight	the	presence	of	differentiated	adipocytes.	
	
	 Once	 cells	were	differentiated,	 they	were	 serum	shocked	 for	2	hours	 (section	2.3.6),	 after	
which	 the	medium	was	 replaced	 by	 the	 same	 counting	medium	 as	 presented	 earlier,	 deprived	 of	
phenol	red	and	supplemented	with	luciferin.	Wells	were	then	sealed	and	placed	into	the	Lumicycle	
device	for	recording	as	described	for	pre-adipocytes.	The	same	way,	measurements	were	taken	for	5	
to	10	days,	after	which	raw	data	were	extracted	and	plotted	against	time.	Baseline-subtracted	data	
were	fitted	to	a	sine	wave	from	which	the	period,	amplitude,	damping	and	phase	were	determined.	
Here	again,	rhythms	were	considered	for	a	goodness	of	fit	>	80%	and	a	periodicity	of	24±5	hours.	The	
first	cycle	was	excluded.	Each	trace	obtained,	all	conditions	considered,	resulted	from	one	35mm	petri	
dish	containing	the	appropriate	cell	line	and	differentiation	state.	The	full	methods	are	described	in	
200	
	
sections	2.4.2.1	(for	the	differentiation	of	pre-adipocytes	into	adipocytes)	and	2.4.2.2	(for	the	study	
of	the	success	of	the	differentiation).		
	
5.4	Statistics	
	
	 Sigma	 Plot	 (version	 13.0)	 was	 used	 to	 perform	 a	 two-way	 analysis	 of	 variance	 (ANOVA,	
repeated	measures	over	time),	where	the	two	parameters	of	interest	were	the	differentiation	state	
(pre-adipocytes	 or	 adipocytes)	 and	 the	 gene	 studied	 (Per2	 or	Bmal1).	 This	 in	 order	 to	 be	 able	 to	
determine	 if	 there	were	any	 significant	effects	of	 the	cell	 line	and	 the	differentiation	 state	on	 the	
period,	the	amplitude,	the	phase	and	the	damping.	Significant	differences	were	considered	for	a	p-
value<0.05.	If	so,	a	post-hoc	test	was	performed	to	see	in	between	which	conditions	the	differences	
were	significant.	All	graphs	and	analyses	were	made	using	Graph-Pad	Prism	version	7.0.	
	
	 The	phase	of	bioluminescence	rhythms	was	analysed	using	the	NCSS	software	version	11.0.5,	
and	a	Rayleigh	 test	was	performed	 to	determine	whether	 there	was	a	uniform	distribution	of	 the	
angles	(null	hypothesis	H0),	or	if	the	distribution	was	unimodal.	Rose	plots	were	used	here,	with	data	
represented	around	a	circle.	A	directional	vector	was	also	built	in	order	to	point	towards	the	averaged	
phase,	for	each	cell	line	and	differentiation	state.	A	p-value<0.05	was	considered	to	be	a	significant	
effect,	and	indicated	a	unimodal	distribution	of	the	angles.		
	 	 	
5.5	Results	
		 	
5.5.1	Lumicycle	analysis	program	and	extraction	of	circadian	parameters	
	
	 Below	is	illustrated	an	example	of	bioluminescence	recording	via	the	LumiCycle	measurement	
program	 (version	2.31,	 panel	A	 figure	5.2),	with	panel	B	 (figure	5.2)	 illustrating	 the	 corresponding	
baseline-subtracted	data.	A	cosine	fit	to	these	baseline-subtracted	data	automatically	gave	the	period	
(in	hours),	the	amplitude	(in	counts/sec),	the	damping	and	the	phase	(in	hours).	The	goodness	of	fit	
(in	%	variance)	was	also	given	(panel	C,	figure	5.2).		
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Figure	5.2:	Analysis	of	bioluminescence	recording	of	reporter	cells.	A:	The	top	panel	is	an	example	of	
raw	data	 representing	 the	counts	of	photons/seconds,	 calculated	every	 ten	minutes	during	here	a	
total	of	approximately	10	days	and	a	half.	B:	The	lower	panel	represents	the	baseline-subtracted	data,	
also	plotted	against	the	time	in	days.	The	red	curve	illustrated	the	cosine	fit	to	the	baseline-subtracted	
data,	from	which	the	values	for	the	period,	amplitude,	phase,	damping	and	goodness	of	fit	(C)	were	
automatically	generated.		
	
5.5.2	Pre-adipocytes	display	bioluminescence	rhythms	of	gene	expression	
	
	 Baseline-subtracted	traces	representing	the	activity	of	the	Per2	and	the	Bmal1	promoter	were	
determined	using	a	 LumiCycle	 luminometer	and	 the	LumiCycle	analysis	program	presented	above.	
Wells	hosting	the	cells	were	pre-coated	with	either	collagen	or	gelatine.	Results	are	presented	in	figure	
5.3	 below,	 and	 showed	 persistent	 rhythms	 of	 gene	 expression	 in	 pre-adipocytes	 (between	
approximately	 2	 to	 8	 days).	 For	 all	 traces,	 the	 amplitude,	 period,	 phase,	 damping	 as	 well	 as	 the	
goodness	of	 fit	 are	 summarised	 in	 table	 5.1.	 Periodicities	were	 comprised	between	23.6	 and	25.9	
hours,	therefore	close	to	the	approximate	24-hour	periodicity	of	a	circadian	rhythm.	For	each	coating	
condition	and	each	cell	line,	rhythms	were	presenting	a	high	amplitude	and	a	periodicity	close	to	the	
expected	24-hour	period	of	a	circadian	rhythm.	The	goodness	of	the	fit	was	always	superior	to	88%	
(table	 5.1).	 Lastly,	 the	 baseline-subtracted	 bioluminescence	 data	 of	 both	 reporters	 for	 the	 same	
examples	 of	 traces	were	 plotted	 together,	 for	 each	 coating	 condition,	 to	 show	 the	 expected	 and	
approximately	anti-phasic	reporter	expression	for	both	cell	types	(figure	5.4).		
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Figure	5.3:	3T3-L1	pre-adipocytes	display	bioluminescence	rhythms	of	gene	expression.	3T3-L1	Per2	
(panels	 A	 to	 D)	 and	 Bmal1	 –	 dLuc	 (panels	 E	 to	 H)	 pre-adipocytes	 were	 synchronised	 prior	 to	
measurements	and	were	cultured	in	wells	pre-coated	with	collagen	(A,	B,	E,	F)	or	gelatine	(C,	D,	G,	H).	
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Table	5.1:	Period,	amplitude,	phase,	damping	and	goodness	of	fit	comparisons	between	bioluminescence	rhythms	recorded	using	3T3-L1	Per2	and	Bmal1	
–	dLuc	pre-adipocytes	following	a	collagen	or	gelatine	coating.	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
A	-	3T3-L1	Per2-dLuc	PRE-
ADIPOCYTES	–	COLLAGEN	
Period	(hours)	 23.7	 C	-	3T3-L1	Per2-dLuc	PRE-
ADIPOCYTES	-	GELATINE		
Period	(hours)	 25.8	
	 Amplitude	(counts/sec)	 487.11	 	 Amplitude	(counts/sec)	 505.69	
	 Phase	(hours)	 -0.42	 	 Phase	(hours)	 6.79	
	 Damping	(days)	 2.56	 	 Damping	(days)	 2.09	
	 Goodness	of	fit	(%)	 92.5	 	 Goodness	of	fit	(%)	 88.7	
B	-	3T3-L1	Per2-dLuc	PRE-
ADIPOCYTES	-	COLLAGEN		
Period	(hours)	 23.8	 D	-	3T3-L1	Per2-dLuc	PRE-
ADIPOCYTES	-	GELATINE		
Period	(hours)	 25.9	
	 Amplitude	(counts/sec)	 1426.21	 	 Amplitude	(counts/sec)	 4969.77	
	 Phase	(hours)	 0.21	 	 Phase	(hours)	 -11.48	
	 Damping	(days)	 1.9	 	 Damping	(days)	 1.47	
	 Goodness	of	fit	(%)	 94	 	 Goodness	of	fit	(%)	 92.8	
E	-	3T3-L1	Bmal1-dLuc	PRE-
ADIPOCYTES	-	COLLAGEN		
Period	(hours)	 23.2	 G	-	3T3-L1	Bmal1-dLuc	PRE-
ADIPOCYTES	-	GELATINE		
Period	(hours)	 24.3	
	 Amplitude	(counts/sec)	 2748.62	 	 Amplitude	(counts/sec)	 2561.74	
	 Phase	(hours)	 5.47	 	 Phase	(hours)	 11.84	
	 Damping	(days)	 1.31	 	 Damping	(days)	 1.45	
	 Goodness	of	fit	(%)	 93.2	 	 Goodness	of	fit	(%)	 93.7	
F	-	3T3-L1	Bmal1-dLuc	PRE-
ADIPOCYTES	-	COLLAGEN		
Period	(hours)	 23.6	 H	-	3T3-L1	Bmal1-dLuc	PRE-
ADIPOCYTES	-	GELATINE		
Period	(hours)	 24	
	 Amplitude	(counts/sec)	 2709.44	 	 Amplitude	(counts/sec)	 7650.79	
	 Phase	(hours)	 3.14	 	 Phase	(hours)	 9.2	
	 Damping	(days)	 5.4	 	 Damping	(days)	 2.18	
	 Goodness	of	fit	(%)	 90.1	 	 Goodness	of	fit	(%)	 96	
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Figure	 5.4:	Per2	 and	Bmal1	 –	 dLuc	 pre-adipocytes	 display	 anti-phasic	 bioluminescence	 rhythms.	
Baseline-subtracted	 data	 of	 bioluminescence	 for	 both	 reporters	 plotted	 together,	 showed	
approximate	anti-phasic	reporter	expression,	in	both	coating	conditions:	collagen	(A)	or	gelatine	(B).			
	
5.5.3	Adipocytes	display	bioluminescence	rhythms	of	gene	expression	
	
	 Cellular	morphology	was	investigated	every	two	days	from	the	induction	of	the	differentiation	
(with	and	without	Oil	Red	O),	and	results	are	presented	in	figure	5.5.	For	the	Bmal1-dLuc	cell	line,	the	
staining	of	lipid	droplets	could	be	seen	as	soon	as	2	days	post-induction	of	differentiation.	At	day	8,	
the	triglycerides	accumulation	raised	above	undifferentiated	cells	for	the	Bmal1-dLuc	cells	(figure	5.5	
A),	 and	 approximately	 70%	 of	 the	 cells	 were	 presenting	 signs	 of	 differentiation	 and	 lipid	 droplet	
accumulation.	For	the	Per2-dLuc	cell	line	however,	although	some	staining	was	seen	across	time	after	
the	induction	of	the	differentiation,	the	success	of	the	process	seemed	significantly	less	than	for	the	
Bmal1-dLuc	cell	line,	with	a	reduced	accumulation	of	triglycerides	(figure	5.5	B).	It	was	estimated	that	
50%	of	cells	had	accumulated	lipid	droplets	after	12	days	following	the	initiation	of	differentiation.			
	
	 In	the	same	manner	as	for	pre-adipocytes,	3T3-L1	Per2	and	Bmal1	–	dLuc	adipocyte	rhythms	
of	 bioluminescence	 were	 recorded	 using	 a	 LumiCycle	 device.	 Rhythms	 were	 again	 persistent	 for	
approximately	3	to	8	days,	and	similar	amplitude	rhythms	(see	table	5.2)	were	observed	for	both	cell	
lines,	 after	 coating	 with	 collagen	 or	 gelatine.	 Two	 examples	 of	 each	 (gene	 and	 coating	 type)	 are	
illustrated	 figure	 5.6.	 When	 traces	 were	 put	 together	 for	 Per2	 and	 Bmal1,	 we	 found	 anti-phasic	
rhythms	of	gene	expression,	following	both	coating	conditions,	as	for	pre-adipocytes	(figure	5.7).	Table	
5.2	summarises	 the	circadian	parameters	extracted	from	the	bioluminescence	rhythms	traces,	and	
shows	a	periodicity	between	22	and	25.9	hours,	close	to	24-hour.	Furthermore,	the	goodness	of	fit	
was	always	superior	to	88%.	
	
BA
1 2 3 4 5 6
-400
-200
0
200
400
600
1 2 3
-800
-600
-400
-200
0
200
400
600
800
3T3-L1 Per2-dLuc adipocytes  
3T3-L1 Bmal1-dLuc adipocytes  
205	
	
	
	
Figure	5.5:	Evolution	 in	 the	cellular	morphology	of	3T3-L1	Per2	and	Bmal1	 -	dLuc	pre-adipocytes	
after	induction	of	differentiation	into	adipocytes.	Cells	were	grown	in	35mm	petri	dishes	pre-coated	
with	gelatine.	When	confluent,	the	differentiation	was	induced	using	insulin,	IBMX	and	DEX.	From	2	
days	following	the	induction	of	the	differentiation	up	to	12	days,	the	morphology	of	the	cells	was	taken	
either	without	Oil	Red	O	(upper	panels)	or	with	Oil	Red	O	(lower	panels),	for	Bmal1	(A)	and	Per2	(B).	
Pictures	were	taken	using	a	magnification	x20,	and	a	scale	bar	indicated	a	length	of	75µM.		
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Figure	 5.6:	 3T3-L1	 adipocytes	 display	 bioluminescence	 rhythms	 of	 gene	 expression.	 3T3-L1	Per2	
(panels	A	to	D)	and	Bmal1	-	dLuc	(panels	E	to	H)	adipocytes	were	synchronised	prior	to	measurements	
and	were	cultured	in	wells	pre-coated	with	collagen	(A,	B,	E,	F)	or	gelatine	(C,	D,	G,	H).		
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Table	5.2:	Period,	amplitude,	phase,	damping	and	goodness	of	fit	comparisons	between	bioluminescence	rhythms	recorded	using	3T3-L1	Per2	and	Bmal1	
–	dLuc	adipocytes	between	collagen	and	gelatine	coating.	
	
	
	
	
A	-	3T3-L1	Per2-dLuc	
ADIPOCYTES	–	COLLAGEN	
Period	(hours)	 24	 C	-	3T3-L1	Per2-dLuc	
ADIPOCYTES	-	GELATINE	
Period	(hours)	 25.9	
	 Amplitude	(counts/sec)	 556.07	 	 Amplitude	(counts/sec)	 4226.19	
	 Phase	(hours)	 11.89	 	 Phase	(hours)	 7.39	
	 Damping	(days)	 1.82	 	 Damping	(days)	 1.4	
	 Goodness	of	fit	(%)	 93	 	 Goodness	of	fit	(%)	 94.7	
B	-	3T3-L1	Per2-dLuc	
ADIPOCYTES	–	COLLAGEN	
Period	(hours)	 24.3	 D	-	3T3-L1	Per2-dLuc	
ADIPOCYTES	-	GELATINE	
Period	(hours)	 25.9	
	 Amplitude	(counts/sec)	 443.11	 	 Amplitude	(counts/sec)	 1657.96	
	 Phase	(hours)	 -7.1	 	 Phase	(hours)	 1	
	 Damping	(days)	 2.18	 	 Damping	(days)	 1.86	
	 Goodness	of	fit	(%)	 91.8	 	 Goodness	of	fit	(%)	 98.7	
	 	 	 	 	 	
	 	 	 	 	 	
E	-	3T3-L1	Bmal1-dLuc	
ADIPOCYTES	–	COLLAGEN	
Period	(hours)	 23.7	 G	-	3T3-L1	Bmal1-dLuc	
ADIPOCYTES	-	GELATINE	
Period	(hours)	 24.9	
	 Amplitude	(counts/sec)	 980.81	 	 Amplitude	(counts/sec)	 3385.09	
	 Phase	(hours)	 -4.03	 	 Phase	(hours)	 -11.06	
	 Damping	(days)	 3.38	 	 Damping	(days)	 1.76	
	 Goodness	of	fit	(%)	 95.9	 	 Goodness	of	fit	(%)	 96.5	
F	-	3T3-L1	Bmal1-dLuc	
ADIPOCYTES	–	COLLAGEN	
Period	(hours)	 22	 H	-	3T3-L1	Bmal1-dLuc	
ADIPOCYTES	-	GELATINE	
Period	(hours)	 24.4	
	 Amplitude	(counts/sec)	 1048.29	 	 Amplitude	(counts/sec)	 2572.4	
	 Phase	(hours)	 2.73	 	 Phase	(hours)	 11.27	
	 Damping	(days)	 -28.37	 	 Damping	(days)	 1.5	
	 Goodness	of	fit	(%)	 83.6	 	 Goodness	of	fit	(%)	 88.6	
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Figure	 5.7:	 Per2	 and	 Bmal1	 –	 dLuc	 adipocytes	 display	 anti-phasic	 rhythms	 of	 gene	 expression.	
Baseline-subtracted	 data	 of	 bioluminescence	 for	 both	 reporters	 plotted	 together,	 showing	
approximate	anti-phasic	reporter	expression,	in	both	coating	conditions:	collagen	(A)	or	gelatine	(B).			
	
5.5.4	Analysis	of	circadian	parameters	from	bioluminescence	rhythms	in	pre-adipocytes	and	
adipocytes	
	
	 Successful	bioluminescence	traces	(goodness	of	fit	≥	85%	and	periodicity	of	24±5	hours)	were	
analysed.	A	total	of	40	recordings	were	obtained	for	3T3-L1	Per2-dLuc	pre-adipocytes,	31	for	3T3-L1	
Bmal1-dLuc	pre-adipocytes	and	10	for	each	adipocyte	cell	line	(unless	otherwise	stated).	The	period,	
amplitude,	damping	and	phase	are	illustrated	in	figures	5.8,	5.9,	5.10	and	5.12,	respectively.	Tables	
5.3,	5.5	and	5.7	summarise	the	n,	mean	and	standard	deviation	between	all	traces	(each	cell	line	and	
differentiation	 state	 considered)	 for	 the	period,	 the	amplitude	and	 the	damping,	 respectively.	 The	
periods	ranged	between	24.27	and	25.17	hours,	therefore	within	accepted	limits	for	circadian	rhythms	
(table	5.3).	For	each	parameter,	Tukey’s	multiple	comparisons	tests	revealed	no	significant	differences	
between	pre-adipocytes	and	adipocytes,	as	well	as	between	the	3T3-L1	Per2	and	Bmal1	–	dLuc	cell	
lines	(tables	5.4,	5.6	and	5.8	for	the	period,	amplitude	and	damping,	respectively).	
	
	 It	is	also	important	to	emphasize	that	the	damping	given	by	the	LumiCycle	analysis	software	
was	 determined	 through	 an	 overall	 trend-line	 across	 the	 whole	 trace,	 which	 did	 not	 take	 into	
consideration	 the	 specific	 peak-to-trough	 values	 across	 the	 rhythms.	 Therefore,	 for	 all	 traces	
considered	 in	 the	analysis	of	circadian	parameters,	 the	peak-to-trough	values	were	calculated	 (the	
first	14	values	of	the	trace,	representing	the	7	first	cycles),	illustrated	in	figure	5.11.	A	two-way	ANOVA	
between	 cell	 type	 and	 differentiation	 state	 confirmed	 significant	 differences	 in	 the	 data	 with	
p=0.0035.	 A	 Tukey’s	 multiple	 comparisons	 test	 identified	 these	 differences	 to	 be	 between	 pre-
adipocytes	and	adipocytes	3T3-L1	Per2-dLuc	(p=0.0097),	between	3T3-L1	Bmal1	and	Per2-dLuc	pre-
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adipocytes	(p=0.0291),	as	well	as	between	3T3-L1	Bmal1-dLuc	adipocytes	and	3T3-L1	Per2-dLuc	pre-
adipocytes	(table	5.9).	Both	adipocyte	cell	 lines	and	3T3-L1	Bmal1-dLuc	pre-adipocytes	presented	a	
similar	 reduction	of	 the	peak-to-trough	value	with	 time	 (representing	a	damping	or	a	 reduction	 in	
amplitude	of	the	rhythm,	figure	5.11),	as	indicated	by	no	significant	differences	in	the	data	(table	5.9,	
p>0.05).	This	behaviour	was	quite	different	for	3T3-L1	Per2-dLuc	pre-adipocytes,	where	we	observed	
a	decrease	in	the	peak-to-through	values	up	until	the	second	peak-to-trough,	followed	by	an	increase	
for	the	next	two	peak-to-troughs,	and	a	gradual	decrease	up	to	the	end	of	the	measures	(figure	5.11).	
This	explained	the	significant	differences	described	above	(table	5.9).			
	
	 For	each	differentiation	state	and	cell	line,	the	phases	of	the	traces	were	also	extracted.	We	
used	rose	plots,	represented	in	figure	5.12.	These	plots	represented	a	distribution	of	the	data	around	
a	circle	with	vectors	pointing	towards	the	mean	direction	or	mean	phase,	each	condition	considered.	
The	plot	was	divided	into	8	segments	representing	different	phase	values	intervals,	and	the	red	was	
indicating	the	percentage	of	traces	which	fitted	in	these	intervals.	The	more	red	was	used	to	fill	the	
segment,	the	higher	was	the	percentage	of	traces	whose	phases	fitted	into	the	interval	represented	
by	the	segment.	The	circles	on	the	inside	of	the	plot	were	each	indicating	a	specific	percentage,	higher	
as	the	circles	became	bigger.		
	
5.5.4.1	Period	
	
Figure	5.8:	Period	of	bioluminescence	 rhythms	of	
3T3-L1	 Per2	 and	Bmal1	 –	 dLuc	 pre-adipocytes	 as	
well	as	adipocytes.	The	different	colours	 indicated	
traces	recorded	at	various	times	from	distinct	initial	
cryovials	of	cells	(n=9	biological	replicates	for	3T3-L1	
Per2-dLuc	pre-adipocytes,	n=10	biological	replicates	
for	3T3-L1	Bmal1-dLuc	pre-adipocytes,	n=2	for	3T3-
L1	Per2-dLuc	adipocytes	and	n=2	for	3T3-L1	Bmal1-
dLuc	 adipocytes).	 Differences	 in	 the	 mean	 values	
among	 the	 differentiation	 states	 were	 not	 great	
enough	to	exclude	the	possibility	that	the	difference	
was	 just	 due	 to	 random	 sampling	 variability	 after	
allowing	 for	 the	 effects	 of	 differences	 in	 the	
differentiation	 state	 (for	Per2	 or	Bmal1),	 p=0.455.	
The	 reverse	 was	 also	 true,	 when	 studying	 the	
differences	in	the	mean	values	among	the	two	genes	
of	 interest,	with	 a	 p-value	 =	 0.823.	 Statistical	 analyses	were	 done	 considering	 all	 replicates	 (n=10	
technical	replicates	for	3T3-L1	Per2	and	Bmal1-dLuc	adipocytes,	n=31	technical	replicates	for	3T3-L1	
Bmal1-dLuc	pre-adipocytes	and	n=40	for	3T3-L1	Per2-dLuc	pre-adipocytes).	
0 5 20 22 24 26 28 30
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Table	5.3:	Analysis	of	the	period	of	bioluminescence	rhythms	for	3T3-L1	Per2	and	Bmal1	–	dLuc	pre-
adipocytes	and	adipocytes.	
	
	
Table	 5.4:	 Results	 of	 the	 Tukey’s	 multiple	 comparisons	 test	 for	 the	 period	 of	 bioluminescence	
rhythms	for	3T3-L1	Per2	and	Bmal1	–	dLuc	pre-adipocytes	and	adipocytes.	
		
	
	
	
	
	
	
5.5.4.2	Amplitude	
	
	
Figure	 5.9:	 Amplitude	 of	 bioluminescence	
rhythms	 of	 3T3-L1	 Per2	 and	 Bmal1	 –	 dLuc	
pre-adipocytes	 as	 well	 as	 adipocytes.	 The	
colour	 differences	 indicated	 traces	 recorded	
at	various	times	using	different	initial	cryovials	
of	 cells	 (n=9	 biological	 replicates	 for	 3T3-L1	
Per2-dLuc	 pre-adipocytes,	 n=10	 biological	
replicates	 for	 3T3-L1	 Bmal1-dLuc	 pre-
adipocytes,	 n=2	 for	 3T3-L1	 Per2-dLuc	
adipocytes	 and	 n=2	 for	 3T3-L1	 Bmal1-dLuc	
adipocytes).	 The	 differences	 in	 the	 mean	
values	 among	 the	different	 levels	 of	 the	 cell	
line	(3T3-L1	Per2	and	Bmal1	–	dLuc)	were	not	
great	 enough	 to	 exclude	 the	 possibility	 that	
the	 difference	 was	 just	 due	 to	 random	
sampling	 variability	 after	 allowing	 for	 the	
effects	 of	 differences	 in	 the	 differentiation	
state	 (p=0.051).	 The	 reverse	 statement	 was	
also	 true	 (p=0.873).	 Statistical	 analyses	were	 carried	 out	 considering	 all	 replicates	 (n=10	 technical	
replicates	 for	 3T3-L1	 Per2,	 n=9	 technical	 replicates	 for	 Bmal1-dLuc	 adipocytes,	 n=31	 technical	
replicates	for	3T3-L1	Bmal1-dLuc	pre-adipocytes	and	n=40	for	3T3-L1	Per2-dLuc	pre-adipocytes).					
PERIOD	
(HOURS)	
3T3-L1	Per2-dLuc	
pre-adipocytes	
3T3-L1	Per2-
dLuc	adipocytes	
3T3-L1	Bmal1-dLuc	
pre-adipocytes	
3T3-L1	Bmal1-
dLuc	adipocytes	
N	 40	 10	 31	 10	
MEAN	 24.64	 24.92	 25.17	 24.27	
STANDARD	
DEVIATION	
1.59	 1.76	 1.98	 0.74	
Conditions	tested	 Adjusted	p-value	 Significant?	
Bmal1	adipocytes	vs.	Bmal1	pre-adipocytes	 0.46	 No	
Bmal1	adipocytes	vs.	Per2	adipocytes	 0.826	 No	
Bmal1	adipocytes	vs.	Per2	pre-adipocytes	 0.926	 No	
Bmal1	pre-adipocytes	vs.	Per2	adipocytes	 0.976	 No	
Bmal1	pre-adipocytes	vs.	Per2	pre-adipocytes	 0.553	 No	
Per2	pre-adipocytes	vs.	Per2	adipocytes	 0.966	 No	
0 2000 4000 6000 8000 10000 12000
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Table	5.5:	Analysis	of	the	amplitude	of	bioluminescence	rhythms	for	3T3-L1	Per2	and	Bmal1	–	dLuc	
pre-adipocytes	and	adipocytes.	
	
	
Table	5.6:	Results	of	the	Tukey’s	multiple	comparisons	test	for	the	amplitude	of	bioluminescence	
rhythms	for	3T3-L1	Per2	and	Bmal1	–	dLuc	pre-adipocytes	and	adipocytes.	
	
Conditions	tested	 Adjusted	p-value	 Significant?	
Bmal1	adipocytes	vs.	Bmal1	pre-adipocytes	 0.43	 No	
Bmal1	adipocytes	vs.	Per2	adipocytes	 0.387	 No	
Bmal1	adipocytes	vs.	Per2	pre-adipocytes	 0.078	 No	
Bmal1	pre-adipocytes	vs.	Per2	adipocytes	 0.973	 No	
Bmal1	pre-adipocytes	vs.	Per2	pre-adipocytes	 0.536	 No	
Per2	pre-adipocytes	vs.	Per2	adipocytes	 0.966	 No	
	
5.5.4.3	Damping		
	
Figure	5.10:	Damping	of	bioluminescence	
rhythms	of	3T3-L1	Per2	and	Bmal1	–	dLuc	
pre-adipocytes	as	well	as	adipocytes.	The	
use	 of	 different	 colours	 was	 to	 identify	
traces	recorded	at	different	times	and	on	
cells	 coming	 from	 different	 initial	
cryovials	 (n=9	 biological	 replicates	 for	
3T3-L1	 Per2-dLuc	 pre-adipocytes,	 n=10	
biological	 replicates	 for	 3T3-L1	 Bmal1-
dLuc	pre-adipocytes,	n=2	for	3T3-L1	Per2-
dLuc	 adipocytes	 and	 n=2	 for	 3T3-L1	
Bmal1-dLuc	 adipocytes).	 There	were	not	
great	 enough	 differences	 in	 the	 mean	
values	 among	 the	 different	 levels	
between	the	two	cell	lines	to	exclude	the	
possibility	that	the	difference	was	just	due	
to	 random	 sampling	 variability	 after	
allowing	for	the	effects	of	the	differences	in	the	differentiation	state	(p=0.557)	and	the	gene	of	interest	
(p=0.058).	Statistical	analyses	were	carried	out	considering	all	replicates	(n=10	technical	replicates	for	
3T3-L1	 Per2	 and	 Bmal1-dLuc	 adipocytes,	 n=29	 technical	 replicates	 for	 3T3-L1	 Bmal1-dLuc	 pre-
adipocytes	and	n=40	for	3T3-L1	Per2-dLuc	pre-adipocytes).		
AMPLITUDE	
(COUNTS/SEC)	
3T3-L1	Per2-dLuc	
pre-adipocytes	
3T3-L1	Per2-dLuc	
adipocytes	
3T3-L1	Bmal1-dLuc	
pre-adipocytes	
3T3-L1	Bmal1-
dLuc	adipocytes	
N	 40	 10	 31	 9	
MEAN	 1305.56	 1676.57	 2031.65	 3328.44	
STANDARD	
DEVIATION	
1750.51	 1100.22	 2602.75	 3587.12	
-10 -8 -6 -4 -2 0 2 4 6 8 10
Bmal1 ADIPOCYTES 
Bmal1 PRE-ADIPOCYTES
Per2 ADIPOCYTES
Per2 PRE-ADIPOCYTES
Damping (days)
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Table	5.7:	Analysis	of	the	damping	of	bioluminescence	rhythms	for	3T3-L1	Per2	and	Bmal1	–	dLuc	
pre-adipocytes	and	adipocytes.	
	
	
Table	5.8:	Results	of	 the	Tukey’s	multiple	 comparisons	 test	 for	 the	damping	of	bioluminescence	
rhythms	for	3T3-L1	Per2	and	Bmal1	–	dLuc	pre-adipocytes	and	adipocytes.	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	5.11:	Dampening	of	 the	peak-to-trough	distance.	For	each	trace	analysed,	all	cell	 lines	and	
differentiation	states	considered,	the	first	14	peak-to-trough	values	were	determined,	corresponding	
to	7	cycles.	3T3-L1	Bmal1-dLuc	(pre-adipocytes	and	adipocytes)	as	well	as	3T3-L1	Per2-dLuc	adipocytes	
were	displaying	a	similar	behaviour,	showing	decreased	peak-to-trough	values	across	time.	However,	
traces	for	3T3-L1	Per2-dLuc	pre-adipocytes	behaved	very	differently,	with	a	decrease	for	the	first	cycle	
followed	by	an	increase	before	a	decrease	to	finally	meet	the	values	of	the	three	other	conditions	at	
the	10th	peak-to-trough	value.	This	was	confirmed	by	a	significant	p-value=0.0035.	The	result	of	the	
Tukey’s	multiple	comparisons	post-hoc	test	is	presented	thereafter.		
DAMPING	
(DAYS)	
3T3-L1	Per2-dLuc	
pre-adipocytes	
3T3-L1	Per2-dLuc	
adipocytes	
3T3-L1	Bmal1-dLuc	
pre-adipocytes	
3T3-L1	Bmal1-
dLuc	adipocytes	
N	 40	 10	 29	 10	
MEAN	 1.94	 0.52	 2.41	 0.93	
STANDARD	
DEVIATION	
0.98	 4.19	 2.75	 2.9	
Conditions	tested	 Adjusted	p-value	 Significant?	
Bmal1	adipocytes	vs.	Bmal1	pre-adipocytes	 0.32	 No	
Bmal1	adipocytes	vs.	Per2	adipocytes	 0.982	 No	
Bmal1	adipocytes	vs.	Per2	pre-adipocytes	 0.619	 No	
Bmal1	pre-adipocytes	vs.	Per2	adipocytes	 0.16	 No	
Bmal1	pre-adipocytes	vs.	Per2	pre-adipocytes	 0.843	 No	
Per2	pre-adipocytes	vs.	Per2	adipocytes	 0.366	 No	
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Table	 5.9:	 Results	 of	 the	 Tukey’s	 multiple	 comparisons	 test	 for	 the	 peak-to-through	 values	
determined	 for	 the	 first	 14	 values,	 for	 each	 cell	 line	 and	 differentiation	 state	 of	 interest.	 “NO”	
indicated	no	significant	differences	 in	the	peak-to-trough	values	between	two	different	conditions,	
with	“YES”	revealing	significant	differences	in	the	data.	Values	were	considered	significantly	different	
for	a	p-value	<0.05.	
	
Conditions	tested	 Adjusted	p-value	 Significant?	
Bmal1	adipocytes	vs.	Bmal1	pre-adipocytes	 0.94	 No	
Bmal1	adipocytes	vs.	Per2	adipocytes	 0.1	 No	
Bmal1	adipocytes	vs.	Per2	pre-adipocytes	 0.01	 Yes	
Bmal1	pre-adipocytes	vs.	Per2	adipocytes	 0.97	 No	
Bmal1	pre-adipocytes	vs.	Per2	pre-adipocytes	 0.03	 Yes	
Per2	pre-adipocytes	vs.	Per2	adipocytes	 0.01	 Yes	
	
5.5.4.4	Phase	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	5.12:	Phase	of	bioluminescence	rhythms	of	3T3-L1	Per2	and	Bmal1	–	dLuc	pre-adipocytes	as	
well	as	adipocytes.	Each	red	circle	represented	on	the	circular	plots	are	phase	values	for	3T3-L1	Per2-
dLuc	pre-adipocytes	(n=9	biological	replicates)	(A)	and	adipocytes	(n=2	biological	replicates)	(C)	as	well	
as	for	3T3-L1	Bmal1-dLuc	pre-adipocytes	(n=10	biological	replicates)	(B)	and	adipocytes	(n=2	biological	
replicates)	(D).	The	circular	plot	is	divided	in	8	sections,	and	each	of	the	sections	containing	data	is	
represented	by	the	red	segments.	The	more	values	there	are,	the	larger	the	segment	is.	A	vector	points	
towards	 the	 average	 phase	 values	 for	 each	 condition:	 (A)=0.5683,	 (B)=0.6951,	 (C)=0.6554	 and	
(D)=0.7913.	Rayleigh	tests	were	done	for	pre-adipocytes	as	these	samples	were	of	n>20.	For	3T3-L1	
Per2-dLuc	pre-adipocytes,	the	p-value	was	p=0.2196,	which	meant	a	uniform	distribution	of	angles.	
However,	 for	 3T3-L1	 Per2-dLuc	 pre-adipocytes,	 the	 p-value	 was	 p=0.0097	 and	 was	 therefore	
significant,	meaning	a	unimodal	distribution	of	the	data.	Statistical	analyses	were	done	considering	all	
replicates	 (n=10	 technical	 replicates	 for	 3T3-L1	 Per2	 and	 Bmal1-dLuc	 adipocytes,	 n=31	 technical	
replicates	for	3T3-L1	Bmal1-dLuc	pre-adipocytes	and	n=40	for	3T3-L1	Per2-dLuc	pre-adipocytes).	
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5.6	Discussion	and	concluding	remarks	
	
	 In	 animals,	 circadian	 rhythms	 in	 physiology	 and	 behaviour	 result	 from	 coherent	 rhythmic	
interactions	between	clocks	in	the	brain	and	those	throughout	the	body	(Liu	et	al.,	2007a,	Mohawk	et	
al.,	2012),	critical	for	normal	physiology	and	behaviour	(Hastings	et	al.,	2003,	Green	et	al.,	2008).	There	
are	many	tissue-specific	clocks,	but	most	understanding	of	the	molecular	core	clock	mechanism	comes	
from	 studies	 on	 the	 SCN	 of	 the	 hypothalamus	 and	 a	 few	 other	 cell	 types.	 Individual	 cells	 are	 the	
functional	units	for	the	generation	and	maintenance	of	circadian	rhythms	(Nagoshi	et	al.,	2004,	Welsh	
et	al.,	2004),	and	these	oscillators	of	different	tissue	types	in	the	organism	share	a	remarkably	similar	
biochemical	negative	 feedback	mechanism.	However,	due	 to	 interactions	at	 the	neuronal	network	
level	in	the	SCN	and	through	rhythmic,	systemic	cues	at	the	organismal	level,	circadian	rhythms	at	the	
organismal	 level	 are	 not	 necessarily	 cell-autonomous	 (Kornmann	 et	 al.,	 2007,	 Liu	 et	 al.,	 2007b,	
Hogenesch	et	al.,	2011).	Reporter	cell	lines	have	been	established	to	examine	the	dynamics	of	clock	
function	through	bioluminescence	recording.	For	 instance,	 the	generation	of	P(Per2)-dLuc	reporter	
lines	have	been	described	and	data	from	these	circadian	reporters	(and	others)	have	been	published	
(Ramanathan	et	al.,	2012).	Cell-autonomous	clock	models	were	used,	such	as	3T3	fibroblasts,	3T3-L1	
adipocytes	 and	MMH-D3	 hepatocytes,	 genetically	 tractable	 (Ramanathan	 et	 al.,	 2014).	 Cell	 type-
specific	function	of	clock	genes	may	result	from	their	differential	tissue	expression	and	activity;	such	
as	 the	 expression	 levels,	 ratio	 of	 repressors	 to	 activators,	 rhythmicity	 and	 relative	 amplitudes,	
compensatory	mechanisms,	 alternative	 splice	 variants,	 and	 post-translational	modifications,	 all	 of	
which	can	be	rendered	cell	type	specific	by	local	physiology.	
	
	 We	 therefore	 thought	 that	 using	 3T3-L1	 pre-adipose	 reporter	 cells	 transduced	 with	 the	
promoters	of	two	core	clock	genes:	Per2	and	Bmal1,	could	provide	information	on	the	basic	molecular	
core	 clock	mechanism	within	 the	 adipose	 tissue,	 and	 deeper	 insights	 into	mechanism	 of	 adipose	
clocks.	In	contrast	to	previous	cellular	clock	models,	these	models	were	amenable	to	high-throughput	
experiments	 with	 inexpensive	 off-the-shelf	 recording	 systems,	 making	 these	 cell	 lines	 especially	
suitable	 for	 screening	 small	molecules	 or	 genomic	 entities	 for	 impacts	 on	 cell-autonomous	 clocks	
relevant	 to	metabolism	 (Ramanathan	 et	al.,	 2014).	 Interestingly,	 the	models	used	were	previously	
validated	by	development	and	testing	of	an	shRNA	panel	of	selected	known	clock	genes	such	as	Per1,	
Per2,	Per3,	Bmal1,	Cry1	 and	Cry2.	 This	paper	 showed	 that	 fibroblasts,	adipocytes	and	hepatocytes	
displayed	persistent	high	amplitude	bioluminescence	rhythms	in	culture	dishes;	and	that	for	each	cell	
type,	baseline-subtracted	bioluminescence	data	of	both	reporter	lines	(Per2	and	Bmal1)	revealed	an	
expected	and	approximately	anti-phasic	reporter	expression.	We	worked	with	the	same	3T3-L1	Per2	
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and	Bmal1-dLuc	cell	 lines,	and	have	been	able	to	replicate	the	finding	that	both	cell	 lines	exhibited	
high	amplitude	bioluminescence	rhythms.	Between	both	cell	lines,	rhythms	of	bioluminescence	were	
also	anti-phasic,	consistent	with	the	function	of	E-box	and	RORE-containing	promoters	in	regulating	
distinct	and	opposite	phases	of	gene	expression.	This	was	true	for	pre-adipocytes	and	adipocytes	(cells	
in	 differentiation).	 These	 cellular	 clock	 models	 offered	 experimental	 tractability,	 efficiency	 and	
versatility,	difficult	or	impossible	to	apply	to	traditional	tissue	or	animal	models.							
	
	 	For	both	pre-adipocytes	and	pre-adipocytes	in	differentiation,	rhythms	were	found	persistent	
for	up	to	10	days.	We	observed	that	after	10	days,	cells	tended	to	lose	synchronicity	initially	coming	
from	the	serum	shock	treatment.	Two	types	of	coating	were	used	(collagen	and	gelatine),	in	order	to	
test	for	any	impact	on	the	differentiation	process	and	the	quality	of	the	traces.	In	pre-adipocytes,	the	
examples	given	showed	that	for	3T3-L1	Per2-dLuc	pre-adipocytes,	rhythms	were	persistent	for	4	to	6	
days	with	collagen,	whilst	only	persistent	between	2	to	3	days	in	3T3-L1	Bmal1-dLuc	pre-adipocytes,	
also	coated	with	collagen.	When	culture	dishes	were	coated	with	gelatine,	rhythms	were	persistent	
for	at	least	6	days,	both	cell	 lines	considered	at	the	pre-adipose	stage,	with	some	cultures	showing	
rhythms	persisting	for	7	and	8	days	for	3T3-L1	Bmal1-dLuc	pre-adipocytes.	It	therefore	seemed	that	
using	gelatine	allowed	rhythms	to	be	more	persistent,	and	that	this	coating	could	ensure	a	stronger	
cellular	 adhesion	 of	 the	 cells	 (and	 a	 lower	 cell	 loss	 after	 procedures	 of	 pipetting	 and	 through	 the	
differentiation	process)	as	compared	to	collagen.	The	traces	were	recorded	at	different	times	(at	least	
separated	by	a	week)	and	cells	were	coming	 from	different	 initial	 cryovials,	and	we	demonstrated	
similar	periodicities	in	the	traces,	all	coating	conditions	and	cell	lines	considered,	varying	only	between	
23.2	and	25.9	hours	(in	pre-adipocytes).	Therefore,	the	periodicities	were	close	to	the	approximate	24	
hours	of	a	circadian	rhythm.	When	taking	 into	consideration	the	8	traces	chosen	as	representative	
examples,	 the	 amplitudes	 differed	 greatly	 as	 the	 lowest	 was	 487.11	 counts/sec	 and	 the	 highest	
7650.79	 counts/sec,	 again	 in	 pre-adipocytes.	 All	 traces	 could	 however	 be	 considered	 of	 high	
amplitude,	in	line	with	the	study	published	by	Ramanathan	et	al.	(Ramanathan	et	al.,	2014).					
	
	 For	this	study,	we	tested	the	hypothesis	that	the	differentiated	versions	of	the	same	reporter	
cell	lines	also	exhibited	anti-phasic	and	persistent	circadian	rhythms	of	gene	expression,	alongside	a	
lower	amplitude	and	a	more	rapid	damping.	Cells	were	differentiated	using	an	adipogenic	cocktail	
constituted	of	insulin,	DEX	and	IBMX,	following	a	method	well	described	in	the	literature	(Klemm	et	
al.,	2001).	We	revealed	the	expected	accumulation	of	lipid	droplets	in	both	Bmal1	and	Per2	reporters,	
within	days	following	the	initiation	of	the	differentiation	process.	However,	 lipid	accumulation	was	
more	apparent	in	Bmal1-dLuc	cells	than	in	Per2-dLuc	cells,	with	lipid	droplets	detected	after	only	2	
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days	post	initiation	of	the	differentiation,	as	shown	after	Oil	Red	O	staining	(in	Bmal1-dLuc	cells).	At	
day	 6,	 lipid	 droplets	 started	 to	 be	 strongly	 stained,	 and	 at	 day	 8	 most	 cells	 had	 successfully	
differentiated,	with	a	percentage	of	differentiated	cells	above	that	of	undifferentiated	cells.	For	Per2-
dLuc	cells	however,	although	pictures	showed	a	stain	of	lipids	at	every	stage	observed	starting	from	
day	 2	 post	 induction	 of	 the	 differentiation	 process,	 the	 signal	 remained	 weak	 throughout.	 One	
important	element	to	add	is	that	using	these	particular	reporter	cells,	it	was	advised	by	the	researchers	
who	gifted	 these	 reporters	 to	us	 that	differentiation	could	 take	several	weeks	 to	occur	 (i.e.	2	 to	5	
weeks),	and	that	the	proportion	of	the	population	which	differentiates	could	be	limited.		
	
	 In	 3T3-L1	 pre-adipocytes	 in	 differentiation,	 we	 were	 again	 able	 to	 show	 persistent	
bioluminescence	 rhythms	 of	 gene	 expression,	 for	 both	 Per2	 and	 Bmal1,	 using	 the	 same	 coating	
conditions	(either	collagen	or	gelatine).	For	Per2,	we	managed	to	obtain	persistent	rhythms	of	gene	
expression	for	3	to	4	days,	when	dishes	were	pre-coated	with	collagen.	When	dishes	were	pre-coated	
with	gelatine,	the	persistence	of	the	rhythms	was	increased	to	almost	6	days.	When	studying	3T3-L1	
Bmal1-dLuc	 pre-adipocytes	 in	differentiation,	with	dishes	 coated	using	gelatine,	 the	 rhythms	were	
again	much	more	persistent	than	a	collagen	coating,	as	we	recorded	persistent	rhythms	over	a	period	
of	8	days	against	3.	This	same	observation	was	made	earlier	on	pre-adipocytes.	The	periodicities	were	
all	 of	 similar	 value,	 close	 to	 the	 expected	 approximate	 24-hour	 periodicity	 of	 a	 circadian	 rhythm,	
varying	between	22	hours	and	25.9	hours.	As	for	pre-adipocytes,	we	showed	anti-phasic	rhythms	of	
Per2-dLuc	 and	Bmal1-dLuc	 gene	expression	 in	3T3-L1	adipocytes,	both	genes	and	 types	of	 coating	
considered.	 Examining	 all	 recordings	 and	 types	 of	 coating,	 it	 was	 confirmed	 that	 there	 were	 no	
significant	differences	 in	periodicities	between	cell	 lines	and	differentiations	states,	which	were	all	
close	to	24	hours,	ranging	from	24.27	hours	to	25.17	hours).	We	also	demonstrated	that	the	amplitude	
as	well	as	damping	values	were	not	significantly	different	between	each	gene	and	differentiation	state	
studied.		
	
	 Because	 the	 damping	 values	 provided	 by	 the	 LumiCycle	 analysis	 program	 took	 into	
consideration	a	trend	line	throughout	the	whole	trace,	we	set	out	to	study	the	specific	peak-to-trough	
values	 across	 the	 traces.	 We	 found	 that	 both	 3T3-L1	 Per2	 and	 Bmal1-dLuc	 pre-adipocytes	 in	
differentiation	and	3T3-L1	Bmal1-dLuc	pre-adipocytes	exhibited	the	same	profile	with	a	decrease	in	
the	 peak-to-trough	 values	 with	 time.	 However,	 the	 pattern	 observed	 for	 3T3-L1	 Per2-dLuc	 pre-
adipocytes	was	significantly	different,	for	the	first	10	values,	with	an	increase	in	the	peak-to-trough	
value	after	a	decrease	to	finally	meet	the	behaviour	of	other	conditions	studied.	Based	on	the	effect	
of	the	serum	shock	to	synchronise	the	clocks	within	the	cells	and	“boost”	bioluminescence	rhythms	
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reflecting	the	activity	of	the	Per2	and	Bmal1	promoters,	the	dampened	rhythms	observed	may	be	due	
to	a	desynchronization	of	the	clocks	after	approximately	10	days,	or	to	an	attenuated	intra-cellular	
rhythm	amplitude.	Nonetheless,	this	meant	that	we	were	able	to	validate	the	hypothesis	that	Per2-
dLuc	pre-adipocytes	presented	a	higher	amplitude	than	their	adipocytes	counterparts.	However,	this	
was	not	true	for	the	3T3-L1	Bmal1-dLuc	cell	line.	
	
Concluding	remarks	
	
	 The	 cell	 type	 specific	 functions	 of	 clock	 genes	 may	 result	 from	 their	 differential	 tissue	
expression	 and	 activity,	 such	 as	 expression	 levels,	 ratio	 of	 repressors	 to	 activators,	 rhythmicity,	
relative	amplitudes,	alternative	splice	variants,	and	post-translational	modifications,	all	of	which	can	
be	 rendered	 cell	 type	 specific	 by	 local	 physiology	 (Ramanathan	 et	 al.,	 2014).	 Interestingly,	 studies	
suggested	 a	 similar	 circadian	 clock	 robustness	 and	 periodicity	 among	 clock	 proteins,	 calling	 for	
mechanistic	studies	in	a	tissue-specific	manner	(Ye	et	al.,	2011,	Kim	et	al.,	2012).	In	the	context	of	the	
adipose	 tissue	 function,	 it	 is	 plausible	 that	 the	 basic	 core	 clock	mechanism	 incorporates	 cell	 type	
specific	 factors,	 generating	 distinctive	 functional	 networks	 to	 regulate	 different	 local	 physiologies	
(Eckel-Mahan	et	al.,	2013).	This	is	interesting	as	the	post-translational	modifications	of	clock	factors	
are	critical	 regulatory	mechanisms,	 such	as	ATP-ribosylation,	acetylation	and	O-GlcNAcylation,	and	
therefore	tissue-specific	cellular	functions	and	metabolic	states	affecting	these	modifications	would	
provide	important	inputs	to	adjust	local	circadian	clocks,	and	vice	versa	(Asher	et	al.,	2011,	Hart	2013).		
	
	 We	were	able	to	replicate	locally	results	obtained	from	the	team	of	Dr	Andrew	Liu	in	Memphis,	
USA	 (Ramanathan	 et	 al.,	 2014).	 They	 showed	 persistent,	 anti-phasic	 and	 high-amplitude	
bioluminescence	rhythms,	when	using	the	same	LumiCycle	device	as	us	and	the	exact	same	reporter	
cell	 lines.	 However,	 they	 worked	 only	 using	 adipocytes,	 and	 not	 on	 their	 undifferentiated	
counterparts.	Although	authors	did	not	specify	amplitude	values	in	this	study,	the	bioluminescence	
traces	and	corresponding	amplitudes	seemed	to	be	similar	between	our	work	and	their	experiments.	
Furthermore,	 they	 found	a	periodicity	of	 24.6±0.32	hours	 for	 3T3-L1	Per2-dLuc	 adipocytes	 against	
24.92±1.76	hours	in	our	study,	for	the	same	cell	line.	For	3T3-L1	Bmal1-dLuc	adipocytes,	we	found	a	
periodicity	of	24.27±0.74	hours,	when	they	had	25.01±0.19	hours,	revealing	another	analogy	between	
the	 two	 sets	 of	 experiments.	 Although	 we	 only	 had	 10	 traces	 for	 each	 adipose	 cell	 line,	 these	
similarities	strengthened	our	confidence	in	our	results,	as	they	worked	with	24	different	traces.		
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	 A	 study	published	10	 years	 ago	 also	used	3T3-L1	pre-adipocytes	 (but	not	 transduced	with	
luciferase	reporters),	and	researchers	successfully	differentiated	these	pre-adipocytes	into	adipocytes	
using	the	same	method	as	us,	although	in	their	case	cells	were	cultured	in	6-well	plates	throughout	
the	process	instead	of	in	individual	dishes	for	us	(Otway	et	al.,	2009).	It	was	revealed	that	lipid	droplets	
were	 first	 observed	 four	 days	 after	 the	 onset	 of	 differentiation.	 By	 day	 8,	 many	 cells	 had	 large	
unilocular	lipid	droplets.	This	was	also	observed	in	our	study,	especially	for	Bmal1,	where	we	saw	a	
clear	 staining	 of	 lipid	 droplets,	 particularly	 visible	 from	 4	 days	 following	 the	 initiation	 of	 the	
differentiation.	For	Per2,	we	failed	to	obtain	a	successful	stain,	although	a	few	large	unilocular	droplets	
were	stained	after	10	days.	The	work	of	Otway	et	al.	also	assessed	circadian	rhythms	in	various	clock	
genes	and	adipokines	on	murine	3T3-L1	pre-adipocytes	and	adipocytes.	Cells	were,	as	 in	our	case,	
treated	with	a	2-h	serum	pulse	before	sampling	every	4	hours	over	a	48-h	period.	Researchers	showed	
that	the	amplitude	of	Per2	rhythms	in	differentiated	adipocytes	was	greatly	attenuated	in	comparison	
to	 pre-adipocytes	 (Otway	 et	 al.,	 2009).	 In	 our	 case,	 we	 did	 find	 a	 reduced	 amplitude	 of	 Per2	 in	
adipocytes	when	 compared	 to	 pre-adipocytes,	 of	 a	 temporary	 nature.	 Indeed,	we	 saw	 that	when	
considering	all	traces,	the	amplitude	of	Per2	pre-adipocytes	diminished	to	match	the	values	of	their	
adipocytes	counterparts,	after	5	cycles	(10	peak-to-trough	values).	The	question	then	remains	of	“how	
much	rhythm”	is	visible	after	5	cycles;	and	more	precisely	how	much	of	the	cellular	clocks	had	been	
desynchronised	due	to	a	dampened	effect	of	the	serum	pulse	on	maintaining	the	rhythm	after	this	
period	of	time.	Otway	and	co-workers	also	revealed	a	reduced	amplitude	of	Bmal1	in	adipocytes	in	
comparison	to	pre-adipocytes.	In	this	case,	we	did	not	find	similar	results:	when	considering	the	peak-
to-trough	values	on	5	cycles,	3T3-L1	Bmal1–dLuc	adipocytes	had	significantly	similar	values	as	3T3-L1	
Bmal1-dLuc	 pre-adipocytes.	 This	 could	 be	 explained	 by	 the	 fact	 that	 they	 used	 quantitative	
polymerase	chain	reaction	(q-PCR)	over	48	hours,	which	meant	that	the	timing	at	which	researchers	
harvested	the	cells	was	critical	for	analysis,	when	we	used	a	continuous	method.	As	a	result,	we	were	
able	to	see	the	amplitude	variations	over	time.	In	this	study,	although	researchers	showed	temporal	
rhythmicity	of	various	clock	and	clock-controlled	gene	expressions	in	pre-adipocytes	and	adipocytes	
(i.e.	Per2,	Dbp	and	Rev-Erbα),	they	failed	to	observe	a	circadian	rhythmicity	of	adipokines	and	other	
key	clock	genes	(such	as	Leptin,	Adiponectin,	Per1,	Cry1,	Bmal1	and	PPARα)	(Ando	et	al.,	2005,	Ptitsyn	
et	al.,	2006).	
	
	 Additionally,	 animal	 studies	 revealed	 rhythmic	 mRNA	 expression	 of	 clock	 genes	 and	
adipokines	in	the	visceral	adipose	tissue	of	mice	(Ando	et	al.,	2005).	The	technique,	similar	to	the	one	
described	above	(Otway	et	al.,	2009),	measured	mRNA	from	perigonadal	fat	samples	every	6	hours	
throughout	 a	period	of	 time	of	 24	hours.	Per2	 and	Bmal1	 exhibited	 a	 24-h	 rhythmicity,	with	Per2	
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peaking	in	the	latter	half	of	the	light	phase	(Ando	et	al.,	2005).	This	was	confirmed	by	other	studies	
(Panda	et	al.,	2002a,	Yamamoto	et	al.,	2004,	Yoo	et	al.,	2004).	These	findings	revealed	the	importance	
of	 functional	 circadian	 clocks	within	 the	 adipose	 tissue	 for	 an	 appropriate	 regulation	of	 adipocyte	
biology.	To	better	understand	the	mechanisms	explaining	why	people	become	obese	as	a	result	of	a	
circadian	 dysregulation,	 it	 was	 reported	 that	 a	 disruption	 of	 Bmal1,	 in	 mice,	 led	 to	 an	 increased	
adipogenesis,	adipocyte	hypertrophy	and	obesity,	in	comparison	to	WT	mice	(Guo	et	al.,	2012a).	This	
highlighted	the	importance	of	a	functional	expression	of	Bmal1	within	pre-adipocytes	and	adipocytes.	
If	 the	 function	 of	Bmal1	 is	 somehow	attenuated,	 the	 genes	 implicated	 in	 adipogenesis	 are	 down-
regulated;	 with	 the	 example	 of	 the	 genes	 involved	 in	 the	 canonical	 wingless/integrated	 (Wnt)	
pathway.			
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CHAPTER	6:	DISCUSSION		
	
	 Circadian	clocks	regulate	daily	changes	in	a	wide	range	of	physiological,	and	also	behavioural	
functions.	 These	 rhythms	 are	 essential	 to	 maintaining	 normal	 metabolic	 homeostasis,	 and	 their	
disruption	 (in	 i.e.	 night	 shift	 work)	 is	 associated	 with	 increased	 adiposity	 and	 risk	 of	 developing	
pathologies	such	as	obesity	and	type	2	diabetes	(Spiegel	et	al.,	2005,	Zvonic	et	al.,	2007).	Night	shift	
workers	are	also	more	likely	to	develop	metabolic	syndrome	(Brum	et	al.,	2015).	Besides	changing	our	
activity	timing,	people	sleeping	less	than	6	hours	or	more	than	9	hours	per	night	have	increased	risk	
of	developing	type	2	diabetes	as	well	as	an	impaired	glucose	tolerance	(Gottlieb	et	al.,	2005).	Given	
the	metabolic	nature	of	 these	consequences,	biological	 rhythms	 in	metabolically	active	 tissues	are	
thought	to	be	key.	Here	In	particular,	we	focused	om	the	adipose	tissue,	a	metabolically	active	organ	
expressing	a	multitude	of	biological	rhythms	(Shostak	et	al.,	2013a).	
	
	 There	is	 increasing	evidence	linking	the	circadian	cellular	clock	to	metabolism,	arguing	that	
studying	single-cell	biological	 rhythmicity	 in	vitro	 can	help	to	study	how	the	molecular	oscillator	 in	
adipocytes	link	to	metabolic	and	physiological	events	presenting	a	circadian	rhythmicity.	Therefore,	
we	aimed	 to	 increase	our	understanding	of	biological	 rhythmicity	of	metabolism	 in	adipocytes,	by	
addressing	the	following	general	hypotheses:	
	
Hypothesis	 1:	 In	 vitro	 utilisation	 dynamics	 of	 glucose	 in	 pre-adipose	 cells	 are	 exhibiting	 circadian	
rhythms,	and	of	other	carbon	sources	predictors	of	the	development	of	obesity,	markers	of	 insulin	
resistance,	and	intermediates	in	key	metabolic	pathways.	
	
Hypothesis	2:	 Electrophysiological	parameters	 reflecting	 the	cellular	morphology	and	 ionic	activity	
between	the	cell	and	its	external	environment	vary	according	to	a	circadian	manner	in	pre-adipocytes.	
	
Hypothesis	3:	3T3-L1	pre-adipocytes	and	adipocytes	possess	an	endogenous	circadian	clock	driving	
robust,	persistent,	and	anti-phasic	circadian	rhythms	in	the	activity	of	the	promoters	of	two	core	clock	
genes:	Per2	and	Bmal1.	3T3-L1	adipocytes	exhibit	a	faster	damping	rate	and	lower	amplitude	rhythms	
as	compared	to	their	pre-adipocytes	counterparts.		
	
	
	 In	order	to	address	hypothesis	1,	we	used	murine	3T3-L1	cells	that	were	previously	used	to	
study	 various	 aspects	 of	 adipocyte	 biology,	 to	 (for	 the	 first	 time)	 comprehensively	 map	 glucose	
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utilisation	rate,	as	well	as	utilisation	rates	of	90	other	different	carbon	energy	sources.	This	allowed	
us	to	validate	our	approach	by	comparing	the	glucose	utilisation	rate	between	two	protocols,	and	the	
literature.	We	then	aimed	to	determine	whether	any	other	carbon	sources	were	utilised	by	adipocytes	
in	a	circadian	manner,	and	if	so,	what	the	relationship	between	these	rhythms	was,	especially	in	terms	
of	their	peak	utilisation	phase	between	each	other	(Chapter	3).			
	
	 In	order	to	address	hypothesis	2,	attempts	were	made	to	use	dielectrophoresis	potential	in	
order	 to	 determine	 circadian	 rhythms	 in	membrane	 and	 cytoplasmic	 properties	 of	 pre-adipocytes	
(using	the	same	cell	line	as	hypothesis	1).	This	allowed	an	elegant	link	between	hypotheses	1	and	2,	
as	the	same	cell	line	was	used	and	different	techniques	were	presented	with	measures	done	at	regular	
intervals	across	the	circadian	time	(Chapter	4).		
	
	 Lastly,	we	aimed	to	determine	whether	there	were	changes	in	the	expression	of	the	cellular	
circadian	clocks,	before	and	after	differentiation.	To	these	ends,	we	used	two	different	3T3-L1	cell	
lines,	where	a	lentiviral	reporter	harbouring	the	rapidly	degradable	firefly	luciferase	(dLuc)	was	under	
the	 control	 of	 the	 mouse	 Per2	 or	 Bmal1	 gene	 promoters.	 Using	 these	 cells,	 we	 recorded	
bioluminescence	 rhythms	 of	 gene	 expression,	 and	 analysed	 these	 for	 differences	 between	
differentiation	states	(Chapter	5).											
	
	 The	overall	conclusions	drawn	from	this	thesis	and	how	this	work	helps	fill	 the	gaps	 in	the	
current	 understanding	 of	 adipose	 chronobiology,	 obesity	 and	 T2DM	will	 now	 be	 outlined.	 Finally,	
limitations	of	this	work	and	options	for	future	research	to	extend	the	current	data	will	be	discussed.					
	
6.1	Metabolism	of	 the	 adipose	 tissue	 and	 circadian	 clocks:	 utilisation	 of	 various	 carbon	
sources			
	
	 Several	in	vivo	studies	have	exposed	a	diurnal	rhythm	of	glucose	uptake	(but	not	utilisation)	
in	adipose	tissue,	with	the	highest	uptake	occurring	at	the	end	of	the	light	period	in	mice	(la	Fleur	et	
al.,	 2001,	 Kalsbeek	 et	 al.,	 2014).	 In	 humans,	 a	 similar	 picture	 emerged,	 where	 intrinsic	 glucose	
production	and	concentrations	increased	before	waking,	when	at	the	same	time	glucose	utilisation	is	
high	 (Bolli	et	al.,	 1984).	 This	 suggests	mechanisms	 in	place	 that	make	glucose	available	when	 it	 is	
needed,	and	that	there	is	a	strong	circadian	component	to	this	relationship.	Indeed,	circadian	glucose	
uptake	was	measured,	also	in	vivo,	in	the	brown	adipose	tissue	of	mice	using	PET	scanning,	revealing	
a	strong	24-h	profile	of	glucose	uptake	by	the	adipose	tissue,	peaking	at	approximately	ZT	9	(van	der	
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Veen	et	al.,	2012b).	The	same	type	of	circadian	dynamics	in	glucose	uptake	was	also	observed	in	the	
mouse	brain,	albeit	with	a	different	peak	phase	in	glucose	uptake	at	ZT	18	(van	der	Veen	et	al.,	2012a).	
It	has	been	shown	that	this	24-h	profile	of	adipose	tissue	glucose	uptake	can	be	governed	by	signals	
from	the	ANS	(Amir	et	al.,	1989,	Cannon	et	al.,	2004)	and	plasma	hormones	(Stephens	et	al.,	2011).	
The	 glucose	 transporter	GLUT4	 is	 specifically	 expressed	 in	 insulin	 sensitive	 tissues	 (i.e.	 fat),	 and	 is	
responsible	 for	 the	 insulin	 effect	 on	 blood	 glucose	 clearance.	 The	 action	 of	 insulin	 led	 to	 GLUT4-
containing	vesicles	to	fuse	with	the	plasma	membrane	and	deliver	the	transporter	to	its	site	of	action.	
As	a	 result,	 the	 content	of	GLUT4	on	 the	plasma	membrane	 is	 increased	 (Saltiel	et	al.,	 2001).	 It	 is	
however	 also	 possible	 that	 these	 rhythms	 in	 adipose	 glucose	 uptake	 and/or	 utilisation	 can	 be	
governed	by	local	circadian	clocks,	which	can	be	–	at	least	in	part	–	synchronised	to	external	cues	such	
as	the	autonomic	drive,	and	insulin.	Early	on,	studies	following	workers	experiencing	night	shift	work	
measured	blood	levels	of	glucose.	Significant	elevations	in	the	serum	levels	of	glucose	were	found,	
alongside	potassium	and	cholesterol.	Interestingly,	these	levels	were	normal	upon	return	to	day	work	
(Theorell	 et	 al.,	 1976).	 The	 investigation	 of	 the	 weight	 and	 BMI	 of	 day	 and	 shift	 workers	 led	 to	
inconsistent	results:	one	study	found	similar	body	mass	indices	in	day	and	shift	workers,	and	reported	
a	more	 centrally	 disposed	adipose	 tissue	 in	 shift	workers	 (Nakamura	 et	 al.,	 1997).	Other	 research	
revealed	that	weight	gains	were	more	frequent	among	night	than	daytime	workers	(Niedhammer	et	
al.,	1996).	Additionally,	it	was	revealed	that	a	disruption	of	circadian	rhythms	in	the	SCN	and	peripheral	
tissues	may	lead	to	manifestations	of	the	metabolic	syndrome	(Broberger	2005,	Buijs	et	al.,	2006a,	
Staels	2006).	In	obesity	and	diabetes,	abnormalities	in	the	diurnal	variation	of	glucose	tolerance	were	
demonstrated	(Qian	et	al.,	2016).	Therefore,	an	in-depth	understanding	of	the	mechanisms	underlying	
glucose	regulation	by	the	circadian	system,	especially	in	the	adipose	tissue,	and	its	desynchrony	could	
help	 in	 the	 development	 of	 therapeutic	 interventions	 against	 associated	 deleterious	 health	
consequences.		
	 	
	 In	the	literature,	very	few	publications	reported	glucose	utilisation,	and	especially	measuring	
the	utilisation	of	glucose	across	the	circadian	time,	and	most	were	limited	to	observations	of	glucose	
uptake,	inferring	utilisation	from	these	data.	More	worryingly,	there	is	sometimes	confusion	on	the	
distinctions	between	glucose	uptake,	utilisation,	and	metabolism.	In	chapter	3,	we	first	measured	the	
in	 vitro	 glucose	 utilisation	 by	 3T3-L1	 pre-adipocytes,	 and	 exposed	 a	 clear	 and	 significant	 circadian	
rhythm	over	72	hours.	Our	finding	is	in	line	with	a	study	published	in	2004,	where	researchers	recorded	
2-Deoxy-D-(1-3H)	glucose	uptake	over	48	hours	from	diabetic	and	control	rats	(Feneberg	et	al.,	2004).	
In	control	animals,	deoxy	glucose	was	presenting	a	circadian	rhythm	(in	fat	cells),	maximal	30.6	hours	
after	serum	shock	(acrophase),	which	was	quite	similar	to	what	we	obtained	for	glucose	utilisation	
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(36.07	and	34.83).	Furthermore,	the	amplitude	of	the	rhythm	was	35,	when	we	found	31.21	and	36.03.	
Lastly,	 this	 work	 showed	 that	 the	 circadian	 rhythm	 observed	 in	 deoxy	 glucose	 was	 perturbed	 in	
diabetic	animals.	What	is	now	needed	is	to	relate	these	in	vitro	circadian	rhythms	to	real-life	rhythms	
in	vivo.	This	could	be	done	using	experiments	of	co-culture,	for	instance.		
	
	 We	therefore	showed	the	presence	of	a	circadian	oscillator	in	adipose	cells	in	culture,	driving	
circadian	rhythms	of	glucose	utilisation	in	vitro.	We	next	indicated	a	clear	circadian	rhythm	of	glucose	
utilisation,	of	similar	acrophase	and	amplitude	in	comparison	to	the	previous	study	and	using	the	same	
novel	 approach	 (BIOLOGTM	 technology).	 This	 strengthened	 greatly	 our	 confidence	 in	 the	 data	 and	
validated	 our	 approach,	 as	 we	 were	 able	 to	 replicate	 the	 results	 between	 a	 large	 number	 of	
experimental	and	technical	replicates	across	two	different	types	of	protocols	of	study.	These	rhythms	
could	be	generated	by	molecular	transcription-translation	feedback	loops	within	each	cell.		
	
	 Furthermore,	we	were	able	to	measure	utilisation	rates	of	various	other	carbon	sources	and	
group	them	into	different	clusters:	one	cluster	contained	substrates	sharing	the	same	acrophase	as	
glucose,	and	a	second	presented	carbon	sources	which	utilisation	rates	were	peaking	with	a	shift	of	9	
to	12	hours	in	comparison	to	the	first	cluster.	We	also	found	a	group	of	substrates	which	were	not	
being	utilised	in	a	circadian	fashion.	This	provided	an	important	 insight	 into	adipose	chronobiology	
and	metabolism,	as	some	of	the	substrates	were	implicated	in	key	metabolic	pathways,	such	as	the	
Krebs	 cycle	 or	 the	 glycolysis,	 whilst	 others	 are	 largely	 used	 in	 the	 food	 industry	 as	 stabilisers	 or	
sweeteners.	For	example,	α-hydroxy-butyric	acid	has	been	demonstrated	 to	be	an	early	marker	of	
insulin	 resistance	 through	 oxidative	 stress	 and	 increased	 lipid	 oxidation	 (Gall	 et	 al.,	 2010).	 This	
component	 was	 also	 identified	 as	 a	 selective	 and	 reproducible	 metabolic	 biomarker	 of	 isolated	
impaired	 fasting	 glucose	 and	 impaired	 glucose	 tolerance,	 often	 characterised	 by	 a	 higher	 BMI,	
diabetes,	elevated	systolic	blood	pressure	and	triglycerides	levels	as	well	as	lower	levels	of	HDL	(Cobb	
et	al.,	2016).	Moreover,	beta	cell	metabolism	of	mono-methyl	succinate	and	leucine,	like	glucose,	are	
known	to	influence	dehydrogenases	producing	NADH	(MacDonald	et	al.,	1989).	As	other	examples,	D-
glucose-6-phosphate	was	shown	to	be	implicated	in	the	action	of	insulin	to	control	glucose	production	
(Gardner	 et	 al.,	 1993).	 Methyl	 pyruvate	 was	 of	 interest	 because	 of	 its	 insulinotropic	 action,	
consequence	of	a	direct	 inhibition	of	ATP-sensitive	K+	channels.	This	was	particularly	 interesting	as	
steps	preceding	the	closure	of	these	ATP-sensitive	K+	channels	may	be	disturbed	in	T2DM	(Dufer	et	
al.,	2002).	All	in	all,	we	validated	the	hypothesis	that	the	in	vitro	glucose	utilisation	by	pre-adipocytes	
was	circadian,	and	potentially	of	other	carbon	sources	implicated	in	important	metabolic	pathways	
linked	with	the	development	of	obesity.	
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6.2	Dielectric	properties	of	3T3-L1	pre-adipocytes	and	circadian	rhythmicity	
	
	 To	 test	 the	 hypothesis	 that	 pre-adipose	 cells	 were	 able	 to	 maintain	 circadian	 rhythms	 in	
membrane	and	cytoplasmic	electrophysiology,	we	used	a	tool	called	dielectrophoresis	potential.	This	
technique	had	not	been	used	on	pre-adipocytes	prior	to	this	work	for	measures	across	the	circadian	
time.	 Dielectrophoresis	 permits	 a	 rapid	 measurement	 of	 population-level	 electrophysiological	
properties	 in	a	 large	number	of	cells	 simultaneously,	and	 is	 compatible	with	circadian	 time	course	
sampling	in	cell	populations	maintained	under	constant	conditions	over	several	days.	In	this	method,	
non-uniform	 alternating	 electric	 fields	 induce	 a	 cellular	 motion,	 which	 depends	 on	 both	 field	
frequency	and	cellular	electrical	properties	(Pohl	1978).	Presenting	the	advantages	of	being	of	low-
cost,	low-loss,	high-throughput	as	well	as	label-free,	dielectrophoresis	has	been	used	quite	extensively	
in	a	range	of	cellular	applications	including	drug	discovery,	stem	cell	characterisation	and	for	the	study	
of	apoptosis	(Chin	et	al.,	2006,	Pethig	2010).	Analysis	of	the	frequency	dependence	of	cell	movement	
during	DEP	enables	to	determine	cellular	electrophysiological	parameters	such	as	effective	membrane	
conductance,	whole-cell	capacitance	and	cytoplasmic	conductivity	(figures	2.7,	2.8,	2.9	and	2.10).				
	
	 One	of	the	most	used	cell	type	in	dielectrophoresis	are	red	blood	cells.	Results	suggested	that	
in	the	absence	of	conventional	transcription	cycles,	RBCs	maintained	a	circadian	rhythm	in	membrane	
electrophysiology	 (Henslee	 et	 al.,	 2017).	 This	 rhythm	 could	 not	 be	 explained	 by	 the	 established	
transcription-translation	feedback	loops,	as	the	cells	lack	nuclei,	but	rather	by	a	dynamic	regulation	of	
K+	 transport	 across	 the	 cellular	membrane.	 This	 also	 suggested	 the	 existence	of	 post-translational	
cellular	 clock	 mechanisms	 in	 these	 cells.	 Based	 on	 this,	 we	 transcribed	 the	 technique	 on	 pre-
adipocytes:	 3T3-L1	 cells	 were	 serum	 shocked	 for	 synchronisation	 of	 the	 cellular	 clocks,	 prior	 to	
recording,	 every	 4	 hours	 between	 0	 and	 72	 hours	 following	 serum	 shock.	 We	 found	 that	 the	
membrane	 capacitance	 was	 indeed	 presenting	 a	 circadian	 rhythmicity,	 confirming	 was	 we	
hypothesised	 but	 not	 replicating	 the	 study	 presented	 just	 above,	 as	 they	 did	 not	 find	 a	 temporal	
variation	 for	 this	 parameter.	 Our	 finding	 also	 showed	 an	 ultradian	 rhythmicity	 of	 the	membrane	
conductance,	 when	 the	 RBCs	 exhibited	 a	 circadian	 rhythm	 of	membrane	 conductance.	 Lastly,	 we	
found	no	temporal	variations	in	the	cytoplasm	conductivity,	shown	circadian	in	RBCs.		
	
	 The	membrane	conductance	 is	 indicative	of	 the	 ionic	 transport	across	 the	membrane,	and	
although	not	 found	circadian	 in	 this	 study,	emphasizes	 the	circadian	 regulation	of	various	voltage-
gated	sodium	(Na+)	and	potassium	channels,	Na+/K+-ATPase,	and	a	long-opening	cation	channel	(Ko	et	
al.,	2009).	Later	studies	also	revealed	circadian	rhythms	in	the	concentration	of	intracellular	Mg2+	in	a	
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range	of	eukaryotic	cells	including	mouse	fibroblasts,	but	not	of	calcium	(Feeney	et	al.,	2016a).	The	
rhythms	of	 ion	 levels	could	confer	 the	capacity	 to	dynamically	 tune	ATP	consumption	and	primary	
metabolism	to	the	appropriate	time	of	day,	without	impacting	upon	the	absolute	size	of	the	ATP	pool	
itself.		
	
				 The	membrane	capacitance	has	been	shown	to	be	linked	to	the	membrane	morphology,	and	
in	our	 study	was	 found	circadian.	We	did	not	 find	any	 significant	differences	 in	volume,	diameter,	
sphericity	 and	 surface,	 for	 the	 cytoskeleton	 and	 the	membrane,	 after	 use	of	 the	 confocal	 tool,	 to	
explain	this	result.	This	although	the	invariant	results	for	the	diameter	were	confirming	the	stable	radii	
values	 across	 time	 (figure	 4.4).	 Another	 important	 fact	 to	 be	 stating	 is	 that	we	 found	 a	 factor	 10	
difference	between	 the	peak	and	 trough	values	of	 the	 rhythm,	potentially	 indicating	a	 connection	
between	the	membrane	and	chemical	groups	at	its	level.	This	result,	interestingly,	is	in	line	with	the	
very	 emerging	 notion	 that	 the	 membrane	 capacitance	 is	 more	 than	 just	 related	 to	 the	 cellular	
morphology	 and	 could	 be	 also	 be	 linked	 to	 membrane	 potential,	 representing	 the	 differences	 in	
electric	potential	between	the	intracellular	and	extracellular	compartments.		
	 	
	 The	 last	 parameter	 of	 study	 was	 the	 cytoplasmic	 conductivity,	 indicative	 of	 free	 ionic	
concentration	within	the	cytoplasm.	The	work	published	on	red	blood	cells	by	Henslee	and	co-workers	
revealed	a	circadian	rhythmicity	in	this	parameter,	showing	that	the	steady	state	ionic	content	of	the	
cytoplasm,	determining	the	cytoplasmic	conductivity,	is	lowered	by	an	increased	net	rate	of	ion	efflux	
occurring	in	isolated	RBCs.	This	during	the	subjective	night	with	respect	to	the	entraining	temperature	
cycle.	 We	 found	 no	 significant	 variations	 in	 the	 data,	 meaning	 that	 the	 ionic	 charge	 within	 the	
cytoplasm	remained	invariant	throughout	time.		
	
6.3	Circadian	rhythmicity	in	murine	pre-adipocytes	and	adipocytes	cells	
	
	 In	 order	 to	 address	 hypothesis	 3,	 that	 pre-adipocytes	 and	 adipocytes	 possessed	 an	
endogenous	circadian	clock	driving	rhythmic	gene	expression	of	core	clock	genes,	murine	3T3-L1	cells	
were	 used	 to	 establish	 an	 in	 vitro	 pre-adipocyte	 and	 adipocyte	 model:	 reporters	 were	 made	 by	
introducing	a	lentiviral	reporter	harbouring	the	rapidly	degradable	firefly	luciferase	(dLuc)	gene	under	
the	control	of	either	mouse	Per2	or	Bmal1	gene	promoters	into	cells	(Ramanathan	et	al.,	2012).	These	
reporters	were	kindly	given	to	us	by	the	team	of	Dr	Andrew	Liu	in	Memphis,	USA.	This	team	published	
bioluminescence	rhythms	of	Per2	and	Bmal1	promoter	activity	in	3	different	cell	lines:	3T3	fibroblasts,	
MMH-D3	hepatocytes	and	3T3-L1	adipocytes,	showing	baseline-subtracted	bioluminescence	data	of	
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selected	clonal	 lines	 representing	both	 reporter	 types	plotted	 together.	Anti-phasic	and	persistent	
reporter	 expression	 for	 each	 cell	 type	was	 indicated	 (Ramanathan	 et	 al.,	 2014).	We	were	 able	 to	
replicate	these	results	locally	using	the	same	LumiCycle	device.	In	Chapter	5	were	shown	individual	
and	 grouped	 examples	 of	 traces	 for	 each	 cell	 line	 and	 each	 differentiation	 state,	 demonstrating	
persistent	and	high-amplitude	rhythms	of	bioluminescence	(figures	5.3,	5.4,	5.6	and	5.7).	In	addition	
to	being	able	to	replicate	the	study,	what	we	brought	was	that	pre-adipocytes	as	well	as	adipocytes	
were	 displaying	 persistent	 and	 anti-phasic	 bioluminescence	 rhythms,	 when	 the	 work	 from	
Ramanathan	et	al.	published	in	2014	on	the	same	reporters	only	showed	bioluminescence	rhythms	
for	adipocytes.	We	also	specified	that	the	coating	type	had	an	effect	on	the	persistence	of	the	rhythms,	
as	in	most	cases	traces	were	proving	more	persistent	following	a	gelatine	coating	in	comparison	to	a	
collagen	coating.	This	then	led	to	study	the	differences	between	collagen	and	gelatine.	Collagen	is	one	
of	 the	 key	 structural	 proteins	 found	 in	 the	 extracellular	 matrices	 of	 many	 connective	 tissues	 in	
mammals,	making	up	about	25%	to	35%	of	the	whole-body	protein	content	(Muyonga	et	al.,	2004).	
This	component	is	mostly	found	in	fibrous	tissues	(skin,	tendons,	ligaments),	and	is	also	abundant	in	
corneas,	cartilages,	bones,	blood	vessels,	gut,	as	well	as	intervertebral	discs	(Shoulders	et	al.,	2009).	
Collagen	is	synthesized	by	fibroblasts,	and	over	90%	of	the	collagen	in	the	body	is	of	type	I.	Gelatine	is	
the	product	of	 thermal	denaturation	or	disintegration	of	 insoluble	collagen	with	various	molecular	
weights	 and	 iso-ionic	 points,	 depending	 on	 the	 source	 of	 collagen	 (Gomez-Guillen	 et	 al.,	 2009).	
Although	gelatine	is	known	to	be	providing	a	more	effective	way	to	absorb	collagen	boosting	amino	
acids,	 a	 study	 revealed	 no	 significant	 differences	 in	 terms	 of	 cell	 adhesion	 between	 collagen	 and	
gelatine	in	fibroblasts	(Ratanavaraporn,	J	et	al.,	2006).	We	found	that	the	cellular	morphology	seemed	
better	with	gelatine	in	comparison	to	collagen.	
	
	 It	 is	 now	 well-known	 that	 approximately	 20%	 of	 the	 white	 adipose	 tissue	 transcriptome	
(including	 core	 genes)	 follow	 a	 daily	 oscillatory	 pattern,	 with	 many	 of	 these	 genes	 linked	 to	
metabolism	 and	 adipose	 function	 (Ptitsyn	 et	 al.,	 2006,	 Zvonic	 et	 al.,	 2006).	 These	 studies	 showed	
robust	and	coordinated	expression	of	circadian	oscillator	genes,	measured	using	RT-PCR	over	a	48-
hour	period,	 for	Per2	and	Bmal1	but	also	 for	Per1,	Per3,	Cry1,	Cry2	and	Dbp	among	others.	 It	was	
indicated	that	the	expression	of	Dbp	showed	an	oscillatory	pattern	similar	to	Per	and	Rev-Erb	genes,	
but	anti-phasic	to	Bmal1.	Therefore,	the	expression	of	Per2	and	Bmal1	were	shown	anti-phasic	from	
one	another	in	the	inguinal	and	epididymal	adipose	tissues	of	mice.	Our	study	also	demonstrated	anti-
phasic	rhythms	between	Per2	and	Bmal1	in	vitro.	Similar	rhythms	and	anti-phases	were	observed	in	
the	 brown	 adipose	 tissue	 and	 liver.	 This	 clearly	 demonstrated	 the	 presence	 of	 active	 peripheral	
circadian	clocks	in	the	brown	adipose	tissue,	and	epididymal	as	well	as	inguinal	white	adipose	tissue.		
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	 Furthermore,	 the	 oscillations	 of	 Bmal1	 occurring	 in	 anti-phase	 to	 those	 of	 Per,	 and	 Cry,	
recapitulated	auto-regulatory	mechanisms	of	an	active	circadian	clock,	previously	identified	in	other	
mammalian	tissues	(Allada	et	al.,	2001).	Interestingly,	this	notion	was	supported	by	cosine-fit	analyses,	
which	clearly	showed	harmonic	trends	of	gene	expression	to	the	cosine	curve,	as	well	as	anti-phasic	
oscillations	within	the	circadian	clock.	Anti-phasic	clock	gene	expression	has	been	known	for	a	long	
time	 to	 result	 from	active	 transcription-translation	 feedback	 loops,	with	REV-ERBα	and	β	acting	as	
negative	 transcriptional	 regulators	 by	 binding	 to	 RORE	 response	 elements	 in	 gene	 promoters,	
preventing	 the	 binding	 of	 a	 positive	 transcription	 regulator,	 RORα.	 A	 direct	 regulation	 of	 the	
expression	of	Bmal1,	Clock,	and	Cry1	was	also	sharing	the	same	mechanism	(Storch	et	al.,	2002).	The	
expression	 of	 Rev-erbα	 and	 Rev-erbβ	 is	 positively	 regulated	 by	 CLOCK:	 BMAL1	 and	 negatively	
regulated	by	PER:	CRY	heterodimers,	in	agreement	with	the	expression	profiles	observed	in	our	study	
and	 in	the	 literature	mentioned	here.	 Interestingly,	 the	expression	of	Rev-erbα	has	been	shown	to	
correlate	with	adipogenesis	(Chawla	et	al.,	1993).	Indeed,	it	was	indicated	in	2005	that	Rev-erbα	was	
highly	expressed	in	the	adipose	tissue,	but	also	in	the	skeletal	muscle,	heart	and	liver	as	well	as	the	
brain.	 Its	 expression	 increases	 during	 adipocyte	 differentiation	 of	 3T3-L1	 cells	 induced	 by	 PPAR-g	
(Laitinen	et	al.,	2005).		
	
	 The	 studies	 presented,	 however,	 did	 not	 lead	 to	 more	 understanding	 needed	 for	 the	
rhythmicity	in	adipocytes	cells	per	se,	and	did	not	study	pre-adipocytes	versus	adipocytes.	Therefore,	
an	 in	 vitro	 approach	 was	 used	 rapidly	 after,	 investigating	 temporal	 variations	 of	 clock	 genes	 and	
adipokines	in	murine	pre-adipocyte	and	adipocyte	3T3-L1	cells.	Authors	used	q-PCR	to	reveal	robust	
rhythms	of	clock	genes	Per2,	Rev-erbα	and	Dbp,	but	not	of	Per1,	Cry1	and	Bmal1,	nor	of	metabolic	
genes	 such	as	PPARα	 and	g	 or	SREBP1.	 Similar	profiles	of	mRNA	 expression	were	observed,	 albeit	
markedly	reduced	for	Per2	and	Dbp	rhythms	(Otway	et	al.,	2009).	The	attenuated	amplitude	observed	
in	3T3-L1	adipocytes	in	this	study	is	consistent	with	a	reduced	amplitude	of	the	rhythmicity	in	adipose	
tissue	from	obese	mice	(Ando	et	al.,	2005,	Kohsaka	et	al.,	2007b),	indicative	of	a	possible	inhibition	of	
the	molecular	clock	mechanism	by	intra-cellular	triglyceride	accumulation.	In	our	case,	we	used	the	
Lumicycle	analysis	program	to	fit	a	cosine	curve	to	the	baseline-subtracted	data	of	bioluminescence	
and	extract	key	circadian	parameters.	When	comparing	the	cell	lines	and	the	differentiation	states,	
we	did	not	find	any	significant	differences	in	the	amplitude,	with	a	comparable	mean.	However,	this	
was	 taking	 into	 consideration	 the	 cosine	 curve	 equation	 across	 the	 whole	 trace.	 We	 therefore	
calculated,	 for	each	condition,	up	 to	14	peak-to-trough	values	across	all	 traces.	We	 found	 that	 for	
Per2,	pre-adipocytes	presented	a	significantly	higher	amplitude	in	comparison	to	adipocytes,	in	line	
with	the	findings	presented	below.	After	10	peak-to-trough	values,	data	were	not	anymore	different	
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between	the	two	differentiation	states.	We	also	indicated	that	for	adipocytes,	peak-to-trough	values	
were	diminishing	with	time,	presenting	the	same	pattern	than	the	Bmal1	counterparts	(adipocytes	
and	 pre-adipocytes).	 Therefore,	 we	 did	 not	 highlight	 a	 reduced	 amplitude	 in	 3T3-L1	 Bmal1-dLuc	
adipocytes	in	comparison	to	pre-adipocytes.	Expectedly,	all	traces	for	each	condition	presented	similar	
periodicities	close	to	24	hours.	Damping	values	were	not	significantly	different	when	comparing	the	
cell	line,	or	gene	studied,	and	differentiation	state.								
	
6.4	Limitations,	improvements	and	future	work		
	
	 My	 data	 from	 Chapter	 3	 have	 shown	 an	 expected	 circadian	 utilisation	 of	 glucose,	 which	
validated	our	novel	approach	against	the	literature.	We	confirmed	similar	utilisation	rates	between	
cells	exposed	to	 low	glucose	concentrations,	and	those	measured	using	plates	pre-inoculated	with	
glucose	by	the	company	(Technopath).	However,	one	limitation	is	that	whilst	the	company	confirmed	
low	concentrations	of	glucose	and	other	carbon-based	substrates	in	PM-M1	plates,	we	did	not	know	
the	exact	concentrations.	Furthermore,	we	recorded	glucose	utilisation	rates	between	6	and	72	hours	
following	serum	shock	using	 the	 first	protocol,	and	only	between	24	and	51	hours	 for	 the	second,	
which	means	that	the	cosine	fit	analysis	(on	which	we	based	our	circadian	parameters)	could	be	biased	
as	taking	into	consideration	three	cycles	in	one	case	and	only	one	in	another.	This	could	explain	the	
differences	in	periodicities	observed,	as	well	as	the	slight	contrasts	in	acrophase	and	amplitude.	Across	
the	different	carbon	sources	studied,	we	were	able	to	replicate	strongly	the	data	at	each	time	point	
for	different	biological	and	technical	replicates.	A	slight	disparity	in	the	data	could	be	due	to	pipetting	
errors,	 especially	when	 using	 a	multichannel	 pipette.	 The	 automated	 cell	 counter	 also	 could	 be	 a	
potential	source	of	error,	but	we	saw	similar	values	of	cell	density	across	the	time	points	of	study.		
	
	 Future	 work	 would	 involve	 increasing	 the	 period	 of	 study	 and	 the	 number	 of	 biological	
replicates	when	using	PM-M1	plates	in	order	to	strengthen	the	arrhythmic	and	rhythmic	patterns	of	
utilisation	rates	of	the	various	carbon	sources	obtained,	and	confirm	the	acrophases	evaluated	for	the	
rhythmic	groups.	Furthermore,	as	we	identified	a	circadian	utilisation	rate	in	carbon	sources	involved	
in	important	metabolic	pathways	such	as	the	Krebs	cycle	and	the	glycolysis,	with	many	others	used	in	
the	 food	 industry	 as	 sweeteners	 and	 therefore	 potentially	 involved	 in	 weight	 gain,	 this	 could	 be	
investigated	 further.	 It	 would	 be	 interesting,	 for	 instance,	 to	 study	 utilisation	 rates	 of	 other	
components	involved	in	these	pathways	or	other	key	metabolic	pathways	involved	in	energy	balance	
for	comparison.	This	could	provide	additional	information	in	regard	to	the	circadian	orchestration	of	
metabolic	pathways.	So	far,	it	is	known	that	components	of	the	Krebs	cycle,	such	as	NADP-dependent	
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isocitrate	dehydrogenase,	exhibit	a	circadian	periodicity	in	their	abundance	or	activity,	but	in	marine	
species	 and	 not	 the	 adipose	 tissue	 (Akimoto	 et	 al.,	 2005).	 Furthermore,	 a	 key	 regulator	 of	
gluconeogenesis	 and	 glycolysis,	 PGC-1α,	 provides	 an	 additional	 contribution	 to	 clock	 ticking	 in	
metabolically	active	tissues,	this	via	its	role	in	Bmal1	gene	transcription.	PCG-1α	acts	in	with	RORα	to	
activate	Bmal1	gene	transcription,	linking	metabolism	to	the	circadian	clock.	Here	again,	this	was	done	
using	PGC-1α-deficient	fibroblasts	and	mice	with	liver-specific	knockdown	of	PGC-1α.	Therefore,	this	
was	not	an	in	vitro	study	and	not	specifically	targeting	the	adipose	tissue	(Liu	et	al.,	2007c).	In	line	to	
this,	another	future	work	to	consider	would	be	metabolomics,	specifically	on	the	human	white	adipose	
tissue.	This	could	be	an	important	tool	to	identify	pathway	differences,	even	between	different	types	
of	adipose	tissue,	as	shown	by	a	recent	study	which	identified	pathway	differences	between	visceral	
and	subcutaneous	adipose	tissue	in	colorectal	cancer	patients	(Liesenfeld	et	al.,	2015).	This	was	only	
strengthened	 by	 the	 fact	 that	 metabolomics	 play	 an	 important	 role	 in	 identifying	 biomarkers	
associated	with	metabolic	diseases,	as	well	as	increasing	molecular	mechanisms	of	cellular	signalling	
(Tadi	et	al.,	2014).		
	
	 The	two	main	physiological	roles	of	adipose	tissue	are	endocrine	and	energy	storage.	In	terms	
of	 the	metabolic	 function	of	 the	 tissue,	we	 indicated	 that	 fat	 cells	were	 involved	 in	 key	 signalling	
pathways	such	as	the	Krebs	cycle	or	the	glycolysis	among	others,	which	increases	the	understanding	
of	the	role	of	the	adipose	tissue	in	circadian	desynchrony.	However,	very	few	publications	focus	on	
carbon	sources	other	than	glucose	and	therefore	the	metabolism	of	other	substrates	remain	unclear.	
One	main	conclusion	of	my	PhD	work	is	that	adipose	tissue	shows	rhythmic	utilisation	of	many	energy	
substrates	besides	glucose,	and	that	this	utilisation	does	not	have	to	resemble	glucose.	A	clear	future	
prospective	that	arises	from	this	observation	is	that	we	need	to	assess	circadian	rhythmicity	in	energy	
metabolism	of	adipose	tissue	as	a	whole	(and	not	just	glucose),	as	well	as	other	peripheral	tissues.	The	
development	of	the	circadian	protocols	of	BIOLOGTM	metabolic	fingerprinting,	as	we	have	done	here,	
is	 very	well	 suited	 to	 undertake	 this,	 and	 therefore	 the	methods	 applied	 here	 could	 be	 generally	
adapted	to	address	 this	 specific	knowledge	gap	 in	 the	 field	of	circadian	metabolism	(and	circadian	
misalignment	during	i.e.	shift	work).		
	
	 Dielectrophoresis	potential	used	in	Chapter	4	presents	a	circadian	rhythmicity	in	membrane	
capacitance	 and	 ultradian	 rhythmicity	 in	 membrane	 conductance,	 but	 an	 arrhythmicity	 for	 the	
cytoplasmic	conductivity.	In	red	blood	cells	was	found	circadian	rhythms	in	membrane	conductance	
and	 cytoplasmic	 conductivity,	 which	 differed	 from	 our	 findings	 (Henslee	 et	 al.,	 2017).	 This	 was	
therefore	interesting	as	confirming	recent	ideas	emerging	that	the	membrane	capacitance	was	more	
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than	 only	 reflecting	 the	 cellular	morphology,	 and	 also	 confirmed	 that	 different	 cell	 types	 possess	
different	 dielectric	 makeup.	 As	 a	 result,	 it	 would	 be	 interesting	 to	 determine	 which	 ions	 were	
increasing	 or	 decreasing	 across	 the	 circadian	 time,	 as	 well	 as	 the	 chemical	 groups	 located	 at	 the	
membrane.	Studies	have	started	to	emerge,	for	instance	finding	that	NSPCs	differing	in	fate	potential	
express	distinct	patterns	of	glycosylation	enzymes.	Co-workers	 then	showed	that	enhancing	highly	
branched	N-Glycans	on	NSPCs	increased	the	membrane	capacitance	in	a	significant	manner,	leading	
to	the	generation	of	more	astrocytes	at	the	expense	of	neurons	with	no	effect	on	cell	size,	viability,	or	
proliferation	(which	we	observed)	(Yale	et	al.,	2018).	Furthermore,	an	important	thing	would	be	to	
study	the	ionic	output	affected	and	quantify	the	ions,	in	order	to	ultimately	know	which	ion	channels	
were	impacting	the	dielectric	parameters	related	to	pre-adipose	cells.	In	order	to	do	so,	a	technique	
of	SEM	could	be	used,	which	for	years	has	provided	insights	 into	cellular	morphology	(Keller	et	al.,	
1977).	Another	technique	which	could	be	of	importance	for	future	work	is	ICPMS,	to	quantify	the	ions.	
Using	 this	 method,	 ions	 are	 dispersed	 in	 the	 mass	 analyser	 based	 on	 their	 mass-to-charge	 ratio.	
Ultimately,	it	would	also	be	interesting	to	measure	DEP	on	differentiated	pre-adipocytes,	in	order	to	
assess	any	potential	changes	 in	membrane	capacitance,	conductance	and	cytoplasmic	conductivity	
between	 the	 two	 differentiation	 states.	 Limitations	 are	 essentially	 linked	 to	 the	 analysis	 software	
which	prevents	the	measures	of	cytoplasmic	permittivity	as	not	equipped	to	go	over	frequencies	of	
100MHz.	
		
	 Lastly,	Chapter	5	presented	traces	of	bioluminescence	from	lentiviral	reporters	of	the	Per2	or	
Bmal1	 promoter	 used	 to	 transduced	 3T3-L1	 pre-adipocytes.	 We	 showed	 persistent	 and	 high-
amplitude	circadian	rhythms	in	the	activity	of	both	promoters,	this	for	pre-adipocytes	and	adipocytes.	
This	 replicated	 data	 published	 using	 the	 same	 technique	 on	 the	 same	 cells,	 although	 only	 at	 the	
adipose	state	(Ramanathan	et	al.,	2014).	We	used	a	well	described	protocol	for	the	differentiation	of	
pre-adipocytes	into	adipocytes,	but	using	individual	petri	dishes	where	cells	were	cultured	for	a	long	
period	 of	 time	 proved	 challenging	 as	 contamination	 seemed	 to	 appear	 over	 time,	 therefore	
questioning	the	quality	of	the	results.	The	data	were	in	this	case	excluded.	Another	aspect	was	that	
the	differentiation	did	not	seem	as	successful	as	expected,	especially	for	the	3T3-L1	Per2-dLuc	cell	line.	
We	 initially	explained	this	by	 the	type	of	staining,	which	revealed	that	when	capturing	the	cellular	
morphology,	cells	seemed	to	develop	a	morphology	moving	away	from	fibroblast-like	after	collagen	
coating.	Confirming	this	was	the	fact	that	we	found	more	persistent	bioluminescence	rhythms	after	
gelatine	coating	in	both	cell	lines	and	both	differentiation	states.	However,	the	limitation	here	is	that	
it	would	have	been	 informative	 to	 compare	 in	more	details	both	 types	of	 coating.	 Furthermore,	a	
triglyceride	quantification	would	be	needed,	which	was	not	done	here	as	captured	for	the	Per2	gene	
231	
	
proved	unsuccessful.	Future	work	would	be	to	increase	the	quality	of	the	differentiation	by	allowing	
more	time	for	the	cells	to	differentiate,	and	the	number	of	successful	replicates	analysed	for	both	cell	
lines	at	a	differentiated	state.		
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APPENDICES	
	
Appendix	 1:	 Utilisation	 of	 carbon	 sources	 from	 PM-M1	 plates	 using	 the	 OMNILOGTM	
platform,	across	the	circadian	time.		
	
The	following	presents	the	utilisation	rates	of	carbon	sources	from	PM-M1	BIOLOGTM	plates	by	3T3-L1	
pre-adipocytes,	which	have	not	been	shown	in	Chapter	3.	Data	were	recorded	every	3	hours	between	
24	and	51	hours	following	serum	shock.	For	carbon	sources	presenting	rhythmic	utilisation	rates,	the	
circadian	parameters	extracted	from	the	cosine	fit	equation	(following	the	method	described	in	section	
2.4.2.5)	and	R2	values	are	also	summarised.		
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KETONE	BODIES	AND	SHORT	CHAIN	FATTY	ACIDS
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Appendix	2:	Pathway	analyses	results.	
	
This	 appendix	 presents	 the	 signalling	 pathways	 described	 in	 the	 results	 section	 3.5.6.2;	 with	 the	
compounds	involved	described	as	their	KEGG	identification	number.	All	metabolites	highlighted	in	red	
are	metabolites	of	the	pathway	of	interest	included	in	our	PM-M1	plates.		
	
A	–	CLUSTER	1	
	
A1:	Propanoate	metabolism	
	
	
	
	
	
	
	
	
	
	
	
	
2-Hydroxybutyric	 acid
2-Ketobutyric	acid
Propionic	acid
Succinic	acid
278	
	
A2:	Purine	metabolism	
	
	
	
A3:	Cysteine	and	methionine	metabolism		
	
	
Adenosine
Inosine
2-Ketobutyric	acid
Pyruvic	acid
279	
	
A4:	Pyrimidine	metabolism	
	
	
	
A5:	Synthesis	and	degradation	of	ketone	bodies	
	
	
	
	
Thymidine
Uridine
Acetoacetic	acid
280	
	
B	–	CLUSTER	2	
	
B1:	Glycine,	serine	and	threonine	metabolism	
	
	
	
B2:	Valine,	leucine	and	isoleucine	biosynthesis	
	
	
Pyruvic	Acid
Pyruvic	Acid
281	
	
B3:	Pentose	phosphate	pathway	
	
	
	
B4:	Glycolysis	or	gluconeogenesis	
	
	
	
Glucose-6-phosphate
Pyruvic	Acid
Glucose-6-phosphate
282	
	
B5:	Synthesis	and	degradation	of	ketone	bodies		
	
	
	
B6:	Cysteine	and	methionine	metabolism	
	
	
	
(R)-3-Hydroxybutyric	acid
Pyruvic	Acid
283	
	
B7:	Glycerophospholipid	metabolism	
	
	
	
B8:	Butanoate	metabolism	
	
	
	
	
Glycerol-3-phosphate
Pyruvic	Acid
(R)-3-Hydroxybutyric	acid
284	
	
B9:	Aminosugar	ad	nucleotide	sugar	metabolism	
	
	
	
B10:	Starch	and	sucrose	metabolism	
	
	
L-Fucose
Glucose-6-phosphate
Glucose-6-phosphate
D-Glucose
285	
	
B11:	Pyruvate	metabolism	
	
	
	
C	–	CLUSTER	3	
	
C1:	Inositol	phosphate	metabolism	
	
	
Pyruvic	Acid
MyoInositol
D-Glucuronic	Acid
286	
	
C2:	Ascorbate	and	aldarate	metabolism	
	
	
	
C3:	D-Glutamine	and	D-Glutamate	metabolism	
	
	
	
	
D-Glucuronic	Acid
MyoInositol
Oxoglutaric Acid
287	
	
C4:	Arginine	and	proline	metabolism	
	
	
	
C5:	Glycerolipid	metabolism	
	
	
	
Gamma-Aminobutyric	Acid
Propylene	Glycol
Glycerol
288	
	
C6:	Citrate	cycle	
	
	
	
C7:	Alanine,	aspartate	and	glutamate	metabolism	
	
	
	
Succinic	Acid
Oxoglutaric Acid
Citric	Acid
Succinic	Acid
Oxoglutaric Acid
Gamma-Aminobutyric	Acid
289	
	
C8:	Glyoxylate	and	dicarboxylate	metabolism	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Citric	Acid
290	
	
Appendix	 3:	 Parameters	 extracted	 from	 the	 NIS-Elements	 confocal	 analysis	 software	
related	to	cell	orientation.	
	
	These	parameters	were	not	presented	in	Chapter	4	as	related	to	the	orientation	of	the	cell	and	not	to	
the	 cellular	morphology.	 They	 are	 the	 following:	 volume	 centroid,	mean	 and	 sum	 intensity,	 pitch,	
elongation,	orientation,	 intensity	weighted	centroid	(IWC),	major	axis	 length,	minor	axis	 length	and	
minor	2	axis	length,	for	the	membrane	and	cytoskeleton	stain.	Values	are	plotted	between	24	and	52	
hours	following	serum	shock	of	pre-adipocytes.	A	final	table	summarises	the	standard	deviations	(SD)	
and	standard	errors	of	the	mean	(SEM,	as	well	as	a	summary	of	the	p-values	obtained	after	one-way	
ANOVA	or	fit	of	a	cosine	curve	against	a	straight	line	(section	2.4.2.5),	averaged	for	each	time	point	
and	across	the	various	experimental	replicates	of	the	experiments,	after	cytoskeleton	and	membrane	
stain.	All	figures	and	analyses	were	done	using	Graph-Pad	Prism	version	7.0.	
	
	
	
Mean	and	sum	 intensity	of	 the	cytoskeleton	and	membrane	stain	measured	every	4	hours	after	
serum	shock	on	3T3-L1	cells,	between	24	and	52	hours.	The	upper	left	panel	represents	the	mean	
intensity	of	the	cytoskeleton	stain	(A).	The	sum	intensity	for	the	same	stain	is	illustrated	on	the	bottom	
left	(panel	C).	The	mean	and	sum	intensities	of	the	membrane	stain	are	shown	on	the	upper	and	lower	
right	panels	(B	and	D,	respectively).	Values	for	each	biological	replicate	are	represented	by	the	blue	
circles,	 and	 correspond	 to	 an	 average	 of	 all	 cells	 measured	 for	 a	 same	 time	 point	 and	 biological	
replicate.	For	analysis,	a	one-way	ANOVA	was	done	as	well	as	a	 fitting	of	a	cosine	curve	against	a	
straight	line.	The	preferred	model	in	all	cases	was	the	latest,	showing	that	the	variation	of	the	data	
was	not	circadian.	
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Volume	centroid	X,	Y	and	Z	after	the	cytoskeleton	and	membrane	stain	measured	every	4	hours	
after	serum	shock	on	3T3-L1	cells,	between	24	and	52	hours.	The	upper	panels	represent	the	volume	
centroid	X	of	 the	 cytoskeleton	 (A)	and	 the	membrane	 (B).	 The	middle	 figures	 indicate	 the	volume	
centroid	Y	plotted	across	the	circadian	time	after	cytoskeleton	(C)	and	membrane	(D)	stain.	Lastly,	the	
bottom	graphs	illustrate	the	volume	centroid	Z,	when	cells	were	stained	for	the	cytoskeleton	(E)	and	
the	 membrane	 (F).	 Values	 for	 each	 biological	 replicate	 are	 represented	 by	 the	 blue	 circles,	 and	
correspond	 to	an	average	of	all	 cells	measured	 for	a	 same	 time	point	and	biological	 replicate.	 For	
analysis,	a	one-way	ANOVA	was	done	as	well	as	a	fitting	of	a	cosine	curve	against	a	straight	line.	The	
preferred	model	in	all	cases	was	the	latest,	showing	that	the	variation	of	the	data	was	not	circadian.		
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Pitch,	 orientation	 and	 elongation	 measured	 every	 4	 hours	 after	 serum	 shock	 on	 3T3-L1	 cells,	
between	24	and	52	hours.	The	left	panels	illustrate	the	pitch	(A),	orientation	(C)	and	elongation	(E)	
for	 the	 cytoskeleton	 stain.	 The	 same	 parameters	 analysed	 for	 the	 membrane	 stain	 (B,	 D	 and	 F	
respectively)	are	represented	on	the	right	panels.	Values	for	each	biological	replicate	are	represented	
by	 the	blue	circles,	and	correspond	 to	an	average	of	all	 cells	measured	 for	a	 same	time	point	and	
biological	 replicate.	A	one-way	ANOVA	and	 fit	of	a	 cosine	curve	 to	 the	data	against	a	 straight	 line	
revealed	insignificant	p-values	>	0.05,	therefore	no	significant	variations	in	the	data.	
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Intensity	weighted	centroid	for	the	X,	Y	and	Z	axes	measured	every	4	hours	after	serum	shock	on	
3T3-L1	cells,	between	24	and	52	hours.	Panel	(A)	represents	the	IWC	of	the	X	axis	for	the	cytoskeleton	
stain,	with	the	corresponding	results	for	the	membrane	stain	indicated	on	panel	(B).	The	middle	panels	
illustrated	the	IWC	of	the	Y	axis	(figure	C	for	the	cytoskeleton	and	D	for	the	membrane).	Finally,	the	
IWC	of	the	Z	axis	can	be	found	panel	E	(cytoskeleton)	and	F	(membrane).	Each	experimental	replicate	
is	represented	by	the	blue	circles.	For	analysis,	a	one-way	ANOVA	was	done,	as	well	as	a	fit	of	a	cosine	
curve	to	the	data	against	the	null	hypothesis	of	a	straight	 line.	All	measurements	gave	a	preferred	
model	of	a	straight	line	and	therefore	the	data	were	not	circadian.			
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Major,	 minor	 and	 minor	 2	 axis	 lengths	 determined	 for	 the	 cytoskeleton	 and	 membrane	 stain	
measured	every	4	hours	after	serum	shock	on	3T3-L1	cells,	between	24	and	52	hours.	The	left	panels	
illustrate	the	results	for	the	cytoskeleton	stain:	(A)	major	axis	length,	(C)	mean	minor	axis	length	and	
(E)	mean	minor	2	axis	length.	The	corresponding	data	for	the	membrane	stain	are	presented	panels	
(B),	(D)	and	(F).	3	biological	replicates	were	plotted	per	time	point,	as	indicated	by	the	blue	circles.	A	
cosine	curve	was	fitted	to	the	data	against	the	null	hypothesis	of	a	straight	line	in	order	to	determine	
if	there	were	any	significant	differences	in	the	data.	As	the	preferred	model	was	a	straight	line	for	all	
cases,	 as	 shown	 in	 the	 graphs,	 the	 data	 were	 not	 presenting	 any	 temporal	 variations.	 This	 was	
confirmed	by	a	one-way	ANOVA.		
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	 The	table	below	summarises	the	mean,	standard	deviation	and	standard	error	of	the	means	
as	well	as	the	p-values	obtained	after	one-way	ANOVA	analysis	and	fit	of	the	cosine	curve	against	the	
null	hypothesis	of	a	straight	line;	this	for	each	parameter.	Mean,	SD	and	SEM	were	averaged	for	all	
time	points	and	experimental	replicates,	and	values	for	each	type	of	staining	are	presented	separately.	
	
	
	
	
	
	
	
	
	
	
	
	
	
PARAMETER MEAN SD SEM P-VALUE	ANOVA P-VALUE	COSINE	FIT MEAN SD SEM P-VALUE	ANOVA P-VALUE	COSINE	FIT
MEAN	INTENSITY 2460.96 325.87 88.9 1 0.81 2829.28 409.15 106.96 0.85 0.53
SUM	INTENSITY 2602622057 1016380440 275606116.8 0.46 NA 3049498343 1556665625 412903402.9 0.47 0.51
VOLUME	CENTROID	X 31.24 5.69 1.55 0.93 0.34 30.42 5.3 1.37 0.41 0.42
VOLUME	CENTROID	Y 28.29 5.15 1.4 0.87 0.82 28.59 4.71 1.22 0.08 0.34
VOLUME	CENTROID	Z 7.7 2.43 0.66 0.69 0.12 7.14 1.56 0.4 0.99 0.62
PITCH 2.21 2.93 0.75 0.7 NA 2.32 2.75 0.68 0.71 0.35
ORIENTATION	 87.8 48.91 13.19 0.26 NA 92.21 47.84 12.33 0.19 0.27
ELONGATION 2.14 0.48 0.13 0.77 0.25 2.02 0.38 0.1 0.75 0.44
INTENSITY	WEIGHTED	CENTROID	X 31.27 5.72 1.56 0.93 0.35 30.45 5.33 1.38 0.42 0.44
INTENSITY	WEIGHTED	CENTROID	Y 28.25 5.19 1.41 0.84 0.79 28.68 4.78 1.23 0.07 0.37
INTENSITY	WEIGHTED	CENTROID	Z 7.86 2.52 0.68 0.73 0.15 7.22 1.59 0.41 0.99 0.62
MAJOR	AXIS	LENGTH	 32.19 6.35 1.72 0.95 0.6 29.07 5.5 1.41 0.51 0.21
MINOR	AXIS	LENGTH	 22.21 4.35 1.19 0.96 0.46 20.68 3.42 0.88 0.33 0.06
MINOR	2	AXIS	LENGTH 8.51 2.81 0.75 0.66 0.11 8.66 1.92 0.49 0.9 NA
CYTOSKELETON	STAIN MEMBRANE	STAIN
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PRESENTATIONS	AND	PERSONAL	DEVELOPMENT	
	
COURSES	
	
1/	Sort	course	at	UCL	on	mammalian	cell	biology,	particularly	to	learn	advanced	laboratory	techniques	
in	cell	culture	organised	by	Professor	Ivan	Gout	(2016).		
2/	Liquid	nitrogen	training,	university	of	Surrey	(2016).	
	
CONFERENCES	
	
1/	Poster	presentation	at	the	festival	of	research	within	the	University	of	Surrey:	‘Circadian	rhythms	
within	3T3-L1	pre-adipocyte	cells’	(2017).		
2/	UK	clock	club	attendance:	Surrey	(2016),	Leicester	(2017)	and	London	(2014).		
	
PRESENTATIONS	
	
1/	School	seminar	(2017).	
2/	Regular	data	and	journal	club	presentations.	
	
DEMONSTRATION	WORK	
	
1/	Cell	biology	(BMS	1025)	–	2014,	2015	and	2018.		
2/	Biochemistry,	the	molecules	of	life	(BMS	1049	and	1050)	–	2017.		
	
	
	
	
	
